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Abstract 
 
Background: Early health interventions affecting child development can subsequently 
influence lifetime health and economic outcomes. These lifetime effects may be excluded from 
economic evaluation as empirical evidence covering the required time horizon is rarely available. 
One example is screening for postnatal depression where current guidelines do not account for 
lifetime effects despite evidence of a detrimental association between maternal depression and 
child development.  
Aims: To develop a methodological approach to estimate lifetime effects for economic 
evaluation and determine their influence on an evaluation assessing the cost-effectiveness of 
postnatal depression screening.  
Methods: Lifetime effects are estimated by linking results from two empirical studies. Firstly, 
growth curve models establish the effects of postnatal depression on development measures for 
children aged 3-11 using data from the Millennium Cohort Study. Secondly, child development 
measures are entered as explanatory variables in linear regression models predicting effects on 
lifetime health and economic outcomes using data from the 1970 British Cohort Study. An 
economic evaluation is conducted for scenarios which exclude/include lifetime effects to 
determine their influence on cost-effectiveness results.  
Findings: Postnatal depression was detrimentally associated with children’s cognitive and 
socioemotional development up to age 11. Detrimental changes in cognitive and 
socioemotional development were negatively associated with lifetime outcomes. Postnatal 
depression exposure was predicted to reduce children’s lifetime Quality Adjusted Life Years, 
increase healthcare and crime costs, and generate fewer monetary returns in education and 
employment. Cost-effectiveness results changed when including lifetime effects, leading to the 
recommendation of a screening strategy which treats a greater proportion of depressed 
mothers.  
Conclusions: Lifetime effects can influence cost-effectiveness results and their exclusion risks 
providing a partial analysis. This research demonstrates methods to estimate and include 
lifetime effects in economic evaluation. Similar approaches could be applied elsewhere to 
provide additional evidence for economic evaluation of other childhood interventions.  
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Chapter 1: Introduction  
1.1 Summary 
Healthcare allocation decisions are commonly informed though economic evaluation, a type of 
analysis that ranks competing interventions according to their associated costs and benefits. 
This thesis addresses a challenge faced specifically in the economic evaluation of child health 
interventions: some interventions delivered early in life can affect child development and may 
have subsequent costs and benefits on health and social outcomes across the lifespan. Such 
lifetime effects are expected to occur throughout adulthood, spanning several decades after the 
administration of a childhood intervention. Consequently, lifetime effects are difficult to 
measure empirically and are often excluded from analyses. The purpose of this thesis is to 
investigate methods to include lifetime effects in economic evaluation, and further, to 
demonstrate their importance in decision making.  
The overarching aims of this research are: 
To develop and describe a methodology for estimating lifetime effects.  
To determine the influence of lifetime effects on the cost-effectiveness results in an 
applied, UK based, economic evaluation. 
This introductory chapter further details the rationale for the thesis.  
1.2 Context: Health Decision Making and Economic Evaluation 
Literature  
1.2.1 Health Interventions and Healthcare Allocation Decisions  
Health interventions often require consumption of expensive resources which may include use 
of medical devices, medicines, vaccines, one-on-one time with highly trained specialists and 
accommodation in hospital facilities. In publicly funded health systems, such as the UK 
National Health Service (NHS), it is not possible to adopt every intervention achieving a health 
benefit as the cost of doing so would far exceed the total amount of money society would be 
prepared to pay (Eichler et al., 2004). Therefore, adoption decisions are required that determine 
an appropriate distribution of the finite budget for healthcare (Angelis et al., 2017), (Drummond 
et al., 2015). Each intervention adopted by a health system has an associated opportunity cost as 
healthcare resources are consumed which could have been spent to achieve health benefits 
18 
 
elsewhere (Palmer and Raftery, 1999). As such, the allocation of healthcare resources leads to 
changes in levels of morbidity and mortality for members of society.  
1.2.2 Economic Evaluation to inform Health Decision Making 
UK health decision making is commonly advised or informed by economic evaluation; an 
analytical framework that can provide answers to difficult questions of resource allocation. 
Fundamentally, economic evaluation is a comparative analysis that establishes the best course of 
action based on the costs and consequences associated with different health interventions 
(Drummond et al., 2015). To inform healthcare allocation decisions adequately, economic 
evaluations use socially desirable decision rules to rank competing health interventions according 
to their costs and consequences (Drummond et al., 2015).  
 A key feature of economic evaluation is the use of evidence to support decision making 
(Sculpher et al., 2006). Evidence is required that identifies the costs and consequences 
associated with competing health interventions and this is measured on decision endpoints – the 
outcomes of interest for decision makers. The most reliable sources of evidence are usually 
obtained empirically through primary analysis of data obtained from clinical trials or 
observational study designs (Cooper et al., 2007). In the absence of empirical data, useful 
information might be obtained from other less reliable sources which may include expert 
opinion (Soares et al., 2018). 
The exact type of evidence required varies for each analysis depending on the specifics of the 
decision problem and the adopted analytical framework. Trial based evaluations are single clinical 
studies that split patients into different treatment groups with each receiving a competing health 
intervention or a relevant comparator e.g. treatment as usual. Evidence is obtained in a trial-
based framework by observing the decision endpoints achieved for each group (Hawkins et al., 
2012). Alternatively, economic evaluations can be conducted using decision analytic models (DAMs) 
which represent the decision problem and disease progression as different health/disease and 
exposure states. Evidence is required to inform many factors (or parameters) in a DAM, 
including estimates of the decision endpoints associated with different health/disease/exposure 
states within the model (Cooper et al., 2007).  
1.2.3 Lifetime Horizon in the Economic Evaluation of Child Health Interventions  
Regardless of the framework selected for economic evaluation, evidence should be obtained 
over a time horizon which can account appropriately for all the important costs and benefits of 
the health interventions under investigation (Sculpher et al., 2006). In many cases, a lifetime 
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horizon is most appropriate as the influence of health interventions can often continue across the 
lifespan and influence outcomes such as mortality (Drummond et al., 2015). 
A lifetime horizon is likely to be required when establishing the costs and consequences 
associated with a subset of health interventions delivered during childhood as these 
interventions have the potential to influence a child’s later lifespan development.1 The process 
of lifespan development is the extraordinary change that occurs within all individuals as they 
progress from cellular organisms to increasingly complex infants, children, teenagers and finally 
mature adults, determining how individuals look, think, behave and interact with the world 
around them (Santrock, 2003). Health interventions affecting the development process could 
impact substantially on the individual throughout adulthood and might influence factors 
relevant for health and social decision makers e.g. lifestyle choices, family circumstances, 
education, employment, health behaviours, criminal activity (Halfon et al., 2014) (Heckman, 
2006), (Ben-Shlomo and Kuh, 2002).  
1.2.4 Direct Sources of Evidence for Economic Evaluation   
The adoption of a lifetime horizon poses an analytical problem when conducting economic 
evaluation of early childhood health interventions as long-term evidence is required across a 
time horizon spanning several decades. The usual approach to obtaining empirical evidence is 
by directly estimating the relationship by observing the outcomes achieved in different 
treatment/disease/exposure groups, as is illustrated in Figure 1.1, (Hawkins et al., 2012).  
 
 
Figure 1.1: Depicts the method of direct estimation. Note that group allocation might include treatment, exposure, 
or disease groups versus a relevant control.  
 
Randomised controlled trials (RCTs) are often considered the best, or “gold standard”, method 
when identifying direct evidence as they eliminate several potential biases through the random 
allocation of participants to relevant groups (Akobeng, 2005). For pragmatic reasons, RCTs are 
                                                     
1 Theoretical and empirical evidence is reviewed in chapter two which explains the link between childhood health 
interventions and lifespan development.  
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unlikely to be appropriate when directly estimating lifetime evidence for the economic 
evaluation of childhood health interventions. RCTs are associated with high costs (Bothwell et 
al., 2016) and are therefore unlikely to be commissioned if studies require a very lengthy time 
horizon. Even if commissioned, RCT evidence would not become available until far into the 
future when children had sufficiently progressed across their lifespan. Additionally, RCTs might 
be considered unethical if the required evidence relates to the effects of 
disease/health/exposure states rather than comparisons between different treatment groups i.e. 
children ought not to be knowingly assigned harmful stimuli (Relton et al., 2010).  
If RCTs are inappropriate, direct evidence might be obtained from observational studies which 
can be more ethically viable because harmful stimuli are experienced through natural 
phenomena rather than being purposely assigned in trials (Webb et al., 2016). Longitudinal birth 
cohorts are likely to provide the most relevant observational study design when identifying the 
lifetime effects associated with child health interventions – this type of study design obtains 
information on a group of new-borns and follows them as they progress towards adulthood by 
collecting information in repeated data sweeps.  
Several birth cohort studies have been commissioned in the UK and continue to follow up 
participants into later adulthood. These include the 1946 National Survey of Health and 
Development (Wadsworth et al., 2005), the 1958 National Child Development Study (Power 
and Elliott, 2006) and the 1970 British Cohort Study (Elliott and Shepherd, 2006). Whilst it is 
possible that long term evidence could be obtained from longitudinal birth cohorts, researchers 
are reliant on a relatively small number of historical studies which may not have collected the 
variables required for the specific objectives of research.  
1.2.5 Indirect Sources of Evidence for Economic Evaluation   
Alternatively, relevant evidence could be obtained through indirect estimation, where group effects 
are observed on some intermediate outcome measure(s) that are then translated to the final 
endpoints of interest. The key assumption made when conducting indirect estimation is that the 
intermediate outcomes necessarily occur along the pathway of effect between 
treatment/disease/exposure and the final endpoint of interest, (Figure 1.2.).  A common type of 
indirect estimation is the use of surrogate outcomes as substitutes for final outcomes in clinical 
trials (Fleming and Powers, 2012). For instance, the effects of cardiovascular drugs on reducing 
final endpoints such as stroke or myocardial infarction are sometimes measured in terms of 
their effects in reducing the surrogate endpoint blood pressure (Aronson, 2005).  
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Figure 1.2: Depicts the method of indirect estimation.  
 
Indirect estimation requires empirical evidence to be linked from at least two studies. As with 
direct estimation the most appropriate sources of evidence to identify observed group effects 
on intermediate endpoints are likely to be obtained from RCTs and/or observational study 
designs. A variety of different techniques might be appropriate when establishing how 
intermediate effects translate to effects on final decision endpoints. For example, direct 
evidence between group allocation and final decision endpoint might be used to quantify this 
relationship as is required when validating surrogate endpoints (Fleming and Powers, 2012); the 
pathway might be represented using a mathematical model whose parameters are informed 
through empirical data (Buxton et al., 1997); or it could be assumed that the relationship is 
appropriately represented by a mathematical function or distribution (Garnett et al., 2011).2 
The benefit of indirect estimation is to increase the feasibility of obtaining evidence as it reduces 
the time horizon required for the empirical studies. A reduced time horizon could also mean 
more appropriate measures are available as these studies are less likely to rely on historical data 
collections. The use of indirect evidence in economic evaluation is demonstrated by the 
Washington State Institute for Public Policy (WSIPP) (2017) who make recommendations 
regarding the cost-benefit of several early childhood social policies, and by Hummel et al. (2011) 
when assessing the cost-effectiveness of early years public health programmes. In both 
examples, indirect evidence facilitated the conduct of economic evaluation where no direct 
empirical evidence was available.  
Whilst the evaluations by WSIPP (2017) and Hummel et al. (2011) demonstrate the potential to 
inform economic evaluation through indirectly estimated evidence, the primary purpose of 
these studies was to inform policy and neither study provides a detailed justification regarding 
the appropriateness of the methods adopted. In addition, the studies are not reported in enough 
detail to enable other analysts to replicate their methodologies.  
                                                     
2 Chapter four provides a detailed discussion regarding the different techniques that might be applied when 
translating observed intermediate effects to final lifetime decision endpoints.  
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1.2.6 Gap in the Existing Evidence  
There is a sparsity of published literature transparently discussing appropriate methods for 
estimating the lifetime effects of childhood health interventions for economic evaluation. 
Limitations in data availability can leave decision makers uninformed (Soares et al., 2013), and 
may impact on policy recommendations if the size of lifetime effects is substantial enough to 
affect the results of economic evaluation. Indirect estimation might provide the most feasible 
route to obtaining lifetime evidence and future research developing these methods could 
facilitate decisions in the allocation of child health interventions.   
1.3 Research Aims  
This thesis addresses methods in the economic evaluation of childhood health interventions 
where analyses may be limited due to the unavailability of evidence across the lifetime.   
The aims of this research are to:    
1. Develop and describe a methodology which indirectly estimates the lifetime effects of 
early childhood circumstances by linking results across two empirical analyses.  
2. Determine whether lifetime estimates influence the cost-effectiveness results in an 
applied, UK based, economic evaluation. 
3. Discuss the appropriateness of indirect estimation when estimating lifetime decision 
endpoints for economic evaluation.  
 
This research could be used to inform the design of other studies and may provide additional 
and important evidence in the economic evaluation of child health interventions.  
1.4 Research Methodology and Applied Example   
The research objectives are addressed throughout this thesis by demonstrating methodologies 
within an applied economic evaluation as this provides a realistic test of how indirect estimation 
could work in practice. The applied economic evaluation assesses the cost-effectiveness of UK 
population screening strategies for postnatal depression.   
Screening is a clinical method used to identify a sub group of a population who are at high risk 
of having a disease/disorder. Following a positive screen this sub group will usually proceed to 
further diagnostic tests and/or be offered an appropriate treatment (Gilbert et al., 2001). There 
is evidence to suggest that child development is detrimentally affected following exposure to 
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symptoms of postnatal depression (Kingston and Tough, 2014), (Sanger et al., 2015). However, 
published economic evaluations do not consider children’s lifetime outcomes when assessing 
the cost-effectiveness of screening of mothers which may be due to a lack of direct evidence.  
This research advances a method for indirectly estimating the effects of postnatal depression on 
children’s lifetime decision endpoints and uses these estimates to conduct an economic 
evaluation assessing the cost-effectiveness of screening for postnatal depression. The evaluation 
updates and extends an existing NICE (2018) analysis by accounting for the costs and 
consequences of screening on children’s lifetime decision endpoints. The influence of the 
lifetime outcomes on final policy recommendations is demonstrated by comparing the results of 
the applied economic evaluation with and without children’s lifetime effects. Recommendations 
from the applied research could be used to update existing clinical guidelines regarding the 
appropriate screening strategy for postnatal depression in the UK.  
1.5 Thesis Structure 
Chapter two begins with a literature review summarising some of the background theory in the 
fields of lifespan development and health economics. The review explains why early 
intervention can affect development and speculates on the nature of these effects across the 
lifespan. A further objective of the chapter is to establish an appropriate philosophical 
framework for UK economic evaluation of childhood health interventions given their potential 
to affect lifespan development. Accordingly, the different philosophical approaches that can be 
taken when conducting economic evaluation are discussed.  As the philosophical approach 
determines the type of evaluation, chapter two informs the design of the applied analyses 
subsequently used in the research by specifying the decision endpoints to be adopted – these 
being Quality Adjusted Life Years (QALYs), healthcare costs, monetised costs/returns incurred 
in sectors outside of health, and economic productivity.   
The thesis continues with three empirical chapters estimating indirect lifetime evidence. Chapter 
three introduces the postnatal depression applied example and specifies the additional lifetime 
evidence on child development required when assessing the cost-effectiveness of screening. The 
purpose of the chapter is to demonstrate the first stage in the methodological approach when 
obtaining indirect lifetime evidence. A primary empirical analysis is conducted identifying the 
association between childhood exposure to symptoms of postnatal depression and cognitive 
and socioemotional development outcomes. The analysis uses time series data from the 
Millennium Cohort Study allowing intermediate effects to be identified at multiple time points 
for children aged between three and eleven years.  
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Chapter four focuses on identifying an appropriate method for extrapolating the observed 
intermediate effects to effects on lifetime decision endpoints. It is suggested that this second 
stage of indirect estimation could be achieved through mathematical modelling. A scoping 
review is conducted with the objective of identifying a mathematical model suitable for 
predicting lifetime decision endpoints for the applied example. Several models are identified 
which estimate lifetime effects from measures of child development, but none use outcomes 
that are fully relevant decision endpoints (i.e. Quality Adjusted Life Years /healthcare costs). To 
inform the further primary analyses in this thesis, a synthesis is performed across the identified 
studies establishing some common characteristics that should be adopted when using models to 
estimate the lifetime effects of child development.  
In the absence of relevant evidence in the secondary literature, chapter five reports the results 
of a primary analysis which applies a mathematical model in data from the 1970 British Cohort 
Study. This analysis uses several parallel linear regression models to predict lifetime decision 
endpoints from measures of cognitive and socioemotional development when children were 
aged ten. The chapter combines results from the mathematical model with observed evidence 
from chapter three to estimate the incremental Quality Adjusted Life Years, healthcare costs 
and monetised returns to the crime and education sectors for children exposed to symptoms of 
postnatal depression, when compared with children who were not exposed. The specific role of 
the empirical chapters in the indirect estimation process is illustrated in Figure 1.3.  
 
 
Figure 1.3: Depiction of the methodological approach for indirect estimation used in the applied example to 
estimate the lifetime effects associated with children exposed to symptoms of postnatal depression.  
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Chapter six describes the applied economic evaluation assessing the cost-effectiveness of 
screening for postnatal depression in the UK. This analysis is conducted with and without the 
previously estimated lifetime effects. The policy recommendations from the applied economic 
evaluation are discussed in full here. Additionally, a value of information analysis is conducted 
to establish future research priorities and to determine whether the acquisition of future lifetime 
evidence is likely to be cost-effective.  
Finally, chapter seven discusses the methodological approach used in this research to indirectly 
estimate lifetime effects. The validity of and methodological extensions to indirect estimation 
are considered, along with alternative approaches that might be applied when estimating lifetime 
effects. The value of including lifetime effects and the cost-effectiveness of obtaining this 
information in the applied example is also discussed. Several recommendations are made that 
could aid other researchers when estimating lifetime effects in the economic evaluation of 
childhood health interventions elsewhere.  
1.6 Boundaries of Research 
This thesis does not consider several other research challenges potentially faced by analysts 
conducting economic evaluation of early childhood health interventions. Ungar (2009) provides 
a comprehensive summary of methodological challenges in child health economic evaluation 
including: the difficulty in measuring children’s health outcomes, the extension of an 
intervention’s effects beyond children and into family members, the patterns of health and 
disease in childhood, and the equity of childhood intervention.  
The boundaries of the thesis are also restricted by considering only the appropriate 
methodologies for the economic evaluation of childhood health interventions. It is recognised 
that other social policies are likely to have effects on child development. The methodological 
approaches for health economic evaluation are not necessarily transferable when conducting an 
economic evaluation of a policy that is commissioned for by, say, the education or crime 
sectors.  
Finally, the applied example in this research adapts a published economic evaluation (NICE, 
2018) assessing the cost-effectiveness of screening for postnatal depression by including 
estimates regarding the lifetime effects associated with postnatal depression. There are several 
other research limitations associated with the published analysis. Whilst some of these 
limitations were accounted for it was not possible to address them all as the research was 
focused on achieving the primary aim of this thesis, which was to discuss the appropriate 
methodologies for estimating lifetime effects.  
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1.7 Key Terms  
Health intervention and health technology are used interchangeably in this thesis. Both terms follow 
the definition provided by the World Health Organisation (WHO, 2018) which describes a 
health technology as “an application of organised knowledge and skills [that is] developed to 
solve a health problem or improve quality of lives”. 
The term “childhood circumstance” is used as an overarching concept that refers to childhood 
health technologies, childhood disease, childhood exposures, and any other event that may 
occur during childhood that has the potential to affect a child’s later development.  
Throughout the thesis the term “lifetime effects” is used to refer to the adulthood health and 
economic consequences of childhood circumstances which specifically occur through their 
effects to the lifespan development process.  
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Chapter 2: Methods for the Economic Evaluation of 
Childhood Health Technologies 
2.1 Summary  
This chapter presents a literature review summarising some of the background theory in the 
fields of lifespan development and UK health economic evaluation of childhood health 
technologies. The review explains why early intervention health technologies can affect child 
development and speculates on the nature of these effects across the lifespan. A further focus 
of the chapter is to establish an appropriate philosophical framework for UK economic 
evaluation of childhood health technologies given their potential to affect lifespan development; 
accordingly, the different philosophical approaches that can be taken when conducting 
economic evaluation are discussed.  As the philosophical approach determines the type of 
evaluation, the chapter informs the design of the applied analyses following later in this thesis. 
2.2 Objectives  
In support of the overarching aims of the research in this thesis the objective of this chapter is:  
To conduct a literature review to inform the design of (i) an approach for the indirect 
estimation of lifetime effects; and (ii) a philosophical framework for economic 
evaluation given the potential lifetime effects associated with child health technologies.  
The findings from the review are used to inform the two primary analyses in chapters three and 
five which indirectly estimate the lifetime effects for children exposed to symptoms of postnatal 
depression, and an economic evaluation assessing the cost-effectiveness of screening for 
postnatal depression in chapter six.  
This chapter begins by reviewing some of the contemporary lifespan development literature 
describing what development is, the mechanisms that drive change, and the importance of early 
life. The review demonstrates that child health technologies have the potential to influence 
lifespan development if they target children’s early environmental conditions. Theoretical and 
empirical evidence further suggests that, if they do influence the lifespan development process, 
early childhood health technologies may go on to affect a variety of other adulthood outcomes 
relevant to social policy makers. A method for indirect estimation is suggested that could 
account for the pathway between child health technologies and adulthood outcomes by 
establishing the effects of a health technology on intermediate outcomes measuring lifespan 
development. 
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The next section of the review describes the contrasting philosophical frameworks that can be 
adopted when conducting economic evaluation. The discussion considers which philosophical 
framework might be appropriate given the potential lifetime effects of child health technologies. 
The chapter also considers the appropriate analytical methods consistent with the suggested 
philosophical framework and the requirements of decision makers in the UK. Specifically, the 
chapter answers the following questions regarding methods used for economic evaluation of 
child health technologies:  
1. What type of economic evaluation should be conducted?  
2. What decision rules should be implemented?  
3. Which decision endpoints should be used to measure costs and benefits?  
2.3 Lifespan Development  
2.3.1 Overview of Lifespan Development  
The human lifespan follows a universal sequence beginning at conception, moving on to birth, 
maturation and reproduction before finally ending at death (Bogin and Smith, 1996). As 
individuals progress through this sequence they undergo unmistakable changes in physique, 
function, ability, emotion, behaviour, personality and in their general interaction with their 
surrounding environment (Santrock, 2003). The term lifespan development is the all-
encompassing concept that describe all the intra-individual (i.e. within person) changes that 
occur over time (Molenaar et al., 2003), (Smith et al., 2015). 
The extent of development is extraordinary when considering changes in structure and function 
that occur as individuals mature from simple cellular organisms to complex adult humans. 
Because of the vast subject area, development is sometimes studied independently as three 
comprehensible sub-domains (Berk, 2013): the physical domain accounts for the structural and 
organisational development of the individual, for example height, weight and neural circuitry; 
the cognitive domain refers to mental capacities such as information processing, language, 
memory and perception; while the socioemotional domain is concerned with emotion, 
personality and social interaction with other individuals (Keenan and Evans, 2009), (Berk, 
2013).      
Whilst studied independently, each development domain influences and is influenced by each 
sub-domain meaning the overarching process is interdependent (Gauvain and Parke, 2008). 
Infantile growth, for example, might lead to walking abilities (physical domain) which enable 
social interaction with others (socioemotional domain) that enhance later language faculties 
(cognitive domain) (Đorđić et al., 2016). Similarly, the growth and refinement of neural 
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networks result in the emergence of cognitive abilities such as logic and reasoning which may 
eventually influence behaviour (Battista et al., 2018).  
The emergence of skills and capabilities from morphological changes describe a type of 
development known as transformational change (Overton, 2010b). A defining example of 
transformation change in nature occurs in the caterpillar-butterfly where the organism develops 
the capacity to fly through organisational changes in its structure i.e. wings (Overton, 2010b). 
Likewise, it is argued that human development may occur as a series of transformations or 
discontinuous changes (Boyd et al., 2014), (Newman and Newman, 2017), (Santrock, 2003). 
Advocates of discontinuous change point to the qualitative differences observed across 
prenatal, infant, child, adolescent and adulthood stages in the human lifespan (Lightfoot, 2013).  
There is also strong evidence that development occurs continuously through small variational 
changes (Overton, 2010a). Continuous development might make sense to parents who see 
children accumulate skills through adaptive changes built upon over time. This is illustrated by 
the development of coordination and motor skills as a child slowly learns to crawl, stand, walk, 
run and jump (Santrock, 2003). While some reviewers emphasise the debate between 
continuous/discontinuous development (e.g. Boyd et al. (2014), Lightfoot (2013) & Santrock 
(2003)), it is the view of Overton (2010b) that development ought to and can only be fully 
considered in terms of both transformational (discontinuous) and variational (continuous) 
change.  
2.3.2 The Mechanisms driving Human Development  
The mechanisms producing development are a topic of much debate. Philosophers, including 
Plato and Descartes, have argued that a natural internal mechanism is responsible for producing 
change (Boyd et al., 2014). In support of the nature hypothesis, Mendel’s research on 
inheritance discovered that internal biological molecules called genes explain characteristics 
shared between parents and offspring (Gottlieb, 1998). Genes have now been clarified as 
specific sequences of DNA that are contained in the cell nucleus and recent research has 
established the complete sequence of DNA that makes up the human genome (IHGSC, 2001).   
Crick’s (1958) theory, the central dogma, attributed the biological role of genes as the sole 
mechanism responsible for protein synthesis, a process that occurs through the joint procedures 
of transcription of DNA to RNA and translation of RNA to protein (Buxbaum, 2007). 
According to the central dogma, genes exist in a “vacuum” cut off from all intracellular and 
extracellular influences (Crick, 1958), (Gottlieb, 1998). The central dogma was an influential 
theory in molecular biology (Thieffry and Sarkar, 1998) where it became a popular assumption 
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that protein synthesis occurs in a unidirectional flow of information from gene to protein 
(Crick, 1958), (Gottlieb, 1998).  
Given their essential biological properties (Buxbaum, 2007), and in accord with the central 
dogma, predetermined epigenesis supposed that proteins provide the basis for structural maturation – a 
term referring to the physiological and anatomical growth and development of cells (Gottlieb, 
1998). The scope of predetermined epigenesis can be further expanded if it is assumed that 
structural maturation determines the function and capabilities of an individual, for example cell 
structures in neural networks are thought to govern cognitive function and behaviours (Battista 
et al., 2018), (Gottlieb, 1998). 
The nature argument for development is based on predetermined epigenesis and can be 
summarised as the gene providing a blue print responsible for protein structure, cellular activity 
and organism function in the path illustrated in Figure 2.1 (Gottlieb, 1998). As species with 
similar gene pools display common developmental sequences, the essential role of genes in 
development is supported by Darwin’s theory of evolution (Santrock, 2003). Meanwhile, explicit 
genes have been confirmed as responsible for specific developmental processes, for instance the 
homeobox gene accounts for the anatomical growth of complete segments in fruit flies 
(Schwartz, 1999).  
 
 
Figure 2.1: The biological role of genes (DNA) as the blue print that determines the functional capacities of 
organisms according to predetermined epigenesis. Image is adapted from Gottlieb (1998) pp.793 
 
At the opposing pole the nurture argument suggests that the causal mechanism for development 
occurs through an individual’s exposure to their social and cultural environment (Boyd et al., 
2014). Psychologists such as Watson, Pavlov, and Skinner demonstrated that behaviour 
repetition and personality development could be predicted by exposure to environmental 
rewards and punishments (Santrock, 2003). Meanwhile some cognitive capabilities are clearly 
products of the surrounding environment; for instance, children’s language is determined by 
imitating the words and sentences spoken to them, not because of an inbuilt mother tongue 
(Anisfeld, 2014).  
The crucial place for nurture in development was confirmed by Tanner (1990) who identified 
differences in the height and cognitive performance of identical twins (sharing the same 
genome) who were raised in diverse environments. Tanner’s (1990) evidence directly disputes 
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the role of the gene in human development as is understood from the perspective of 
predetermined epigenesis as it suggests the existence of feedback loops between gene, individual 
and environment (Gottlieb, 1998).  
Probabilistic epigenesis is a contemporary theory of genetic expression suggesting the flow of 
information from gene to protein occurs as a set of bidirectional relations (Gottlieb, 1998). The 
central dogma might provide an incomplete theory for genetic expression as it does not account 
for evidence confirming the interaction between factors in the cell nucleus and cytoplasm: genes 
can be switched on or off by proteins (Tammen et al., 2013) and RNA (Dykxhoorn et al., 2003); 
RNA activity is affected by protein phosphorylation (Gottlieb, 1998); and a protein’s 
conformational structure can be affected by other proteins (Koonin, 2012). In addition, Cirelli 
et al. (1996) identified the influence of extracellular neurotransmitters on intracellular genetic 
expression in rat brains, which could imply that probabilistic epigenesis extends beyond the cell.  
According to Gottlieb (1998) genetic expression might be best understood by viewing the 
individual as a hierarchical system where bidirectional information passes between each level of 
increasing complexity from gene to chromosome, nucleus, cytoplasm, tissue, organism and 
finally environment. The hierarchical system might be further elaborated by considering 
Bronfenbrenner’s (1977) ecological systems theory which ranks the environment according to 
its proximity to the individual from family (most proximal) to cultural (most distal).  
The effects of both nature and nurture in human development could be accounted for by 
probabilistic epigenesis occurring within a hierarchical system. Bidirectional relations between 
each level of the system might explain how environmental stimuli influence biological processes 
to produce developmental change, as is illustrated in Figure 2.2. Rather than being a cut-off and 
predetermined blueprint, genes might be better viewed as followers (Pigliucci et al., 2010) and 
producers (Schwander and Leimar, 2011) in a larger and all-encompassing developmental 
process.  
Probabilistic epigenesis informs contemporary psychological theory which defines lifespan 
development as the bidirectional individual ←→ context relation (Lerner, 2006), (Lerner and 
Overton, 2010), (Fingerman et al., 2011), (Molenaar et al., 2003). It is now widely accepted that 
the mechanism driving human development is necessarily the interaction between nature and 
nurture. The individual ←→ context relation places importance on all hierarchical levels from 
gene to the wider environment assuming each level is a mutually influential mechanisms driving 
change (Lerner and Overton, 2010).  
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Figure 2.2: The biological role of genes (DNA) in development according to probabilistic epigenesis. Bidirectional 
relations exist between different hierarchical levels of the organism and its environment. Figure is adapted from 
Gottlieb (1998) pp. 797-798.  
 
2.3.3 The Importance of Early Life  
The most crucial and profound developmental changes occur during early life. Developmental 
plasticity refers to the extent that the development system is open to change at a specific point 
in time (Santrock, 2003). Sensitive periods are phases where development occurs most rapidly, and 
the influence of biological and environmental stimuli is unusually strong. It is thought that the 
earliest life stages are particularly plastic and most sensitive (Knudsen, 2004). For instance, the 
extent of change that occurs in the nine-months of prenatal development (i.e. transformative 
changes from cellular to living organism) is not comparable with nine months change that 
occurs in adolescence, (i.e. small changes in height, cognition etc.).  
Developmental plasticity may be explained through the properties of neural circuits and 
transmission between neurons within these circuits (Knudsen, 2004). Connections between 
neurons in a circuit are themselves plastic meaning that the same stimuli can produce different 
responses at different times. The plasticity of neural circuits varies; for instance, neurons in the 
spinal cord always produce the same response where transmission occurs as reflexes which are 
predetermined by genetic expression; in contrast transmission between neurons in a brain 
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region called the amygdala is inconsistent and continuously adapts to environmental stimuli 
(Knudsen, 2004).  
Knudsen (2004) describes three processes of neural plasticity that may explain the existence of 
sensitive periods. Elaboration is a process where connectivity between neurons is enhanced 
following repeated stimulation from sensory information – this reinforces existing connections 
and stimulates growth of new connections. In contrast, elimination is the removal of noise where 
neurons are pruned from the circuitry if they do not contribute to the response. Thirdly, 
Knudsen (2004) hypothesises synapse consolidation as a process where neurons with strong 
functional properties are bound together by cell adhesion molecules making them invulnerable 
to elimination.   
The implication of developmental plasticity is that some abilities can only be learnt at specific 
periods in life; for example, young children are often able to learn a second language spoken 
without an accent, but this becomes increasingly difficult after the age of seven (Boyd et al., 
2014). Equally, irreversible negative effects may occur if development is adversely affected 
during periods of high plasticity: prenatal development accounts for the organisation and 
formation of organs, limbs and the brain (Polin et al., 2016) and exposure to teratogens during 
this period have severe downstream effects including malformation, mental retardation and 
growth deficiencies (Gilbert-Barness, 2010).  
As well as being a period associated with high levels of developmental plasticity, early life is 
important as it can have cascading effects continuing throughout later development. Early life is 
a time where fundamental skills are learnt which act as building blocks for the acquisition of 
future skills (Cunha and Heckman, 2007), (Santrock, 2003). Individuals with less proficient 
fundamental skills may find it difficult to develop abilities based on or requiring initial capacity. 
One example is to consider children with delayed early language acquisition who are likely to be 
at a disadvantage as they may be less able to develop other important skills such as 
communication, forming social relationships and learning through reading.  
2.3.4 Lifespan Development as a target for Early Childhood Health Technologies 
As discussed above, biological and environmental circumstances shape lifespan development 
and are likely to have the most profound impact if they occur early in life. Therefore, by 
targeting early life circumstances childhood health technologies could promote healthy 
development. Whilst certain biological circumstances are known to have severe adverse 
developmental effects, they are likely to prove difficult targets for health technologies. For 
example, genetic mutations are known to cause developmental disorders such as downs 
syndrome and autism (Weijerman and De Winter, 2010), (McRae et al., 2017) which could 
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theoretically be treated by targeting the malfunctioning genes. However, treatment would 
require a complex technology to deliver the new genetic material which might not be possible 
without impairing other important cellular mechanisms (Naldini, 2015).  
Early environmental circumstances might provide a more feasible intervention target. There is 
abundant evidence linking harmful early environmental exposures to unfavourable 
developmental outcomes (Evans, 2006), (Ferguson et al., 2013) (Flora et al., 2012), (Walker et 
al., 2007). Several health technologies/social policies may have fostered lifespan development 
by reducing the exposure of children to damaging environmental conditions including: the 
banning of lead in manufacturing, a potent neurotoxin that can affect neurodevelopment, 
(Meyer et al., 2008); immunisation programmes that prevent the spread of infectious diseases 
such as bacterial meningitis associated with intelligence deficits and stunting (Segal and Pollard, 
2004); and public education programmes that aim to reduce maternal consumption of nicotine 
and alcohol during pregnancy thus reducing the risk of developmental deformities and learning 
difficulties (Serdula et al., 1991), (Windsor et al., 2000).  
It may also be possible for health and social policies to enhance child development by 
promoting positive environmental exposures. The introduction of universal schooling in low 
income countries has the potential to boost the development of a generation and provide long 
term national socioeconomic benefits (Glewwe, 2002). Meanwhile, cognitive and physical 
developmental benefits have been identified for Romanian orphans who were exposed to 
nurturing environmental circumstances after being placed in UK foster homes (Rutter, 1998).  
2.3.5 The Lifetime Consequences of Development  
Upon maturation, development provides an organism with the appropriate adaptive functions 
and behaviours that allow it to prosper within its environment (Lerner and Overton, 2010). As 
development is driven by the environment, the functional capacity and skills of modern humans 
are tailored towards the social and cultural world that they have been exposed to (Rogoff, 2003). 
The influential role of culture in driving change means that lifespan development influences a 
variety of outcomes relevant to health and social policy makers.  
There is strong evidence establishing pathways between lifespan development and adulthood 
health. Theories linking health and development are based on the premise that health is the 
result of previous life events (e.g. accidents, exposure to infectious diseases, health behaviours 
etc.) and therefore the product of the individual ←→context relation. The idea of health as a 
product is central to Grossman’s (1972) model of health demand where populations may 
produce health through investment; and Stoddart and Evans’ (2017) health determinants 
framework where health occurs as a result of previous behaviour, biology, environment and 
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genetic factors. The role of development in producing health is the specific topic of the life 
course health development framework (Halfon et al., 2000), (Halfon et al., 2014) and the 
developmental origins of health and disease hypothesis (Hanson and Gluckman, 2008).   
There is empirical evidence supporting the theoretical argument linking development to 
adulthood health: Malnutrition during early life influences the development of metabolic 
processes (Halfon et al., 2000) which increase the risk of hypertension, obesity, and diabetes 
later in life (Heindel and Vandenberg, 2015). Ben-Shlomo and Kuh (2002) summarise evidence 
suggesting sub-optimal development early in life increases risk of adulthood diseases such as 
cancer and bronchitis mediated through lifestyle factors. Meanwhile Lereya et al. (2015) find 
evidence that maltreatment and bullying can affect socioemotional development associated with 
poor adulthood mental health outcomes.  
It is likely that the later effects of development are widespread and extend beyond health to 
affect outcomes in all areas of later life. A well-known pathway is the link between cognitive 
development and economic productivity, often mediated through the effects of cognition on 
academic achievement (Hanushek and Woessmann, 2008). Cunha and Heckman’s (2008) 
technology of skill formation expands this pathway by formulising child development as a 
vector of cognitive and non-cognitive abilities that determine adulthood education, employment 
and crime outcomes.  
Empirical evidence has also established the effects of development on a wide range of social 
outcomes for example: reduced cognitive function is correlated with adulthood unemployment, 
incarceration, crime, receipt of welfare and poverty (Cawley et al., 2001), (Herrnstein and 
Murray, 2010), (Frisell et al., 2012); and socioemotional development factors such as personality 
or behaviour are predictors of adulthood wage (Heckman, 2006), academic attainment 
(Hammer et al., 2017) and crime participation (Morizot and Kazemian, 2014), (Sampson and 
Laub, 2005).  
2.3.6 Implications for the Indirect Estimation of Lifetime Effects 
The literature review provides convincing theoretical and empirical evidence supporting the 
conclusion that there are potential lifetime effects associated with childhood health technologies 
which occur through a technology’s influence on biological/environmental circumstances, and 
subsequently, the lifespan development process. This conclusion can be summarised as the 
effect pathway illustrated in Figure 2.3. 
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Figure 2.3: The pathway of effect between a childhood health technology and lifetime decision endpoints.  
 
The identification of an effect pathway provides an important justification for the use of 
indirect estimation as a method to estimate the lifetime effects of child health technologies. The 
logical reasoning that underlies indirect estimation is to suggest that the effects of A (group 
allocation) onto C (decision endpoint) can be established by linking evidence regarding the 
effects of A onto B (intermediate endpoints) and the effects of B onto C. This reasoning requires 
an assumption that B occurs on an effect pathway that exists between A and C. According to 
the effect pathway in Figure 2.3, an appropriate intermediate endpoint that occurs between a 
health technology and a decision endpoint ought to be some measure of lifespan development. 
This method for indirect estimation is taken forward in chapter three which further discusses 
and estimates the effects of children exposed to symptoms of postnatal depression on 
intermediate outcomes that appropriately capture lifespan development.  
2.3.7 Implications for Methods in the Economic Evaluation of Child Health 
Technologies 
A further conclusion drawn from the lifespan development literature is to suggest that child 
health technologies may have fundamental differences compared with other health technologies 
in terms of the nature of their associated costs and benefits. Typically, the important costs and 
benefits associated with health technologies would be expected to be predominantly health 
related, whereas child health technologies affecting lifespan development may be associated 
with lifetime effects across a range of social outcomes including crime, education, employment, 
health and welfare. The size of cross sectoral lifetime effects may be substantial and important 
for decision makers, particularly if a technology is delivered during early life when development 
is highly plastic. The expected nature of lifetime costs and benefits could have implications 
when determining an appropriate philosophical framework and subsequent methodologies that 
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inform the economic evaluation of child health technologies – this forms the topic for 
discussion in the remainder of this chapter.  
2.4 Philosophical Frameworks informing Economic Evaluation  
2.4.1 Introduction  
There are different philosophical frameworks informing the conduct of economic evaluation 
(Brouwer and Koopmanschap, 2000). Philosophical frameworks establish the methodological 
approach taken during analysis, determining the relevant outcomes (decision endpoints) on which 
to measure the costs and benefits of health technologies and designating appropriate methods 
to rank competing technologies (decision rules) (Brouwer and Koopmanschap, 2000). The 
decision to adopt a specific philosophy may be driven by the role assigned to economic 
evaluation in decision making. For example, economic evaluation might be viewed as a 
normative economics exercise meaning that explicit value judgements are made about preferred 
states of the world (i.e. what ought to be); here the role of analysis is to prescribe decisions by 
ranking technologies according to these states. In contrast, economic evaluation applying 
positive economics is concerned with observed states of the world (i.e. what is), where the role 
of analysis is to inform decisions according to the real-life requirements of decision makers 
(Claxton et al., 2007). The following section describes the competing philosophical frameworks 
of welfarism, extra-welfarism and the health/cross-sectoral decision maker’s approach, and 
outlines the common approach adopted in the UK.  
2.4.2 Welfarism  
Economic evaluation can be conducted from the perspective of welfarism, a theory founded in 
principles of traditional welfare and normative economics (Brouwer et al., 2008). As described 
by Culyer (1991) welfarism is based on a fundamental principle which assumes that the social 
good is exclusively determined by the accumulation of individual utility. Within the welfarist 
framework, utility is a term representing the order of an individual’s preferences over specific 
states of the world where higher levels of utility are achieved at higher ranked states (Brouwer et 
al., 2008). While utility is often informed by concepts such as happiness and well-being the 
terms are not synonymous, as utility only relates to individual preference (Brouwer et al., 2008).  
A second principle of welfarism states that individual utility occurs as a function of the goods 
and services (commodities) consumed by the individual (Culyer, 1991). Healthcare might be 
viewed as such a commodity as consumption of healthcare can provide benefits (e.g. reduced 
pain, mobility, return to work etc.) which mean the post-consumption state is preferred to the 
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pre-consumption state. According to microeconomic theory, if viewed as an economic 
commodity in a perfect market, the efficient distribution of healthcare resources could be 
achieved through unregulated market forces, i.e. the invisible hand (Brazier et al., 2017). In this 
instance there would be no place for economic evaluation as efficient allocation of healthcare 
would be achieved through supply and demand.  
However, the structure of publicly funded health systems does not represent a simple buyer-
seller market place – the commodity of healthcare is associated with several interacting market 
failures including asymmetry of information, existence of externalities and lack of certainty 
(Brazier et al., 2017). From the perspective of welfarism the role of economic evaluation is to 
provide corrective evidence-based planned resource allocation that produces more efficient 
allocations of healthcare than would have been achieved in an unregulated and distorted market 
for healthcare (Brazier et al., 2017). To achieve efficient allocation of healthcare, welfarism 
attempts to establish whether the introduction of a health intervention would improve the social 
good (social welfare) or not. This means that the decision requires a valuation of society’s 
preference (utility) towards the intervention (Brouwer et al., 2008).  
A major challenge in welfare economics is the method used to aggregate individual utility to 
obtain an appropriate ordering of social welfare i.e. the identification of rules which consistently 
establish whether one state of the world is more socially desirable than another (Morris et al., 
2007). Two contrasting views are; the utilitarian argument for efficiency where social welfare is 
assumed to be the sum of all individual utilities; and the Rawlsian argument for equity which 
values social welfare as the utility associated with society’s least well-off member (Morris et al., 
2007). Clearly efficiency and equity concerns are not always compatible, for instance a health 
intervention that increased utility in 10% of society’s most well-off members and equally 
decreased utility in 5% of society’s least well-off members would be accepted by utilitarians and 
rejected by Rawlsians.  
In theory, society’s views on efficiency and equity could be captured mathematically in what is 
termed a Bergson and Samuelson Social Welfare Function (Brouwer et al., 2008), (Feiwel, 2016). 
While capturing the ethical beliefs of society is likely to be a challenge, the major complication 
in defining a specific social welfare function is that utilities can only be reliably compared 
between individuals using ordinal (i.e. ordered preferences) and not cardinal (i.e. numerical) 
scales (Blackorby et al., 2002) (Hammond, 1991). Kenneth Arrow’s impossibility theorem 
proved that individual ordinal preferences cannot be aggregated into rational social preferences 
unless under the restrictive conditions that a dictator’s preference always dominates the 
preferences of any other individual in society (Feldman, 1989) (Hammond, 1991).  
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In the absence of an appropriate method to order social welfare, adoption decisions in 
economic evaluation could be informed by the Pareto principle: an intervention might only be 
recommended if it improved the utility of at least one individual without reducing the utility of 
any member of society (Johannesson, 1996). Whilst the Pareto principle is a weak value 
judgement likely to be acceptable to everyone, it is rarely realised for social interventions which 
are typically associated with opportunity costs. Kaldor and Hicks extended the Pareto principle 
into a more applicable compensation test framework suggesting that a change would be socially 
desirable if, hypothetically, those who experience an increase in utility following the change 
could provide adequate monetary compensation for individuals who were disadvantaged, whilst 
remaining better off themselves (Johannesson, 1996), (Morris et al., 2007).  
Cost-benefit analysis (CBA) is a type of economic evaluation founded in welfarism which utilises 
the Kaldor-Hicks compensation test framework by monetising the costs and benefits associated 
with health interventions (Drummond et al., 2015), (Morris et al., 2007). In CBA, health 
interventions are recommended for adoption if they have a positive net benefit where the 
monetary value of social benefits achieved through consumption of the healthcare exceeds the 
monetary value of the associated costs (including opportunity costs) (Drummond et al., 2015).  
Therefore, when conducting CBA, analysts must establish an appropriate way to monetise the 
costs and benefits associated with intervention. One method commonly applied to monetise 
outcomes in CBA is contingent valuation where hypothetical markets are constructed to 
establish an individual’s willingness-to-pay (WTP) for a good. Contingent valuation using WTP 
is consistent with theoretical principles of welfarism as it can be interpreted in terms of 
compensation (Drummond et al., 2015).  
Despite its theoretical grounding in welfarism there are some arguments regarding the accuracy 
and consistency of contingent valuation using WTP. For example: hypothetical WTP values 
derived from surveys may not be equivalent to the amount individuals would be willing to pay if 
actual markets existed (Kennedy, 2002); individuals might not be capable of providing an 
accurate valuation of healthcare products or health benefits (Donaldson et al., 2006); and, as 
individuals often view healthcare as a necessity, contingent valuation may lead to distributive 
issues as better-off individuals who are able to pay more are likely to state higher WTP values 
than less well-off individuals (Olsen and Donaldson, 1998).  
In addition to issues faced when monetising costs and benefits, there are fundamental 
arguments against the use of compensation tests and monetary valuation in cost-benefit 
analysis. It may not be appropriate to establish a social net benefit through the summation of 
individual WTP. Blackorby and Donaldson (1990) claim that the summation of WTP requires 
an assumption and subsequent ethical judgement that income increases are equally socially 
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valuable no matter for whom they occur. It seems reasonable to question why a policy that, say, 
compensated the top 1% of earners by £X is necessarily of equal social value to a policy that 
compensated the bottom 1% of earners by same magnitude of £X. Furthermore, Boadway 
(1974) demonstrated methodological inconsistencies where the most desirable policies 
according to compensation test principles are not necessarily the best policies in terms of 
summed compensation variation (i.e. summed WTP). 
There are further arguments against the application of welfare economics as a general 
framework to inform health economic evaluation. Welfarism is built on the assumption that 
individuals will make choices that rationally maximise their utility. It is often the case that 
choices are required when outcomes are uncertain. An individual, for example, might have to 
decide whether to have a surgery or not, knowing that the surgery has an associated probability 
of success and failure. In welfare economics, rational individuals would be expected to make 
decisions by multiplying the probabilities of the outcome occurring by the expected utilities and 
summing across all possible outcomes (Machina, 1987). However, Machina (1987) describes 
several choice scenarios where the assumption of utility maximisation under uncertainty fails to 
hold.  
Meanwhile, policy recommendations from welfare economics are informed through the analysis 
of a perfect market in a “first best world”. Real world economies are likely to be characterised 
by several market failures and imperfections including moral hazard, asymmetry of information 
and imperfect competition through oligopolies/monopolies. The application of first-best 
solutions to a second-best world is not necessarily appropriate and might reduce social welfare 
(Claxton et al., 2007), (Sculpher et al., 2005), (Richardson, 2007).  
2.4.3 Extra Welfarism  
Also founded within normative economic principles, extra-welfarism is an alternative perspective 
informing the conduct of economic evaluation which questions the fundamental assumption of 
welfarism. Arguing against the exclusive use of individual utility to determine the social good, 
Sen (2008) suggests that utility occurs through an individual’s mental reaction to a good. Sen 
provides an example of a deprived individual who may generate higher levels of utility from 
smaller levels of consumption when compared with a less deprived individual, as they have 
learnt realistic desires and may “take pleasure in small mercies”. Goods are likely to have 
benefits beyond utility in terms of what they enable an individual to do or be (Sen, 2008). 
Welfarism might be flawed given its failure to account for objectively desirable social benefits 
that occur beyond individual utility maximisation.  
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Extra-welfarism, as termed by Culyer (1991) and applied in health economics, is an alternative 
philosophical perspective for economic evaluation which suggests that additional factors should 
be included as an objective to maximise alongside individual utility. One such factor is health 
which is likely to be an important consideration when informing decisions regarding the 
allocation of health interventions (Brouwer and Koopmanschap, 2000), (Brouwer et al., 2008).  
Morris et al. (2007) suggest health may be accounted for within economic evaluation by 
considering the effect of intervention on the quality of an individual’s health state (morbidity) 
and their expected length of life (mortality). An example of such a measure is the Quality 
Adjusted Life Year (QALY) which combines multiple concepts of morbidity and mortality into 
a single index (Drummond et al., 2015). QALYs are constructed using questionnaires which 
rank patients into one of many specific health states and use methods such as the standard 
gamble or time trade off to establish society’s preference for each health state. The preference-
based valuation produces cardinal values termed health-related quality of life (HRQoL) and 
these are accumulated over the remainder of an individual’s life expectancy to derive their 
lifetime QALYs (Drummond et al., 2015).  
Cost-utility analysis (CUA) is partially consistent with the principles of extra-welfarism as it is a 
specific type of economic evaluation establishing the net-benefit of an intervention by 
comparing the ratio of incremental costs with its incremental benefits measured as QALYs 
(Drummond et al., 2015). A new health intervention is recommended for adoption if the 
incremental cost-effectiveness ratio (ICER) is below a pre-specified threshold value when 
compared with current practice (Drummond et al., 2015). By comparing ICERs to a cost-
effectiveness threshold, which is defined as the ‘cost per unit of health benefit forgone’ (Woods 
et al., 2016), CUA accounts for the opportunity costs that occur through the decision not to 
adopt a competing intervention.  
Brouwer et al. (2008) suggest the extra-welfarist perspective might provide a more pragmatic 
approach to economic evaluation not requiring adherence to restrictive Pareto principles or 
unreliable methods of valuation associated with contingent valuation in welfarism and CBA. 
Explicit between-person comparisons can be obtained on measures of health, such as the 
QALY, that cannot be obtained for ordinal utilities. As stated above, the QALY is a cardinal 
measure based on social preferences meaning QALYs are implicitly assumed to be of equal 
social value irrespective of who achieves them (i.e. a QALY should always equal a QALY) 
(Whitehead and Ali, 2010). 
There is, however, some debate regarding the consistency of CUA with the principles of extra-
welfarism. The objective of extra-welfarism is not exclusively health driven but is the 
maximisation of the social good of which health is only one factor alongside many others 
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including individual utility. For CUA to be considered as fully consistent with the “extra” 
welfarist paradigm, QALY maximisation would need to capture individual utility maximisation. 
Dolan and Edlin (2002) describe fundamental theoretical restrictions that may prevent this, for 
instance, a health intervention might increase individual utility by improving health and capacity 
to work. It is debateable whether both arguments are captured when measuring QALYs. 
Acknowledging the limitations of the QALY, Coast et al. (2008) argue that the health centred 
perspective of extra-welfarism that informs CUA focuses on function rather than “freedoms 
(capabilities) to pursue health improvement”.  
Wider measures of well-being have been developed for economic evaluation and are beginning 
to be applied in some empirical literature: A well-being QALY has been advocated by Cookson 
et al. (2016) which attempts to operationalise Sen’s capabilities’ approach by accounting for 
health as well as other factors related to income and the consumption of goods. The 
Investigating Choice Experiences for the Capabilities in Adults (ICECAP-A) is a preference 
based capability measure that has been applied in UK populations by Mitchell et al. (2017) and 
contains items for stability, attachment, autonomy and achievement; meanwhile, the Warwick-
Edinburgh Mental Wellbeing Scale (WEMWBS) is a non-preference based measure used to 
assess mental well-being where participants score 14 items related to positive mental health 
including confidence, optimism, relaxation and cheerfulness (Tennant et al., 2007).  
The different dimensions used in Cookson’s well-being QALY, the ICECAP-A and the 
WEMWBS however demonstrate a pragmatic limitation faced in the application of well-being 
measures: there is a general lack of consensus about what the key theoretical components of 
well-being are, and how these ought to be measured (Cookson, 2005; Nussbaum, 2003). This 
might explain why, despite being theoretically inconsistent with some aspects of extra-
welfarism, the health centric QALYs is often the preferred outcome measure in CUA.  
2.4.4 A Health Centric Decision Maker’s Approach  
Both welfarism and extra-welfarism are structurally similar in the sense that they provide a 
theoretical basis for healthcare allocation decision making within a normative economic 
framework. A contrasting decision maker’s approach (DMA) views economic evaluation within 
a positive economics framework and aims to inform rather than prescribe decisions (Brouwer 
and Koopmanschap, 2000). The DMA addresses pragmatic issues faced by policy makers and 
moves away from questions of what ought to be i.e. maximising the social good, and towards 
questions of what is, i.e. achieving the explicit objectives of a legitimate social decision maker 
(Brouwer and Koopmanschap, 2000).  
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The pragmatic issues faced by decision makers in the UK often relate to the appropriate 
distribution of collective funds which are allocated into sector specific budgets providing 
diverse public services such as health, education, transport, crime prevention etc. If the decision 
maker’s responsibility is limited to a specific sector then their role might be summarised as a 
constrained optimisation problem, where they wish to maximise some measure of benefit 
within that sector subject to an exogenous budget constraint (Sculpher et al., 2005).  
The appropriate methods for economic evaluation for the DMA are determined by the specific 
optimisation problem faced. In general, cost-effectiveness analysis (CEA) provides a tool for 
non-specific constrained optimisation problems where the benefit of an intervention can be 
obtained on the primary outcome of interest to the decision maker (Drummond et al., 2015). 
For example, economic evaluations conducted from a DMA and informing policy decisions in 
the crime sector might value the benefits of intervention in terms of reduced 
crime/incarceration rates, whereas decision makers in the education sector might assess benefits 
on endpoints including graduation success or scholastic achievement.  
The National Institute for Health and Care Excellence (NICE) is an institution which might be 
thought of as a legitimate decision maker in the health sector as it has delegated authority to 
make healthcare policy recommendations from a democratically elected central government 
(Sculpher et al., 2005). The role of NICE (2013) is reflected in their perspective for economic 
evaluation which is to maximise health benefits given the exogenous resources made available 
to the National Health Service (NHS) and the Personal Social Services (PSS). The methodology 
proposed by NICE (2013) is to conduct a CUA using QALYs and healthcare costs incurred by 
the NHS and PSS as decision endpoints.  
There are considerable cross-overs in the methodology for economic evaluation as prescribed 
by a health centric DMA and the extra-welfarist perspective and this may have led 
commentators such as Brouwer et al. (2008) to term the DMA as a “branch” of extra-welfarism. 
This terminology is avoided here given the fundamental differences in normative and positive 
economic principles informing each perspective. From the health centric DMA, cost-utility 
analysis might be best thought of as a specific form of cost effectiveness analysis using a group 
of common methodologies to inform adoption decision in the health sector (Drummond et al., 
2015). Unlike the extra-welfarist perspective, the sole objective of the health centric DMA is to 
achieve as much health as possible and therefore does not require measures to capture both 
health and utility. It follows that health centric measures like the QALY are most suitable when 
establishing intervention benefits for a health centric DMA perspective when compared with 
more generalised measures of capability/well-being like the ICECAP-A/WEMWBS.  
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According to Claxton et al. (2010), the health centric DMA, which maximises health given a 
budget for healthcare, is only a reasonable option if the following five criteria are met: (i) the 
social objective is to improve health; (ii) measures of health gained and forgone capture enough 
aspects of the social objective; (iii) the budget is exogenous (i.e. cannot be changed by the 
decision maker); (iv) the costs associated with the health technology are all in terms of health 
forgone; and (v) all the benefits of the intervention are in terms of health.  
Claxton et al. (2010) justifies a health centred social objective if the budget for health is a 
legitimate expression of social value. In this case maximising measures of health (QALYs) 
subject to the healthcare budget in cost-effectiveness analysis might be entirely appropriate as 
society’s willingness to pay for health is represented by the money made available in the 
healthcare budget. The shadow price of the budget (society’s willingness to pay) is accounted 
for using a cost-effectiveness threshold which compares health gained from new interventions 
with health forgone in displaced interventions as is indicated in the decision rule in Equation 2.1 
(Claxton et al., 2007), (Claxton et al., 2010).  
Equation 2.1: Decision Rule from a Health Centric Decision Makers Perspective 
 
Decision rule: Adopt an intervention if; 
  
[Δh – ΔCh/k] >0  
  
Where:  
Δh=  incremental health effects e.g. QALYs  
ΔCh=  incremental costs that fall on the healthcare budget  
k=  The cost effectiveness threshold (the additional costs that would displace 1 
 unit of health elsewhere in the healthcare system) 
Notes: Taken from Claxton et al. (2010). The incremental costs and benefits of an intervention are identified versus a 
relevant competitor i.e. usual care or an alternative intervention strategy.  
2.4.5 The Cross-Sectoral Decision Maker’s Approach   
2.4.5.1 Structure of Decision Problem  
 The final two above criteria specified by Claxton et al. (2010) are unlikely to hold for all 
healthcare interventions which may have spill-over effects in other sectors, for example; health 
interventions often incur costs and/or benefits for carers and may also have effects on 
economic productivity allowing sick individuals to return to work. The health centric DMA may 
be defensible if these spill-over costs and benefits are inconsequential to the overall decision 
(Drummond et al., 2015). However, in some cases cross-sectoral effects are substantial, such as 
in the evaluation of public health policies, and it might not be advisable to ignore these 
outcomes as this may lead to bias during decision making (Claxton et al., 2010).  
45 
 
To account for spill-over effects, the health centric DMA can theoretically be extended to a 
cross-sectoral DMA with an objective function that maximises health with respect to healthcare 
costs, but also maximises other relevant outcomes across different sectors (e.g. education, 
crime, transport) with respect to costs incurred by that sector.  
According to Claxton et al. (2007) the more complicated optimisation problem with multiple 
measures of benefit and multiple costs cannot be solved mathematically given the information 
currently available to analysts. Considering this, Claxton et al. (2007) suggests a theoretical rule 
for cross-sectoral decision making which employs compensation test principles; for instance, if 
an intervention had a small negative net health benefit but a large positive net education benefit, 
it could be adopted if the education sector adequately compensated the health sector. However, 
this method for decision making cannot be applied as it requires administrative procedures that 
transfer actual monetary compensation between sectors which are not currently available 
(Claxton et al., 2007). 
Claxton et al. (2010) conducted further research and established a conceptual framework 
consistent with the cross-sectoral DMA that can account for costs and benefits occurring in 
multiple sectors. Within this framework Claxton et al. (2010) assume that budgets are sub-
optimal expressions of social value (i.e. do not entirely represent society’s willingness-to-pay). 
This means that consumption in one sector does not necessarily equate to the same level of 
consumption in another sector (i.e. £1 spent in health is not necessarily equivalent to £1 spent in 
education). Claxton et al. (2010) suggest that some other legitimate valuation of sector-specific 
outcomes relative to consumption is required and formulised this by including a consumption 
value for health (v) in the decision rule described in Equation 2.2. 
Equation 2.2: Decision Rule from a Cross-Sectoral Decision Makers Perspective 
Decision rule: Intervention should be adopted if;  
 
v.[Δh – ΔCh/k] -ΔCc >0  
  
 Where: 
 v=  The consumption value of heath (the amount of consumption in the 
  wider economy regarded as equivalent to 1 unit of health) 
 ΔCc=  The net effects which do not fall on the healthcare budget expressed 
  as net consumption cost to the wide economy. 
 Δh=  Incremental health effects  
 ΔCh=  Incremental costs that fall on the healthcare budget  
 k=  The cost effectiveness threshold 
   
Notes:  Taken from Claxton et al. (2010). The incremental costs and benefits of an intervention are identified 
 versus a relevant competitor e.g. usual care or an alternative intervention strategy.  
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The consumption value for health provides a mechanism for weighting costs and benefits 
falling on the wider economy. Claxton et al. (2010) suggest this value may fall between zero and 
one placing it between the two policy extremes that either (a) ignore cross-sector costs and 
benefits or (b) treat cross-sector costs and benefits as if they fall directly on the healthcare 
budget. Whilst the precise value of this weighting is not known the cross-sectoral DMA could 
operationalise Equation 2.2 in an economic evaluation by providing net-benefit calculation 
across a range of feasible consumption values for health. This information would be useful for 
decision makers as it would illuminate the potential biases that may occur when adopting a 
health centric DMA which excluded cross-sectoral costs and benefits. 
2.4.5.2 Measuring Intervention Benefits   
 A further consideration if adopting a cross-sectoral DMA is establishment of an 
appropriate method to assess intervention benefit. Intuitively, the extension of the decision 
perspective beyond health might appear to favour extended measures of capability/well-being 
(e.g. ICECAP-A/WEMWBS) over narrower and more health centric measures (e.g. QALYs). 
However, the optimisation problem specified by the cross-sectoral DMA assumes budgets are 
assigned according to specific objectives. For example, the health budget is delivered to 
improve population health, the education budget to improve education, the transport budget to 
improve transport etc. It is not likely that sector specific objectives are appropriately captured 
by dimensions like enjoyment, achievement, and stability within extended well-being QALYs.  
In theory, researchers applying a cross-sectoral DMA might adopt multiple sector specific 
outcomes measures. As with the health centric DMA, QALYs provide a measure of 
intervention benefit directly relevant to the objectives of the health sector. In addition, the cross 
sectoral DMA might include QALY equivalent measures specific to the requirements of other 
sectors e.g. education QALYs, crime QALYs etc. One such example is the Adult Social Care 
Outcomes Toolkit (ASCOT) a measure of social care related quality of life (Peasgood et al., 
2014).  
There are, however, two issues regarding the use of multiple sector specific measures of benefit 
with the cross-sectoral DMA. Firstly, intervention benefits might be double counted if outcome 
measures have overlapping items – a problem that is illustrated by QALY and ASCOT 
measures which both contain items assessing psychological function (Peasgood et al., 2014). 
Secondly, and more fundamentally, appropriate QALY equivalent outcome measures have yet 
to be developed within each sector. Economic evaluations in the education sector, for example, 
do not typically adopt specific outcome measures and instead measure education benefits in 
terms of monetary returns accrued through increased earnings, akin to willingness to pay 
methods in cost-benefit analysis (Cookson et al., 2016; Levin and Belfield, 2015).  
47 
 
In the absence of relevant and unique sector specific outcome measures, a pragmatic solution to 
assigning benefits within the cross sectoral DMA could (i) assign QALYs as the outcome 
measure in the health sector, and (ii) assign monetary returns as benefits specific to each of the 
other sectors (i.e. WTP). Monetary returns and QALYs could be combined within a single 
decision rule by monetising QALYs using the cost-effectiveness threshold (k) and weighting 
monetary benefits using sector specific consumption values relative to health (v). An example of 
the adapted and expanded decision rule including benefits and costs for health, education and 
crime sectors is reported in Equation 2.3. The equation is consistent with those described by 
Claxton et al. (2010) who categorised decision endpoints outside of the health sector in 
monetary terms as either: (i) direct costs of treatment that are not incurred by the health sector 
or (ii) indirect effects on the wider economy that are external to patients and their family.  
Equation 2.3: Decision Rule from a Cross-Sectoral DMA in Health, Education & Crime 
Decision rule: Intervention should be adopted if;  
 
[Δh – ΔCh/k] + [ΔRe - ΔCe]/ve  + [ΔRc – ΔCc]/vc  >0  
  
 Where: 
 Δh=  Incremental QALYs 
 ΔCh=  Incremental costs that fall on the healthcare budget 
 k=  The cost effectiveness threshold 
 ΔRe =  Incremental monetary returns for the education budget  
 ΔCe=  Incremental costs that fall on the education budget 
 ve=  The consumption value of heath relative to education (the amount of 
  consumption in education regarded as equivalent to 1 unit of  
  health) 
 ΔRc =  Incremental monetary returns for the crime budget  
 ΔCc=  Incremental costs that fall on the crime budget 
 vc=  The consumption value of heath relative to crime (the amount of  
  consumption in crime regarded as equivalent to 1 unit of   
  health) 
   
Notes:  Equation is adapted from those presented by Claxton et al. (2010). The incremental costs and benefits of 
 an intervention are identified versus a relevant competitor e.g. usual care or an alternative intervention 
 strategy.  
2.4.6 Economic Evaluation in the UK   
2.4.6.1 UK Central Government   
The publicly funded UK health system operates at many different levels. Healthcare 
provision is influenced by national policies made by the government’s Department of Health 
through to individual choices made by GPs/consultants regarding the healthcare available to 
specific patients (Corbacho and Pinto-Prades, 2012). Whilst the UK municipalities (local 
authorities) are given some autonomy regarding service provision, over recent decades, the UK 
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government has taken a central role in decision making and funding for healthcare and other 
public services including education, criminal justice and transportation (Walshe et al., 2016).  
In 1999, the Department of Health began delegating national (central) decision-making 
authority and NICE was set up with the objective of providing recommendations on the 
adoption of new and existing health interventions, (Buxton, 2006). Currently, in England the 
NHS has a legal constitution which specifies that patients have the right to treatments identified 
as cost-effective in NICE technology appraisals if GPs or consultants deem them to be 
clinically appropriate (Raftery, 2014). Several other bodies now exist across the UK whose role 
is also to prescribe or advise healthcare decisions including: the Scottish Medicines Consortium, 
the Scottish Intercollegiate Guidelines Network, the All Wales Medicines Strategy Group, the 
UK National Screening Committee, and the Joint Committee on Vaccinations and 
Immunisations (Buxton, 2006), (Corbacho and Pinto-Prades, 2012), (Raftery, 2014).  
Economic evaluation plays a fundamental role in informing the decision-making process 
undertaken by NICE (and the other UK healthcare jurisdictions) and this can include internal 
primary analyses or analyses submitted by external (often academic) institutions (Buxton, 2006), 
(Raftery, 2014). In fact, NICE has been a primary driver in the development of methods for 
economic evaluation and has been influential in promoting economic evaluation as a method to 
facilitate healthcare decisions across Europe (Corbacho and Pinto-Prades, 2012). To inform the 
methods for economic evaluation NICE has published a reference case (2013) which all 
external submissions are required to conform to if they are to be considered in NICE policy 
appraisals.  
The NICE (2013) reference case adopts a health centric DMA as the primary perspective of 
analysis. As stated in the NICE (2013) reference case, the primary submission should be a cost-
utility analysis that considers the health benefits of interventions measured as QALYs and 
healthcare costs incurred by the NHS and Personal Social Services (PSS). The health centric 
perspective adopted by NICE reflects both the assumed political role of the UK central 
government (i.e. to provide budgetary funding for specific public services including health) and 
the role assigned to NICE as an authority for healthcare decision making. In addition, NICE 
(2013) do consider secondary “non-reference case” submissions if researchers are able to justify 
theoretically why the reference case methods are inappropriate. In these cases, it would be 
appropriate for analysts to conduct a primary reference case analysis which is presented 
alongside any additional evaluations employing non-reference case methods.   
NICE (2013) argue that the reference case provides a “crucial” approach for healthcare 
decision-making as it provides methodology that can be applied consistently and transparently 
across a wide range of healthcare decisions in the UK. Consequently, analysts may prefer to 
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adopt NICE (2013) reference case methods regardless of their own view on the appropriate 
perspective for analysis as these methods may provide the most likely route to policy influence 
in the UK.  
2.4.6.2 Devolution and Service Integration     
 Section 2.4.6.1 described the role of modern UK governments, which have tended to 
operate and fund health (and other public services) at a central level. Recently, some political 
initiatives have reversed the trend towards centralisation by transferring power to more local 
political structures through devolution. Examples include deals for Scotland, Northern Ireland 
and Wales in 1999; regional governments in England in 2004; and a £6 billion per year 
agreement for Greater Manchester known as “Devo Manc” in 2015 (Walshe et al., 2016).  
According to Walshe et al. (2016), a benefit of devolution is the ability to integrate public 
services as smaller local governments are better placed to deliver collective care across multiple 
organisations, when compared with central based systems that are disconnected through 
complex governance structures. A primary objective of the Devo Manc project, for example, 
has been the integration health and social care services which now fall under a single budget 
(Gains, 2015).  
The integration of budgets under devolution has implications for the appropriate perspectives 
from which to conduct economic evaluation. The health centric DMA does not appear to 
sufficiently fulfil the requirements of, say, a Devo Manc decision maker whose objective is likely 
to be the maximisation of both health and social care subject to an integrated budget for health 
and social care. Theoretically, it might be desirable to extend the health centric perspective to a 
health and social care centric DMA requiring analyses to consider all costs falling on the 
integrated budget, and possibly measuring intervention benefits on an expanded QALY which 
includes additional items relevant to social care.  
Pragmatically, tailoring perspectives for economic evaluation to the exact requirements of 
devolved local regions/authorities might be unrealistic: Regions may differ in terms of how and 
which services/budgets are integrated, and therefore different regions would require a unique 
analytical perspective and subsequent set of methods relevant to their specific political 
organisation. The adoption of a cross-sectoral DMA might be more feasible approach as it: (i) 
accounts for monetary costs and benefits falling in multiple sectors and is therefore likely to be 
consistent with the structure and objectives of most devolved governments; and (ii) would be 
applicable for analyses across different devolved regions thus maintaining a consistent set of 
national methodological standards.  
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Whilst there are no specific guidelines on methods for economic evaluation in light of recent 
devolution deals, the precedent for moving towards a cross-sectoral approach may have been 
set by NICE with respect to their guidelines for analyses of public health interventions. Funding 
for public health in England has been devolved to local authorities (Greer, 2016); such 
interventions are known to have costs and consequences that span multiple sectors and budgets 
(Claxton et al., 2010), and most NICE guidelines for economic evaluations of public health 
interventions include costs across multiple sectors beyond health (Hinde et al., 2017). If future 
devolution initiatives continue to integrate budgets for public services, it may be that a cross-
sectoral (rather than health centric) DMA becomes the primary analytical perspective 
recommended by NICE in the UK.   
2.4.7 Conclusion   
The review of the health economics literature above summarises the key perspectives informing 
the conduct of economic evaluation, identifying pragmatic and theoretical arguments for and 
against the perspectives of welfarism, extra-welfarism and the health/cross-sectoral DMA. 
Section 2.5 draw on this background and consider the selection of methods and evaluation 
vehicle to be used in the applied economic evaluation which is the subject of the empirical 
research in this thesis. The discussion provides answers to the questions posed in 2.1 about the 
type of economic evaluation to be conducted, the decision rules to be applied and the decision 
endpoints to be used.  
2.5 Synthesis and Future Research Methods 
2.5.1 Perspectives informing the Economic Evaluation of Early Childhood Health 
Technologies 
In the UK, decision making is influenced by institutions such as NICE and methods for health 
economic evaluations generally follow those prescribed by NICE which requires primary 
submissions to adhere to methodologies reported in the reference case (NICE, 2013). As seen 
above this specifies that economic evaluations adopt the perspective of a health centric DMA 
and conduct a CUA where the benefits of interventions are measured in terms of QALYs and 
costs are limited to those incurred by the NHS and PSS. NICE may also consider secondary 
analyses alongside reference case analyses if theoretical justification is provided that identifies 
why the reference case methods may be insufficient. If UK healthcare decision making requires 
consistent methods to be applied for all allocative decisions, then the economic evaluation of 
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UK child health interventions should follow NICE (2013) guidelines and adopt the health 
centric DMA as a perspective for analysis.  
Based on these conclusions, the applied economic evaluation conducted in this thesis assesses 
the cost-effectiveness of screening strategies for postnatal depression by establishing the costs 
and benefits of each strategy using children’s lifetime QALYs and direct healthcare costs as 
decision endpoints. The analysis identifies the cost-effective strategy by applying the decision rule 
described by Claxton et al. (2010) and reported in Equation 2.1.  
The review of the lifespan development literature identified the potential effects of early life 
diseases/interventions on child development and revealed the influence that development has 
on all manner of later life outcomes. Therefore, and like the public health literature, early 
childhood intervention may be associated with spill-over effects in sectors beyond health that 
are consequential in decision making. As was identified by Claxton et al. (2010), reference case 
analyses which exclude important cross-sectoral effects could result in biased decisions being 
made. For instance, if, in general, early life interventions that foster development produce larger 
cross-sectoral benefits than health benefits, then the exclusion of these benefits might result in 
decisions that do not recommend early interventions despite them providing a social benefit.  
The potential for substantial cross-sectoral benefits and the subsequent possibility of bias 
provides a theoretical reason to diverge from the reference case methods. Therefore, based on 
the findings in this literature review, it is suggested that the economic evaluation of child health 
technologies in the UK provide a second analysis alongside the reference case analysis. The second 
analysis should extend the perspective to that of a cross-sectoral DMA and consider the costs 
and benefits associated with health interventions that occur in sectors outside of health.  
The decision rule suggested by Claxton et al. (2010) for the analysis of public health interventions 
(Equation 2.2) and the expanded Equation 2.3 provide a conceptual framework for analysing 
the social costs of interventions when adopting a cross sectoral DMA. The decision endpoints 
relevant to the cross-sectoral DMA perspective include QALYs and direct healthcare costs, but 
also require the costs and benefits of interventions to be assessed on outcomes in sectors 
outside of health. In theory, cross-sectoral effects could be captured as costs incurred by other 
budgets and on QALY equivalent outcomes that measure benefits specific to each sector i.e. 
education QALYs, crime QALYs etc. However, no QALY equivalent exists in these sectors 
where public policy is usually evaluated in a Cost-Benefit Analysis (Cookson et al., 2016). 
Consequently, the spill-over effects of early intervention might be best measured in monetary 
terms as lifetime costs and savings incurred by sector specific budgets.  
More research is required to establish the precise consumption values for health with relation to 
consumption in other sectors. However, a set of secondary analyses could provide useful 
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information to decision makers by investigating cost-effectiveness across a range of feasible 
consumption values, illustrating how different consumption values might affect decisions 
regarding cost-effectiveness.  
It is debatable which of the analyses ought to be presented to decision makers as the 
primary/secondary results. On one hand it is desirable to include all important costs and 
benefits associated with health technologies, but on the other hand it is equally desirable to 
uphold consistent methods for economic evaluation across all health allocation decisions. By 
adopting the perspective of a health/cross-sectoral decision maker the role of economic 
evaluation is assumed to inform rather than prescribe decisions. Therefore, the choice regarding 
the primary/secondary analysis becomes less important as decision makers can select the most 
appropriate analysis given their objectives if the analyses clearly state the philosophical 
frameworks that inform the methodology.  
To remain consistent with NICE (2013) guidelines this research adopts the frameworks of 
healthcare DMA for the primary analysis, and the cross-sectoral DMA for the secondary 
analysis.   
2.5.2 Selecting an Appropriate Vehicle for Economic Evaluation  
The final consideration in this chapter is to briefly discuss the appropriate analytical technique 
and use of empirical evidence within economic evaluation consistent with the selected 
perspective. As described by Sculpher et al. (2006) economic evaluation can be conducted using 
one of two vehicles for analysis.  Firstly, trial based economic evaluations are an expansion of the 
traditional randomised clinical trials(RCTs): participants are randomly allocated into 
intervention/control groups; follow up information is collected related to each participants 
healthcare usage and health utility; and mean incremental healthcare costs and QALYs (or 
equivalent measure of health/clinical benefits) are used to calculate ICERs between the 
intervention/control groups based on the observed data (Sculpher et al., 2006).  
According to Sculpher et al. (2006) trial based economic evaluations should not be used as the 
sole vehicle for economic evaluation for the following pragmatic restrictions: it is not possible 
to compare all the relevant treatment strategies within single trials; RCTs often fail to account 
for the longer term (lifetime) effects of intervention as they usually have truncated time 
horizons due to high costs; the results of trials are conducted in specific populations that might 
not be generalisable to the population being targeted by the policy; trials are not able to measure 
all relevant evidence and cannot incorporate evidence from outside sources; and finally, trial-
based evaluation cannot establish the probability of the correct decisions being made and 
therefore cannot quantify the opportunity costs of making a wrong decision. 
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For the economic evaluation of early interventions, a trial-based approach appears particularly 
insufficient given the expected duration of treatment effects, which could occur decades after 
treatment initiation. The inadequacy of a trial-based approach is exemplified by the applied 
economic evaluation that is the subject of this thesis where it was not feasible to conduct an 
RCT which allocated mothers into the relevant treatment groups (different screening strategies 
for postnatal depression) whilst identifying lifetime treatment effects for children on the 
relevant lifetime decision endpoints.  
The second vehicle for economic evaluation described by Sculpher et al. (2006) is the decision 
analytic model (DAM), a mathematical model which conceptualises disease progression. 
Usually, a hypothetical patient population is simulated through the different disease states 
within a DAM. Analysts split the hypothetical population into equal groups which receive all 
relevant competing intervention strategies. Each intervention strategy differently affects the 
probability of progression between disease states. Healthcare costs and QALYs are assigned to 
each disease state and the cost-effective strategy is identified by summing costs and QALYs for 
(and identifying ICERs between) the hypothetical treatment groups (Briggs et al., 2006).  
The parameters within DAMs (i.e. probabilities of transmission between disease/remission 
states, healthcare costs and QALYs) are informed through secondary data usually relying on 
evidence obtained from randomised clinical trials or observational studies but can also 
potentially include evidence from less robust sources such as expert elicitation (Sculpher et al., 
2006). The use of secondary data lifts the pragmatic restrictions faced by trial-based evaluations, 
allowing DAMs to compare all treatment options over the appropriate time horizon in 
populations relevant to the decision maker (Sculpher et al., 2006).  
In addition, DAMs can account for all available evidence by applying a bayesian approach to 
statistical analysis which views probabilities as subjective beliefs updated based on new 
information (Cooper et al., 2004). This is opposed to the traditional frequentist view that assigns 
probability through observations made from repetitive experiments (Cooper et al., 2004). The 
application of Bayesian techniques allows economic evaluation to be conducted in a way that 
mirrors a real-life decision-making process: initial decisions are made, new evidence is gathered, 
and decisions are revised given the new evidence (Claxton et al., 2007). Using mathematical 
simulation techniques, bayesian DAMs allow probabilities of cost-effectiveness to be calculated 
alongside mean estimates of cost-effectiveness which is an important consideration in decision 
making (Claxton, 1999).  
It is the view of Sculpher et al. (2006) that DAMs provide the only vehicle for analysis that can 
meet all the objectives of the decision maker. When compared with trial-based evaluations, 
DAMs are better suited to deal with some empirical challenges faced when conducting 
54 
 
economic evaluation of interventions that affect child development. For example, there is no 
requirement (as needed for trial-based evaluations) to directly compare all treatment strategies 
within a single study over the full life cycle. Instead the structure of the DAM specifies the 
evidence that is required which can be obtained and synthesised from multiple sources e.g. 
RCTs, observational studies, expert elicitation etc.  
2.6 Summary of Conclusions and Empirical Research Design 
2.6.1 Conclusions  
By bringing together evidence from the lifespan development and the economic evaluation 
literature this chapter identifies several methodological approaches informing the primary 
research in this thesis.  
Firstly, the identification of an effect pathway suggests a design for indirect estimation where 
the effects of early life circumstances on lifetime decision endpoints can be estimated by: (i) 
observing effects on intermediate endpoints measuring lifespan development, and (ii) 
extrapolating intermediate development measures to effects on decision endpoints across the 
lifespan.  
Secondly the review suggests an appropriate perspective and methodology for conducting 
economic evaluation of child health technologies. To provide the most influence on UK policy, 
the design of the economic evaluation in this thesis is consistent with the NICE (2013) 
reference case i.e. a cost-utility analysis that identifies benefits of health technologies on QALYs 
and costs in terms of those borne by the healthcare budget.  
As early technologies affecting child development are likely to be associated with substantial 
cross-sectoral effects, a second analysis is included in addition to the reference case analysis. 
The non-reference case analysis applies a cross-sectoral decision maker’s approach establishing 
effects of interventions using QALYs, healthcare costs, costs and cost savings in sectors outside 
of health (including economic productivity) as decision endpoints. The second analysis includes 
a feasible range of consumption values for health.   
Bayesian DAMs provide the most appropriate vehicle for this economic evaluation. The models 
are particularly useful given some of the methodological difficulties likely to be faced when 
estimating the lifetime effects of child health technologies as the structure of the model specifies 
the exact research priorities, and these can be informed by evidence from multiple and diverse 
sources. 
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2.6.2 Research Design for the Applied Economic Evaluation 
The applied economic evaluation in the thesis adopts the perspectives, methodologies and 
analytical vehicle suggested in this chapter. The economic evaluation assesses the cost-
effectiveness of screening for postnatal depression, extending an existing cost-effectiveness 
study by NICE (2018) which was limited as it did not formally consider the costs and 
consequences of screening on children’s lifetime decision endpoints.  
The economic evaluation in chapter six includes children’s lifetime effects by adding additional 
states for children exposed to symptoms of postnatal depression. The underlying structure of 
the DAM follows the NICE (2018) design: screening is administered 6 weeks after childbirth 
which results in women being assigned to one of four diagnosis groups (i.e. true positives, true 
negatives, false positives false negatives); mothers then receive treatment according to their 
diagnosis group; and the model culminates by grouping women into either depressed or non-
depressed health states. Figure 2.4 depicts the treatment part of the NICE (2018) DAM for 
mothers who are correctly (true positives), and wrongly (false positives) diagnosed with 
depression by a screen. The full structure of the DAM is detailed later in chapter six.  
 
Figure 2.4: Depicts the true positive and false positive treatment components of the decision tree used to assess the 
cost-effectiveness of screening for postnatal depression by NICE (2018).  
 
The DAM in this thesis adds health states for children who are either assumed to be exposed or 
not exposed to symptoms of maternal depression according to their mother’s depression status 
at the culmination of the DAM. The addition of an exposure state for children is illustrated in 
Figure 2.5. Informed through the structure of the DAM, the lifetime effects evidence needed 
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for the application in this thesis requires the estimation of the incremental effects in children 
exposed to postnatal depression versus children who are not exposed to postnatal depression. 
 
 
Figure 2.5: True positive and false positive treatment components in the decision analytic model used to assess the 
cost-effectiveness of screening for postnatal depression in chapter six.  
 
Following the conclusions from this chapter, the specific objective for the empirical research 
example described over chapters three to six of this thesis is:  
To estimate the lifetime incremental effect of childhood exposure to symptoms of 
 postnatal depression on the following decision endpoints: (i) QALYs (ii) costs incurred 
 by the National Health Service & Personal Social Services, (iii) consumption costs and 
 benefits on budgets outside of health and (iv) economic productivity.  
Expanding on methodologies for indirect estimation, chapters three, four and five estimate 
lifetime evidence using observational data from two longitudinal birth cohort studies. Chapter 
six incorporates the evidence in an applied cost utility analysis.  
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Chapter 3: Postnatal Depression and Child Development  
3.1 Summary  
Within the overall context of the thesis, the purpose of the research described in this chapter is 
to carry out the first stage of the indirect estimation process by observing the impact of early 
life circumstances on intermediate child development outcomes. The research uses an applied 
empirical example exploring the relationship between maternal postnatal depression and child 
development. It firstly examines how the timing and chronicity of maternal depression 
symptoms are associated with socioemotional and cognitive development outcomes in children 
aged three to eleven and secondly specifies the additional lifetime evidence that is required 
when assessing the cost-effectiveness of the health intervention of post-natal screening. The 
final element of the chapter discusses appropriate methodologies for the first stage of indirect 
estimation which could be used to inform the design of future research. The following three 
methodological challenges are addressed: the different causal pathways through which early life 
circumstances can influence lifespan development outcomes; the need to observe long term 
intermediate outcomes at several observation points during childhood; and the selection of 
appropriate outcomes on which to measure lifespan development outcomes. Figure 3.1 
summarises how the empirical evidence from this chapter contributes to the estimation of 
lifetime effects later in this thesis.  
 
Figure 3.1: Demonstrates how evidence from this chapter contributes to the overall estimation of lifetime effects.  
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3.2 Introduction  
3.2.1 Maternal Depression   
Postnatal depression specifically diagnosed within the first year of childbirth, is highly prevalent 
and affects between 10-15% of new mothers (Grace et al., 2003). Symptoms are not distinct 
from major depressive disorder and include low mood, loss of energy, self-loathing, sleep 
disturbances, feelings of helplessness and despair, and in severe cases suicidal or infanticidal 
thoughts (Beck and Alford, 2009), (Goodman, 2004).  
As described by Stewart et al. (2003), there are a variety of factors which may increase the risk 
of postnatal depression including: pre-existing mental health conditions; a genetic susceptibility 
for depression; pregnancy problems e.g. increased stress and hormonal changes leading to 
antenatal depression and anxiety; distress and trauma occurring as a result of obstetric 
complications; socioeconomic factors; social isolation; maternal attributes including reduced 
cognitive ability and a highly neurotic personality type; and unusually temperamental infants 
causing increased childcare stress and lack of sleep.  
While most mothers enter remission twelve months following the onset of postnatal 
depression, symptoms can persist in up to 36-49% of cases (Vliegen et al., 2014). Therefore, 
postnatal depression represents a significant risk factor for future mental health conditions and 
may predict the onset of chronic depression (Vliegen et al., 2014). Following the postnatal 
period, the course of symptoms can vary in severity, timing, chronicity and duration given the 
heterogeneous nature of mental health disorders (Hammen and Brennan, 2003), (Vliegen et al., 
2014). 
The detrimental effects of maternal depression may extend beyond mothers to their children. 
Depression symptoms can affect interpersonal functioning (Kroenke et al., 2001) meaning that 
depressed mothers may be less likely to form secure attachment relationships with their infant 
which are important for child development (Broth et al., 2004), (Cornish et al., 2006), (Grace et 
al., 2003). Insecure attachment is linked to negative personality traits, poor peer relationships, 
reduced cognitive function, behavioural problems and mental health issues later in childhood 
(Weinfield et al., 2000), (Monique van Londen et al., 2007). The association between maternal 
depression and child development is well documented in theoretical and empirical literature 
(Cummings and Davies, 1994), (Grace et al., 2003), (Murray and Cooper, 1997). 
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3.2.2 Causal Pathway: Latency and Accumulation Models.  
Two prominent hypotheses from the development literature aim to describe the causal pathway 
between maternal depression and child development. Firstly, the latency model indicates that 
developmental effects could occur if children are exposed to negative stimuli during a critical 
period, usually early in life, resulting in permanent biological changes (Power and Hertzman, 
1997). An example of the latency model is provided through the effects of alcohol on the 
developing foetus, which increases the risk of genetic deformities if exposure occurs during a 
specific (critical) period in pregnancy (Rice and Barone Jr, 2000).   
The latency model has been recognised in child attachment theory where it is suggested that a 
critical period of attachment occurs during the first two years of life (Bowlby, 1978). A large 
body of empirical evidence has assessed the effects of postnatal depression symptoms occurring 
during this supposed critical period. As indicated in systematic reviews by Kingston and Tough 
(2014) and Sanger et al. (2015), associations were identified between postnatal depression and 
measures of development in cognitive and socioemotional domains. However, these findings 
are not consistent across all studies.  
The accumulation hypothesis is a second model that could explain the link between maternal 
depression and child development. This model assumes that the effects of negative exposures 
are cumulative (Power and Hertzman, 1997) (i.e. repeated exposures add up over time) which 
might be thought of similarly to the increased risk of cancer resulting from repeated cigarette 
smoking. The accumulation model may account for the effects of poor socioeconomic 
conditions on child development as children are repeatedly exposed to detrimental early 
environments (Power and Hertzman, 1997). Whilst only a small number of studies have 
investigated the accumulation hypothesis, findings consistently identify a significant negative 
association between chronic symptoms of maternal depression and both cognitive and 
socioemotional development (Brand and Brennan, 2009), (Sanger et al., 2015) (Bell, 2014).  
3.2.3 Identifying Longitudinal Effects using Growth Curve Models  
The effects of postnatal/maternal depression (as with the effects associated with early life 
circumstances in general) on lifespan development outcomes have the potential to change over 
time: early environments can have increasing, cascading or snowballing developmental effects if 
they influence fundamental abilities that are important determinants of future abilities 
(Heckman, 2008) (Masten and Cicchetti, 2010). On the other hand, decreasing effect sizes 
might occur if the detrimental effects of significantly adverse environments can be ameliorated 
by later beneficial factors such as strong family relationships, safe neighbourhoods and effective 
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schooling (Masten and Reed, 2002). This process is more commonly known as developmental 
“catch-up” and is exemplified by Rutter (1998) who found Romanian orphans with significant 
deficiencies in early physical and cognitive development achieved similar outcomes to British 
controls after being placed in nurturing UK foster homes.  
The potential for lifespan development effect sizes to change over time has implications for 
research design. Typical studies collecting outcomes at one measurement interval may not be 
appropriate as they can provide no information regarding temporal changes to effects sizes after 
the study endpoint. Single outcome studies could lead to inappropriate assumptions if used to 
estimate lifetime effects. For instance, it is possible that a study which observes outcomes at a 
single observation might identify two early life circumstances with equivalent effects sizes on 
intermediate endpoints. Without any further information, these effect sizes would be assumed 
to extrapolate to equivalent effect sizes on lifetime endpoints. But this might not be appropriate 
if, say, one of the intermediate effects was increasing whilst the other was decreasing over time.  
Temporal changes in effect sizes could ultimately place limitations on the reliability of policy 
recommendations from economic evaluation. For example, Hollingworth et al. (2012) evaluated 
the cost-effectiveness of different lifestyle intervention to treat childhood obesity by estimating 
the effectiveness of intervention on children’s BMI, and extrapolating BMI trajectories to 
estimate lifetime healthcare costs. Hollingworth et al. (2012) suggest that the study may have 
either under or over exaggerated the cost-effectiveness of intervention as treatment effects had 
the potential to change over time and effectiveness evidence was obtained from short term 
RCTs (<2 years) with outcomes measured at a single follow up interval.  
The indirect estimation of lifetime effects is likely to be more appropriately informed through 
studies designed to identify effects on repeated developmental outcomes in time 
series/longitudinal databases. Growth curve models are a group of analytical techniques applied 
to time series data which can identify changes in developmental effects over time (Curran et al., 
2010). Specifically, growth curve models establish inter-individual (between people) differences 
in intra-individual (within person) change (Curran et al., 2010):  
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Figure 3.2: Displays development trajectories for four hypothetical children using four observations within each 
individual over time. For simplicity the line of best fit has only linear terms, but these can be extended to quadratic, 
cubic, exponential etc. depending upon the function of change. 
Initially, growth curve models use longitudinal data to identify development trajectories for each 
child in a sample. Development trajectories are latent (unobserved) functions describing the 
trend in development outcomes within each child over time. A line of best fit is used to calculate 
each individual development trajectory as illustrated in Figure 3.2. Growth curve models then 
calculate an average development trajectory across all individuals within a sample by estimating 
the mean intercept and mean gradient of change, as shown in Figure 3.3. In growth curve 
modelling the mean trajectory is also known as the fixed effect.  
 
 Figure 3.3: Illustrates the mean (fixed effects) development trajectory for four hypothetical children. Between 
individual changes relate to the variance (random effects) between individual and mean development trajectories in 
terms of intercept and/or gradient.    
 
62 
 
As with linear regression techniques, explanatory variables are introduced into growth curve 
models to explain the variability between individuals and the mean. Residual differences between 
individual trajectories and the mean development trajectory are known as random effects and 
these occur both in terms of variability in intercept and slope (gradient of change over time). 
For example, an explanatory variable such as gender might be introduced into a model to 
determine whether, on average, boys achieve better or worse initial development outcomes than 
girls (intercept), and whether their rate of change (gradient) is expected to be faster or slower 
over time, Figure 3.4. 
By including explanatory variables capturing children’s exposure status to symptoms of 
maternal depression, growth curve models can account for potentially changing effect sizes over 
time and provide an appropriate method to inform indirect estimation in this research. In 
addition to informing the thesis objectives, this form of analysis adds new evidence to the 
existing postnatal/maternal depression literature base. Whilst there are several longitudinal 
studies estimating the effects of postnatal depression on child development into adolescence 
there is less frequent evidence regarding the longitudinal effects of chronic maternal depression 
in studies with large sample sizes (n>1000) (Sanger et al., 2015).   
 
Figure 3.4: A hypothetical growth curve model that illustrates between person differences in within person change 
that are explained through gender. In this example males tend to achieve initially lower developmental outcomes but 
have a steeper gradient of change when compared with females.  
3.2.4 Empirical Study Aims and Research Questions  
The aim of this first stage of the indirect estimation process is to explore the relationship 
between symptoms of maternal postnatal depression on intermediate child development 
outcomes and investigate latency and accumulation hypotheses in a large longitudinal birth 
cohort. 
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This study determines whether the timing and chronicity of depressive symptoms differently 
affects the association between maternal depression and children’s cognitive and socioemotional 
development by estimating growth curve models in time-series data across four observation 
points from infancy (age 3) to early adolescence (age 11).  
The chapter also focuses on the impact of maternal depression symptoms later in childhood 
given their potentially confounding effects. Postnatal depression is a risk factor for future 
depression. Later episodes of maternal depression are not always accounted for in the current 
literature which may explain some of the inconsistent findings in the empirical evidence. This 
chapter attempts to isolate the effects of postnatal depression on child development such that 
evidence may be appropriately used to estimate lifetime effects through indirect estimation 
(chapter five). The chapter also provides recommendation for policy and identifies future 
research directions.  
Given the aims above, the following research questions were devised:  
1. Do symptoms of maternal depression affect children’s cognitive and socioemotional 
development through a latency and/or accumulation model?  
▪ Are symptoms of postnatal depression negatively associated with cognitive and 
socioemotional development up to age 11?  
▪ Are cumulative symptoms of maternal depression after the postnatal period 
negatively associated with cognitive and socioemotional development up to age 
11?  
▪ Does the size of association between symptoms of postnatal/maternal 
depression and children’s cognitive and socioemotional development change 
over time?  
2. Does the timing of symptoms have an impact on the size of association between 
maternal depression and cognitive and socioemotional development up to age 11? 
3.3 Methods 
3.3.1 Study Sample  
Data was obtained from the Millennium Cohort Study (MCS), a longitudinal birth cohort study 
collecting information on 19,000 children born in the UK from 2000-2001 (UoL., 2017). The 
MCS has a disproportionately stratified sample to represent ethnic minorities and the four 
countries within the UK (Plewis et al., 2007). At the date of this research the MCS had 
administered five surveys when children were nine (months), three, five seven and eleven years 
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old. Each of the sweeps obtained detailed information on children’s health, socioeconomic and 
family circumstances through parental questionnaires. Sweeps 2-5 also collected children’s 
scores across several developmental measures within cognitive, socioemotional and physical 
domains. Parents and immediate family members were also questioned in each survey including 
items identifying their health, education, employment, living situation, parenting practices and 
well-being (Plewis et al., 2007). 
In addition to the core MCS database, this analysis merged academic attainment data for Key 
Stage One and Key Stage Two (sweep five) from the MCS Linked Education Administrative 
Datasets (UoL, 2015a), (UoL, 2015b). Academic attainment data was available for 8,500 cohort 
members from England whose parents had consented to data linkage. The available variables 
include an average point score across all English National Curriculum SATs tests and individual 
point scores within each tested subject (Johnson and Setakis, 2015).  
The study sample in this research was limited to natural mothers as children who are not 
biologically related to their parents may have complicated attachment relationships which might 
not be fully accounted for by variables available in the MCS: For example, adopted children are 
often at an increased risk of forming insecure attachment relationships when compared with 
non-adopted children (Van Den Dries et al., 2009). The study was also limited to analysing a 
maximum of one child from multiple births (i.e. twins/triplets) to avoid double counting effects 
for individual mothers.  
3.3.2 Variables  
3.3.2.1 Socio-emotional Development   
 Socioemotional development refers to children’s capacity to form relationships with 
others and their ability to regulate and appropriately express emotions (Halle and Darling-
Churchill, 2016). As suggested by Halle and Darling-Churchill (2016) socioemotional capacities 
might be characterised by four (overlapping) subdomains: social competence describes the ability of 
children to successfully interact with others; emotional competence is the ability to understand the 
emotions of others; behaviour relates to the ability of children to act in an appropriate way 
consistent with their emotions; and self-regulation relates to attention and control of behaviour.   
It may not be appropriate to obtain a direct measure of socioemotional development from 
children as they are not good at objectively recognising and reporting their relationships and/or 
emotions (Atkins-Burnett and Meisels, 2001). Instead, proxy measures provide a useful method 
of assessment and are usually obtained from the observations of individuals close to the child 
e.g. parents, siblings and teachers (Atkins-Burnett and Meisels, 2001).  
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Observational measures of socioemotional development are often based on assessments of 
child behaviour: as outlined above, behaviour is an important socioemotional construct but may 
also reveal characteristics within other subdomains as social, emotional and self-regulatory 
competencies can manifest in chosen behaviours (Atkins-Burnett and Meisels, 2001). 
Behavioural measures are sometimes dichotomised as either externalising behaviours such as 
tantrums and aggressiveness which might indicate adaptive emotional problems, or internalising 
behaviours including social withdrawal, worrying, and excessive clinging which may be 
indicative of affective disorders such as depression or anxiety (Atkins-Burnett and Meisels, 
2001), (Halle and Darling-Churchill, 2016).  
Here, socioemotional development was measured using maternal responses to the Strengths 
and Difficulties Questionnaire (SDQ). The SDQ is a behavioural screening questionnaire for 
children aged 3-16, consisting of twenty-five items each scored from 0-2 (Flouri et al., 2014), 
(Goodman, 2001). While the SDQ was primarily designed for the identification of childhood 
mental health conditions (Vliegen et al., 2014), it has been applied in multiple peer reviewed 
studies as the primary assessment for socioemotional development e.g. Hintermair (2006), Kelly 
et al. (2012), McMunn et al. (2011), and Rogers et al. (2012).  
The SDQ has multiple scales which include: the externalising subscale with ten items relating to 
behaviours such as aggression, impulsiveness and lack of control; the internalising subscale 
containing ten items assessing control over thoughts where problems may manifest as social 
withdrawal, depression and anxiety; and the total difficulties scale a continuous measure scored 
from 0-40 on twenty items, these being the sum of the externalising and internalising subscales 
(Goodman, 2001).  
As this empirical research is primarily concerned with the effect of maternal depression on 
global child development this study used the SDQ total difficulties score as the primary 
outcome measure providing the widest assessment of socioemotional behaviours. Secondary 
results were obtained for both the externalising and internalising subscales to establish whether 
effects differ according to different types of behaviour. All socio-emotional outcomes were 
measured at four distinct time points for MCS sweeps 2-5.   
3.3.2.2 Cognitive Development  
 The cognitive domain relates to the development of children’s mental capacities. 
Cognition is defined by Bjorklund and Causey (2017) as the process by which knowledge is 
acquired and manipulated. As cognition is a mental process it cannot be directly measured but 
can be inferred by assessing an individual’s performance on tasks requiring cognitive function 
(Bjorklund and Causey, 2017). Global cognition is difficult to assess as it includes a wide range 
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of diverse capacities (Bjorklund and Causey, 2017) and it is not immediately evident which are 
most significant. For example, researchers might be equally interested in the development of 
specific cognitive abilities such as auditory perception, decision making, intelligence, learning, 
memory, processing speed, quantitative knowledge, reading, retrieval, visual perception and/or 
writing (Alfonso et al., 2005).  
The field of psychometrics is directed at understanding and providing appropriate measures of 
cognition. A pioneering theory in this field was Spearman’s g-factor hypothesis which suggested 
an overarching cognitive ability exists that subsumes all other narrower abilities (Jensen, 1998). 
This theory explained empirical evidence that identified high correlations between tests 
assessing narrower cognitive abilities. It also offered an explanation as to why bright individuals 
tend to repeatedly outperform less bight individuals across a wide range of academic testing 
scenarios (Jensen, 1998). 
The idea of an overarching general cognitive ability has been adopted in modern cognitive theories 
including Carroll’s three stratum theory and Cattell-Horn-Carroll (CHC) theory (Alfonso et al., 
2005). General cognitive ability (GCA) forms the basis of many psychometric tests and 
measures of cognitive development. One example is the British Ability Scales II which test 
children on different scales for verbal, non-verbal reasoning and spatial abilities. A group of 
statistical techniques termed factor analyses are used by psychometric tests to derive an overall 
measure of GCA from scores on underlying subscales (Hill, 2005), Figure 3.5.   
 
 
 
Figure 3.5: Illustrates the derivation of general cognitive ability from tests of narrower cognitive abilities using factor 
analysis. Image adapted from Hill (2005) 
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Table 3.1: Summary of Variables used to Identify General Cognitive Ability  
Measure  Description  
Sweep 2  
    BAS Naming 
    Vocabulary1  
A verbal scale which assesses spoken vocabulary. Children are 
required to identify coloured objects from a booklet. 
  
    Bracken School 
    Readiness Assessment1 
Evaluates children’s readiness for primary school by assessing their 
understanding of 88 basic concepts.   
  
Sweep 3  
    BAS Naming 
    Vocabulary1    
As sweep 2. 
  
    BAS Picture Similarities1 Measures problem solving ability. Children are given a picture and 
asked to place it below the most similar picture from a row of four.  
  
    BAS Pattern 
    Construction1 
Tests spatial awareness by assessing children’s ability to fit together 
flat squares or solid cubes with different patterns on them.  
  
Sweep 4  
    BAS Pattern 
    Construction1 
As sweep 3.  
  
    BAS Word Reading 
    Score1 
Assesses reading ability. Children are asked to read a series of 
increasingly difficult words aloud.  
  
    National Curriculum Key 
    Stage One2 
The average of points scored in academic tests for Key Stage 1 across 
Reading, Writing, Maths and Science.  
  
    NFER Progress in Maths 
    Test 1 
A shortened version of the National Foundation for Education 
Research (NFER) standard Progress in Maths test. Asks children to 
complete mathematical calculations using pencil and paper.  
  
Sweep 5  
    BAS Verbal Similarities1 Measures verbal abilities. Interviewers read three words to the child 
and the child must say how the words are related. 
  
    CANTAB Spatial 
    Memory Task3 
Tests children’s ability to retain information and manipulate 
remembered items in their working memory. Children are asked to 
find a blue token by process of elimination using a computer.  
  
    National Curriculum Key 
    Stage Two2 
The average of points scored in academic tests for Key Stage 2 across 
English, Maths and Science. 
  
Notes:  Full details and descriptions are provided in; Connelly (2013)1; Johnson and Setakis (2015)2; and 
 Atkinson (2015)3. 
Several psychometric testing subscales were administered to participants in the MCS which 
varied in number and type between sweeps. As no psychometric tests were administered in full 
it was not possible to derive GCA using a validated procedure. Connelly (2013) & Jones and 
Schoon (2008) advocate the use of Principal Component Analysis (PCA), a form of factor 
analysis, to identify children’s GCA using the measures that are available in the MCS. The 
process of PCA uses orthogonal transformation (a form of transformation applied in linear 
algebra to matrices) to convert a set of correlated variables to a smaller set of uncorrelated 
principle components (Shlens, 2014). PCA might be considered appropriate for the cognitive 
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variables in the MCS as each assess a higher-level function that is likely to contribute to GCA 
and are commonly included constructs in validated psychometric tests (Hill, 2005).  
This study extended the methods suggested by Connelly (2013) and Jones and Schoon (2008) 
by incorporating academic attainment scores for Key Stage 1 and Key Stage 2 as variables 
informing PCA. The inclusion of academic attainment variables was considered appropriate as 
GCA is strongly predictive of performance on school as well as psychometric tests (Jensen, 
1998). The academic attainment variables included in this analysis were mean points scores 
across subjects of English, Maths and Science – average performance across these subjects is 
thought likely to assess a range of higher-level cognitive abilities like those assessed in 
psychometric tests. In total the analysis conducted PCA at four separate occasions to identify 
four different GCA variables for sweeps 2-5. Details of all the variables used to identify GCA 
are provided in Table 3.1. 
3.3.2.3 Maternal Variables  
Symptoms of maternal depression/psychological distress were identified at each of the 
five sweeps. For sweep one, the MCS collected mothers’ responses to the reduced 9-Item 
Rutter Malaise Inventory. This asked mothers if, in general, they felt tired, miserable, worried, 
violent, scared, irritated, jittery, or nervous and whether they often suffer from a racing heart. 
Positive responses to each item were given a score of one, and a total score was derived by 
summing the responses. A threshold of four or more was used to identify symptoms of postnatal 
distress (PND) (Dex and Joshi, 2004).  
Symptoms of maternal distress were identified in sweeps 2-5 based on questionnaire responses 
to the Kessler-6 index which asked mothers how often they feel hopeless, restless, that 
everything is an effort, worthless and nervous. Each item is scored from zero “none of the 
time” to four “all of the time” according to the frequency at which the item occurred. A total 
score ranging from 0-24 was obtained by summing each item. A threshold of thirteen or above 
was adopted to indicate the presence of significant psychological symptoms (Prochaska et al., 
2012). Both the 9-Item Rutter Malaise Inventory and the Kessler-6 Index are detailed in 
Appendix 3.1 
3.3.2.4 Child and Family Variables 
 The MCS provided a variety of child and family characteristics that were used as 
covariates in the statistical models. As this was a longitudinal study, the covariates could either 
be defined as time invariant or time variant. Time invariant covariates were assumed to remain 
constant over the study period (i.e. their values could not change for subsequent sweeps). These 
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were obtained during the birth sweep and included the biological sex of the child, the child’s 
ethnicity and the total number of siblings the child had at birth. In contrast, time variant 
covariates are variables that could change across sweeps and were therefore collected at four 
observation points between sweeps 2-5. These included the child’s age (in months) at SDQ 
assessment, the mother’s employment and education status, and low family income status. All 
covariates were derived from the MCS parental response questionnaires and are detailed in 
Table 3.2. The choice of covariates was informed though a literature review conducted by Bell 
(2014), who identified variables in the MCS related to the individual and their environment that 
were likely to influence cognitive and socioemotional development. The inclusion of these 
variables is consistent with the theoretical literature reviewed in chapter two. 
Table 3.2: Summary of Child and Family Covariates 
Measure  Description  
Time Invariant (Sweep 1)  
    Biological Sex Dichotomous variable identifying the child’s biological sex at birth 
(male/female). 
  
    Ethnicity  Categorical variable grouping a child’s ethnicity at birth as either: 
White British; Mixed Race; Indian; Pakistani or Bangladeshi; Black; or 
Other.  
  
    Siblings Categorical variable indicating the total number of siblings a child had 
at birth. The four categories were: zero; one; two; three or more.  
  
    Maternal Age at Birth Continuous variable identifying the age of the mother at child birth.  
  
Time Variant (Sweeps 2-5) 
    Age  Continuous variable identifying the age of a child (to the nearest 
month) at each SDQ assessment. 
  
    Mother’s Employment Dichotomous variable identifying whether the mother is in 
employment (yes/no).  
  
    Mother’s Education Categorical variable for the mother’s highest education level achieved 
at each sweep. Education is grouped by UK National Vocational 
Qualification Scale: None; NVQ level 1; NVQ level 2; NVQ level 3; 
NVQ level 4; NVQ level 5; overseas qualification 
  
    Family Income Dichotomous variable identifying whether the family income falls 
below 60% of the UK median (yes/no).  
  
    Single Mother  Dichotomous variable identifying whether the mother is in a 
relationship with another individual living in the child’s household 
(yes/no). 
3.3.2.5 Omitted Variables  
 Several other variables could not be included as covariates in the growth curve models 
as they were not measured in the MCS dataset, comprising: maternal/child genetic markers, 
maternal depression/mental health symptoms during the antenatal period, and maternal 
cognitive/personality assessments. Each of these variables may potentially confound the 
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observed relationship between PND and child development as they are identified risk factors 
for maternal PND (Stewart et al., 2003) which could separately predict effects on child 
development outcomes.  
An additional two potentially confounding variables were measured in the MCS but were not 
included as covariates to avoid over specifying/complicating the analysis. Infant temperament 
was measured on the Carey Infant Temperament Scale at the 9-month sweep, and whilst likely 
to strongly predict children’s later development was considered unlikely to have a strong 
confounding effect given the classification of  infant temperament as a relatively minor risk 
factor for PND (Stewart et al., 2003). Paternal depression symptoms (measured equivalently to 
maternal symptoms throughout the MCS) are likely to be correlated with maternal depression 
symptoms (Nutall et al., 2019) and are detrimentally associated with children’s later 
development (Ramchandani et al., 2005). However, Nuttall et al. (2019) suggest the 
interdependent nature of maternal and paternal PND requires dyadic data analytic models if 
including both as covariates in a single regression equation – the application of dyadic data 
models within an already complex growth curve modelling specification was beyond the scope 
of this analysis.   
3.3.3 Statistical Methods 
3.3.3.1 Underlying Growth Curve Models   
 Growth curve models were fit to the data using a multi-level linear regression 
framework: multi-level regression models are designed to account for different levels of 
hierarchical data where observations are nested within groups (Curran et al., 2010). Typical 
linear regression models do not account for nested data as they only incorporate one source of 
residual variance. In contrast, multiple residuals are included in the multilevel framework at each 
hierarchical level (Steele, 2008). For instance, the multi-level framework was originally 
developed to analyse educational data, assuming that children are nested in classrooms which 
are nested in schools, by including three sets of residuals one each for children, classrooms and 
schools (Curran et al., 2010).  
Growth curve models can be fit as multi-level regression models by assuming time series data is 
hierarchical. This requires each repeated outcome to be nested within individual children, thus 
incorporating residuals for both repeated outcomes and for children (Curran et al., 2010). This 
research conducted growth curve analysis using multi-level regression for GCA and SDQ 
outcomes separately. Both models included four observation points at sweeps 2-5.  
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A square root transformation was applied to the SDQ outcome variable given its positive skew. 
Justification for this transformation is based on the argument that skewed outcome variables 
can lead to imprecise or biased regression coefficients (Jones, 2010), further justification is 
described in the results section when conducting residual diagnostics. All analyses were 
conducted using the computer software STATA. 
The growth curve models were fit in several stages as recommended by Curran et al. (2010). 
First, an underlying fixed effects growth function (mean development trajectory) was fit by 
averaging effects across individual development trajectories. The estimation of a fixed effects 
growth function required specification of a time metric (i.e. a variable to denote when an 
observation occurred). For SDQ outcomes the time metric was defined as the child’s age when 
outcomes were measured. Likelihood ratio tests were used to determine whether the fixed 
effects function was best represented by constant, linear, or quadratic terms for age. For GCA, 
no single time metric could be defined as multiple tests were administered at different intervals. 
Therefore, time was entered as a categorical variable using the average age of all children within 
each of the sweeps.  
Second, random effects terms for the intercept and for the gradient were fit which allowed the 
covariance between an individual’s observations to depend on the timing of the measurement 
(Steele, 2008). Likelihood ratio tests were used to assess the significance of each random effect. 
At this stage each model was also tested using unstructured, autoregressive and exponential 
covariance structures. The most appropriate covariance structure was selected as the one with 
the lowest Akaike Information Criteria (Steele, 2008).  
Next, between-individual differences were identified by adding child and family covariates to 
the underlying growth function, thus establishing a conditional growth curve. It was anticipated 
that differing covariate categories might non-identically influence the rate of future 
development. For example, whilst the average development trajectory for boys and girls is likely 
to follow a similar shape over time, it is unlikely that the gradient of change is identical. To 
allow for these differences, interaction terms were tested between each covariate and the time 
metrics in the model. Likelihood ratio tests were used to identify significant interactions and 
non-significant interactions were dropped from the model on the grounds of parsimony.  
Finally, two separate growth curve models were estimated for each of the GCA and SDQ 
outcomes which differed in terms of the specification of the maternal distress variable 
(described below). Two separate specifications were designed as this allowed investigation of 
different research questions relating to (i) the pathway of effect between maternal depression 
and child development (latency or accumulation hypotheses) and (ii) whether the timing of 
exposure was important. Interactions were assessed between each maternal distress variable and 
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the time metrics in both model specifications. Further detail on growth curve modelling using 
multilevel regression is described in Curran et al. (2010) and Steele et al. (2008). 
3.3.3.2 Specification of Growth Curve Model 1 
Growth Curve Model 1 addresses the first research question – to determine whether 
symptoms of maternal depression affected children’s cognitive and socioemotional 
development through a latency and/or accumulation model.  
The latency model was investigated by including a time invariant explanatory variable to 
determine the influence of postnatal depression symptoms on child development outcomes. 
Symptoms of postnatal distress (PND) were assigned if mothers scored above threshold on the 
9-Item Malaise Inventory during sweep one.   
A second explanatory variable evaluated the accumulation hypothesis and was thus named 
cumulative distress. This time-variant variable was obtained by summing the total number of times 
that mothers had scored above threshold on the Kessler 6 index between sweeps 2-5. Each 
child’s outcome was adjusted for cumulative distress up to the time of the observation but not 
after e.g. outcomes at sweep four were adjusted for accumulated symptoms of distress for 
sweeps two, three and four, but not adjusted for symptoms at sweep five. For more clarity 
Table 3.3 illustrates (hypothetical) maternal distress trajectories and the associated value for the 
cumulative distress variable at each sweep.    
Table 3.3: Example Coding Scheme for the Cumulative Distress Variable 
Maternal Depression 
Trajectory (Sweeps 2-5) 
 
Value of Cumulative Distress variable 
 Sweep 2 Sweep 3 Sweep 4 Sweep 5 
N2N3N4N5 0 0 0 0 
D2D3D4D5 1 2 3 4 
D2N3D4N5 1 1 2 2 
N2D3N4D5 0 1 1 2 
N2N3D4D5 0 0 1 2 
Key:  N2=No depression symptoms during sweep 2 
 D3=Depression symptoms during sweep 3 
Notes:  Cumulative Distress variable is time variant and can take different values at each sweep. The value of the 
 variable is obtained by summing total instances of depression symptoms up to the current sweep, 
 beginning at sweep two: For example, a mother with depression trajectory D2D3D4D5 would have 
 cumulative distress equal to 1 at Sweep 2 (D2); 2 at Sweep 3 (D2 + D3), 3 at Sweep 4 (D2 + D3 + D4) and 4 
 at Sweep 5 (D2 + D3 + D4 + D5).  
 
The β coefficient attached to the cumulative distress variable was interpreted as a continuous 
regression coefficient: it identified the impact per each additional episode of maternal distress. 
Therefore, a significant β coefficient would predict that more frequent episodes of distress were 
73 
 
associated with larger effect sizes, providing evidence of a dose dependent relationship between 
symptoms of distress and SDQ/GCA outcomes. The coding for the cumulative distress 
variable follows methods by McCoach and Kaniskan (2010) who use growth curve models to 
evaluate the impact of an intervention on longitudinal measures of children’s reading fluency. 
3.3.3.3 Specification of Growth Curve Model 2 
Growth Curve Model 2 estimates the association between children’s GCA/SDQ scores 
and different trajectories of maternal distress, a method commonly used in the literature. 
Allocating mothers to trajectories is a method commonly used in the literature (for examples see 
Brennan et al. (2000) and Vliegen et al. (2014)) and enabled comparison of different exposure 
groups for combined postnatal and maternal distress symptoms. This was useful for objective 
two, which assessed whether the timing of depression symptoms was important.  
Trajectories were initially defined by splitting mothers into groups according to whether they 
had symptoms of PND or not. It was then assumed that mothers followed trajectories of no, 
episodic, or persistent symptoms between sweeps 2-5. Episodic trajectories were defined 
(arbitrarily) as infrequent symptoms and were assigned if mothers scored above threshold one 
or two times on the Kessler 6 Index between sweeps 2-5. Persistent trajectories were frequent 
symptoms assigned if mothers scored above threshold three or four times between sweeps 2-5.  
The six maternal depression trajectories are described below:  
1. No symptoms if mothers were below threshold across all sweeps 
2. PND symptoms & no further symptoms if mothers were above threshold during sweep 1, 
and below threshold for sweeps 2-5 
3. No PND symptoms & episodic depression if mothers were below threshold during sweep 1, 
and above threshold either one or two more times for sweeps 2-5 
4. PND symptoms & episodic depression if mothers were above threshold during sweep 1, and 
above threshold either one or two more times for sweeps 2-5 
5. No PND symptoms & persistent depression if mothers were below threshold during sweep 
1, and above threshold either three or four more times between sweeps 2-5 
6. PND symptoms & persistent depression if mothers were above threshold during sweep 1, 
and above threshold either three or four more times for sweeps 2-5 
Each maternal distress trajectory was specified as a time-invariant dummy variable which 
assumed that mothers followed the same trajectories throughout the study (i.e. mothers could 
not move from having persistent depression to episodic depression). Pairwise comparisons were 
used to identify significant effects between groups. The cumulative distress variable was not 
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included in Growth Curve Model 2 as later symptoms of distress were accounted for within the 
trajectories. 
3.3.3.4 Interpreting Results  
Parameter estimates, standard deviations and confidence intervals were obtained for 
each model with outcomes predicted for children aged three, five, seven, and eleven. These 
were estimated by appropriately centering the time metrics used in the model. For example, to 
predict outcomes for children aged three, the time metrics were coded as time equal to the age 
at SDQ outcome minus three (years). The methods used for making time-specific predictions in 
growth curve models followed recommendations by Biesanz et al. (2004). 
As SDQ model predictions were made on the square root scale, where appropriate, incremental 
effects were back transformed onto the raw scale: average marginal effects were estimated in 
STATA using the “margins” command. These effects were then squared, to obtain the 
incremental differences on the raw scale.3 Back transformed outcomes were compared to 
models where no transformation was applied to confirm their legitimacy.   
3.3.4 Data Imputation 
As data was obtained from a longitudinal study which predominantly used large self-report 
questionnaires it was anticipated that there would be a large amount of missing data. As missing 
data can result in parameter estimates being inefficient and biased (Briggs et al., 2003) this 
analysis used imputation methods to obtain complete databases. Multiple imputation by chained 
equations (MICE) was applied assuming that the data was Missing at Random (MAR) (Briggs et 
al., 2003), (White et al., 2011).  
The MAR assumption requires the missing data to either occur randomly or for any systematic 
changes to be explained through characteristics within the observed dataset (Briggs et al., 2003). 
Whilst it is not possible to formally test the MAR assumption, it is likely that the non-random 
missing data in the MCS could be explained through a variety of the other child/family variables 
included in the analysis. For example, missing data might occur more often for lower income 
                                                     
3 In some cases, back transformations may be biased if they do not include the addition of a constant known as a 
smearing estimator. Smearing estimators might be required if the back transformations affect the predicted mean, and 
these typically occur for multiplicative functions (e.g. exponential) or through additive effects of polynomial 
functions (e.g. square, cube etc.). Smearing estimators are not required for back transformations of incremental 
effects in square models as was applied in this analysis. Further information on smearing estimators is provided by 
Buntin et al. (2004) and Jones (2010). 
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families and this lower probability might be identified through other observed socioeconomic 
variables e.g. employment and education status.  
The MICE procedure predicts missing values based on an individual’s observed values using 
multivariate regression. Here, separate regression equations were estimated for all variables 
including outcomes. Where possible each equation incorporated observations for the missing 
variable from the previous and subsequent sweeps, for example, the regression equation to 
predict the SDQ outcome at sweep three included SDQ outcomes at sweeps two and four in 
the explanatory variable vector.  
Predictive mean matching (PMM) was used on all SDQ scores and the 9- Item Rutter Malaise 
Inventory to ensure feasible values were imputed (White et al., 2011). The variables for 
cumulative maternal distress were derived after imputation to ensure that the value of each 
variable was possible according to the observed scores identified in previous sweeps (i.e. the 
imputed cumulative value could not decrease across subsequent sweeps).  
The imputation process was repeated 10 times to generate 10 imputed databases. Each model 
was estimated on all of the imputed databases and combined into a single estimate using 
Rubin’s law (Royston, 2004), (Rubin, 2004), (White et al., 2011). As suggested by Young and 
Johnson (2015), data was imputed for cases where observations were missing within sweeps and 
was also imputed for observations where individuals did not reply to entire sweeps.  
Growth curve models do not require all observations within an individual to be present for that 
individual to be included in the analysis (Kwok et al., 2008), therefore the impact of missing 
data was likely to be minimal in this analysis. It was considered most appropriate to report 
primary results for the complete case database, and secondary results for the imputed databases: 
complete case analysis is often appropriate as the primary analysis where the impact of missing 
data is negligible (Jakobsen et al., 2017).  
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3.4 Results  
3.4.1 Descriptive Summary  
3.4.1.1 Response Rates  
 Responses were obtained from 14,501 mother-child dyads during sweep one of the 
MCS. Of these, 9,206 (65.46%) responded to all subsequent sweeps. The response rates 
between sweeps varied and was lowest for sweep five. A lower number of responses were 
recorded for the GCA outcomes as data was only available for English respondents, compared 
with UK response for the SDQ variables. Table 3.4 summarizes response rates for the non-
imputed database across all sweeps in the MCS. 
Table 3.4: Total Number of Questionnaire Responses 
   Any 
Item   
SDQ Response GCA Response 
Sweep 1 
Sweep 2 
Sweep 3 
Sweep 4 
Sweep 5 
14,501  
13,305  
13,629  
12,564  
11,526  
N/A 
12,957 
13,450 
12,404 
11,279 
N/A 
5,619 
6,555 
6,803 
5,850 
All Sweeps  9,206  8,830 4,618 
3.4.1.2 Identifying General Cognitive Ability  
 There was a high level of correlation observed between psychometric and academic 
variables. The correlations within each sweep ranged from -0.20 (between the CANTAB Spatial 
Working Memory Tasks and BAS Verbal Abilities subscale at sweep five) to 0.72 (between BAS 
Word Reading Score and Key Stage 1 Average Points Score at sweep four). All within sweep 
correlation coefficients for the cognitive variables are reported in Table 3.5  
Principal component analysis was performed separately on four occasions for sweeps 2-5. The 
PCA procedure condenses a vector of variables to a smaller vector of variables by analysing the 
correlations matrix between variables using linear algebraic matrices rotations (Steger et al., 
2006). Variables making up the vector of condensed factors are termed principal components. Each 
PCA analysis across a vector of n variables produces n-1 principal components and each 
principal component explains a different proportion of the total correlation between the 
original variables. It is typical for analysts to discard principal components that explain a small 
proportion of the total variance. Significant principal components are often identified if their 
associated Eigenvalue is greater than one, or by analysing a Scree plot of Eigenvalues (Steger et 
al., 2006).  
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Table 3.5: Within Sweep Correlation Matrices for all Cognitive Variables 
Sweep 2 
 Bracken 
SRA  
BAS NV   
Bracken School Readiness Assessment  1.00    
BAS Naming Vocabulary (NV) 0.56 1.00   
     
 
Sweep 3 
    
 BAS NV BAS PS BAS PC  
BAS Naming Vocabulary 1.00    
BAS Picture Similarities (PS) 0.31 1.00   
BAS Pattern Construction (PC 0.36 0.36 1.00  
 
Sweep 4 
    
 KS1 AP  NFER 
Maths  
BAS PC BAS WR  
Key Stage 1 Average Points (KS1 AP) 1.00    
NFER Progress in Maths  0.57 1.00   
BAS Pattern Construction (PC) 0.45 0.49 1.00  
BAS Word Reading (WR)  0.72 0.54 0.33 1.00 
 
Sweep 5 
    
 KS2 AP BAS VS CANTAB 
SP 
 
Key Stage 2 Average Points (KS2 AP)  1.000    
BAS Verbal Similarities (VS) 0.45 1.00   
CANTAB Spatial Memory (SP  -0.41 -0.20 1.00  
 
Table 3.6: Principal Component Analysis Results 
 
 
 
Eigenvalue  % of Variance 
Explained 
Cumulative % 
of variance 
explained  
Is solution a 
significant 
component?  
Sweep 2 (n=12,990)     
Component 1  1.58 79 79 Yes 
Component 2 0.42 21 100 No 
     
Sweep 3 (n=14,277) 
Component 1 1.64 55 55 Yes 
Component 2 0.72 24 79 No 
Component 3 0.64 21 100 No 
     
Sweep 4 (n=6,844) 
Component 1 2.57 64 64 Yes 
Component 2 0.72 18 82 No  
Component 3 0.45 11 93 No 
Component 4 0.26 7 100 No  
     
Sweep 5 (n=5,879) 
Component 1 1.72 57 57 Yes 
Component 2 0.80 27 84 No  
Component 3 0.48 16 100 No 
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Eigenvalues (Table 3.6) and scree plots (Appendix 3.2) in this analysis identified a single 
(unrotated) significant principal component for each of the sweeps two, three, four and five. 
This single component explained at least 50% of the variance between the cognitive variables 
within each sweep (Table 3.6).  
It was assumed that each significant factor identified in the PCA represented GCA at each 
sweep. This assumption was justified as mean group GCA scores followed trends that are 
typical for cognitive variables in UK data (Jones and Schoon, 2008), where higher scores were 
associated with girls, children with higher family income, and children who were not from an 
ethnic minority group, Table 3.7. The face validity of GCA variables were further illustrated by 
the high level of correlation between variables for each of the sweeps, Table 3.8.  
Table 3.7: Between Sweep Correlation Matrix GCA  
 GCA Sweep 2 GCA Sweep 3 GCA Sweep 4 GCA Sweep 5 
GCA Sweep 2 1.000    
GCA Sweep 3 0.5158 1.000   
GCA Sweep 4 0.4874 0.5995 1.000  
GCA Sweep 5 0.4466 0.5284 0.7273 1.000 
 
The PCA results were consistent with those obtained by Jones and Schoon (2008) who also 
identified a single factor explaining correlations between cognitive variables in the MCS. This 
provided further vindication for their use as cognitive outcome variables here. All GCA 
variables were transformed to a common scale with mean=100 and standard deviation=15, 
which is often used for cognitive variables e.g. IQ.  
Table 3.8: Mean GCA Scores by Covariate Category 
 GCA  
Sweep 2 
GCA  
Sweep 3 
GCA 
 Sweep 4 
GCA  
Sweep 5 
Biological Sex 
    Male  
    Female  
 
98.06 
101.93 
 
98.87 
101.16 
 
99.36 
100.6 
 
99.93 
100.06 
 
Family Income 
     <60% median UK income  
     >=60% median UK income 
 
 
93.02 
103.35 
 
 
94.19 
102.99 
 
 
93.44 
103.017 
 
 
93.39 
102.75 
 
Ethnicity 
     White  
     Not White  
 
 
101.64 
89.22 
 
 
101.39 
92.57 
 
 
100.82 
96.84 
 
 
100.71 
97.05 
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3.4.1.3 Imputation Results 
Missing values occurred through non-response to complete sweeps and non-response 
to items within sweeps. The number of participants with at least one missing value increased 
with each subsequent sweep and totalled 8,246 by sweep five. Multi-response variables GCA, 
SDQ, the 9-Item Rutter Malaise Inventory, and the Kessler-6 inventory were responsible for 
the largest amounts of missing data. Table 3.9 summarises the missing data in each variable 
across all sweeps. 
Table 3.9: Total Number of Imputations per Variable per Sweep 
  
Variable  Sweep 1 Sweep 2  Sweep 3 Sweep 4 Sweep 5 
GCA N/A 1392 551 333 1444 
SDQ N/A 1544 1051 2097 3222 
Malaise Inventory Total Score  578 N/A N/A N/A N/A 
Kessler 6 Inventory  N/A 3393 2649 3765 5090 
Family Income  N/A 1777 1996 3261 3793 
Mother Employment Status  N/A 1758 1955 3254 4196 
Single Mother  N/A 1787 1955 3254 3793 
Maternal Age  3 N/A N/A N/A N/A 
Mother Education  No missing values 
Child Ethnicity  No missing values  
Child Gender   No missing values  
Child Age  No missing values  
Number of Siblings  No missing values  
      
At least 1 Imputation (all variables) 582 3661 5253 6611 8246 
 
 
 
Figure 3.6: Histograms illustrating the distribution of observed (coloured) and imputed (clear) values for: sweep two 
SDQ externalising scale (top left); sweep two SDQ internalising scale (top right); sweep one Rutter 9-item malaise 
index (bottom left); and sweep two for the Kessler 6 index (bottom right).  
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3.4.1.4 Distribution of Covariates by Exposure Groups  
 When compared with mothers with no symptoms, children exposed to symptoms of 
PND were more likely to be from an ethnic minority group; had a higher proportion of 
mothers who were unemployed, not married and had no educational qualifications; and had 
larger families with lower household incomes. This combination of factors suggests that the 
exposure groups were imbalanced for important characteristics that may affect development, 
despite differences between individual characteristics being relatively small. Table 3.10 
summarises the distribution of covariates for sweep one (if time invariant) and sweep two (if 
time variant) by exposure status to symptoms of PND. 
Table 3.10: Baseline Characteristics by Postnatal Depression Exposure Status 
 Child Not Exposed to 
 PND Symptoms  
Child Exposed to  
PND Symptoms   
Total Number (n) 12,029 2,034 
 
Child Biological Sex (%) 
 Female  
 Male  
 
 
49.17  
50.83 
 
 
47.20  
52.80 
Child Ethnicity (%) 
 White  
 Mixed race 
 Indian  
 Pakistani or Bangladeshi  
 Black  
 Other  
 
87.38 
2.69 
1.97 
4.17 
2.84 
0.95 
 
82.35 
3.10 
3.15 
7.52 
3.00 
0.88 
Total Number of Siblings (%) 
 0 
 1 
 2  
 3+ 
 
43.26 
34.83 
14.88 
7.02 
 
37.36 
35.35 
18.14 
9.14 
Household Income1 (%) 
 <60% of UK Median  
 >=60% of UK Median 
 
28.35  
71.65 
 
43.62  
56.38 
Mothers Education Qualifications1 (%) 
  NVQ 1 
  NVQ 2 
  NVQ 3 
  NVQ 4 
  NVQ 5 
  Overseas 
  None 
 
7.60 
28.91 
15.34 
31.04 
4.19 
2.12 
10.79 
 
10.18 
29.96 
15.69 
20.46 
2.66 
3.74 
17.31 
Mother is Single Parent1 (%) 
 Yes 
 No 
 
14.84  
85.16 
 
23.68  
76.32 
Mother is in Employment1 (%) 
 Yes  
 No 
 
56.38  
43.62 
 
42.65 
57.35 
 
Mother’s Age at Child Birth (mean) 
 
28.77  
 
27.59 
Notes:  Values for time variant covariates1 were obtained at sweep two.  
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3.4.1.5 Trajectories of Mean Outcomes over Time  
In general, SDQ total difficulties scores appeared to follow a curvilinear trajectory with 
respect to time decreasing between the ages of three and five, remaining relatively constant 
thereafter. As expected GCA scores remained relatively stable as variables for each sweep were 
centred with mean equal to 100. Children exposed to symptoms of PND had higher (worse) 
unadjusted mean SDQ total difficulties scores and lower (worse) unadjusted mean GCA scores 
than children whose mothers did not have symptoms of PND where incremental differences 
were equal to 3.20 (SDQ)  & -3.78 (GCA) (sweep two), 3.08 & -2.31 (sweep three), 3.14 &  -
3.19 (sweep four), and 3.06 & -2.88 (sweep 5). Similarly, differences in unadjusted mean SDQ 
total difficulties and GCA scores were identified for children who were exposed to at least one 
episode of maternal depression during sweeps 2-5, Figure 3.7. 
 
 
Figure 3.7: Unadjusted mean SDQ total difficulties (left) and GCA (right) scores for sweeps 2-5 and associated 95% 
confidence intervals by: exposure status to symptoms of postnatal distress (top); exposure status to at least one 
episode of symptoms of maternal distress (bottom). Unadjusted scores provide face validity to the adjusted growth 
curve models.  
3.4.2 Specification of Underlying Growth Function  
3.4.2.1 Specification of Time Metrics  
 There was large variation in the age at which children’s SDQ measurements were 
obtained across each MCS sweep, as illustrated in Table 3.11, with age ranges for sweeps two 
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(eldest= 55 months) and three (youngest=53 months) overlapping. This justified the use of age 
at the time of SDQ assessment as the time metric rather than using discrete variables to signify 
which sweep measures were reported in. An additional quadratic time metric was specified as 
age2. It was not possible to obtain children’s age at GCA measurement as the GCA variable was 
derived from multiple test scores conducted at different points in time. Consequently, the 
growth curve models for GCA outcomes used sweep number as a discrete indicator for time. 
Table 3.11: Summary Statistics of Children’s Age (in months) at SDQ Measurement 
 Mean SD Youngest Eldest Range 
Sweep 2 37.65 2.46 32.02 55.00 22.98 
Sweep 3 62.63 2.99 53.00 74.04 21.04 
Sweep 4 86.76 2.96 76.01 98.07 22.06 
Sweep 5 134.07 3.94 122.07 148.11 26.03 
3.4.2.2 Transformation to SDQ outcome Variables  
Square root transformations were applied for each SDQ outcome and compared to 
non-transformed outcomes in a random intercepts model (which included covariates for age, 
gender, ethnicity and family income). The most appropriate specification for the outcome 
variables were determined by assessing whether any modelling assumptions were violated i.e. if 
residuals were not normal or evenly distributed around the error terms. The square root 
transformation was adopted as it was found to be an improvement on the non-transformed 
outcomes: level 1 residuals deviated from the normal distribution for the non-transformed 
model, but not the square root transformed model. Diagnostics plots for the transformed/non-
transformed SDQ total difficulties scale are illustrated in Figure 3.8.   
 
Figure 3.8: Residuals plots for random intercepts models comparing non-transformed (top) and square root 
transformed (bottom) SDQ total difficulties outcomes. Plots are provided for quantile normal plot (left) and scatter 
diagrams of standardised vs. fitted level 1 residuals (middle) and standardised vs. fitted level 2 residuals (right)  
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3.4.2.3 Growth Equations  
As SDQ scores followed a curvilinear trajectory, models were fit with linear and 
quadratic terms for the time metrics (age and age2). A model which included both linear and 
quadratic terms was found to significantly fit the data better than the model with only the linear 
term (Likelihood Ratio test p<0.001), Figure 3.9. Given that time metrics for the GCA 
outcomes were categorical the growth function was specified using dummy variables for sweeps 
2-5 (i.e. whether the observation occurred at sweep x (yes/no)). 
Next, random effects were added for each time metric. Random effects for age and age2 (SDQ) 
and sweep number (GCA) were found to be significant (p<0.001) using likelihood ratio tests. 
The final underlying growth models for SDQ and GCA outcomes are described in Equation 
3.1a & 3.1b. An unstructured covariance matrix was selected for each outcome variable as 
likelihood ratio tests suggested it to produce the best model fit when compared with first order 
autoregressive and exponential covariance structures.  
 
Figure 3.9: Predicted SDQ Total Difficulties Scores vs. age for 10 individuals for models with linear (red) and 
quadratic (green) terms for age.  
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Equation 3.1a: Underlying Growth Curve Specification for SDQ outcomes 
 Y1/2ij= β0j + β1jtij + β2jtij2 + eij 
 β0j= β0 + u0j  β1j= β1 + u1j  β2j= β2 + u2j 
Equation 3.1b: Underlying Growth Curve Specification for GCA outcome 
 Yij= β1jS2ij + β2jS3ij+ β3jS4ij+ β4jS5ij+ eij 
 β0j= β0 + u0j  β1j= β1 + u1j  β2j= β2 + u2j  β3j= β2 + u3j  β4j= β2 + u4j 
For individuals:   
 j= (1, .., n)  with observations i =(1, 2, 3, 4) 
Where:  
 Y=  SDQ or GCA scores 
 t=  age centred at Sweep 5 (age of child at SDQ measurement – 134 months) 
 S2=  Sweep two (yes/no)  
 S3=  Sweep three (yes/no)  
 S4=  Sweep four (yes/no)   
 S5=  Sweep five (yes/no) 
 e= Level 1 residuals 
 u= Level 2 residuals  
 
3.4.3 Specification of Conditional Growth Curves  
Conditional growth curves were estimated by adding covariates to the underlying growth 
function. Covariates were added one at a time and were all statistically significant (p<0.05) for 
the square root SDQ total difficulties outcome, while all covariates excluding the employment 
status of the mother were significantly associated with children’s GCA score, Table 3.12.   
Interaction terms were tested between each covariate and each model’s time metrics, the 
significance of which is summarised in Table 3.12. Adding an interaction term between 
covariates and the time metric allowed the effect of the covariate to differ according to the age 
at which the observation occurred. In contrast covariate effect sizes remain constant across all 
sweeps where no interaction with time is specified.  
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Table 3.12: Explanatory Variables Included in SDQ and GCA Growth Curve Models  
 SDQ  GCA  
 Covariate  Time 
Interaction  
Covariate  Time 
Interaction  
Time metrics     
 Age Yes N/A N/A N/A 
 Age2 Yes N/A N/A N/A 
 Sweep Number  N/A N/A Yes N/A 
Maternal Depression Variables      
 Postnatal Depression Symptoms  Yes Yes Yes Yes 
 Maternal Distress Symptoms  Yes Yes Yes Yes 
Covariates      
 Child Biological Sex  Yes Yes Yes Yes 
 Child Ethnicity  Yes Yes Yes Yes 
 Maternal Age at Child Birth  Yes Yes Yes Yes 
 Number of Siblings  Yes No Yes Yes 
 Household Income Yes Yes Yes Yes 
 Maternal Education  Yes Yes Yes Yes 
 Single Mother  Yes Yes Yes No 
 Mother Employment Status   Yes No No  No 
Notes:  Time interaction specified as an interaction term between the explanatory variable and the relevant time 
 metric(s). All explanatory variables and time metrics were included in growth curve models if t-test results 
 indicated the variable to be statistically significant (p<0.05).  
 
3.4.4 Growth Curve Model 1 Results  
The following results section focuses specifically on the effects of postnatal and maternal 
depression symptoms on children’s development outcomes. The full regression results 
reporting coefficients for all covariates can be found in Appendix 3.3.  
3.4.4.1 Postnatal Symptoms  
Symptoms of maternal distress occurring during the postnatal period were significantly 
associated with increased (square root) SDQ total difficulties scores. Incremental differences 
between those exposed (n=1706)/ not exposed (n=10,098) to symptoms of distress remained 
constant for children aged three (0.38, p<0.001) to eleven (0.39, p<0.001), Figure 3.10 & Table 
3.13. The age eleven exposure effect was estimated to equate to 2.07 on the SDQ raw scale 
following back transformation.  
Children exposed to symptoms of maternal distress during the postnatal period were also 
associated with significant increases in both SDQ subscales: incremental differences between 
postnatal distress and (square root) SDQ internalising scores increased with each subsequent 
sweep with largest differences occurring at age eleven (0.32, p<0.001) (Figure 3.10); while 
(square root) SDQ externalising scores effect sizes diminished, but remained statistically 
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significant by age eleven (0.23, p<0.001). Interpretations remained consistent when comparing 
results for the imputed and non-imputed datasets for all outcomes, Table 3.13.  
There were no statistically significant differences identified in GCA scores for those children 
exposed to postnatal symptoms (n=4682) vs. those not exposed (n=775). A null effect was 
observed across each of the four sweeps and for both the complete case and imputed databases, 
Table 3.13, Figure 3.10. 
 
 
Figure 3.10: Incremental effect sizes and 95% confidence intervals from Growth Curve Model 1. Compares children 
exposed to symptoms of postnatal distress vs. non-exposed children for all square root transformed SDQ (top) and 
GCA (bottom) outcomes.   
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Table 3.13: Mean Incremental Effects in Children Exposed to PND vs. Not Exposed  
 Coefficient  95% Lower 
CI 
95% Upper 
CI 
Pr>|z| 
SQRT SDQ Total Difficulties 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed) 
 
0.38  
0.37  
0.37  
0.39  
0.34 
 
0.33  
0.33  
0.32  
0.32  
0.28 
 
0.42  
0.42  
0.43  
0.45  
0.39 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001  
<0.0001 
GCA 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed)  
 
-0.65  
-0.28  
-1.03  
-0.27 
-0.85 
 
-1.69  
-1.40  
-2.18  
-1.51 
-2.00 
 
0.40  
0.84  
0.11  
0.98 
0.29 
 
0.2306 
0.5614 
0.0862 
0.6733 
0.1541 
SQRT SDQ Internalising Scale 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed)  
 
0.28 
0.29  
0.30  
0.32 
0.29 
 
0.24  
0.25  
0.25  
0.26 
0.24 
 
0.32  
0.34  
0.34  
0.39 
0.35 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
SQRT SDQ Externalising Scale 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed) 
 
0.27  
0.27  
0.26  
0.23 
0.21 
 
0.24  
0.22  
0.21  
0.18 
0.16 
 
0.32  
0.31  
0.31  
0.29 
0.25 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Notes:  Results obtained from Growth Curve Model 1 for the complete case database across all sweeps, 
 and imputed databases (in italics) for Sweep 5.  
 SDQ (all scales) n=11,804 (n=16,033); GCA n=5,457 (6,643). 
3.4.4.2 Accumulated Symptoms of Distress 
  A positive and statistically significant association was identified between (square root) 
SDQ total difficulties scores and accumulated symptoms of maternal distress occurring during 
sweeps 2-5. The coefficient attached to the cumulative distress variable decreased from 0.37 
(p<0.001) at age three to 0.25 (p<0.001) for children aged eleven, Table 3.14. The age eleven 
cumulative distress effect size was equal to 1.19 on the raw SDQ total difficulties scale 
following back transformation.  
Accumulated symptoms of distress were associated with reduced GCA scores and these were 
also statistically significant. Largest effects were observed at sweep two -2.05(p<0.05) which 
persisted until sweep five -1.83 (p<0.001), Table 3.14. Results were consistent on both the SDQ 
externalising and internalising scales and all interpretations remained constant across complete 
case and imputed databases.  
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Table 3.14: Mean Effect per Episode of Maternal Distress Symptoms (Sweeps 2-5)  
 Coefficient  95% Lower 
CI 
95% Upper 
CI 
Pr>|z| 
SQRT SDQ Total Difficulties 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed) 
 
0.37  
0.35  
0.32  
0.25  
0.26 
 
0.29  
0.30  
0.27  
0.21  
0.23 
 
0.44  
0.39  
0.36  
0.29  
0.29 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001  
<0.0001 
GCA 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed)  
 
-2.05  
-1.91  
-1.59  
-1.83 
-1.29 
 
-4.06  
-3.16  
-2.15  
-2.62 
-1.99 
 
-0.05  
-0.66  
-0.11  
-1.05 
-0.58 
 
0.0263 
0.0024 
0.0021 
<0.0001 
0.0005 
SQRT SDQ Internalising Scale 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed)  
 
0.28 
0.30  
0.29  
0.22 
0.23 
 
0.21  
0.25  
0.24  
0.18 
0.20 
 
0.36  
0.34  
0.33  
0.27 
0.27 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
SQRT SDQ Externalising Scale 
 Sweep 2  
 Sweep 3  
 Sweep 4  
 Sweep 5 
 Sweep 5 (Imputed) 
 
0.27  
0.24  
0.21  
0.16 
0.17 
 
0.21  
0.20  
0.17  
0.13 
0.14 
 
0.34  
0.28  
0.25  
0.20 
0.20 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Notes:  Table reports beta coefficient attached to the Cumulative Distress Variable, indicating the mean 
 impact per episode of maternal depression for sweeps 2-5. Results obtained from Growth Curve 
 Model 1 for the complete case database across all sweeps, and imputed databases (in italics) for 
 Sweep 5.  
 SDQ (all scales) n=11,804 (n=16,033); GCA n=5,457 (6,643). 
 
The effect of repeated exposures to maternal distress is illustrated in Figure 3.11, which depicts 
the predicted (square root) SDQ and GCA scores for Growth Curve Model 1 for a set of 
hypothetical trajectories of maternal distress symptoms. Predicted (square root) SDQ and GCA 
scores are affected most largely for children whose mothers suffer from persistent distress 
(symptoms at sweeps one, two, three, four and five), then episodic symptoms (arbitrarily 
defined as symptoms at sweeps one, two and four) and lastly for children whose mothers suffer 
from distress only during the postnatal period (sweep one).  
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Figure 3.11: Plots the predictions of Growth Curve Model 1 for four hypothetical individuals for sqrt SDQ total 
difficulties (top) and GCA (bottom). Predictions are obtained for children whose mothers suffer from (1) no 
symptoms of postnatal or maternal distress, (2) symptoms of postnatal distress but not maternal distress, (3) 
symptoms of postnatal distress and episodic symptoms of maternal distress which occur at sweeps 2 & 4 (but no 
symptoms at sweeps 3 & 5), and (4) symptoms of postnatal distress and persistent symptoms of maternal distress at 
sweeps 2, 3, 4 and 5. Each individual is assumed to have the following reference case covariate characteristics: child 
gender= female; child ethnicity= white; child siblings at birth=0; mother’s qualification= NVQ level 2, mother’s 
income= not below 60% of median, mother’s age= 28, mother’s relationship status=married; mother’s work status= 
not in work).  
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3.4.5 Growth Curve Model 2 Results 
Growth Curve Model 2 grouped children according to their mother’s trajectory of symptoms 
through sweeps 1-5. To further investigate the effects of PND three pairwise comparisons were 
made between mothers’ distress trajectories. Comparisons were made between trajectories 
which reported the same frequency of symptoms after the postnatal period but differed 
according to PND symptoms:  
1. No PND with no further symptoms (SDQ n=6548/GCA n=3516) vs. PND with 
no further symptoms (SDQ n=736/ GCA=383) 
2. No PND with episodic maternal symptoms (n=372/203) vs. PND with episodic 
maternal symptoms (n=229/120) 
3. No PND with persistent maternal symptoms (n=23/15) vs. PND with persistent 
maternal symptoms (n=62/34) 
The effect of PND symptoms on (sqrt) SDQ total difficulties scores at sweep five appeared to 
be dependent on the presence of later depression: if no later depression occurred then PND 
had a significant impact (0.37, p<0.01); there was no significant difference between children 
whose mothers had later episodic depression with or without PND (0.11 p>0.05); while 
children whose mothers had persistent depression with PND scored lower than those without 
PND (-0.04, p>0.05), Figure 3.12. No effects were identified in any of the pairwise comparisons 
for the GCA outcomes where each incremental effect size was not significantly different to zero 
(p<0.05). 
 
 
Figure 3.12: Incremental effect sizes identified in pairwise comparisons between maternal distresses trajectories. 
Later episodic symptoms were defined as 1-2 episodes of distress between sweeps 2-5; later persistent symptoms 
were defined as 3-4 episodes of distress between sweeps 2-5. Results are obtained at sweep five (age eleven) for 
square root SDQ Total Difficulties (left) and GCA (right). 
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As with results from Growth Curve 1, when compared with groups who had no symptoms of 
depression between sweeps 2-5, substantial effects were identified for children exposed to 
episodic and persistent symptoms. These results are presented in full in Appendix 3.4. 
3.5 Discussion  
3.5.1 Interpretation of Results  
3.5.1.1 Key Findings 
The results from this study suggest that symptoms of maternal depression may affect 
child development, at least up to the age of eleven. Symptoms of PND were significantly 
associated with socioemotional but not cognitive development outcomes when adjusting for 
symptoms of maternal distress occurring later in childhood. The study provided no evidence of 
increasing/diminishing effects for PND on child development, rather the incremental effect 
sizes for both SDQ and GCA outcomes remained consistent across all sweeps.  
3.5.1.2 Latency Model  
There was no evidence suggesting that the immediate postnatal period is specifically 
critical for the effects of maternal depression on child development. Symptoms of PND were 
associated with increased internalising, externalising and global socio-emotional problems, but 
effects were not distinct from the effects of symptoms occurring during later sweeps. 
Furthermore, negligible differences were identified for children exposed/not exposed to 
symptoms of PND if their mothers suffered from later episodic or persistent depression.  
No association was found between PND and children’s cognitive development at any age.  
Interestingly, PND was initially associated with detrimental effects to GCA (solely for a latency 
model), but these were attenuated by later cumulative distress when this variable was added to 
Growth Curve Model 1. These results demonstrate the importance of adjusting for later periods 
of depression when attempting to identify effects occurring specifically during the postnatal 
period.  
The results from this study are largely consistent with the existing literature. In a systematic 
review Kingston and Tough (2014) concluded that, between ages 2-8, socioemotional but not 
cognitive development was likely to be affected by symptoms of postnatal depression, finding 
no evidence for increased sensitivity during the postnatal period. Meanwhile Sanger et al. (2015) 
reviewed longitudinal studies that reported (non-significant) associations between postnatal 
depression and increased internalising and externalising symptoms in adolescents aged 11-16. 
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The increased precision resulting from the larger sample size used here may explain why these 
results were statistically significant.  
Inconsistencies were identified with studies by Murray et al. (2011) and Hay et al. (2008) who 
found an association between symptoms of postnatal depression and cognitive/academic 
outcomes in adolescence. Differences in study design may explain these discrepancies. For 
instance, PND symptoms were measured here at nine months following birth compared with at 
six weeks (Murray et al., 2011) and three months (Hay et al., 2008). Furthermore Murray et al. 
(2011) did not account for maternal depression after the postnatal period and both studies used 
diagnosis of depression rather than symptoms of distress as the postnatal exposure.  
3.5.1.3 Accumulation of Symptoms  
This study provides robust evidence in support of the accumulation hypothesis. A dose 
dependent relationship was identified between the number of times children were exposed to 
symptoms of maternal distress and worse scores on measures of both cognitive and 
socioemotional outcomes. These results were replicated when mothers were grouped according 
to the frequency of their depression symptoms, with persistent symptoms associated with larger 
effect sizes than episodic symptoms.  
These results extend findings by Brennan et al. (2000) and Kingston and Tough (2014) who 
identified significant effects for chronic maternal depression on early child development. The 
results also provide further vindication for conclusions drawn by Sanger et al. (2015) who, 
based on studies with limited sample sizes, suggested that persistent maternal depression was 
likely to be associated with adverse cognitive and socioemotional outcomes in adolescence.  
The effect of cumulative distress on cognitive and socioemotional outcomes appeared to be 
largest for observations at sweep two and diminished for each subsequent sweep. This might be 
interpreted as evidence that early periods were more sensitive to the effects of maternal distress. 
Alternatively, the reduced marginal effect of cumulative distress during later sweeps may have 
occurred as a result of a dose-dependent response plateauing with each increasing episode. That 
is, the impact of moving from three to four instances of symptoms is less than moving from a 
frequency of one to two. Therefore, the cumulative distress coefficient may have been larger in 
earlier sweeps given the lower maximum frequency of symptoms associated with these sweeps. 
This latter interpretation is supported by results from Growth Curve Model 2 which identified 
differences between PND and no PND which decreased in size with the increased frequency of 
later symptoms.  
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3.5.2 Policy Implications  
The negative impact of maternal depression on child development is likely to have implications 
for health policy. Measures of socioemotional development such as the SDQ can provide an 
indication of children’s mental health status, for example, Furber et al. (2014) suggest that SDQ 
scores represent child utility and map SDQ onto the Children’s Health Utility-9 scale in an 
Australian sample. Additionally, and as outlined in chapter two, increasing evidence links child 
development with prosperity during adulthood across health (Campbell et al., 2014), education 
(Rabiner et al., 2016), crime (Frisell et al., 2012) and employment (Heckman, 2006). Health 
technologies that prevent the exposure of children to maternal depression symptoms, therefore, 
have the potential to be cost-effective by both improving early life health whilst also reducing 
the detrimental effects of PND on children’s later lifespan development. Typical treatments for 
depression include psychological and pharmacological therapy and there is evidence from 
several randomised studies suggesting that both can significantly reduce depression 
symptomatology in postnatal women (Cuijpers et al., 2008).  
There is also promising evidence suggesting treatment benefits for maternal symptoms may 
translate into benefits on child outcomes. In a meta-analysis of randomised studies Cuijpers et 
al. (2015) identified the effects of psychological therapy for PND versus a relevant control (e.g. 
usual care) on both maternal and child outcomes. The meta-analysis by Cuijpers et al. (2015) 
included nine studies measuring treatment effects on maternal depression outcomes, seven of 
which also measured effects on behavioural, emotional or mental health screening 
questionnaires for children between ages of nine months and two years. Results by Cuijpers et 
al. (2015) identified significant reductions in maternal depression symptoms following 
psychological therapy (standardised effect size g=0.66) and significant reductions on children’s 
mental health symptoms where effects sizes were around two thirds (g=0.40) of those observed 
on maternal outcomes.  
The translation of treatment effect across maternal and child outcomes is likely to be mediated 
through the mother-child attachment relationship, thus providing an alternative target for PND 
intervention. The meta-analysis by Cuijpers et al. (2015) included a third analysis which 
identified a significant effect for psychological therapy (vs. control) on outcomes measuring the 
quality of mother-child interactions. Effect sizes (g=0.38) were almost equivalent to the effect 
size on child outcomes (g=0.40). Parenting interventions target the maternal-child attachment 
relationship and there is some empirical evidence identifying positive effects for these 
interventions on toddlers’ emotional and behavioural development outcomes (Fitelson et al., 
2011). Treatment for depression and parenting interventions need not be delivered in isolation. 
As suggested by Goodman (2004) the most effective intervention strategy for reducing the 
94 
 
effects of postnatal depression on child development might be an integrated approach that 
offers psychological/pharmacological treatment for postnatal depression alongside parenting 
interventions.  
While there is evidence demonstrating the benefits of intervention during the postnatal period, 
the results from this study suggest that children are at most risk if they are exposed to 
accumulated symptoms over time. The largest treatment benefits are likely to be achieved for 
health technologies which target chronic maternal depression occurring throughout child 
development. It is the view of Goodman and Garber (2017) that the benefits of parenting 
interventions could be maintained across childhood through annual visits which provide 
mothers with skills relevant to the child’s developmental stage. Similarly, large treatment 
benefits could be achieved through pharmacological/psychological therapy if these reduce the 
probability of depression reoccurrence. There is currently a sparsity of randomised literature 
identifying the long-term effects of depression treatments/parenting interventions and this 
should be an objective for future research.  
Finally, health technologies which screen women for postnatal depression soon after birth could 
enable the timely delivery of treatments and may enhance the early child attachment relationship 
and prevent detrimental exposure to maternal depression symptoms. Current guidelines 
regarding the cost-effectiveness of screening for postnatal depression do not formally account 
for effects of depression on children (NICE, 2018). The cost-effectiveness of this guidance is 
reassessed in an economic evaluation in chapter six using evidence from this chapter to inform 
some of the model’s parameters.  
3.5.3 Methodological Considerations for Indirect Estimation 
With respect to the overarching aim of the thesis, this chapter demonstrates methodologies 
appropriate for the first stage of indirect estimation where the effects of an early life 
circumstance (exposure to PND symptoms) were estimated on intermediate lifespan 
development endpoints. This empirical analysis could inform the design of future research as it 
addresses three methodological challenges likely to be faced by other researchers whose 
objective is to (indirectly) identify the lifetime effects associated with early life circumstances 
through effects to lifespan development. 
Firstly, this analysis accounts for potential temporal changes in lifespan development effects 
sizes by estimating growth curve models in time series data. The use of growth curve modelling 
is desirable for indirect estimation as it can provide evidence to justify/dispute assumptions 
regarding the continuation of the indirect effect pathway (from early life circumstances to 
intermediate child development measures and through to lifetime decision endpoints). The 
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results of this analysis identified consistent effect sizes between postnatal depression symptoms 
and both cognitive and socioemotional endpoints between the ages of three and eleven, which 
might suggest a persistent effect for postnatal depression on child development outcomes. 
Therefore, it might be reasonable to assume that the detrimental effects of postnatal depression 
symptoms continue beyond the study time horizon, into adolescence and further into 
adulthood. It would not have been possible to obtain this information from traditional study 
designs which identify effect sizes at a single follow up period.   
Secondly, there is a question regarding the selection of outcome measures which can 
appropriately act as intermediate lifespan development endpoints for indirect estimation. 
Because development is such a vast process, no single measure is available, instead analysts rely 
on measures specific to the cognitive, socioemotional and/or physical domains. Researchers 
should search the literature to establish which domains are most likely to be affected by the 
specific early life circumstance under investigation. Both theoretical and empirical literature 
links cognitive and socioemotional development to maternal postnatal depression (e.g. (Bowlby, 
1978), (Brennan et al., 2000), (Sanger et al., 2015)), which led to the investigation of these 
domains in this analysis. 
This analysis adopted global measures to characterise all the lifespan development effects within 
the cognitive and socioemotional domains. As informed through the psychometric literature 
GCA is a cognitive construct that underlies performance on narrower skills, whilst the SDQ 
total difficulties scale combines scores for both emotional and behavioural problems. In general, 
it is important for global development measures to be adopted as intermediate endpoints for 
indirect estimation as a focus on more specific abilities could risk underestimating effect sizes. 
This risk is illustrated by comparing results of the different SDQ outcomes for Growth Curve 
Model 1 where the detrimental effects associated with postnatal depression were lower in 
magnitude for the narrower Externalising and Internalising subscales when compared with the 
Total Difficulties scale. Methods in this analysis, which used PCA to identify GCA might be 
applicable to other research settings as it is not uncommon for longitudinal cohort studies to 
administer incomplete psychometric scales or apply different types of cognitive tests across 
sweeps as in the MCS.  
Thirdly, the results from this chapter demonstrate the complicated pathways of effect which can 
occur between early life circumstances and lifespan development outcomes. Inappropriate 
specifications of empirical models could result in the identification of different effect sizes. For 
example, the effects of postnatal depression may have been overestimated if it had been 
assumed that the pathway of effect was solely accounted for by a latency model.  As was 
previously described the effect of PND symptoms on cognitive outcomes were found to be 
completely attenuated by the addition of accumulated maternal depression symptoms after the 
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postnatal period. Analysts should consult the existing evidence base to identify the most 
plausible pathway of effect which is likely to be complex and specific to the early life 
circumstance under investigation.  
The methods applied in this analysis could be extended by accounting for the interacting effects 
which may occur between cognitive and socioemotional development outcomes. Multivariate 
growth curve models include more than one outcome variable within the same model (Curran 
et al., 2012) and could simultaneously identify GCA and SDQ development trajectories. By 
incorporating more complex error structures multivariate models can establish the covariance 
between domain specific outcomes (Curran et al., 2012), capturing the cross productive effects 
between outcomes in different domains (i.e. the influence of cognitive development on 
socioemotional development and vice versa).  
A multivariate model which incorporates three intermediate lifespan development outcomes 
with global measures in each of the cognitive, socioemotional and physical domains would 
provide the most complete approach when identifying the developmental effects associated 
with early life circumstances for indirect estimation. Such a model would be desirable as it could 
account for the holistic nature of lifespan development. 
3.5.4 Limitations  
There were several limitations regarding the measures used in this study. Firstly, the 9-item 
Rutter malaise instrument and the Kessler-6 Index were used to measure symptoms of maternal 
distress and are not diagnostic instruments. Therefore, this study could only confirm that 
mental health symptoms rather than diagnoses were associated with child development. As similar 
results have been obtained on instruments with diagnostic validity, such as the Edinburgh Post 
Natal Depression Scale (Sanger et al., 2015), it might be reasonable to assume that effects of 
depression symptoms translate to those with a depression diagnosis.    
Secondly, interpreting differences in effect sizes between sweep one and sweeps 2-5 was 
problematic given that different instruments with different scales were used to identify distress 
symptoms. The validated threshold for the Kessler 6 index (>=13) identifies cases of severe 
maternal distress (Prochaska et al., 2012), while the 9-item Rutter malaise index identifies 
moderate symptoms (Dex and Joshi, 2004). Results were obtained for a lower threshold value of 
the Kessler 6 Index (>=5) which, as suggested by Prochaska et al. (2012) is a non-validated 
indicator of moderate symptoms. Interpretation results remained consistent across the higher and 
lower thresholds, results for the lower threshold model are reported in Appendix 3.5 
97 
 
Thirdly, this study used maternal reports for SDQ outcomes which may have resulted in 
reporter bias if depressed mothers over- reported their child’s socioemotional problems. Some 
discrepancies have been identified between maternal/non-maternal reported outcomes (Leis et 
al., 2014). However, in their review Leis et al. (2014) find evidence that effects of maternal 
depression on socioemotional development occur independently of reporting errors, and 
Kingston and Tough (2014) find that significant effects remain in most studies that use non-
maternal report. Leis et al. (2014) even suggest that depressed mother might be more accurate 
reporters than non-depressed mothers according to the depressive realism hypothesis.  
Finally, as this was not an experimental study a causal relationship between maternal distress 
symptoms and child development cannot be confirmed. It is possible that omitted confounding 
factors explain the observed relationships, for instance: antenatal depression is associated with 
an increased risk of PND and is also associated with child development (Kingston and Tough, 
2014), (Sanger et al., 2015). It is unlikely that the entire effect sizes identified in this analysis are 
explained by antenatal depression as several studies have established effects for maternal 
depression before and after birth on global child development measures within the same model 
(Kingston and Tough, 2014). Similarly, paternal PND is correlated with maternal PND and 
detrimentally associated with child development outcomes (Ramchandani et al., 2005). 
However, evidence from Nuttall et al. (2019) suggests the effects of paternal symptoms may 
occur indirectly through their influence on maternal symptoms. Thus, the inclusion of paternal 
symptoms in an interdependent model might enhance (rather than confound) the effects of 
maternal depression.  
3.5.5 Conclusions  
When placing the results from this longitudinal analysis within the context of existing research 
there is compelling evidence linking maternal depression with effects to child socioemotional 
and cognitive development. This study identified an association between postnatal depression 
symptoms and child development; however, there was no evidence to suggest that the 
immediate post-natal period was critical. Rather, larger effects were identified if children were 
exposed to repeated symptoms that may have accumulated throughout their early development. 
Children are likely to be at highest risk if their mother suffers from postnatal depression and 
develops later chronic depression. Screening for maternal depression soon after birth could 
provide an early opportunity for intervention which may reduce the exposure of children to 
harmful depressive symptoms.  
The methods used in this chapter inform the first stage of a larger methodology estimating the 
lifetime effects associated with postnatal depression. This empirical analysis could be used to 
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inform the design of future research which attempts to establish the lifetime effects associated 
with other early life circumstances.  
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Chapter 4: A Scoping Review Identifying Mathematical Models 
Predicting the Lifetime Health and Economic Outcomes of Child 
Development 
4.1 Summary  
The analysis in the previous chapter addressed the first stage of indirect estimation and 
identified the effects of postnatal depression on intermediate endpoints for children’s cognitive 
and socio-emotional development. The current chapter focuses on the second stage of indirect 
estimation which requires effects on lifetime decision endpoints to be predicted from the 
previously identified effects on intermediate development measures. Mathematical modelling is 
often used in economic forecasting and could be appropriate when forecasting lifetime effects if 
models can appropriately characterise the relationship between cognitive and socio-emotional 
outcomes and the relevant decision endpoints for economic evaluation. This chapter describes a 
scoping review aiming to identify an appropriate mathematical model from existing literature. 
Upon failing to identify any fully relevant studies the search criteria of the review are extended, 
and a second aim is devised, namely, to inform the design of future research (in chapter five) by 
identifying key modelling characteristics through a thematic analysis. Figure 4.1 depicts the 
contribution of evidence in this chapter towards the overall estimation of lifetime effects in this 
thesis.  
 
 
Figure 4.1: Demonstrates how this chapter contributes to the overall estimation of lifetime effects. 
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4.2 Introduction  
4.2.1 Quantitative and Qualitative Forecasting  
Indirectly estimating the lifetime effects of early life circumstances requires an appropriate 
method to predict how unit changes on intermediate outcomes translate to unit changes on 
lifetime decision endpoints. Specifically, the applied example in this thesis requires predictions 
of expected Quality Adjusted Life Years (QALYs), lifetime healthcare costs, monetary 
costs/savings in government sectors outside of health, and economic productivity effects from 
unit changes in children’s Strength and Difficulties Questionnaire (SDQ) and General Cognitive 
Ability (GCA) scores. In the economics literature, predictions of this type are often referred to 
as economic forecasts.  
In general, forecasting can be approached from either a quantitative or qualitative basis 
(Bowerman et al., 2005), (Makridakis et al., 2008). Quantitative forecasts make future 
predictions based on the analysis of historical data, whereas qualitative forecasts are identified 
from the subjective opinions of individuals, usually experts (Bowerman et al., 2005). Due to 
their subjective nature, the reliability of qualitative forecasts can be questioned. Makridakis et al. 
(2008) suggest that qualitative forecasts could be useful when predicting a range of possibilities 
but are less useful when identifying point estimates and should only be used for this purpose if 
quantitative data is scarce or unavailable.  
Quantitative forecasting is selected as the more applicable forecasting approach in this research 
as the ultimate purpose for estimating lifetime effects is to inform parameter estimates in an 
applied economic evaluation – which is itself a predominantly quantitative exercise.  
4.2.2 Mathematical Models for Forecasting in Economic Evaluation  
Mathematical models in their broadest sense are descriptions of systems using mathematical 
language and concepts and are therefore useful tools for obtaining quantitative forecasts. A 
large variety of models exist; the most common types used in economic forecasting include 
decomposition models, dynamic models, exponential smoothing models, linear regression 
models and time series models (Bowerman et al., 2005), (Makridakis et al., 2008).  
Mathematical models could provide an appropriate method when forecasting effects from 
intermediate endpoints to final decision endpoints in economic evaluation (Brennan and 
Akehurst, 2000), (Buxton et al., 1997), (Garnett et al., 2011). Examples of mathematical models 
applied to forecasting lifetime outcomes in economic evaluation include the UKPDS Outcomes 
simulation model which is used to estimates lifetime QALYs and healthcare costs by modelling 
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the pathway between multiple earlier risk factors and the onset of diabetes (Clarke et al., 2004); 
a model by Oster et al. (1999) which uses logistic regression models to account for the pathway 
between cholesterol and coronary heart disease; and the National Heart Formulation model 
which simulates the lifetime BMI related healthcare costs for a hypothetical cohort of 50,000 
children (McPherson, 2007) and is used by Hollingworth et al. (2012) when assessing the cost-
effectiveness of lifestyle interventions to treat overweight and obesity in children.  
Appropriate models should characterise the different diseases, processes and relationships 
occurring between intermediate and final decision endpoint as illustrated in Figure 4.2. There is 
likely to be a complicated relationship between intermediate developmental outcomes and 
lifetime decision endpoints: adulthood outcomes such as health and employment are influenced 
by lifestyle factors (e.g. smoking, diet, exercise etc.) and capabilities (e.g. cognitive function, 
personality, motivation). Factors and capabilities are determined by the lifespan development 
process which continues throughout adolescence and early adulthood.4  An appropriate 
mathematical model used to forecast lifetime effects for indirect estimation should account for 
these processes between intermediate outcome and final decision endpoint.   
 
 
Figure 4.2: Illustrates the path from indirect estimation of treatment effect on decision endpoint via a mathematical 
model. The modelling process occurs within the red box where equations are used to establish the pathway and 
relationship between model inputs (intermediate development endpoints) and model outcomes (decision endpoints). 
Figure is adapted from Garnett et al. (2011) (see Figure 1 pp. 516).  
 
4.2.3 Research Objectives 
The purpose of this chapter is to establish an approach for the second stage of indirect 
estimation (see figure 4.1 above). This allows the estimation of the incremental lifetime effects 
of children’s exposure to postnatal depression to be predicted from the intermediate effects 
identified on developmental outcomes in chapter three.  
The primary objective of the research described in this chapter was therefore:  
                                                     
See chapter two sections 2.2.5 & 2.2.6.  
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To identify a mathematical model in the existing literature that could be used to 
extrapolate the previously observed effects of postnatal depression on children’s 
cognitive and socio-emotional development at age eleven (see chapter 3) to lifetime 
decision endpoints.  
As will be reported later in this chapter, no suitable mathematical model could be identified in 
the existing literature. Therefore, additional primary research was required to provide the data 
needed to support the indirect estimation of lifetime effects in this thesis. This extra evidence is 
obtained through mathematical modelling, the results of which are reported in chapter five. 
Consequently, a second objective for the current chapter was devised to enable the design of 
the further primary analysis, namely: 
To conduct a thematic analysis to identify key modelling characteristics that could be 
applied to the design of a primary analysis used to forecast lifetime effects from 
intermediate development outcomes. 
4.3 Methods 
4.3.1 Analytical Approach   
A scoping review was chosen as the method of enquiry to achieve the research objectives. 
Scoping reviews are commonly used to identify the extent of and map literature for novel 
research questions. This contrasts with systematic reviews which are typically used to synthesise 
evidence for more specific research questions e.g. treatment effectiveness, specificity/sensitivity 
of diagnostic tests, prevalence of disease etc. (Arksey and O'Malley, 2005), (Levac et al., 2010).  
To achieve the first objective, the inclusion criteria for the scoping review specifically required 
the estimation of the decision endpoints relevant for economic evaluation i.e. QALYs, 
healthcare costs, cross-sectoral costs and economic productivity. To achieve the second 
objective, the inclusion criteria were relaxed to include models with outcomes that are not the 
specific decision endpoint of interest for economic evaluation i.e. not necessarily QALYs 
and/or healthcare costs but additional clinical or economic endpoints including outcomes such 
as blood pressure, life-satisfaction, and high school graduation success. The scoping review 
therefore included a thematic analysis to identify key modelling characteristics across studies 
identified through the relaxed search criteria. 
The methods used in this chapter followed recommendations in publications by Arksey and 
O'Malley (2005), Colquhoun et al. (2014) and Levac et al. (2010). These studies appraise the 
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methods used for scoping studies and are often cited in published reviews, for instance in 
O'Flaherty and Phillips (2015) and Pham et al. (2014).  
4.3.2 General Iterative Strategy  
Unlike systematic reviews, the search strategy used in scoping reviews can be flexible and 
iterative. This means researchers can reflect upon and repeat search and selection processes 
before defining final eligibility criteria (Arksey and O'Malley, 2005), (Levac et al., 2010). This is 
particularly useful for researchers with novel objectives working within a large literature base as 
strategies can be conducted and refined within subsections of the literature. The final eligibility 
criteria for this review were derived following several iterative searches carried out within a 
single electronic database.  
The general selection strategy was to (i) propose a broad set of inclusion criteria from which a 
search strategy was derived, (ii) apply the search across a single database and (iii) review and 
refine the search strategy over several iterations until a manageable number of results were 
returned. The next phase was to (iv) pilot the broad eligibility criteria across a small number of 
studies (v) review the returned results and (vi) restrict the eligibility criteria if the proportion of 
included studies appeared to be unmanageable. This general strategy is shown in Figure 4.3. 
 
 
Figure 4.3: Illustrates the iterative methods used for devising the final search strategy and eligibility criteria  
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4.3.3 Eligibility Criteria  
For quantitative systematic reviews the acronym PICO (Population, Intervention, Comparator, 
and Outcome) is often used to formulate inclusion and exclusion criteria and design search 
strategies (Cooke et al., 2012). Some of these terms can be irrelevant in scoping reviews, for 
example there may be no intervention or comparator being investigated, as is the case in this 
analysis. Cooke et al. (2012) recommends an alternative acronym SPIDER (Sample, 
Phenomenon of Interest, Design, Evaluation, and Research type) for use in scoping reviews. 
This analysis developed eligibility criteria according to the SPIDER acronym, details of which 
are provided below:  
Study sample: The research objectives required a model which could extrapolate 
intermediate outcomes in mid childhood (around the age of 11) to adulthood. Therefore, the 
study sample was restricted based on the time horizon of the model. Studies were only included 
if the model contained variables for children aged 12 or younger. This was chosen as a cut-off 
point for mid-childhood given that it is usually the maximum age for primary education for 
children in the UK. Studies were also excluded if they did not obtain an outcome during 
adulthood which was defined as age 16 or above. This was chosen as it is the earliest age that 
individuals can leave education and enter employment in the UK.  
Phenomenon of Interest: The review attempted to identify models that captured the effects 
of child development on later life outcomes. Therefore, it was necessary that included studies 
were informed by theoretical literature on child/lifespan development. No restrictions were 
placed on the discipline of the literature (e.g. psychology, health, social sciences etc.). 
Additionally, studies were excluded if their outcomes were restricted to a single disease as they 
were likely to provide models of specific disease processes that may not appropriately model 
development for a general population without the specific disease.  
Design: Studies were excluded if their models were not estimated using real data. This 
meant that all empirical models based on primary observation (e.g. statistical models) were 
included, as well as any evidence synthesis models which combined multiple sources of 
secondary data. Purely theoretical models were excluded.  
Evaluation: Studies were included/excluded according to the outcomes estimated by the 
models. The primary objective specifically required models to estimate QALYs and/or 
healthcare costs as these are key decision endpoints required for economic evaluation 
conducted from both a health and cross-sectoral decision maker’s perspective.5 The secondary 
                                                     
5 For discussion of health and cross-sectoral decision maker’s perspective see Chapter 2 sections 2.2.3 and 2.2.4. 
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objective relaxed the requirements by including studies that predicted outcomes that were 
relevant clinical or economic endpoints. Relevant clinical endpoints were defined as those which 
could either be used to compile QALYs (i.e. mortality/life-years), be used as 
substitutes/surrogates for QALYs/healthcare costs (e.g. blood pressure, BMI), or could 
potentially be mapped onto QALYs (e.g. self-reported measures of wellbeing/life satisfaction). 
Relevant economic endpoints were defined as being either preference-based measures, 
monetary outcomes, or outcomes which could be monetised through secondary literature (e.g. 
number of violent crimes committed, which might be monetised by estimating the mean cost 
per violent crime).  
Research Type: Due to the size of the evidence base, studies were limited to research 
written in English and published after the year 2000. All animal-based studies were excluded.  
4.3.4 Literature Sources and Search Design  
The search strategy was aided by discussions with a qualified librarian, who provided guidance 
on appropriate literature sources, search terms, synonyms and subject headings. In total 6 
electronic databases were searched: MEDLINE, PSYCINFO, ECONLIT, EMBASE, 
MATERNITY & INFANT CARE (Ovid), and CHILD DEVELOPMENT & 
ADOLESCENT STUDIES (Ebscohost). The search included studies published between 1st 
January 2000 and 31st August 2016.  
The search design was based on the broad eligibility criteria (SPIDER) described above. Key 
search terms with their associated SPIDER category were: (1) “Child”- Sample; (2) 
“Development” – Phenomenon of Interest; (3) “Model” – Design; (4) “Economic” – Evaluation.  
Multiple synonyms were included for all key search terms which were obtained from 
thesauruses, similar published literature, and using electronic database subject headings such as 
MeSH terms on MEDLINE. Economic outcomes were identified using published search filters 
designed to locate economic studies specifically from the electronic databases MEDLINE, 
EMBASE and PSYCINFO (Glanville et al., 2008). If no specific search filter was available 
common economic terms were derived from all other filters. Iterative searches were conducted 
to determine adjacency operators that optimised search specificity and sensitivity. The final 
search strategy is summarised below and is described in full in Appendix 4.1.  
1. “Child”, “development” attached with an adjacency operator (n=2) 
2. “Child development” as a subject heading  
3. Specific model types e.g. “mathematical”, “probabilistic” attached to “model” with an 
adjacency operator (n=5) 
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4. Specific modelling features (e.g. “output” or “outcome” or “input” or “variable” or 
“function”), attached with adjacency operator (n=5) 
5. “Model” as a subject heading 
6. Study filter for “economic” studies  
7. Additional economic outcome terms e.g. “cost”, “human capital” “QALY” 
8. 1 or 2  
9. 3 or 4 or 5 
10. 6 or 7 
11. 8 and 9 and 10  
The results of the final search strategy for each of the 6 databases were imported into the 
citation manager Endnote 7.0. Due to time constraints the strategy did not involve hand 
searching journals, searching grey literature or looking through reference lists. The extent to 
which this limits the review is discussed later. The full search and screen strategies were 
conducted by the author. Regular meetings were held with two senior researchers throughout all 
stages of the review. This allowed for discussion of any methodological issues that were 
identified and helped resolve any ambiguous results.  
4.3.5 Study Screening  
Study screening was performed in two phases. First the title and abstract of all studies identified 
in the systematic search were screened and discarded if they failed to meet the final eligibility 
criteria. Decisions on study inclusion/exclusion were made using Screening Form 1 (Appendix 
4.2a). To minimise error, studies were progressed to the second screening phase if there was any 
uncertainty regarding their eligibility. The second screen was performed using Screening Form 2 
(Appendix 4.2b) on full texts for all studies that remained following the initial screen. Each 
study was read in full and included in the review if it met the eligibility criteria.  
4.3.6 Data Charting  
Data charting is a method used in scoping reviews and is comparable to the data extraction 
process utilised in systematic reviews where relevant information is obtained using a common 
framework applied to all studies (Arksey and O'Malley, 2005). The process is iterative as pilot 
forms are tested on a small number of studies and are refined and retested to produce the final 
data charting form (Levac et al., 2010).  
A single researcher (the author) conducted data charting in this review, aided by regular 
discussions with the larger research team. The iterative process first involved the development 
of a preliminary data charting form which was piloted on two studies. The number of categories 
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in the form was then reduced and piloted on 10 of the included studies and refined further to 
produce the preliminary data charting form.  
Next, the preliminary data charting form was applied to all the studies and obtained detailed 
information on: (i) general study characteristics including the primary author, date of 
publication, article title, the department of the primary author and the stated purpose of study; 
(ii) the development literature informing the study (through a detailed written description); (iii) 
characteristics of the empirical model including categories for study design, the country of the 
study and the statistical methods used; (iv) model variables and the associated age of the 
participants when each variable was measured.  
Finally, the data on the preliminary data charting form was condensed into a final data charting 
form (Appendix 4.3). Condensing the data made it easier to interpret and analyse. This was 
achieved by recoding the data onto a spreadsheet using Microsoft Excel. To recode the data, 
appropriate categories were identified by searching for common repeated responses in the 
preliminary data charting form. The original study data was then sorted according to these new 
categories. Where data could not be condensed into that category it was classified as “other”. 
Each category included in the final data charting form is reported below alongside a brief 
explanation:  
▪ Author: The primary author’s surname.  
▪ Year of Study: The year that the study was published.  
▪ Discipline of Study: The department or discipline of the primary author condensed to 
categories of child development, economics, epidemiology, health, psychology, 
sociology, and other.  
▪ Developmental Theory: It was not possible to clearly identify repeating categories as theory 
was specific and diverse. Instead development was categorised (i) according to the 
author’s perspective on nature-nurture (categories including environmental factors only, 
individual factors only, or both environmental and individual factors) and (ii) according 
to the development domains that were included in the model (physical, cognitive, 
socioemotional, physical & cognitive, physical & socioemotional, cognitive and 
socioemotional, holistic).   
▪ Type of Empirical Model: Model categories included: generalised linear models, structural 
equation models, survival models, dynamic factor models, growth curve 
models/multilevel models, and evidence synthesis models (where more than one 
modelling method was used).  
▪ Time Horizon: The age at which model parameters were collected was recorded as the 
range from earliest child model input to final age of adult outcome.  
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▪ Outcome Sector: Each of the models’ outcomes was classified as occurring in the health 
(yes/no), crime (yes/no), education (yes/no) or employment (yes/no) sectors.  
4.3.7 Data Analysis and Results Synthesis  
Data analysis mapped the general characteristics of all studies included in the review. This was 
performed using tables and graphically representing the condensed study information. All tables 
and graphs were produced on Microsoft Excel. A further analysis was conducted by cross 
tabulating categories form the above data charting form. This allowed patterns to be identified 
that may not have been apparent through the initial mapping. Cross tabulation was performed 
using pivot tables in Microsoft Excel. Given the large number of categories, results are not 
reported for cross tabulations where no relationship was identified.  
4.4 Results  
4.4.1 Results for the Primary Objective 
As concluded in chapter two, the application in this thesis conducts economic evaluation for 
health centric and cross-sectoral decision perspectives, each requiring the adoption of QALYs 
and healthcare costs as decision endpoints. No studies were identified which specifically 
predicted adulthood QALYs and/or healthcare costs from measures of child development. 
Consequently, no studies met the full eligibility criteria for the first objective. Several studies 
were identified which used measures of child development to predict health and economic 
outcomes that are not fully relevant decision endpoints. Three of these studies have made 
substantial contributions to literature linking child development to adulthood outcomes and are 
briefly summarised below.  
Firstly, Cunha and Heckman (2008) and Cunha et al. (2010) contribute to a series of studies 
labelled the “technology of skill formation”. These models define child development as a vector 
of capabilities, ϴt, made up cognitive abilities (such as IQ, attention), non-cognitive abilities 
(such as patience, self-control, temperament and risk aversion etc.), and health stock (e.g. 
propensity for mortality and morbidity). The technology of skill formation incorporates central 
themes from the development literature, where capabilities are produced by genes, the 
environment and investments e.g. education, child healthcare. A multi-staged approach is used 
to model the child development process where a child’s future vector of capabilities (ϴt+1) 
occurs as a function of their current capabilities (ϴt) and investments into these capabilities. 
Upon reaching adulthood ϴt is assumed to determine an individual’s ability to perform tasks 
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and function effectively in economic and social life. The model is used by Cunha and Heckman 
(2008) and Cunha et al. (2010) estimate probabilities of high school graduation and adulthood 
earnings at age 32 in data from the USA. Findings suggest a substantial return on investments in 
child development particularly for educational programs delivered to children from 
disadvantaged backgrounds.  
Secondly, the search identified the “health determinants model” by Hertzman et al. (2001) 
which uses linear regression models to predict adulthood health from a variety of early 
environmental, physical, cognitive, and socioemotional development measures in children aged 
0-7. Hertzman et al. (2001) utilise data from the 1970 British Cohort Study obtaining outcome 
measures of self-rated health on Likert scales when individuals are aged 33. Different empirical 
specifications are used to account for different pathways of effect between child development 
and adulthood health including models which account for the latency and accumulation 
hypotheses (which informed the previous analysis in chapter three). The model establishes an 
association between adulthood health and early child development. Findings by Hertzman et al. 
(2001) have contributed towards a commonly cited theoretical model labelled the life-course 
health development framework which is advocated in Halfon and Hochstein (2002) and Halfon 
et al. (2014).  
Thirdly, mathematical modelling is used by Layard et al. (2014) to predict how child 
development and early life conditions affect adulthood well-being, whilst accounting for early 
environmental family economic and family psychosocial factors. Layard et al. (2014) use a series 
of parallel regression models in the 1958 British Cohort Study to establish the pathway from 
measures of childhood cognitive and socioemotional development at ages 5, 10 & 16 and self-
reported well-being (scored from 1-10) at age 42. The path model includes (i) direct effects 
between child development and adulthood well-being and (ii) indirect effects via a series of 
adulthood outcomes such as income, education, employment, and physical/emotional health 
conditions. Findings indicate that children’s emotional health and early behaviour are the strong 
predictors of several adulthood outcomes including well-being (Layard et al., 2014).  
Whilst these studies contribute significantly to linking child development to adult outcomes, 
they do not specifically predict adulthood QALYs and/or healthcare costs and therefore do not 
provide relevant measures for economic forecasting in this thesis. 
4.4.2 Search and Screen Results for the Second Objective 
As there were no eligible studies for the primary objective, the remainder of the results section 
is directed towards the second objective - a thematic analysis to identify the key modelling 
characteristics that should be applied when forecasting lifetime effects from intermediate 
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development outcomes. The database search was conducted between January 2000 and June 
2016. After duplicates were removed it returned a total of 8,194 potential studies. An additional 
study was identified through prior knowledge of the literature. This left 8,195 studies screened 
for title and abstract, after which, 7,863 citations were discarded as they did not meet the 
eligibility criteria. Full text articles were obtained for the remaining 336 studies which were 
progressed to the second screen.  
For the second objective, 279 studies were discarded upon reading full texts leaving 57 studies 
that met the inclusion criteria. The most common reasons for studies being excluded during the 
second screen were: no empirical model reported (40%); no relevant outcome variables at age 
16 or above (34%); no relevant input variables between ages 0-12 (10%); not informed through 
the child development literature (4%); and any other reasons (12%). The progression of studies 
through the search and screening process for the second objective is illustrated in the PRISMA 
flow chart (Figure 4.4).  
 
 
Figure 4.4: PRISMA flow chart displaying the results of the search and screening process for the second research 
objective. None of the 336 studies that passed the first screen met the eligibility criteria for the first objective.  
111 
 
4.4.3 Mapping Literature  
4.4.3.1 General Study Characteristics  
 A descriptive summary of the general characteristics for each of the 57 studies included 
in the review is provided in Table 4.1. All studies were published between January 2000 and July 
2016 and were evenly distributed between these dates. Most studies were obtained from either 
the USA (n=25), the UK (n=14), or Canada (n=6), and were primarily informed through the 
fields of psychology (n=17), economics (n=13) and epidemiology (n=8).  
 
Table 4.1: Characteristics of Included Studies 
Primary Author Year of Publication Location of Study  Discipline 
Adair, L.  2013 Multiple locations Health Sciences  
Boyle, M.  2007 Canada Human Development  
Chandola, T.  2006 UK  Epidemiology  
Chartier, M.  2010 Canada  Health Sciences  
Creel, M.  2006 USA Economics 
Cunha, F.  2008 USA Economics 
Cunha, F.  2010 USA Economics 
Daniels, M.  2004 Philippines Other 
Dishion, T.  2010 USA  Psychology  
Dubow, E.  2009 USA Psychology  
Engle, P.  2011 Multiple  Human Development  
Fergusson, D. 2004 New Zealand  Psychology  
Ferrer, E. 2004 USA Psychology  
Friedman, H. 2014 USA Psychology  
Frijters, P.  2010 UK  Economics 
Hagger-Johnson, G.  2012 UK  Psychology  
Hagger-Johnson, G.  2011 UK  Epidemiology  
Hampson, S.  2015 USA Psychology  
Hatch, S. 2010 UK  Psychology  
Healey, A. 2004 UK  Economics 
Herrenkohl, T.  2010 USA Sociology  
Hertzman, C.  2001 UK  Epidemiology  
Huang, C. 2011 Mexico  Public Health  
Jimerson, S.  2001 USA Psychology  
Johnson, W. 2006 USA Human Development  
Kuh, D. 2004 UK  Epidemiology  
Kuh, D. 2009 UK  Epidemiology  
Martens, P.  2014 Canada Public Health  
Mason, P. 2010 USA Psychology  
Mason, W. 2007 USA Economics 
Moffit, T. 2011 New Zealand  Psychology  
Moody-Ayers, S.  2007 USA Epidemiology  
Muennig, P. 2009 USA Economics 
Nandi, A. 2014 USA  Epidemiology  
Nikulina, V. 2011 USA Psychology  
Petras, H.  2005 USA Public Health  
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Table 4.1 continued: Characteristics of Included Studies 
Primary Author  Year of Publication Location of Study  Discipline 
Reynolds, A.  2011 USA Human Development  
Risi, S.  2003 USA Psychology  
Roeser, R.  2003 USA Psychology  
Rosa Dias, P. 2009 UK  Economics 
Savage, J. 2002 Multiple  Psychology  
Schoon, I. 2003 UK  Psychology  
Sharieff, W. 2008 Pakistan  Economics 
Shen, K 2014 China Epidemiology  
Slopen, N. 2014 USA Psychology  
Te Velde, S. 2008 Netherlands Economics 
Tran, B. 2015 Canada Public Health  
Tubeuf, S. 2013 UK  Health Sciences  
Vartanian, T.  2005 USA Sociology  
Wodtke, G. 2016 USA Sociology  
World Bank  2003 Multiple  Economics 
 
All the UK studies used data from longitudinal cohorts. These included: the 1931 Lothian Birth 
Cohort (Hagger-Johnson et al., 2012); the 1937 UK Boyd Orr Cohort (Frijters et al., 2010); the 
1946 Medical Research Council National Survey of Health and Development (Kuh et al., 2004) 
(Kuh et al., 2009); the Aberdeen Children of the 1950s Cohort Study (Hagger-Johnson et al., 
2011); the 1958 National Child Development Study (Chandola et al., 2006) (Hatch et al., 2010), 
(Lindeboom et al.), (Rosa Dias, 2009); the 1958 British Cohort Study (Hertzman et al., 2001), 
(Tubeuf et al., 2012); the 1961 Cambridge Study in Delinquent Development (Healey et al., 
2004); and the 1970 British Cohort Study (Layard et al., 2014), (Schoon et al., 2003).   
4.4.3.2 Model Type 
Almost all studies (n=54) used a statistical model as the selected model type. The 
remaining studies used an evidence synthesis framework populated with results from multiple 
sources of secondary data. The most common category of statistical models (n=21) were 
generalised linear models (GLMs) which included ordinary least squares, probit and logit 
models. Other model types included structural equation models (n=15), hierarchical linear 
models (n=5), growth curve models (n=4), dynamic factor models (n=3) and cox proportional 
hazard models (n=2). The statistical model used for each individual study is reported in 
Appendix 4.4. The distribution of model types is illustrated in Figure 4.5.  
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Figure 4.5: A bar chart illustrating the frequency of statistical models used across the included studies. 
 
4.4.3.3 Development Domain  
Model input parameters were defined as variables occurring in childhood (before the 
age of 12) and were used to predict an outcome, for example the vector of independent 
variables in a generalised linear regression model. Most studies (n=42) were categorised as 
holistic as they had input parameters that related to both characteristics of the child and their 
environment.  
The commonest examples of environmental parameters were those associated with children’s 
immediate family, where most studies captured the effects of the family economic (n=45) 
and/or psychosocial (n=27) environment. A smaller number of studies accounted for the wider 
environmental effects on child development, these including parameters relating to the 
children’s neighbourhood (n=12) and their school/peer environment (n=6).  
Each input parameter associated with characteristics of the child (rather than their environment) 
was classified according to whether it fell within the cognitive, socioemotional or physical 
development domain. Examples include IQ/cognitive performance tests (cognitive), 
parent/teacher reports of children’s behaviour (socioemotional) and height and weight 
measurements (physical). In total, 29 studies reported a cognitive input parameter, 29 studies 
reported a socioemotional input parameter, and 21 studies reported a physical parameter. In 
addition, 23 studies reported parameters in more than one domain and 9 studies reported 
parameters in all three developmental domains. The distribution of input parameters by domain 
is illustrated in a Venn diagram in Figure 4.6.  
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Figure 4.6: Venn diagram illustrating model input parameters according to the developmental domain that they fall 
in. Each cross represents an individual study. Studies with parameters in multiple domains are placed in the 
intersection between the relevant domains.  
 
4.4.3.4 Outcomes 
The outcomes of the studies were defined as model parameters occurring in adulthood 
(after the age of 16) predicted or estimated from the model’s input parameters, for example the 
dependent variable in generalised linear regression models. Outcomes were classified according 
to the government sector in which the outcome fell. Several studies predicted outcomes across 
multiple sectors using the same underlying model.  
Health outcomes were most common (n=33) and included measures of self-reported health on 
Likert scales, presence of multiple diseases, healthcare usage, disability adjusted life year, 
surrogate disease markers and mortality. Educational outcomes (n=24) were typically academic 
test scores or total years of education achieved. Outcomes in the employment sector (n=16) 
related to estimations of productivity including human capital, ability to work and employment 
status. Crime outcomes (n=15) were usually related to incarceration rates or risk ratios for 
involvement in crime or risky behaviours.  
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4.4.3.5 Time Horizons 
Model time horizons were calculated as the time from the first model input parameter 
(start) to the last model output parameter (end), representing the maximum time span of the 
model. This was available for 39 of the 57 studies. The mean start age across all studies was 6.34 
years, whilst the mean end age was 33.33 years. The mean time horizon was 28.16 years, but this 
varied substantially as indicated by the large associated standard deviation (16.14 years) and 
range (62 years), Figure 4.7.  
 
 
Figure 4.7: Plotted time horizon of each study. Each line represents an individual study, no colour coding scheme is 
applied. Bars begin at the first reported age of input and the age of final outcome. 
 
4.4.4 Cross Tabulation Results  
4.4.4.1 Development Domain and Outcome Sector  
The distribution of model outcomes according to the domain of the model input 
parameters is illustrated in the Venn diagram in Figure 4.8. A large number (n=20) of models 
predicted effects on multiple outcomes occurring across different sectors. Studies were more 
likely to have outcomes across multiple sectors if their model had input parameters in more 
than one domain. This was particularly evident for the intersection between cognitive and 
socioemotional domains where ten of the seventeen models predicted outcomes in at least two 
sectors.  
The outcome sector of the models appeared to be related to the development domain of their 
input parameters. Cognitive input parameters were estimated in nearly all models (88%) which 
had outcomes in the education sector, and in around half of models with crime, employment 
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and health outcomes. Socioemotional input parameters were frequently estimated in models 
with education (81%) and crime (73%) outcomes, and less frequently estimated in models with 
health (45%) and employment (38%) outcomes. Physical input parameters were regularly 
estimated in models with education (63%) and health (48%) outcomes but were irregularly 
estimated in models with employment outcomes (21%) and were never estimated (0%) in 
models with crime outcomes, Figure 4.9.  
 
 
Figure 4.8: Venn diagram illustrating the development domain of the models input parameters, and the government 
sector of the model’s outputs. Each study is represented by a combination of health, employment, education and 
crime outcomes as illustrated in the Key. Ecological studies are defined as those with only environmental input 
parameters.  
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The type of environmental input parameters remained fairly consistent irrespective of the 
model’s outcome sector. For example, family economic parameters (>=80%) and family 
psychosocial parameters (>=48%) were frequently reported for all outcome sectors, while 
neighbourhood influences consistently occurred in around 20% of studies with crime, 
education, employment or health outcomes. There was a difference in the proportion of studies 
which estimated environmental parameters relating to school and peers which were more 
common if models had outcomes in the crime sector (20%) than in the health sector (6%), 
Figure 4.9.   
 
 
Figure 4.9: Bar charts illustrating the percentage of studies with input parameters in a specified domain, given that 
the model’s outcome occurred in a specified sector. Percentages were calculated by dividing the total number of 
studies with outcomes in sector x and input in domain y by the total number of studies with outcomes in sector x (x 
and y/y). Results are obtained for individual (above) and environmental (below) input parameters.  
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4.4.4.2 Time horizon by development domain and outcome sector 
Study time horizons varied according to the domain of their input parameters. Models 
with physical input parameters had the longest time horizon (mean = 32.89 years), followed by 
models with cognitive input factors (mean =26.69 years), while models with socioemotional 
input parameters had the shortest time horizon (mean = 20.70 years), Figure 4.10. Studies with 
cognitive and physical input parameters had time horizons that varied substantially, while less 
variability was present in studies with socioemotional input parameters. In addition, the mean 
age of model input parameters for the physical domain was younger (5.16 years) when 
compared with cognitive (6.19 years) and socioemotional (6.78 years) domains.  
 
 
Figure 4.10: Time horizon (years) of each study by developmental domains. Each bar represents an individual study. 
Some studies are repeated across domains if their model input parameters occur in multiple domains.  
 
Model time horizons also varied according to the sector in which the model’s outcome fell, 
Figure 4.11.  Models that predicted outcomes in the health sector were typically associated with 
a long-term time horizon with a mean equal to 36.24 years and 6 studies having final outcomes 
that occurred after the age of fifty. This contrasts with models that predicted outcomes in the 
crime sector which had the shortest mean time horizon of 17.4 years and no studies that 
predicted crime outcomes after the age of thirty-three. While less extreme, the time horizon of 
models predicting outcomes in the education sector (mean= 21.11 years) were lower than 
average, and the time horizon for models in the employment sector were higher than average 
(mean=29.5 years). 
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Figure 4.11: Time horizon by outcome sector. Each bar represents a single study and that some studies are repeated 
if they had outcomes across multiple sectors.  
 
 
Figure 4.12: Mean age (years) of final model outcomes by development domain and outcome sector.  
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Time horizons were further investigated by categorising the age of the final outcome according 
to the domain in which their input parameters fell and the sector in which their outcome fell. 
There appeared to be a multiplicative effect between domain and outcome sector. For instance, 
models with physical input parameters reported long-term outcomes if the outcomes occurred 
in the health sector (mean=51.38 years) or the employment sector (mean= 43.29 years), but not 
if they were in the education sector (mean=29.30). Conversely, models with socioemotional 
input parameters reported very short-term final outcomes in the crime sector (mean=23.46) and 
in the education sector (21.73) but longer-term outcomes in both health (36.33) and 
employment (36.33), Figure 4.12.  
4.5 Discussion  
4.5.1 Key Findings  
This scoping review did not identify any models meeting the primary objective – being 
appropriate for forecasting the previously identified effects of postnatal depression on 
children’s cognitive and socio-emotional development (chapter three) to effects on adulthood 
decision endpoints relevant for health economic evaluation in the UK. All studies were 
considered inappropriate as they did not estimate QALYs and/or healthcare costs, defined as 
the decision endpoints of interest in chapter two required for economic evaluation conducted 
from both a health and cross-sectoral decision maker’s perspective.  
4.5.2 Methodological Guidance for Future Research  
Upon expanding the inclusion criteria, several models were identified which predicted outcomes 
that could be either used to partially compile QALYs (for example mortality rates might be used 
to determine the number of life years in the QALY calculation), or might theoretically be 
transformed into QALYs (for example self-rated health on an ordinal scale could, in theory, be 
transformed into utility scores on Visual Analogue Scales and these might be used to compile 
QALYs).  
Whilst these studies could be useful as models for indirect estimation, a primary analysis is 
considered a more desirable option as: (a) partial endpoints cannot establish the full impact of 
child development on decision endpoints, for example, there may be stronger links between 
development and morbidity or healthcare usage, and with a sole focus on mortality these effects 
would be unobserved; and (b) transformation of outcomes to QALYs is likely to require 
resources for primary research which may be better spent by estimating a fully relevant model 
with characteristics informed through the results of this review and a complete set of decision 
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endpoints. Therefore, the results of the synthesis in this scoping review are used to guide the 
design of a primary analysis in chapter five.  
As the results of chapter three identified effects of maternal depression on children’s cognitive 
and socioemotional development, the discussion of methods is directed towards results in these 
development domains. The interpretations are transferable to other early life circumstances that 
also have effects in cognitive and socioemotional domains but may not be wholly applicable if 
the early life circumstances affect development in the physical domain. 
4.5.2.1 Choice of Outcome Sectors 
 The results of this review indicate that children’s cognitive and socioemotional 
development is likely to be associated with outcomes across multiple government sectors: 
models with input parameters in these domains estimated diverse effects across crime, 
education, employment and health. These results are consistent with the theoretical literature 
reviewed in chapter two which suggests that cognitive and socioemotional development is likely 
to have widespread effects later in life.  
Economic evaluations should account for all relevant costs and benefits of an intervention 
(Drummond et al., 2015). Whether a cost or benefit is considered relevant is dependent on the 
perspective of the decision maker. As outlined in chapter two, this thesis conducts economic 
evaluation from both a health and cross-sectoral decision maker’s perspective- the latter 
endpoints estimate QALYs healthcare costs and monetary costs/returns in other government 
sectors.  
4.5.2.2 Model Selection 
 A variety of statistical methods were used by the studies in this review. The most 
common of these were the family of generalised linear models (GLMs). This is a class of 
regression models whose outcome variable (yi) is assumed to follow an exponential family 
distribution, and whose mean (µi) is assumed to be a function of the independent variable 
vector (or model input parameters) (xiβ) (McCullagh, 1984).  
The family of GLMs are often applicable to outcome variables with different characteristics 
given that different distributions can be assumed for yi. For instance, GLMs contain the 
commonly used ordinary least squares, logit and Poisson/negative binomial regression models 
which are often an appropriate choice when modelling continuous, dichotomous and count 
data (McCullagh, 1984). Given their flexibility, GLMs are regularly used when estimating effects 
on outcomes with skewed distributions, which may include decision endpoints such as QALYs 
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and costs (Jones and Schoon, 2008). Accordingly, GLMs are selected as the choice of model for 
the analysis in chapter five.   
4.5.2.3 Selection of Explanatory Variables  
 When estimating a GLM it is possible to both overfit and underfit the model. 
Overfitting is where the residual variance is represented in the model structure which can occur 
if an excessive number of explanatory variables are included in xiβ which have little influence on 
the outcome (Burnham and Anderson, 2003). In contrast, underfitting occurs if important 
variables are excluded from xiβ and might result in models failing to account for confounding 
factors which explain part (or all) of the relationship between the included explanatory variables 
and the model’s outcome (Chen et al., 1999). It is often most desirable to estimate a 
parsimonious model which achieves the required level of explanation with as few (explanatory) 
variables as is needed (Vandekerckhove et al., 2015). 
The results of this review can be used to identify/exclude the important/irrelevant explanatory 
variables to estimate a parsimonious model in chapter five. In general, the results are consistent 
with the theoretical literature reviewed in chapter two suggesting that development is holistic 
occurring across multiple domains (Overton, 2010b), (Santrock, 2003) and being influenced by 
a wide range of environmental factors (Bronfenbrenner, 1992). Variables for (i) cognitive & 
socio-emotional development and (ii) family economic, family psychosocial and neighbourhood 
environmental factors were consistently estimated across all outcome sectors and should be 
included in future models estimating outcomes in crime, education & employment and health.    
In contrast, physical development was only found to be a typical input parameter for models 
with health outcomes and not included as an explanatory variable for future models estimating 
outcomes in crime and education & employment. Meanwhile, school/peer environmental 
factors were infrequently estimated for education, employment and health sectors, and are only 
used as explanatory variables in chapter five for models predicting crime outcomes. 
4.5.2.4 Study Sample   
Economic evaluations should be relevant to the perspective of decision maker (Urdahl 
et al., 2006). This means that evidence to inform economic evaluation should have external 
validity and be generalisable to the target population of the health policy (Carlson and Morrison, 
2009). As this thesis is aimed at informing UK policy making, a relevant study population ought 
to be estimated in a sample that is geographically representative of the UK population. The 
results section of this review summarised all UK samples used within the included studies, and 
these were considered as potential data sources for the analysis in chapter five.  
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Evidence obtained from longitudinal observational studies might lack external validity if the 
study is conducted using historical data occurring a long time before the date of the policy 
decision as the demographics of the target population might change between these dates 
(Carlson and Morrison, 2009). As indicated in the results of this review, this is particularly 
relevant for models forecasting lifetime outcomes from childhood input parameters, which 
typically span multiple decades.  
Therefore, the most appropriate study sample for the analysis in chapter five was selected by 
identifying a UK based study which is conducted closest to the date of the decision (2018) 
whilst also containing an appropriate time horizon – this was assumed to require adulthood 
outcomes collected in the fourth decade as this was the longest mean final age of outcome 
identified in the review (equalling 43.77 for health outcomes). The British Cohort Study 1970 
was selected as most appropriate for the analysis in chapter five as the latest sweep was 
conducted in 2012 when participants were aged 42.  
4.5.3 Strengths and Limitations  
4.5.3.1 Strengths  
This scoping review benefited from the application of rigorous methodology 
throughout which followed published guidelines set out by Arksey and O'Malley (2005), 
Colquhoun et al. (2014) and Levac et al. (2010). This included: the design of a comprehensive 
search strategy and eligibility criteria that was aided by discussion with a qualified librarian; 
screening studies using predesigned screening forms; charting data across predesigned and 
pretested data charting forms; and systematically analysing charted data using a common 
analytic strategy.  
The review also captured an appropriate range of the development literature as the search 
strategy was conducted across six diverse electronic databases. This is exemplified by the 
inclusion of studies that are informed through multiple disciplines such as child development, 
economics, epidemiology, health sciences and psychology.  
It was possible to map a large volume of the literature by streamlining the data charting process 
which extracted only the key study information rather than obtaining a comprehensive list that 
described each study in detail. Limiting the study information and analysis to a smaller number 
of categories enabled key themes to be identified that were useful when informing future 
research objectives.  
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4.5.3.2 Limitations 
This scoping review was limited by resource constraints which meant that the review 
was conducted by a single researcher. Scoping reviews should ideally be conducted by a research 
team where multiple individuals are involved in study screening, study selection, and data 
charting processes to avoid errors and enable discussion of ambiguities (Arksey and O'Malley, 
2005). It is possible that errors could have led to relevant studies being excluded from the 
review, which may have affected the conclusions drawn for both research objectives. Therefore, 
uncertainties were discussed throughout with a larger research team to minimise the potential 
occurrence of error.  
In addition, as research was only conducted by one individual, the review had time constraints 
which resulted in literature searching being limited to electronic databases and to studies written 
in the English language. No grey literature was searched, and no other means of searching was 
applied e.g. hand searching journals or searching reference lists. It is possible that 
supplementary searching methods would have identified additional studies that met the 
inclusion criteria for this review. 
The review may also be limited by the eligibility criteria which excluded models of single 
diseases/health conditions. This was done to increase the specificity of the search strategy. As 
stated by Pham et al. (2014) scoping reviews provide a general account and are not intended to 
be an exhaustive list of the literature. The exclusion of some studies that may have been 
identified through less restrictive eligibility criteria is unlikely to have affected the results of the 
synthesis.  
Finally, this scoping review did not attempt to provide any form of critical appraisal. However, 
Arksey and O'Malley (2005) suggest that the role of a scoping review is not to assess study 
quality but should instead focus resources on mapping and describing the key characteristics of 
the literature. As the studies in this review were used to inform study design rather than being 
used directly as sources of evidence, the impact of not providing critical appraisal is likely to be 
minimal.  
4.5.4 Conclusions  
This chapter described a scoping review aiming to identify a mathematical model to be used to 
forecast the effects of maternal depression on lifetime decision endpoints, based on children’s 
cognitive and socioemotional development outcomes measured in chapter three. The search 
strategy was conducted across six electronic databases and identified 8,195 studies, none of 
which were considered appropriate for the primary research objective. Upon relaxing the 
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eligibility criteria, 57 studies were found to estimate clinical health or economically relevant 
endpoints. These studies were analysed to identify the key modelling characteristics that should 
be applied when forecasting lifetime effects from intermediate development outcomes. The 
results informed the study design of the analysis presented in chapter five.  
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Chapter 5: A Mathematical Model Predicting Lifetime 
Outcomes from Measures of Child Development  
5.1 Summary  
The overarching aims of this thesis focus on development of a methodology which estimates 
the lifetime effects associated with early life circumstances, and determination of whether 
lifetime estimates influence the cost-effectiveness results in an applied health economic 
evaluation. Chapter four began to address the second stage in the estimation of lifetime effects, 
suggesting mathematical modelling as an appropriate method to forecast lifetime decision 
endpoints from measures of child development, whilst also identifying key modelling criteria. 
This chapter builds on these results by estimating a set of generalised linear regression models 
which establish the relationship between children’s cognitive and socioemotional development 
at age ten and lifetime decision endpoints relevant for economic evaluation in the UK. 
Combining the results from the applied example in chapter three with the predictions from 
these models, this chapter conducts the full indirect estimation methodology, forecasting the 
effects of postnatal depression on children’s lifetime Quality Adjusted Life Years, healthcare 
costs, costs/returns to the education sector, and costs/returns to criminal justice sector. The 
applicability of this model to other research settings (i.e. forecasting effects for other early life 
circumstances) is discussed. Lifetime estimates from this chapter are used directly as parameters 
in a decision model which assesses the cost-effectiveness of screening for postnatal depression 
in chapter six. Figure 5.1 illustrates the contributing role of evidence from this chapter in the 
overall methodology estimating lifetime effects in this thesis.  
 
Figure 5.1: Demonstrates how this chapter contributes to the overall estimation of lifetime effects. 
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5.2 Introduction  
5.2.1 Structure of a Mathematical Model for Indirect Estimation  
Chapter four proposed the second stage of indirect estimation could be most appropriately 
conducted using a mathematical model to establish the relationship between intermediate 
measures of child development and lifetime decision endpoints. As demonstrated in Figure 5.2 
the intermediate cognitive and socio-emotional development outcomes enter the mathematical 
model as input parameters. The input parameters are then transformed to the relevant lifetime 
endpoints through a series of modelling equations.  
 
 
Figure 5.2: Illustrates the structure of a mathematical model used to forecast lifetime effects for indirect estimation. 
Cognitive and socioemotional development measures are entered as (two of several) input factors into modelling 
equations which output lifetime decision endpoints.  
 
Results from chapter four suggest that the category of generalised linear models (GLMs) could 
provide an appropriate type of model to forecast lifetime effects during indirect estimation. 
Lifetime estimates could be obtained using this category of model by:  
(i) Identifying the incremental treatment effects of postnatal depression on both 
cognitive (β1) and socioemotional (β2) intermediate outcomes (chapter three 
results);  
(ii) Estimating a GLM with cognitive (X1) and socioemotional (X2) development in the 
explanatory variable vector;  
(iii) Obtaining lifetime predictions for the incremental effects of postnatal depression 
by multiplying the coefficients attached to X1 and X2 by β1 & β2.  
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This approach is advocated by Layard et al. (2014) when predicting the effects of early life 
health policies on lifetime well-being endpoints.  
For indirect estimation to be appropriate the same intermediate constructs are required. That is, 
the development measures adopted when identifying incremental effects (chapter three) should 
align with the development measures entered in the forecasting model as input parameters (or 
explanatory variables). For example, there would be little sense in estimating effects of postnatal 
depression on children’s vocabulary at age 11 and using a different measure, say numerical 
ability at age 5, to predict lifetime outcomes. To remain consistent with previous research in 
chapter three, an appropriate model requires measures for cognitive development to be 
specified as General Cognitive Ability (GCA) informed through g-factor and CHC theory (Hill, 
2005), and socioemotional development to be measured on the SDQ or a similar maternally 
reported and empirically validated child behavioural screening questionnaire.   
5.2.2 Model Outcomes for Economic Evaluation   
If the purpose of a mathematical model is to forecast outcomes to inform economic evaluation, 
then model outputs should be tailored to the requirements of the decision-maker. Ideally, 
economic evaluation identifies the effects of health technologies on all the outcomes relevant 
and influential to policy decisions (Drummond et al., 2015).  As was identified in chapter two, 
the relevant decision endpoints for economic evaluation in the UK according to a health centric 
decision maker’s perspective include Quality Adjusted Life Years (QALYs) and healthcare costs. 
If adopting a cross-sectoral decision maker’s perspective, decision endpoints should also include 
additional costs/cost savings in sectors outside of health and a measure of economic 
productivity. According to the results of chapter four, the adulthood effects of child 
development may be expected to occur in crime, education, employment and health sectors.  
The identification of all relevant and influential outcomes also requires costs/benefits to be 
identified over the appropriate time horizon (Drummond et al., 2015). The literature review in 
chapter two and the results of chapter four suggest that the costs and benefits of childhood 
health technologies are likely to continue throughout the lifespan, particularly for employment 
and health outcomes. The most appropriate decision endpoints for the evaluation of early 
childhood health policy ought, therefore, to be outcomes measured across the entire lifespan. 
However, due to excessive costs, it not usually possible to conduct studies which follow up 
participants until their death. To account for truncated study time horizons, economic 
evaluation can use methods to extrapolate the decision endpoints observed within studies to 
endpoints across the remainder of their lifetime (Garnett et al., 2011). One example is the use of 
survival analysis to extrapolate from observed to lifetime mortality rates (Jackson et al., 2016).  
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Regardless of outcome type, it is generally agreed that decision endpoints should be discounted 
if they are expected to occur over several years after the implementation of the health 
technology. Discounting might be applied to future decision endpoints for a variety of reasons 
including opportunity costs associated with investment now (i.e. positive rates of return); a time 
preference for consumption sooner rather than later; catastrophic risk; and diminishing 
marginal utility (Attema et al., 2018), (Severens and Milne, 2004). Policy makers may not agree 
on the level of discount rates or whether the same rates ought to be applied to both costs and 
benefits (Attema et al., 2018), (Drummond et al., 2015). To account for this uncertainty 
economic evaluations are often reported in scenario analyses which apply different discount 
rates. For example, the NICE (2013) reference case suggests cost-effectiveness results ought to 
be reported with costs and benefits discounted at both 3.5% and 1.5%. 
5.2.3 Research Objectives  
Within the context of the overall thesis aim, to estimate a mathematical model which can be 
used to forecast lifetime effects from measures of child development, the specific objectives of 
the chapter are to:  
1. Predict the effects of a unit change in measures of cognitive and socioemotional 
development on the following adulthood decision endpoints:  
a. QALYs 
b. Healthcare costs 
c. Monetised costs/returns to the criminal justice sector 
d. Monetised costs/returns to the education sector6 
2. To ensure the results of the study can be used to inform economic evaluation in a 
variety of settings, a further objective of the research is to identify predictions for 
model outputs which differed in terms of:  
(i) Time horizon (observed outcomes vs. extrapolated lifetime outcomes)  
(ii) Discount rate (0%, 1.5%, and 3.5%)  
Upon achieving these objectives, this research is combined with results from chapter three, 
enabling the indirect estimation of lifetime decision endpoints associated with children exposed 
to symptoms of postnatal depression. The research in this chapter adds to a sparse scientific 
evidence base: chapter four did not identify any mathematical models which predicted lifetime 
QALYs and healthcare costs from measures of child development.  
                                                     
6 Monetised costs and returns in education include effects to economic productivity. This is further expanded upon 
in the research methods (section 5.3).  
131 
 
5.3 Methods  
5.3.1 Study Sample  
This analysis uses data from the 1970 British Cohort Study (BCS 1970), a longitudinal study 
which obtained information on over 17,000 participants born in England, Scotland and Wales. 
The choice of study sample was informed through the results of chapter four, which suggested 
the BCS 1970 as the longitudinal study most likely to provide temporally relevant data for UK 
health policy over an appropriate time horizon. The BCS recruited participants in a birth survey 
during 1970 and administered follow up sweeps when they were aged: 5, 10, 16, 26, 30, 34, 38 
and 42. The childhood surveys utilised parental questionnaires obtaining information relating to 
children’s health, their physical, cognitive and socioemotional development, and the social and 
economic environment surrounding the child. The surveys conducted in adulthood consisted of 
detailed questionnaires which asked participants to self-report their employment, education, 
health and social circumstances (Elliott and Shepherd, 2006).  
5.3.2 Model Input Variables 
5.3.2.1 Socio-emotional Development  
  Socio-emotional development was measured in the BCS 1970 on a shortened version 
of the Rutter Parental “A” Scale of behaviour (RBS) when children were aged 10. The full RBS 
is a parental questionnaire containing 31 items which relate to eight childhood problems (e.g. 
headaches and bedwetting), five difficulties (e.g. speech and eating disorders) and eighteen 
undesirable behaviours (e.g. aggression, bullying and social isolation). Parents are asked to score 
each item in terms of the frequency at which the child exhibits the described behaviour, 
possible responses (and scores) include: “never applies” (=0), “sometimes applies” (=1), and 
“certainly applies” (=2). The shortened RBS in the BCS 1970 contained 19 items, which were 
summed to produce a continuous measure ranging from 0-38. A full description of the items 
included in the shortened RBS are provided in Appendix 5.1. 
Primary results for this chapter are reported for a standardized RBS variable (mean=0, standard 
deviation=1). In addition, when predicting lifetime effects, the RBS variable was transformed to 
the same scale as was used for SDQ total difficulties in chapter three. Transformation was 
achieved by multiplying the standardised RBS scores by a value of forty (the range of the scale 
for SDQ scores). This ensured indirect estimation was conducted by linking studies with 
consistent measures of child development i.e. measures of the same socioemotional construct 
obtained on the same scale.  
132 
 
5.3.2.2 Cognitive Development  
 This research measured cognitive development as General Cognitive Ability (GCA) 
when children were aged 10. Remaining consistent with methodologies from chapter three, it 
was assumed that GCA could be identified in the BCS 1970 by conducting principal component 
analysis (PCA).7 Parsons (2014) has previously used PCA to identify a single factor of 
intelligence that explained 58% of the correlation between test scores in the BCS 1970. PCA 
was informed by eight psychometric tests which assessed a variety of narrowed cognitive 
abilities in the BCS 1970 when children were aged 10. Each test was self-completed by children 
and included: the Edinburgh Reading Test; the Friendly Maths Test; The Pictorial Language 
Comprehension Test; the Spelling Dictation Task; and four British Ability Scales subtests for 
Word Definitions, Word Similarities, Recall of Digits, and Matrices. Following PCA, the derived 
GCA variable was transformed to the same scale as is commonly used to represent IQ, and 
which was adopted for the growth curve analysis in Chapter 3 (mean=100 and standard 
deviation=15). Descriptions of all the psychometric tests administered in the BCS 1970 are 
summarized in Table 5.1 and described in detail by Parsons (2014).  
 
Table 5.1: Description of the Variables Used for PCA to Identify GCA in the 1970 BCS  
Variable Cognitive Abilities Assessed 
Shortened Edinburgh Reading Test Word recognition: vocabulary, syntax, 
sequencing, comprehension and retention. 
 
Friendly Maths Test 
 
Arithmetic, number skills, fractions, algebra, 
geometry and statistics. 
 
Pictorial Language Comprehension Test 
 
Spelling and phonetic decoding. 
 
Spelling Dictation Task 
 
Vocabulary, sentence comprehension, and 
sequence comprehension.  
 
British Ability Scales Word Definitions 
 
Verbal: Understanding of word definitions. 
 
British Ability Scales Word Similarities 
 
Verbal: Identifying patterns between words.  
 
British Ability Scales Recall of Digits 
 
Non-verbal: Memory and attention.  
 
British Ability Scales Matrices  
 
Non-verbal: Pattern and shape recognition. 
Notes:  All variables obtained from the 1980 sweep for children aged 10  
                                                     
7 Refer to Chapter 3 section 3.3.2.2 for a more detailed discussion regarding the use of Principal Component Analysis 
to identify General Cognitive Ability  
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5.3.2.3 Covariates  
 The models’ covariates were identified from questionnaires delivered to BC1970 study 
participants and their parents during the first three sweeps, when cohort members were aged 
0- 10. The covariates related to individual and environmental factors which could potentially 
influence adulthood outcomes through their effects on the lifespan development process. The 
selection of covariates was informed by the results of chapter four, and specifically a study by 
Layard et al. (2014) who used individual, family economic and family psychosocial covariates in 
a model which estimates adulthood well-being from measures of child development in the BCS 
1970.  
Individual covariates included dummy variables obtained during the birth sweep for biological 
sex (female/male) and whether cohort members were ethnically white British (yes/no). The 
remaining three individual covariates related to the participant’s health status at age 10: a Body 
Mass Index variable was derived by dividing measures for weight (kg) by the square of height 
(m); a dummy variable for hypertension (yes/no) was identified according to whether systolic 
blood pressure measurements at age 10 exceeded specific hypertension thresholds for height 
and sex (as reported in Falkner et al. (2004)); and a dummy variable for poor health status 
(yes/no) was defined according to whether participants were above the 75th percentile (>5) for 
total number of childhood disease according to self-reports of: asthma, bronchitis, eczema, hay 
fever, hearing loss, inguinal hernia, middle ear infection, pathological heart condition, 
pneumonia, recurrent abdominal pain, sore throat, and urinary tract infection.  
Environmental covariates included family economic, family psychosocial & neighbourhood 
conditions in addition to factors relating to each participant’s peer group. Family economic 
conditions were approximated based on parental income and educational status which are 
common measures used in child development research (Bradley and Corwyn, 2002). This 
analysis identified family income as the natural logarithm of both parents self-reported gross 
earnings. Education status was established using a continuous variable for the total number of 
years each participant’s father had been in education.   
Four variables were included to capture the effects of the family psychosocial environment. The 
first was a dummy variable for a stable family environment (yes/no) defined if the participant’s 
parents were married during the birth sweep and remained married during the age 10 sweep. 
Second, a continuous variable established the total number of siblings a child had at birth. 
Thirdly the level of overcrowding in a participant’s household was estimated at age 10 as a 
continuous variable, by dividing the number of people living in a participant’s household by the 
total number of household rooms. The final psychosocial variable was a continuous covariate 
identifying the frequency of participant engagement in family activities when they were aged 10.  
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The BCS 1970 parental questionnaire asked mothers to report (yes/no) whether family activities 
included walking, outings, eating together, holidays, shopping, talking for at least five minutes, 
or eating out at restaurants. The frequency of family activities was derived by summing the total 
number of positive responses across all items resulting in continuous variable which ranged 
from 0-6.  
The quality of the early neighbourhood was identified through questionnaires administered to BCS 
1970 interviewers during the age 5 sweep when they visited the cohort member’s household to 
deliver the parental questionnaire. This analysis specified a categorical variable for 
neighbourhood quality by ranking the interviewers response categories: Poor quality 
neighbourhoods included those stated as “poor quality or closely packed” houses; average 
quality neighbourhoods were those which contained “council houses or flats” or “market or 
rural communities”; whilst good quality neighbourhoods were those which were categorised as 
“well to do, well-spaced and well maintained houses”.  
The final covariate assigned participants as belonging to risky peer groups using a dummy variable 
(yes/no) for peer group smoking status. This was identified at the age 10 sweep where 
participants were directly asked “how many of your friends smoke cigarettes?” – Answers of 
“most of them” and “some of them” were assumed to positively indicate peer smoking.  
As was alluded to in the results from chapter four, the impact of individual health, family 
economic, family psychosocial, neighbourhood and peer covariates may affect each of the 
crime, employment, and health outcomes differently. For example, the results of the scoping 
review suggested neighbourhood and peer influences to be particularly important in predicting 
future crime participation, while childhood health status was less influential. To ensure models 
were parsimonious, covariates were limited to those that were identified as important predictors 
in chapter four. Table 5.2 summarises the covariates used for each outcome sector.  
 
Table 5.2: Summary of Model Covariates According to Outcomes Sector 
 Health Education & 
Employment  
Crime  
Gender & Ethnicity Yes Yes Yes 
Individual Health Yes No No 
Family Economic Yes Yes Yes 
Family Psychosocial Yes Yes Yes 
Neighbourhood  Yes Yes Yes 
Peer Smoking No No Yes 
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5.3.3 Health Outcome Variables  
5.3.3.1 General Approach to Identify Health Outcomes 
The research objectives required the identification of two health outcomes: quality 
adjusted life years (QALYs) and healthcare costs incurred by the NHS and Personal Social 
Services (PSS). Typically, QALYs and healthcare costs are obtained through direct responses 
from participants (Drummond et al., 2015). For instance, QALYs combine length of life with a 
measure of health-related quality of life (HRQoL) which is most commonly obtained from 
preference-based questionnaires such as the EuroQol-5D (EQ-5D), the short form 6D (SF-
6D), and the health utilities index (HUI). Meanwhile, healthcare costs might be best obtained by 
administering healthcare resource usage questionnaires and multiplying each healthcare item 
used by an appropriate price for that resource (Drummond et al., 2015), (NICE, 2013).  
The questionnaire items typically required to identify QALYs/healthcare costs were not 
collected in the BCS 1970. Therefore, health outcomes were approximated by assigning mean 
HRQoL decrements, mean life years, and mean healthcare costs to each participant who 
reported suffering from any of the following five chronic health conditions: cancer, depression, 
diabetes, hypertension and obesity. The five diseases were selected as each has plausible links 
with child development being causally associated with lifestyle factors (Doll and Hill, 1956), 
(DPPRG, 2002), (Krotkiewski et al., 1979) which have antecedents in early childhood (Lerner 
and Busch-Rossnagel, 2013), (Overton, 2003). Further, the five diseases were assumed to 
provide an indication of general health in the population as each is associated with an extremely 
high health and economic burden (Newton et al., 2015), (Wang et al., 2011).  
The presence or absence of cancer, depression diabetes and hypertension were identified based 
on self-reports (yes/no) in health status questionnaires. Meanwhile, obesity was assigned if 
participants BMI was greater than 30, with BMI being derived directly from height and weight 
measures during the BCS 1970 follow-up interviews. All health outcomes were established for 
participants at ages 26, 30, 34, 38 and 42.  
5.3.3.2 Health Related Quality of Life  
Mean HRQoL was obtained in a study by Sullivan et al. (2011) who report a catalogue 
of EQ-5D scores based on UK preferences for 135 chronic (three digit) International 
Classification of Disease (ICD)-9 codes from 79,522 participants in the US based Medical 
Expenditure Panel Survey. Participants without disease were assumed to achieve a “well” 
HRQoL equal to 0.83 which corresponds with the mean HRQoL across all individuals in 
Sullivan et al. (2011). Participants with disease were assigned a HRQoL by subtracting the 
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HRQoL decrements associated with disease from the “well” HRQoL score. The HRQoL for 
well and diseased participants is reported in Table 5.3.  
Table 5.3: Mean Health Related Quality of Life per ICD-9 Code  
Disease ICD-9 Code Mean HRQoL  
Decrement for 
Disease 
Mean HRQoL 
No Disease N/A N/A 0.830 
Cancer 140-239* 0.04179 0.788 
Depression 296 0.12691 0.703 
Diabetes (type 1 and type 2) 250 0.05319 0.777 
Hypertension  401 0.04604 0.784 
Obesity 278  0.07086 0.759 
Notes:  All data is sourced from Sullivan et al. (2011) 
 *mean HRQoL taken across all ICD codes for Neoplasms 
As the BCS 1970 did not provide full information on participants’ cancer type it was considered 
most appropriate to identify a weighted mean utility across all the ICD-9 codes for cancer (all 
neoplasms ICD-9 140-239). The grouping of benign and malignant cancers, along with cancers 
in and out of remission resulted in relatively low overall reduction in health utility (0.042). 
Similarly, the BCS 1970 study does not distinguish between type one or type two diabetes, 
therefore, a grouped HRQoL decrement was obtained for diabetes using ICD-9 code 250. 
Specific utilities were available for both obesity (278) and hypertension (250). Meanwhile, the 
most appropriate three-digit ICD-9 code for depression was the grouped code for all affective 
mood disorders (296) – this corresponds with the more specific ICD-10 codes for single 
episode (F32) and recurrent major depressive disorder (F33) (Fiest et al., 2014).  
Comorbidities were accounted for using additive HRQoL decrements if participants suffered 
from more than one of the five diseases; the study by Sullivan et al. (2011) used multivariate 
regression methods which adjusted utility values for comorbidity meaning HRQoL decrements 
can be added without risk of double counting. No multiplicative effects for comorbidities were 
included. Health utility scores were applied equivalently regardless of the age at which disease 
occurred as the multivariate regression by Sullivan et al. (2011) did not find a significant or 
substantial relationship between age and HRQoL.  
5.3.3.3 Expected Life Years  
 Life expectancies were estimated based on gender and participants’ disease status at the 
final sweep (age 42). Non-diseased participants were assumed to achieve the gender specific 
mean UK life expectancy for individuals born in 1970 (male=81 years, female =84 years) (ONS, 
2017). Life expectancies for participants reporting a disease at age 42 were calculated using 
evidence from a large population survey by the NHS Executive (1996) which utilised UK data 
from multiple secondary sources including Hospital Episode Statistics, OPCS Morbidity 
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Statistics in General Practice, and Death Registration Data. The report obtained information on 
age and cause of mortality to calculate the percentage of life years lost for specific ICD-9 codes.  
Life years lost statistics establish the average years an individual would have lived if they had not 
died prematurely (Martinez et al., 2019). Specifically, the NHS Executive (1996) report 
calculated: total life years lost per individual by subtracting their age of death from a reference age 
representing a normal life expectancy (assumed equal to 75); percentage life years lost per individual 
by dividing their total life years lost by the reference age; and percentage life years lost per disease by 
calculating the mean of percentage life years lost across all individuals with cause of death 
assigned to the relevant ICD-9 code. The NHS Executive (1996) data was selected as it was the 
only study which consistently estimated life years lost for all five diseases included in this 
analysis.  
Final life expectancies for each individual reporting disease at age 42 are described in Table 5.4. 
These were calculated by multiplying the % life years lost per disease ICD-9 code from the 
NHS Executive (1996) report with average ONS (2017) population life expectancies estimates 
by gender (male=81 years, female =84 years). Equivalent ICD-9 codes/groups were used to 
classify diseases as were used for HRQoL. Comorbid participants were assigned the lowest life 
expectancy for the diseases they reported.  
Table 5.4: Mean Life Expectancy by Disease and Gender 
Disease  ICD-9  
Codes 
% Life Years 
Lost1  
Mean Life 
Years (Males) 
Mean Life 
Years 
(Females) 
No Disease N/A N/A 81.00 84.00 
Cancer 140-239* 2.18 79.23 82.17 
Depression 296 0.04 80.97 83.97 
Diabetes (type 1 and type 2) 250 0.92 80.25 83.23 
Hypertension  401 0.44 80.64 83.63 
Obesity 278  0.63 80.49 83.47 
Notes:   (1) Values obtained from NHS Executive (1996). The % years of life lost represents the expected mean 
 reduction in length of life for individuals with disease when compared to non-diseased individuals. Values 
 obtained for population aged 75.  
 *Mean obtained across all ICD codes for Neoplasms.  
 
Ideally, life expectancies would have been calculated using data on % life years lost in 
individuals with a disease onset corresponding with the age of members in the 1970 British 
Cohort (i.e. onset < 42). This information was not available in the NHS Executive (1996) data 
where life years lost were estimated for all individuals aged 0 – 75. The implication of this 
limitation is discussed in Section 5.5.4. 
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5.3.3.4 Quality Adjusted Life Years 
  Within study QALYs were calculated by aggregating HRQoL utility weights for each 
participant across the study period. Aggregation was achieved using the trapezium rule 
(Equation 5.1) to estimate the integral, or area under the curve, over the 16 years during which 
HRQoL data was available (Brazier et al., 2017). Including potential comorbidities there were 30 
possible HRQoL values per sweep, four follow up sweeps, and once aggregated a maximum of 
810,000 (304) unique QALYs values. Given the large number of potential values the QALYs 
variable was assumed to be continuous.  
Equation 5.1: The Trapezium Rule to Estimate the Area under a Curve 
∫ 𝑓(𝑥)𝑑𝑥 =  1/2ℎ[(𝑦0 + 𝑦𝑛) + 2(𝑦1 + 𝑦2 + ⋯ 𝑦𝑛−1)]
𝑥𝑛
𝑥0
 
Where:  
 y = the value of the function f(x) at time interval x0, x1, …, xn 
 h = constant equal to duration of time between intervals x0 & x1, x2 & x3 , …,  xn-1 & xn 
A small number of participants died during the study, and this ought to have been captured in 
the QALYs outcome. The identification of deceased study members requires a special licence 
which could not be obtained due to external time constraints. The limitation of excluding these 
deaths is addressed in the discussion.  
A lifetime QALYs outcome was calculated for each participant by extrapolating the observed 
within study QALYs variable. Extrapolation was applied by calculating a participant’s mean 
yearly QALYs (total within study QALYs /total years in the study) and applying this mean value 
to each life year between the study endpoint (age 42) and their final life expectancy. The 
extrapolation methodology assumed that the distribution of QALYs remains constant with age, 
as informed through findings from Sullivan et al. (2011).  
5.3.3.5 Healthcare Costs 
The mean annual per person healthcare costs associated with the five diseases are 
summarised in Table 5.5. Each mean healthcare cost was derived from published literature: 
Cancer costs (all cancers across ICD-10 codes C00-D48) were obtained from a study which 
compared UK research expenditures to total healthcare expenditures (Luengo‐Fernandez et al., 
2012); costs of depression and obesity were obtained from Rudisill et al. (2016) who used linear 
regression to identify the direct healthcare costs associated with different BMI categories (18.5-
24.9, 25-29.9, 30-34.9, 35-39.9, 40+) and depression status (yes/no); Hex et al. (2012) identified 
the combined direct healthcare costs for type 1 and type 2 diabetes; and the cost of 
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hypertension was obtained from a burden of disease model (Lloyd et al., 2003) which identified 
costs in individual’s by blood pressure. In some cases, it was necessary to derive an average 
annual per person cost by dividing the reported population disease burden by the prevalence of 
disease. All costs were uprated to 2017/18 prices using the Consumer Price Index published by 
the ONS (2018b).  
Table 5.5: Mean per Person Annual Direct Healthcare Costs by Disease 
Disease Source Category Mean Costs  
Cancer Luengo‐Fernandez 
et al. (2012) 
Disease (ICD 10: C00-D48) 
No Disease 
£2442.49 
£0.00 
 
Depression 
 
Rudisill et al. (2016) 
 
Disease  
No Disease 
 
£1095.89 
£0.00 
 
Diabetes 
 
Hex et al. (2012) 
 
Disease (Type 1 or Type 2) 
No Disease 
 
£2841.41 
£0.00 
 
Hypertension1  
 
Lloyd et al. (2003) 
 
Blood Pressure> 140/90 mm Hg 
Blood Pressure<= 140/90 mm Hg 
 
£8.56 
£0.00 
 
Obesity2 
 
Rudisill et al. (2016) 
 
BMI<=25 
25<BMI<=30 
30<BMI<=35 
35<BMI<=40 
BMI>40 
 
£0.00 
£5.24 
£153.26 
£293.92 
£478.66  
Notes:  Mean costs are per person per year uprated to 2018 prices.  
 1: Estimates the costs associated with high blood pressure through direct reduction in major  cardiovascular 
 events (stroke and ischemic heart failure) for individuals aged 16-44.  
 2: Estimates costs directly associated with different BMI categories after adjusting the costs of 
 comorbidities including coronary heart disease, stroke, diabetes and cancer.   
Costs were assigned to each observation where participants reported a disease between ages of 
26-42. Comorbid cases were assigned their largest associated single disease cost to avoid double 
counting. This excluded cases of depression and obesity where comorbid costs could be added 
as they were obtained from the same regression equation. If no disease was reported it was 
assumed participants incurred zero healthcare costs. Within study healthcare costs were 
calculated using the trapezium rule, identifying the area under the curve for all observations 
between ages 26-42. 
Lifetime healthcare costs were estimated by extrapolating within study healthcare costs. It was 
assumed that a greater proportion of healthcare costs would be accrued by cohort members 
towards the end of life based on evidence from Asaria (2017) who identifies an increasing 
distribution of population healthcare costs with respect to age. The population distributions 
identified by Asaria (2017) were used to estimate the proportion of lifetime healthcare costs (phc) 
expected to have been accrued by participants during the study period. This proportion was 
dependent on gender, disease status (at age 42), and life expectancy. Each cohort member’s 
lifetime healthcare costs were estimated by multiplying their aggregated within study healthcare 
costs by 1/phc. 
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5.3.4 Education Outcome Variables  
5.3.4.1 Observed Returns to Education (within study) 
Participants’ within study monetised returns in the education sector were estimated by 
subtracting their monetary costs incurred from non-compulsory education after the age of 
sixteen from their monetary returns through economic productivity. This analysis included 
economic productivity in the construction of educational outcome variable rather than as a 
separate outcome to avoid double counting. Levin et al. (2017) suggests that many educational 
polices are justified because of their benefits to future economic productivity, meanwhile, 
labour market outcomes are often used as a measure of benefit in economic evaluation 
conducted from the perspective of the education sector (Belfield and Levin, 2007), (Levin and 
Belfield, 2015).  
Costs incurred through additional years of education were assigned by establishing the highest 
level of education achieved by each participant from self-reported questionnaire items in the 
BCS 1970 sweep at age 42. Education levels were described as NVQ levels (1-5). No costs were 
assigned to participants whose highest achievement was NVQ level 1 or 2 as this is equivalent 
to GCSE/O-levels usually obtained during the period of compulsory education before the age 
of sixteen. NVQ level 3s, which include A-levels and Scottish Higher Certificates, were assumed 
to require two years of non-compulsory education and were costed as £4,890 based on standard 
learner numbers (SLNs).  Participants were assumed to be in higher education for three years if 
they achieved NVQ level 4 (undergraduate degree) or four years if they achieved an NVQ level 
5 (post-graduate degree). The average costs of higher education per person per year was 
estimated as £1500, assuming the public-sector bears 25% of the total costs (total cost per 
person per year=£6000). All costs were obtained from an econometric study by Hummel et al. 
(2011) and uprated from 2008/09 prices to 2017/18 prices using the Consumer Price Index 
(ONS, 2018b) 
Economic productivity was estimated using the human capital method (Drummond et al., 2015) 
by accumulating participants’ gross earnings over the trial period. All gross earnings were 
uprated to 2017/18 prices using the Consumer Price Index (ONS, 2018b). Accumulated 
earnings were estimated in three stages. First, the age at which individuals entered the labour 
market was identified according to the self-reported age at which they left full time education. 
Participants’ earnings upon entering the labour market were estimated as a proportion of their 
stated earnings at the age 26 sweep. Different proportions were applied for individuals with 
different NVQ levels. Proportions were calculated based on population data from a study by 
HM Revenues & Customs (2017) which reports mean earnings for individuals aged 18-25 and 
25-30 according to NVQ level.  
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Second, self-reported gross earnings were established based on self-reports in questionnaires for 
the five sweeps from ages 26-42. If data was missing due to temporary economic inactivity (e.g. 
unemployment or temporary sick leave) earnings were imputed as the mean earnings achieved 
across all BCS 1970 study members by education level (NVQ levels). If data was missing due to 
permanent economic inactivity (e.g. retirement, looking after family, permanent sick leave) gross 
earnings were imputed as zero. The trapezium rule was used to estimate accumulated earnings 
over the study period with observations at labour market entry, and ages 26, 30, 36 and 42. 
The third stage accounted for non-accrued earnings due to periods of unemployment. At each 
sweep participants were asked to report their current and previous economic activities from the 
date of the last questionnaire – this included all periods of unemployment. Each period of 
unemployment was multiplied by the mean duration of unemployment for that year as 
identified by Long (2009). The total reduction to earnings through unemployment was 
estimated as the total duration of unemployment (years) multiplied by the participant’s mean 
yearly earnings between the ages 16-42. Non-accrued earnings through unemployment were 
then subtracted from accumulated gross earnings.  
5.3.4.2 Extrapolated Lifetime Returns to Education  
Lifetime returns to education were estimated by applying distributional assumptions to 
extrapolate within study gross earnings. As with healthcare costs, the proportion of within study 
to lifetime earnings (pe) was not assumed to be equal for all participants. For example, well-
educated individuals were in higher education during part of the study period and were 
therefore expected to accrue a greater proportion of their total lifetime income after the study 
when compared with participants who had lower levels of education and entered the labour 
market earlier. Meanwhile, on average, females were likely to have experienced more periods of 
economic inactivity than males during the study period due to child rearing. Therefore, the 
value of pe was dependent on participants’ gender and highest achieved NVQ level.  
Specific values for pe were calculated by approximating within study and lifetime earnings in 
population data published by HM Revenue & Customs (2017). Mean population earnings were 
summed for each NVQ group across age ranges of 16-42 (to correspond with within study 
outcomes). This was divided by summed earnings for each NVQ group across age ranges of 16 
to retirement age8 (to correspond with lifetime outcomes), deriving pe. Lifetime earnings were 
calculated by multiplying participants’ within study earnings by 1/pe. The final lifetime returns 
                                                     
8 Retirement age was assumed to be equal to the age at which individuals could draw a state pension if born in the 
UK in 1970 (age 65 for men and age 63 for women).  
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to education outcome was identified by subtracting the previously identified costs of education 
from participants’ lifetime earnings.   
5.3.5 Crime Outcome Variables  
5.3.5.1 Observed Criminal Justice Costs (within study) 
This research identified crime outcomes as public sector costs incurred by the criminal 
justice sector. Within study crime costs were estimated based on questionnaire responses at ages 
30 and 34. Participants were asked to state the total number of times that they had been found 
guilty of a criminal offence by a court. A public sector cost per criminal conviction was 
identified as £513.86, which was obtained by uprating the public sector cost per reported crime 
in studies by Hummel et al. (2011) and Brand and Price (2000) to 2017/18 prices using the CPI 
(ONS, 2018b). The cost per crime did not include any additional personal costs to the victims 
(e.g. loss of possessions, damages, forgone earnings etc.). Crime costs were identified post 
analysis by multiplying the public sector cost per crime by the expected number of crimes 
predicted in the mathematical model. This was necessary as the best fitting regression model 
(negative binomial) requires outcome variables to be specified as counts (integers).  
5.3.5.2 Extrapolated Lifetime Criminal Justice Costs 
Lifetime criminal justice costs were estimated by extrapolating participants’ within study 
court convictions to expected lifetime court convictions. A publication by the Home Office 
(1997) identifies distributions of crime by age and gender and finds most crimes to be 
committed before individuals are thirty. Extrapolation followed similar methods to those used 
when estimating lifetime healthcare costs and lifetime earnings. The Home Office (1997) study 
was used to identify the expected proportion of participants’ lifetime crimes occurring during 
the study period – this proportion was obtained by aggregating population crimes across age 
groups ranging from 16-34 (the age for which crime data is available in the BCS 1970) and 
dividing this by the total number of population crimes for all age ranges. The total number of 
expected lifetime crimes was estimated by multiplying the number of crimes committed by 
participants at age 34 by the reciprocal of the derived proportion. Different distributions and 
proportions were identified by gender. Again, costs were applied to lifetime criminal convictions 
post analysis.  
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5.3.6 Discounting 
Primary (base case) results are reported which discount outcomes (costs and QALYs) at 3.5% 
as this is the recommended rate in the NICE (2013) reference case. Additional results are 
presented which discounted outcomes at rates of 1.5% and 0%. Discounting was applied by 
multiplying the appropriate outcome by a factor of (1/1 + D)n) where D is the discount and n is 
the number of years into the future that the outcomes occur (Severens and Milne, 2004). As the 
subject of this thesis is concerned with early childhood interventions, it was assumed that 
discounting should begin at birth – this was appropriate as it corresponds with the time at 
which a postnatal depression screening intervention would be delivered. 
Discounting was applied to the relevant outcome variables within each sweep prior to the 
implementation of the trapezium rule (which was used to identify aggregated study outcomes). 
As lifetime outcomes were approximated by multiplying within study outcomes by a scalar, 
there were no observation points for n after the study period. Therefore, lifetime outcomes 
occurring after the study period were split into different yearly blocks which ended at final life 
expectancy for health and crime outcomes or retirement for employment outcomes. Different 
discount rates were then applied to each yearly block by applying different n values (i.e. n=age 
43 for the first yearly block after the study, 44 for the second yearly block etc.).  
5.3.7 Empirical Models  
5.3.7.1 Specification and Selection of Generalised Linear Models 
The results from chapter four suggested that generalised linear models (GLMs) would 
be an appropriate method to forecast the health and economic lifetime effects from child 
development measures. GLMs are a class of regression models whose outcome variable (yi) is 
assumed to follow an exponential family distribution, and whose mean (µi) is assumed to be a 
function of the independent variable vector (or model input parameters) (xiβ) (McCullagh, 
1984). Each GLM is specified with a specific distribution and a link function which establishes 
the relationship between µi and xiβ.  
The research in this chapter assessed a variety of GLM distribution and link function 
specifications for each of the outcomes given their differently skewed distributions. These 
included Ordinary Least Squares (OLS), negative binomial, Poisson, and Gamma regression 
models. In addition, transformed OLS, two-part, and zero inflated models were assessed to 
ensure that they did not provide a better prediction of the outcome (Jones and O'Donnell, 
2002). All models were estimated using the STATA 12 software.  
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Several statistical tests/techniques were used to select the most appropriate GLM specification. 
A set of candidate GLMs was established for each outcome using the modified Park test to 
identify suitable distributions (Jones, 2010) and the Pregibon test to identify appropriate link 
functions (Pregibon, 1980). The most appropriate model from all candidate GLMs was then 
identified as that with the lowest associated Akaike Information Criterion (AIC) (Jones and 
O’Donnell, 2002). The AIC criterion was also used to compare the fit of GLM models to 
transformed OLS and two-part regression models. In addition, following recommendation by 
Desmarais and Harden (2013), a bias corrected Vuong test was used to determine whether zero-
inflated Poisson/negative binomial models provided a statistically significant better fit than their 
GLM counterpart. A more detailed explanation of each statistical test is provided in Appendix 
5.2.   
Model selection was also influenced by diagnostic plots which determined how closely the 
empirical data matched the assumptions required for each regression model i.e. deviance 
residuals are normal and homoscedastic (Barber and Thompson, 2004). Models were rejected if 
they severely violated these assumptions.  
The statistical significance of individual explanatory variables e.g. GCA, RBS, gender, ethnicity 
etc. was identified using t-tests. The covariates were also grouped into larger categories as either 
child health, family economic, family psychosocial, neighbourhood or peer influences. 
Likelihood ratio tests were used to determine the impact of the grouped categories by 
estimating nested models with/without the grouped covariates (Casella and Berger, 2002). To 
investigate how outcomes differed across subpopulations, interaction terms were tested 
between all statistically significant covariates. Interactions were retained if they were statistically 
significant and they improved the fit of the models as determined through reductions in the 
AIC statistic (Jones and O'Donnell, 2002). 
5.3.7.2 Model Predictions 
Model predictions identified the impact per unit increase in GCA/RBS score on all 
outcome variables. Predictions were obtained on the raw scale of the outcomes for GLM 
models using the “margins” command in STATA (Williams, 2012). Log transformed OLS 
models were back transformed manually as exponential retransformation of log models can 
sometimes result in biased predictions. Bias was accounted for by adding a manually calculated 
constant, known as Duan’s smearing estimator to the regression equation prior to 
retransformation (Jones, 2010).  
To inform the decision model in chapter six, forecasts were obtained estimating the incremental 
lifetime effects for children exposed to postnatal depression vs. children not exposed. 
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Incremental lifetime effects were calculated using the results from Growth Curve Model 1 in 
chapter three, which identified incremental effects in children exposed to postnatal depression 
symptoms on GCA and SDQ outcomes at age 11.  
Lifetime predictions were obtained by multiplying the incremental effect sizes for GCA and 
SDQ outcomes in chapter three by each models’ marginal effect per unit increase in GCA and 
RBS scores (identified in this chapter). For an illustrative example, assuming the hypothetical 
incremental effects of postnatal depression from chapter three were GCA=-2 and SDQ=3 and 
the magnitude per unit increase on lifetime healthcare costs from this chapter equalled -£100 
for GCA and £300 for SDQ. Then the incremental effects of postnatal depression exposure on 
lifetime healthcare costs would be (-2 ×-£100) + (3×£300) = £1,100.  
5.4 Results  
5.4.1 Identifying General Cognitive Ability  
A high level of correlation is required between the variables informing Principal Component 
Analysis (PCA). Correlations were observed between all eight cognitive variables obtained in the 
BCS 1970, these ranging from 0.29 to 0.73 (Table 5.6). 
Principal component analysis was conducted to identify the factors (principal components) 
which explained the correlation between the cognitive variables in the BCS 1970. The PCA 
identified a single component with an eigenvalue above one, as is indicated in the scree plot in 
Figure 5.3. This single factor explained 57% of the total correlation between the eight BCS 1970 
cognitive variables. The significant principal component (Component 1 in Figure 5.3) was 
assumed to represent the underlying cognitive ability of children in the BCS 1970 at age 10 and 
was suitably renamed General Cognitive Ability (GCA).  
Table 5.6: Correlation Matrix between Cognitive Variables 
 (A) (B) (C) (D) (E) (F) (G) (H) 
BAS Word Definitions   (A) 1.00        
BAS Recall of Digits   (B) 0.31 1.00       
BAS Matrices    (C) 0.46 0.29 1.00      
BAS Word Similarities   (D) 0.62 0.30 0.46 1.00     
Pictorial Language Comprehension  (E) 0.64 0.30 0.50 0.56 1.00    
Spelling Dictation Task   (F) 0.43 0.38 0.38 0.38 0.38 1.00   
Edinburgh Reading Test   (G) 0.63 0.38 0.58 0.56 0.62 0.64 1.00  
Friendly Maths Test   (H)  0.60 0.39 0.63 0.56 0.59 0.55 0.73 1.00 
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Figure 5.3: A Scree Plot (left) and Table (right) illustrating the outputs of PCA. Note that Eigenvalues>1 are 
indicative of important components.  
The validity of the PCA assumption (that component 1 represented GCA) was investigated by 
comparing mean scores for the BCS 1970 GCA variable. The assumption appeared to have face 
validity as the derived GCA variable followed similar patterns to mean IQ scores for different 
sub-groups of population i.e. largely equivalent scores for males and female, higher scores for 
white British children compared with ethnic minorities, and lower scores for children with 
extremely low birth weights.  
5.4.2 Descriptive Analysis  
5.4.2.1 Response Rates  
 The BCS 1970 obtained responses from 16,569 cohort members during the birth 
sweep. In general, there was a high level of attrition with the overall response number tending 
to decrease over time (Table 5.7). Only 3,423 (20.66%) of the BCS 1970 cohort provided 
responses to at least one questionnaire item across all nine sweeps (Mostafa and Wiggins, 2014). 
Table 5.7: Total Number of Questionnaire Responses in BCS 1970 
Sweep  
Number 
Age Response (n)1 Response (%)2 
1 Birth 16,569 100.00 
2 5 12,939 78.09 
3 10 14,349 86.60 
4 16 11,206 67.63 
5 26 8,654 52.23 
6 30 10,833 65.38 
7 34 9,316 56.23 
8 38 8,545 51.57 
9 42 9,354 56.45 
    
All Sweeps N/A 3,423 20.66 
Notes:  Table adapted from Mostafa and Wiggins (2014) pp.7-8 
 1: Responses counted if cohort members answer one or more questionnaire item(s) within a sweep  
 2: Response % is taken from number responding to the initial birth survey 
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There were relatively low response rates for QALYs (n=5,111), healthcare costs (n=4,478), and 
returns to education (n=3,772) as these outcome variables were both derived using multiple 
questionnaire items and accumulated using data from multiple sweeps. A larger number of 
cohort members (n=8,864) provided a response to the question in the age 34 sweep relating to 
their total number of criminal convictions.  
Both General Cognitive Ability and the Rutter Behaviour Scale variables were associated with 
relatively high levels of missing data which is likely due to being multi-attribute questionnaires/ 
being derived from multiple psychometric tests. Generally, less missing data occurred in the 
other explanatory variables as these were obtained during childhood sweeps where response 
rates were highest. Full response rates across all variables are reported in Table 5.8. The 
limitations associated with missing data are discussed in section 5.5.4.  
Table 5.8: Response Numbers across Outcome & Explanatory Variables  
 Age Response (n)1 Response (%)2 
Outcome Variables    
 QALYS 16-42 5,111 30.85% 
 Healthcare Costs 16-42 4,478 27.03% 
 Returns to Education 16-42 3,772 22.77% 
 Criminal Convictions 34 8,864 53.50% 
Explanatory Variables     
 General Cognitive Ability 10 8,102 48.90% 
 Rutter Behaviour Scale 10 11,236 67.81% 
 Ethnicity Birth 13,712 82.76% 
 Sex Birth 14,984 90.43% 
 Hypertension 10 12,520 75.56% 
 BMI 10 12,159 73.38% 
 Cumulative Health Problems 10 11,907 71.86% 
 Family Income 10 12,508 75.49% 
 Age Father Left Education Birth 16,275 98.23% 
 Stable Family 10 12,791 77.20% 
 Large Family 10 13,636 82.30% 
 Crowding in Home 10 12,943 78.12% 
 Freq. Family Activities 10 13,329 80.45% 
 Neighbourhood Quality 5 12,711 76.72% 
 Peers Smoke  10 12,564 75.83% 
Notes:  1: Responses counted if cohort members answer all questionnaire item used to derive the variable  
 2: Response % is taken from number responding to the initial birth survey 
 
5.4.2.2 Distribution of Outcomes  
All outcome variables appeared to follow non-normal distributions which is often the 
case when dealing with variables that relate to count data and monetary costs. Healthcare costs 
and total number of crimes had positively skewed distributions while a negative skew was 
observed for QALYs as HRQoL decrements were assigned to diseases participants, Figure 5.4.  
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Figure 5.4: Illustrates the distribution of outcome variables using histograms overlaid with kernel density plots. 
Outcomes are within study QALYs (top left), healthcare costs (top right), total number of court convictions (bottom 
left) and the natural logarithm of returns to education (bottom right).  
Both health outcomes had a large proportion of null observations as many individuals did not 
suffer from any of the five diseases. This resulted in most participants being assigned zero 
values for healthcare costs and mean QALYs for non-diseased individuals (equal to 13.28). All 
participants had positive returns to education which closely resembled a normal distribution 
after a log-transformation was applied to the outcome variable (Figure 5.4).  
5.4.2.3 Associations between Child Development Measures and Outcomes 
Associations were observed between participants GCA at age 10 and mean/median 
scores on each adulthood outcome. This association followed a gradient where the highest 
(lowest) scoring GCA quartiles were associated with the most (least) desirable outcomes, Table 
5.9.  Similarly, participants who scored in the best (worst) percentile on the Rutter Behaviour 
Scale (RBS) were associated with the most (least) desirable outcomes for QALYs, healthcare 
costs and crime costs. There did not appear to be an associated between RBS scores and 
median returns to education, Table 5.9.  
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Table 5.9: Median/Mean Outcomes by Child Development Percentile 
 QALY1 Healthcare 
Costs1 
Returns to 
Education1 
Crime 
Costs2 
General Cognitive Ability      
     Lowest 25% (worst performers) 12.997 £348.44 £306,800 £161.17 
     25th- 50th Percentile 13.026 £83.84 £346,400 £149.23 
     50th – 75th Percentile 13.138 £73.36 £360,000 £114.24 
     75th – 100th Percentile 13.138 £52.40 £422,900 £62.79 
      
Rutter Behaviour Scale       
     Lowest 25% (best performers) 13.138 £62.88 £369,600 £85.16 
     25th- 50th Percentile 13.138 £73.36 £363,300 £107.82 
     50th – 75th Percentile 13.099 £73.36 £366,100 £117.51 
     75th – 100th Percentile 13.026 £337.96 £363,400 £170.24 
Notes:  All are undiscounted within study outcomes. 1=median and 2=mean 
 
5.4.2.4 Associations between Covariates and Outcomes 
The association between model covariates and outcomes are reported in Table 5.10. 
Adulthood health was strongly associated with childhood health, where median (undiscounted 
within study) QALYs were lower and healthcare costs were larger for: the highest childhood 
BMI quartiles (12.86, £971.96) compared with the lowest (13.19, £31.44); for those with 
hypertension during childhood (12.91, £112.84) compared with normal blood pressure (13.10, 
£73.36) and for participants who suffered from a high number of diseases (12.68, £379.88) 
versus participants with a history of few disease (13.10, £73.36). Health outcomes also appeared 
to be worse for participants who were not ethnically white British, and who came from a large 
family with low income. 
Gender was strongly associated with mean (undiscounted within study) crime costs during 
adulthood (male =£232.50/ female=£33.11), as were family income (highest quartile 
=£97.06/lowest quartile= £237.27), neighbourhood quality (good quality= £87.63/ poor 
quality =£210.60), being from a stable family (yes= £108.95/ no= £202.26) and the smoking 
status of participants’ peer groups (smoke= £206.34/don’t smoke= £112.30). 
Median (undiscounted within study) returns to education were much larger for males 
(£446,700) than for females (£287,900); for participants who came from high income families 
(highest quartile=£400,600/lowest quartile=£350,100) whose fathers were highly educated 
(highest quartile= £398,700/lowest quartile= £338,900), and for participants from good 
neighbourhoods (good neighbourhood=£396,500/ poor neighbourhood=£358,900) whose 
peers did not smoke (peers smoke=£399,00/ peers do not smoke=£360,300). There were no 
obvious associations between returns to education and childhood ethnicity, child health and 
family psychosocial variables, Table 5.10.  
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Table 5.10:  Median/Mean Outcomes by Covariate Category  
 QALYs1 Healthcare 
Costs1 
Returns to 
Education1 
Crime 
Costs2 
Child Demographic Covariates      
      Gender 
      Male 
      Female  
 
 
13.138 
13.026 
 
 
£73.36 
£65.68 
 
 
£446,700 
£287,900 
 
 
£232.50 
£33.11 
     Ethnicity  
      White British 
      Not White British  
 
13.099 
12.997 
 
£73.36 
£83.84 
 
£365,900 
£374,800 
 
£125.98 
£174.54 
Child Health Covariates      
      BMI 
      Lowest (best) 25% 
      25-50th Percentile 
      50th-75th Percentile 
      Highest 25% 
 
 
13.188 
13.138 
13.138 
12.855 
 
 
£31.44 
£62.88 
£83.84 
£971.96 
 
 
£368,400 
£391,400 
£378,600 
£345,200 
 
 
£125.89 
£134.93 
£137.01 
£105.13 
      Hypertension 
      No  
      Yes 
 
13.099 
12.906 
 
£73.36 
£112.84 
 
£366,500 
£365,400 
 
£128.88 
£61.27 
      >=5 Childhood Diseases 
      No 
      Yes 
 
13.099 
12.680 
 
£73.36 
£379.88 
 
£368,500 
£325,700 
 
£121.77 
£114.47 
Family Economic Covariates    
   Family Income  
      Lowest (worst) 25% 
      25-50th Percentile 
      50th-75th Percentile 
      Highest 25% 
 
 
13.048 
13.026 
13.099 
13.138 
 
 
£83.84 
£90.48 
£73.36 
£62.88 
 
 
£350,100 
£344,600 
£356,800 
£400,600 
 
 
£237.27 
£142.53 
£118.01 
£97.06 
      Age Father Left Education  
      Lowest (worst) 25% 
      25-50th Percentile 
      50th-75th Percentile 
      Highest 25% 
 
13.026 
13.032 
13.138 
13.138 
 
£81.40 
£83.84 
£62.88 
£52.40 
 
£338,900 
£349,900 
£382,900 
£398,700 
 
£125.35 
£149.08 
£90.63 
£73.74 
Family Psychosocial Covariates 
      Stable Family  
      No 
      Yes 
 
 
13.026 
13.138 
 
 
£90.48 
£73.36 
 
 
£372,200 
£364,600 
 
 
£202.26 
£108.95 
      Large Family 
      No 
      Yes 
 
13.099 
13.008 
 
£73.36 
£414.12 
 
£368,000 
£320,000 
 
£123.53 
£181.36 
      Ratio of people to rooms  
      Lowest (best) 25% 
      25-50th Percentile 
      50th-75th Percentile 
      Highest 25% 
 
13.138 
13.099 
13.138 
13.048 
 
£73.36 
£73.36 
£62.88 
£83.84 
 
£382,400 
£363,500 
£374,500 
£349,000 
 
£75.10 
£111.43 
£150.56 
£165.61 
      Number of Family Activities 
      Lowest (worst) 25% 
      25-50th Percentile 
      50th-75th Percentile 
      Highest 25%  
 
12.855 
13.096 
13.026 
13.046 
 
£83.84 
£112.84 
£83.84 
£73.36 
 
£323,400 
£317,500 
£367,400 
£364,400 
 
£307.44 
£224.95 
£164.64 
£132.81 
Neighbourhood and Peer Covariates 
      Neighbourhood Quality 
      Poor 
      Average       
      Good 
 
 
13.006 
13.099 
13.138 
 
 
£102.36 
£73.36 
£62.88 
 
 
£358,900 
£356,700 
£396,500 
 
 
£210.60 
£130.67 
£87.63 
      Peer Smoking  
      No 
      Yes 
 
13.099 
13.096 
 
£73.38 
£83.84 
 
£360,300 
£399,000 
 
£112.30 
£206.34 
Notes:  All are undiscounted within study outcomes. 1=median and 2=mean 
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5.4.2.5 Extrapolation and Discounting  
The effect of extrapolation was investigated by comparing (mean and median) within 
study outcomes with lifetime counterparts (all discounted at 3.5%). The extrapolated lifetime 
outcomes were considerably larger than the observed within study outcomes for variables in the 
health and education sectors. For example, median within study vs lifetime outcomes equalled 
4.13 vs 7.62 QALYs, £22.12 vs £44.07 for healthcare costs and £120,000 vs. £190,000 for 
returns in the education sector. In contrast mean lifetime crime costs (£75.88) were only slightly 
larger than the mean crime costs observed within the study (£69.83), Figure 5.5.  
 
Figure 5.5: Box and whisker plots illustrating median values and inter-quartile ranges for QALYs (top left), 
healthcare costs (top right), and returns to education (bottom left). A bar graph reports mean crime costs (bottom 
right). Plots are obtained according to discount rate and for within study and lifetime outcomes.  
Similarly, mean/medians were identified to establish the impact of discounting. The application 
of different discount rates had a substantial effect on the size and the variability of all outcomes. 
Again, these effects were larger for health and education, for example median lifetime 
undiscounted outcomes (QALYs=54.20; healthcare costs=£376.16; returns to 
education=£790,000) were over four times the size of median lifetime outcomes discounted at 
3.5% (QALYs=7.62; healthcare costs=£44.07; returns to education=£190,000). As most crimes 
occurred earlier in the lifespan, the impact of discounting was less severe with mean lifetime 
undiscounted costs equal to £152.73 compared with mean lifetime costs discounted at 3.5% 
equal to £75.88, Figure 5.5.  
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5.4.3 Regression Models  
5.4.3.1 Model Specifications   
A generalised linear model specified with a log link function and a gamma distribution 
was used when modelling healthcare costs (n=1,305) – this GLM specification was identified as 
most appropriate by the modified Park test and Pregibon’s link test and outperformed an OLS 
model which violated assumptions that residuals were normal and homoscedastic. While 
healthcare costs had a large proportion of zero observations, there was no evidence to suggest 
that a two-part model (logit and GLM) was more appropriate than the single GLM given the 
higher associated AIC criterion. In contrast, the QALYs (n=1,488) outcome was modelled 
using OLS regression as the modified Park and Pregibon’s link tests suggested a Gaussian 
distribution with an identity link function as most appropriate. These results were supported by 
the lower associated AIC criterion for the OLS model when compared with all other GLM 
specifications.  
Returns to education (n=1,317) were estimated using OLS regression whilst applying a log 
transformation to the dependent variable. The distribution of the log transformed variable 
(Figure 5.3, section 5.4.2.1) appeared to follow a normal distribution, and produced a much 
better fit than OLS regression on the non-transformed variable. Despite the benefit of 
providing easy to interpret coefficients, GLMs with non-transformed outcomes were rejected as 
the modified Park test suggested no distribution would provide a suitable fit. This choice was 
supported by lower AIC associated with the log transformed model when compared to the best 
fitting GLM.  
A GLM with a log link function and a negative binomial distribution was used to model the 
total number of criminal convictions in 2,869 participants. The negative binomial distribution 
was selected in favour of the Poisson distribution given the lower associated AIC. This decision 
was further justified as the data appeared to be over dispersed, meaning the expected variance 
was greater than the expected mean, thus violating a required assumption in Poission regression 
of equivalence between expected means and variance. Whilst most participants reported zero 
values (no criminal convictions) the zero-inflated negative binomial model was not a significant 
improvement on the selected model according to the bias corrected Vuong test.  
5.4.3.2 Model Fit  
Figure 5.6 depicts the residual plots for each of the models. The returns to education 
model appeared best fitting with heteroscedastic residuals that followed a (symmetrically) heavy 
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tailed distribution mimicking the normal distribution reasonably closely. The QALYs model had 
heteroscedastic residuals which diverged from normality, displaying a slight positive skew.  
 
Figure 5.6: Above are Q-norm plots of deviance/standardised residuals, below displays scatter plots of 
deviance/standardised residuals vs. model predictions for all outcome variables. 
The deviance residuals for the healthcare costs model diverged from normal at the tail of the 
distribution and were largely heteroskedastic but may have demonstrated a slight tendency to 
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decrease for larger healthcare costs. The worst fitting model appeared to be the negative 
binomial regression model predicting participants’ total number of crimes, where the deviance 
residuals appeared to be neither normal nor heteroscedastic, Figure 5.6. The importance of 
violations to model assumptions is discussed in detail later in the chapter.   
5.4.3.3 Statistical Inference 
All models revealed strong and consistent associations between measures of child 
development and adulthood outcomes. Increased GCA (better cognitive outcomes) at age 10 
was significantly associated with increased QALYs (p<0.0001), reduced healthcare costs 
(p=0.015), positive returns to education (p=0.011), and fewer criminal convictions (p=0.002). 
Increased RBS (worse socioemotional outcomes) at age 10 was significantly associated with 
reduced QALYs (p=0.017), increased healthcare costs (p=0.008), and more criminal 
convictions (p=0.002), and was non-significantly associated with reduced returns to education 
(p=0.472), Table 5.11. 
There was also an association between all outcomes and gender, where females had significantly 
worse health outcomes (p=0.001 QALYs, p=0.001 healthcare costs), lower returns to education 
(p<0.0001) and fewer court convictions (p<0.0001) compared with males. Other covariates 
relating to the participant included: child health which was significantly associated with 
adulthood health (QALYs & healthcare costs p<0.0001) particularly through the effects of 
childhood BMI; meanwhile a participant’s ethnicity was only associated with criminal 
convictions (p=0.004), Table 5.11.  
The impact of early environmental covariates differed across outcomes. The most consistent 
associations were identified for children’s neighbourhoods where the most desirable outcomes 
were more likely to be observed for children growing up in good quality neighbourhoods; these 
associations were statistically significant for both healthcare costs (p<0.0001), and crime costs 
(p<0.0001). The family economic environment was not associated with health outcomes but 
was associated with returns to education (p=0.0073) and the number of court convictions 
(p<0.0001). Meanwhile the family psychosocial environment was significantly associated with 
healthcare costs (p<0.0001) and criminal convictions (p<0.0001) but not QALYs or returns to 
education.  
All hypothesis tests are reported for within study outcomes discounted at 3.5%. These 
interpretations remained constant irrespective of whether outcomes were discounted at 
different rates or whether the time horizon was for the study period or extrapolated over the 
lifetime. This excluded the effects of gender on lifetime QALYs which were influenced by the 
additional life expectancy experienced by females.  
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Table 5.11: Untransformed Model Coefficients and Associated P-values  
Notes:  Reports untransformed β coefficients and the associated p-values for all explanatory variables. P-values obtained from t distribution for individual covariates, and from likelihood ratio tests 
 for groups of covariates. Results are for within study outcomes discounted at 3.5%.  
    
 QALYs Healthcare Costs Returns to Education Crime Costs 
 Coeff. P-Value  
(t-test) 
P-Value  
(lr-test) 
Coeff. P-Value  
(t-test) 
P-Value  
(lr-test) 
Coeff. P-Value  
(t-test) 
P-Value  
(lr-test) 
Coeff. P-Value  
(t-test) 
P-Value  
(lr-test) 
Child Development Variables   <0.0001   <0.0001   0.0092   <0.0001 
 General Cognitive Ability 0.0015 <0.0001  -0.0110 0.0150  0.0037 0.0110  -0.0158 0.0020  
 Rutter Behaviour Scale -0.0115 0.0170  0.1948 0.0080  -0.0113 0.4720  0.2540 0.0020  
Child Demographic Variables      0.0010   <0.0001   <0.0001 
 Female -0.0281 0.0010  0.3903 0.0010  -0.4932 <0.0001  -2.2135 <0.0001  
 White British 0.0479 0.0680  0.0362 0.8950  0.1731 0.0530  -0.8666 0.0040  
Child Health Variables   <0.0001   <0.0001   N/A   N/A 
 Hypertension -0.0128 0.5510  -0.3092 0.2970  N/A N/A  N/A N/A  
 BMI  -0.0166 <0.0001  0.1449 <0.0001  N/A N/A  N/A N/A  
 Cumulative Health Problems -0.0927 0.001  0.3996 0.1870  N/A N/A  N/A N/A  
Family Economic Variables   0.7338   0.4009   0.0073   <0.0001 
 Log Family Income -0.0039 0.6930  0.0589 0.6420  0.0799 0.0100  0.1838 0.2410  
 Age Father Left Education 0.0012 0.4580  -0.0156 0.5620  0.0068 0.1960  -0.0823 0.0240  
Family Psychosocial Variables    0.5165   <0.0001   0.0626   <0.0001 
 Stable Family 0.0054 0.7010  -0.1093 0.5280  -0.0925 0.0430  -0.1792 0.2950  
 Large Family (>=4 Siblings)  -0.0348 0.1790  0.3931 0.2510  -0.1395 0.1130  -0.8059 0.0220  
 Crowding (people/rooms) 0.0223 0.1940  -0.007 0.9980  0.0687 0.2580  N/A N/A  
 Freq. Family Activities -0.0017 0.7400  0.1568 0.0150  0.0220 0.1870  0.0454 0.5100  
Neighbourhood & Peer Variables   0.4366   <0.0001   0.6028   <0.0001 
 Poor Neighbourhood  0.0042 0.8550  0.2449 0.4400  0.0444 0.5700  0.7069 0.0050  
 Good Neighbourhood  0.0120 0.2020  -0.0955 0.5080  0.0363 0.2320  0.7069 0.0460  
 Peers Smoke N/A N/A  N/A N/A  0.0200 0.6420  -0.0825 0.6530  
Interaction Terms              
 GCA#Female N/A N/A  N/A N/A  0.0060 0.0030  N/A N/A  
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5.4.3.4 Model Predictions  
Model predictions on the raw scale of the outcome variables are reported in Table 5.12. 
For within study outcomes discounted at 3.5%, a unit increase in a participant’s GCA score at 
age 10 (better cognitive development) predicted: an increase in QALYs of 0.001; decreases in 
healthcare costs of -£8.04; £2,514.17 accrued through additional returns to education and small 
reductions in costs incurred by the crime sector (-£0.92). Meanwhile, a one unit increase in a 
participant’s standardised Rutter Behavioural Scale (RBS) score (worse socioemotional 
development) predicted: a 0.012 decrease in QALYs; an increase in healthcare costs of £143.20; 
negative returns to the education equal to -£3,166.20 and additional crime costs of £14.84.  
 
Table 5.12: Mean Marginal Effects of GCA/RBS by Time Horizon and Discount Rate 
 Within Study 
(Discount 
=3.5%)  
Lifetime  
(Discount 
=3.5%)  
Lifetime 
(Discount 
=1.5%) 
Lifetime  
(Discount 
= 0 %) 
QALYs 
 GCA 0.001 
(0.001, 0.002) 
0.003 
(0.001, 0.004) 
0.007 
(0.004, 0.010) 
0.019 
(0.010, 0.027) 
 RBS -0.012 
(-0.021, -0.002) 
-0.021 
(-0.039, -0.004) 
-0.055 
(-0.101, -0.010) 
-0.155 
(-0.282, -0.027) 
Healthcare Costs 
 GCA -£8.04 
(-£14.50, -£1.63) 
-£15.81  
(-£28.96, -£2.66) 
-£40.62  
(-£75.40, -£5.85) 
-£133.58  
(-£249.68, -£17.49) 
 RBS £143.20  
(£35.50, £250.92) 
£292.42 
(£72.71, £512.12) 
£769.87 
(£190.32, £1349.42) 
£2564.39 
(£633.47, £4495.30) 
Returns to Education1 
 GCA £2,514.17 
(£1,611, £3,419) 
£4,524.81 
(£3,153, £5,900) 
£10,895.39 
(£7,840, £13,958) 
£21,781.50 
(£15,914, £24,690) 
 RBS  -£3,166.20 
(-£16,064, £10,181) 
-£3,104.10 
(-£22,741, £17,206) 
-£4,342.77 
(-£48,130, £40,965) 
-£5,312.39 
(-£89,453, £81,779) 
Crime Costs 
 GCA -£0.92 
(-£1.55, -£0.30) 
-£1.00 
(-£1.68, -£0.32) 
-£1.29 
(-£2.16, -£0.42) 
-£2.02 
(-£3.38, -£0.65) 
 RBS £14.84  
(£4.91, £24.78) 
£16.13 
(£5.33, £26.92) 
£20.72 
(£6.85, £34.58) 
£32.46 
(£10.73, £54.19) 
Notes:  Mean (and 95% confidence intervals) reported for all outcomes. Each marginal effect is per unit increase in 
 GCA and standardized RBS.   
 1: Results were back transformed to the raw scale using Duan’s smearing estimator. 
 
There was a substantial difference between within study/lifetime predictions and between 
outcomes discounted at different rates (Table 5.12). This was most evident when comparing 
healthcare costs where the predicted size per unit increase in standardised RBS was over 
seventeen times larger for undiscounted lifetime outcomes (£2564.39) when compared to 
within study outcomes discounted at 3.5% (£143.20). Similar effects were observed when 
predicting returns to education where each unit increase in GCA was over eight times larger for 
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undiscounted lifetime outcomes (£21,781.50) vs. within study outcomes discounted at 3.5% 
(£2,514.17).   
5.4.4 Lifetime Incremental Effects for Children Exposed to Postnatal Depression 
Incremental mean lifetime outcomes, discounted at 3.5%, were estimated for children exposed to 
maternal depression symptoms using results from chapter three, from Growth Curve Model 1. 
As the effect sizes from Growth Curve Model 1 were identified on the SDQ total difficulties 
scale, results were obtained for each model in this chapter using an equivalent measurement 
scale where the standardised RBS was transformed to a scale ranging from 0-40. The full results 
for the RBS transformed scale are described in Appendix 5.3.   
Children exposed to symptoms of postnatal distress at nine months were predicted to have 
worse cognitive and socioemotional outcomes, with incremental effects equal to -0.27 (GCA) 
and 2.07 (SDQ). The incremental effects on child development measures were predicted to 
translate into fewer lifetime QALYs (mean=-0.01), increased lifetime healthcare costs (£125.61), 
fewer lifetime returns to the education sector (-£2,512.52), and increased lifetime costs to the 
criminal justice sector (£6.96) when compared with children whose mothers were not depressed 
during the postnatal period, Table 5.13a & 5.13b.  
 
Table 5.13a: Incremental Effects of Maternal Depression on Child Development  
 GCA SDQ/ 
Rutter 
  
Postnatal depression symptoms1 -0.27 2.07   
Maternal depression symptoms2 -1.83 1.19   
Notes:  Results obtained from chapter three, Growth Curve Model 1.  
 Incremental effects vs. children not exposed to maternal depression symptoms. 
 1: Children exposed to postnatal depression symptoms at 9 months.  
 2: Per episode of exposure to maternal depression symptoms for children aged 3-11.  
 
 
 
Table 5.13b: Incremental Effects of Maternal Depression on Lifetime Outcomes  
 
 Adulthood Effects (Lifetime, Discount=3.5%) 
 QALY s Healthcare  
Costs 
Returns to 
Education 
Crime Costs 
Postnatal depression symptoms1 -0.01 £125.61 -£2,512.52 £6.96 
Maternal depression symptoms2 -0.01 £98.86 -£9,024.31 £5.69 
Notes:  Incremental effects vs. children not exposed to symptoms of maternal depression.   
 1: Children exposed to postnatal depression symptoms at 9 months.  
 2: Per episode of exposure to maternal depression symptoms for children aged 3-11.  
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The impact per each additional exposure to maternal depression symptoms occurring between 
ages three and eleven was identified using the cumulative distress variable from chapter three. 
Incremental effects were like those of postnatal depression and resulted in fewer QALYs 
(- 0.01), additional healthcare (£98.86) and crime (£5.69) costs, and fewer returns to education 
(-£9,024.31) across the lifespan.  
The results predicted large lifetime effects (discounted at 3.5%) for children repeatedly exposed 
to maternal depression throughout their childhood. These were obtained from chapter three, 
Growth Curve Model 2 where the incremental difference between children exposed to postnatal 
symptoms and persistent symptoms of depression (vs. no symptoms) were substantial (-0.04 
QALYs, £473.46 healthcare costs, -£30,740.97 returns to education, £26.86 crime costs). Full 
results for trajectories from Growth Curve Model 2 are reported in Appendix 5.4. 
The lifetime effects estimates can be used to establish the overall population disease burden 
associated with postnatal depression. Assuming a prevalence rate of depression as 13% per birth 
(Leahy-Warren and McCarthy, 2007), the burden of postnatal depression (through effects to 
children) for a one-year cohort of 774,835 live births in the UK for 2016 (ONS, 2017) is 
projected to equal 916 QALYs, £12.6 million through direct healthcare costs, £253.5 million in 
the education sector, and £702,000 in crime costs. If it is assumed that roughly 30% of 
postnatally depressed women suffer from at least one further episode of depression symptoms 
later during childhood (Vliegen et al., 2014) the impact of maternal depression on a one-year 
cohort of children is estimated to result in at least 1,218 fewer QALYs, £15.6 million in 
additional healthcare costs, £526 million fewer returns in education, and £900,000 in crime 
costs.  
5.5 Discussion   
5.5.1. Key Findings  
This analysis identified a strong association between cognitive and socioemotional development 
at age 10 and later life outcomes relevant as decision endpoints for economic evaluation. The 
empirical results support developmental theory and suggest that improvements to children’s 
cognitive performance and reductions to their behavioural and emotional problems are likely to 
result in improved health outcomes, reduced healthcare costs, increased returns to education, 
and reduced costs to the criminal justice sector during adulthood.  
Results were wholly consistent, occurring in the expected direction, with both cognitive and 
socioemotional development measures associated with later life outcomes and seven of eight 
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outcomes being statistically significant. The magnitude of effects was large for the returns to 
education outcome, not trivial for later life QALYs and healthcare costs, but insubstantial for 
crime costs.  These key findings are supported by similar results from empirical studies in UK 
cohorts linking measures of child development at (roughly) age 10 to self-rated health (Layard et 
al., 2014), (Hertzman et al., 2001), employment/education (Layard et al., 2014), (Healey et al., 
2004), and criminal outcomes (Herrnstein and Murray, 2010).  
5.5.2 Informing Policy through Model Predictions  
The models presented in this analysis provide a mechanism for estimating the lifetime effects of 
childhood health interventions, if evidence is available regarding the incremental effects 
associated with the intervention on General Cognitive Ability (β1) and/or the Rutter Behaviour 
Scale (β2) at age 10. Given this availability, mean (per individual) QALYs, healthcare costs, 
monetised returns to education and costs of crime can be estimated by multiplying the GCA 
and Rutter Behaviour Scale regression coefficients reported in this analysis by factors of β1 
and/or β2.  
The estimation of lifetime effects could be useful for decision makers when assessing the cost 
effectiveness of childhood interventions. As was described in Chapter 4, no other models were 
identified that obtained effect sizes on multiple decision endpoints directly relevant for 
economic evaluations conducted in the UK (i.e. QALYS and healthcare costs).  
Additionally, this study was tailored for UK evaluations, obtaining estimates for the lifetime 
horizon and with discount rates at 0%, 1.5% and 3.5% in accordance with recommendations in 
the NICE (2013) reference case. The results for each model and for each discount were 
reported separately, providing a useful source for analysts who might wish to apply different 
discount rates to healthcare costs and benefits (QALYs).  
5.5.3 Lifetime Effects of Postnatal Depression   
The above methodology was applied in this research to estimate the lifetime effects for children 
exposed to symptoms of postnatal depression using incremental effect sizes obtained from the 
analysis in chapter three. The estimation of lifetime effects demonstrates the full indirect 
estimation process and fulfils one of the overarching aims of the research in this thesis. The 
predicted incremental difference in lifetime effects for children exposed to postnatal depression 
symptoms vs. not exposed were not trivial and may have implications for health decision 
making. These estimates are used in chapter six to complete the applied example by assessing 
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the cost-effectiveness of screening for postnatal depression whilst considering effects to 
children, updating a NICE (2018) report which did not include child outcomes. 
Whilst the predicted magnitude of lifetime effects for each individual child exposed to 
symptoms of postnatal depression appeared relatively modest, the predicted lifetime effects of 
postnatal depression on population outcomes were substantial (916 QALYs, £12.6 million 
through direct healthcare costs, £253.5 million in the education sector, and £702,000 in crime 
costs). The yearly disease burden of postnatal depression through effects to children was large 
given the high population prevalence of postnatal depression and the subsequent high risk of 
childhood exposure to symptoms (McCarthy 2007). These lifetime effects to children are in 
addition to the detrimental health and social effects incurred by mothers who suffer from 
depression symptoms.  
5.5.4 Limitations    
The results from this research should be interpreted with caution given several limitations in 
this empirical analysis. Firstly, the fit between the models and the empirical data was not 
optimal. Regression assumptions that (deviance) residuals were homoscedastic and normal were 
not met for the crime outcome and appeared to be somewhat violated for both QALYs and 
healthcare costs outcomes. It is possible that these violations may have led to imprecise and 
potentially biased estimates (Dobson and Barnett, 2008).   
The cause of heteroscedastic (deviance) residuals may have resulted from omitted/unobserved 
covariates. For example, concurrent adulthood variables (e.g. adulthood income, marital status 
and health behaviours) likely to be associated with the outcomes were not included in the 
analysis. This was decided as theory implies that child development is likely to predict both 
adult concurrent and outcome variables (Overton, 2003). Therefore, the inclusion of concurrent 
adulthood variables in a GLM may have resulted in multicollinearity and reduced the 
interpretability of regression coefficients attached to the child development measures (Farrar 
and Glauber, 1967). Evidence from a similar empirical study suggests the relative impact of 
excluding adulthood variables may have been insubstantial: Hertzman et al. (2001) predict 
adulthood self-rated health using GLMs and find consistent associations for cognitive and 
socioemotional development in the presence and absence of concurrent adulthood variables.  
Nonetheless, results from this analysis might be improved using a more sophisticated model 
which could be estimated using structural equation regression methods. This type of model 
could account for the effects of child development on lifetime outcomes which occur through 
their effects on concurrent adulthood outcomes. While this was beyond the scope of this 
chapter it should be an objective for future research.  
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For health outcomes, model violation may have occurred due to the distribution of the 
outcome variables. No direct questionnaire items were available to identify healthcare costs or 
HRQoL, so participants were assumed to incur the mean (per person) HRQoL decrement and 
healthcare costs associated with five diseases (cancer, depression, diabetes, hypertension or 
obesity). As some values occurred at a relatively high frequency (e.g. obesity), the distribution of 
the outcome variable may have been multimodal despite there being a possible 304 unique 
values. One of the limiting factors of working with large cohort data is the reliance on 
measurements not pre-specified by the investigators. It would be very useful for health 
economics research if future cohort studies prioritised the collection of healthcare cost and 
HRQoL data.  
The measures available in the BCS 1970 might have led to further research limitation, as the 
model outcome may not have identified all the important decision endpoints. For instance, it 
was not possible to include within study deaths in the calculation of within study QALYs as this 
information required a special user’s licence. According to a report by Heywood et al. (2015) 
roughly 1% of participants died during the period for which QALYs were obtained in this 
study.  
Additional health effects would also have occurred in BCS 1970 study participants through 
diseases beyond the five for which data was available – these effects are no less relevant to 
decision makers. Furthermore, all costs of crime were unlikely to be identified from information 
on court convictions as costs occur in other areas for example, extending to victims through the 
crimes themselves e.g. theft, vandalism etc. (Brand and Price, 2000). Although it is impossible to 
know the exact impact of the unobserved outcomes on model interpretations, it might be 
sensible to assume that effect sizes occur in the same direction as the observed outcomes. For 
example, the impact of child development on, say, coronary heart disease may well be similar to 
the association between child development and cancer, depression, diabetes, obesity and 
hypertension. If this were the case, then predictions from this analysis would conservatively 
estimate the lifetime effects of child development on lifetime outcomes.  
Effect sizes on health outcomes may have been doubly underestimated given the assumptions 
used to calculate life expectancies from cohort members’ disease status at age 42. Firstly, most 
of the cancer, diabetes and hypertension cases may be expected later in life but the extrapolation 
did not predict additional cases of disease with onset after the study endpoint. Secondly, the % 
life years lost per disease were obtained from an NHS Executive (1996) report, but these 
calculations were not stratified by age of disease onset. On average, individuals who experience 
diseases earlier in life would have a higher % life years lost than individuals with later onset 
because they have a larger proportion of life expectancy to lose. Therefore, the average % of life 
years lost for individuals with disease onset during the study period (<42) is likely to be larger 
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than for those obtained from the NHS Executive (1996) report which included data from many 
individuals with disease onset after the age of 42.   
A third study limitation relates to the indirect estimation of the lifetime decision endpoints 
associated with maternal depression. It was assumed that development measures identified in 
chapter three at age eleven were equivalent to measures in this chapter obtained at age ten. The 
difference in ages is unlikely to be problematic given the results of the growth curve model 1 in 
chapter three which identified consistent incremental effects of postnatal depression for 
children across ages 3-11. Meanwhile, the assumption of measurement equivalency between the 
SDQ and the RBS might be appropriate as: the SDQ was designed based on the RBS, both 
have highly correlated scores (r=0.88) (Goodman, 1997), and RBS scores were transformed to 
the same scale as SDQ scores for this research. A thorough discussion of the appropriateness of 
the methods applied to estimate the lifetime decision endpoints for children exposed to 
postnatal depression is included in chapter seven.  
Fourth, while this study identified a strong association between child development and later life 
outcomes, a broad limitation of observational studies is the inability to establish causality. 
However, if these findings are considered alongside evidence in the current literature base the 
case for causality becomes much stronger. The study design was informed through lifespan 
developmental theory where lifetime outcomes are considered to be the direct consequence of 
childhood abilities (Overton, 2003), (Halfon and Hochstein, 2002), (Lerner and Busch-
Rossnagel, 2013), and whilst sparse, randomised evidence is available to support this theory 
(Currie, 2001). The limitation of the causality assumption in the overall estimation of lifetime 
effects is discussed in more detail in chapter seven.  
Finally, a considerable number of participants dropped out of the 1970 BCS. Drop out can lead 
to attrition bias if data is not missing completely at random (MCAR) – MCAR assumes the 
probability of participants leaving the study is not correlated with any characteristics of cohort 
members. The results of a logistic regression analysis by Mostafa and Wiggins (2014) suggest the 
MCAR assumption is unlikely to hold in the 1970 BCS. Individual characteristics including 
being male, unmarried, and having parents of low social class with fewer years of education 
were found to significantly increase the probability of non-response. Based on the associations 
identified in this study, individuals with characteristics fitting this profile might be expected to 
have relatively worse lifetime crime, education and health outcomes.  
Even if it is assumed that missing observations have relatively worse lifetime outcomes, it is 
difficult to speculate on the direction of any potential attrition bias. If associations follow those 
identified in this study, then it would seem more likely that the missing data also included 
individuals with relatively worse development outcomes. In this instance, effect sizes might be 
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underestimated if individuals with the worst development and lifetime outcomes are those with 
the highest probability of non-response. Conversely, the observed effect sizes could be 
overestimated as there are feasible reasons why missing data might occur more frequently in 
individuals with relatively better development outcomes. For example, it may be that individuals 
with better cognitive development have higher wage expectations making them less likely to 
respond to questionnaires when their earnings do not meet these expectations. Future research 
could explore the problem of attrition bias by generating complete case databases using 
imputation methods, as demonstrated with the application of multiple imputation by chained 
equations (MICE) in chapter three.  
5.5.5 Usefulness of Predictions for Decision Makers & Future Research 
Bearing in mind the above limitations, the model predictions from this study might be 
questioned in terms of their usefulness to inform decision makers. Here, the commonly cited 
phrase by George Box (1976), that “all models are wrong, but some are useful”, is particularly 
apt. The empirical models in this analysis have enabled estimates to be made regarding the 
effects of child development on later life outcomes based on logical simplifications of the real 
world.  
The question of usefulness is to ask whether a model estimate is better than no estimate at all. 
NICE (2018) guidelines on maternal depression screening recognise the potential impact of 
postnatal depression on child development but terms these outcomes as “intangible”. The 
impact of including/excluding lifetime outcomes of maternal depression on child development 
will be investigated in chapter six when assessing the cost-effectiveness of screening for 
postnatal depression. The usefulness of predictions generated in this chapter will be revisited in 
chapter seven.  
5.5.6 Conclusions    
The empirical analysis in this study identified strong associations between cognitive and 
socioemotional development and several lifetime outcomes that are likely to be important for 
healthcare decision making in the UK. Predictions from the models can be used to estimate 
lifetime effects of childhood health technologies and could be informative for decision makers 
assessing cost-effectiveness.  
The research in this chapter estimated the lifetime effects of children exposed to postnatal 
depression, suggesting a substantial population burden occurring predominantly in the 
education sector through effects to economic productivity. The lifetime effects estimates 
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obtained from this chapter are used in the final part of the applied research in this thesis 
(Chapter 6) as parameters in a decision model evaluating the cost-effectiveness of screening for 
postnatal depression.  
Future research could address some of the study limitations by using a more sophisticated path 
model. Researchers might also attempt to replicate findings in different longitudinal cohorts, 
which could increase the external validity of these results, reduce uncertainty around estimates 
and increase their usefulness when informing decisions.  
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Chapter 6: An Economic Evaluation Assessing the Cost-
Effectiveness of Screening for Postnatal Depression  
6.1 Summary  
The overarching aims of this thesis focus on developing a methodology for estimating the 
lifetime effects of early childhood circumstances and determining whether lifetime estimates can 
be used to inform cost-effectiveness decisions in UK economic evaluations. This chapter 
addresses these research aims presenting the results of an economic evaluation assessing the 
cost-effectiveness of competing screening strategies for postnatal depression. The parameters in 
this analysis are informed by the research in the previous chapters which estimated the lifetime 
incremental effects of childhood exposure to postnatal depression symptoms on health and 
economic decision endpoints. This chapter investigates the overall usefulness and influence of 
the lifetime estimates for decision-makers by identifying the cost-effective screening strategy for 
scenarios which either include or exclude the child parameters. The analysis also explores the 
importance of the philosophical framework applied in the economic evaluation of child health 
technologies by considering the screening strategy for postnatal depression from a health 
centric and cross-sectoral decision maker’s perspective. As well as informing the overarching 
aims of this thesis, the applied research in this chapter can be used to update current policy 
recommendations regarding the appropriate screening strategy for postnatal depression in the 
UK.   
6.2 Introduction 
6.2.1 Background to Screening  
Screening is a clinical method used to identify a sub group of a population at high risk of having 
a disease/disorder. Following a positive screen this sub group will usually proceed to further 
health technology interventions including diagnostic tests and/or the offer of an appropriate 
treatment (Gilbert et al., 2001). Therefore, screening allows for the timely identification and 
treatment of conditions which may not yet display clinical symptoms. Screening can be 
particularly beneficial for diseases with high population prevalence that may be left undiagnosed 
(Goldberg, 2014).  
Screening is seldom perfect and typically leads to the identification of four distinct groups. Two 
of these are correctly classified: true positives who have the condition and have a positive screen 
and true negatives who do not have the condition and have a negative screen. The other two 
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groups are the misclassified false positives who do not have the condition but achieve a positive 
screen, and false negatives who have the condition but are not identified by the screen. These 
classifications are often summarised in terms of the screen’s sensitivity, which is the ability of the 
test to detect the condition (true positives/ (true positives + false negatives)), and specificity, the 
ability of the test to identify those without the condition (true negatives/ (true negatives + false 
positives)) (Greenhalgh, 1997), (Lalkhen and McCluskey, 2008).  
6.2.2 Screening for Postnatal Depression  
There is some debate in the literature regarding the benefit of screening for postnatal 
depression (Paulden et al., 2009). On one hand screening fulfils many of the twenty criteria for 
viable population screening set out by the UK National Screening Committee (UK NCS, 2015). 
For example, postnatal depression is an important health condition with a high population 
prevalence (Sharp et al., 2010), has available and relatively non-invasive screening instruments 
whose sensitivity and specificity are established in randomised trials (Hewitt et al., 2009), and 
has cost-effective treatments available in the form of psychological and pharmacological 
therapies (NICE, 2018).  
However, a study by Paulden et al. (2009) and the associated Health Technology Assessment 
(HTA) submission by Hewitt et al. (2009) did not find screening for postnatal depression to be 
cost-effective measured against cost-effectiveness thresholds commonly used in the NHS. 
Hewitt et al. (2009) suggests this result is primarily due to the cost of treating false positive 
cases. This evidence may have contributed to the UK National Screening Committee’s (UK 
NCS, 2011) decision not to recommend population screening for postnatal depression.  
More recently, NICE (2018) have investigated the cost-effectiveness of a dual phase screening 
strategy which reduces the number of costly false positive diagnoses. The suggested strategy 
implements a low costing screen with very high sensitivity (proportion of correct true positives) 
but low specificity, (proportion of correct true negatives) followed by a more thorough screen 
with higher specificity – the second screen being limited to positive cases identified through the 
initial screen (true positives and false positives). When compared to case identification through 
standard care, NICE (2018), find the dual strategy to be cost-effective when using the Whooley 
questions as the initial screen and either the Patient Health Questionnaire-9 (PHQ-9) or 
Edinburgh Postnatal Depression Scale (EPDS) as the second screen.  
While the dual screening strategy is identified as cost-effective, current NICE (2018) guidelines 
do not require the formal administration of a population screen but suggest GPs consider asking 
these questions during a woman’s first contact with primary care after child birth.  
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6.2.3 Research Objectives  
To recap, the overarching aims of the research in this thesis are: to develop and describe a 
methodology for indirectly estimating the lifetime effects of early childhood circumstances by 
linking results across two empirical analyses; and to determine whether lifetime estimates 
influence the cost-effectiveness results in an applied, UK based, economic evaluation.  
The primary objective of this chapter is to address the second research aim by presenting the 
results of an economic evaluation assessing the cost-effectiveness of screening for postnatal 
depression with and without the inclusion of lifetime effects for children exposed to symptoms 
of postnatal depression. The influence of lifetime effects is investigated for two separate 
decision perspectives as was suggested in chapter two. Firstly, an economic evaluation is 
conducted from the perspective of a health centric decision maker, limiting the decision 
endpoints to health benefits valued as QALYs and healthcare costs incurred directly by the 
NHS and PSS. Secondly, the perspective is extended to that of a cross-sectoral decision maker, 
adopting a perspective which extends the decision endpoints to include monetized costs and 
benefits falling on sectors outside of health. 
In addition to addressing an overarching thesis aim, a second objective of the research in this 
chapter is to provide evidence which could be used to inform a UK health policy decision. 
Current recommendations for postnatal depression screening in the UK are informed through 
an economic evaluation conducted by NICE (2018). The analysis in this chapter extends the 
NICE (2018) model by addressing two limitations: firstly NICE (2018) did not formally account 
for the effects of postnatal depression in children; secondly, NICE (2018) did not assess cost-
effectiveness across a full range of threshold values shown to influence the specificity and 
sensitivity of the EPDS/PHQ-9 screening instruments (Hewitt et al., 2009). The analysis in this 
chapter assesses the cost-effectiveness of screening for postnatal depression across all cut-off 
points for which data is available.  
The final objective of this chapter is to determine whether future research is worthwhile and to 
establish research priorities if this is the case. Alongside policy implementation 
recommendations, economic evaluations should assess whether it is cost-effective to conduct 
future research (Drummond et al., 2015). With respect to the aims of the thesis, the analysis 
establishes the potential cost-effectiveness of future research obtaining more precise estimates 
of lifetime effects in children exposed to postnatal depression.  
The above objectives were addressed through the following research questions: 
1. What is the cost-effective screening strategy for postnatal depression when considering 
maternal outcomes only and assuming a healthcare decision maker’s perspective?  
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2. What is the cost-effective screening strategy for postnatal depression when considering 
maternal and child outcomes and assuming a healthcare decision maker’s perspective?  
3. What is the cost-effective screening strategy for postnatal depression when considering 
maternal and child outcomes and assuming a cross-sectoral decision maker’s 
perspective?  
4. Is it cost-effective to obtain future evidence and should this evidence include further 
research regarding the estimation of lifetime outcomes associated with children who are 
exposed to postnatal depression?  
6.3 Methods  
6.3.1 Decision Analytic Model  
The economic model in this analysis predominantly follows the same structure, adopts the same 
underlying assumptions and is informed by the same model parameters as the previously 
mentioned NICE (2018) model. Any departure from NICE (2018) methodology is 
distinguished using italics.  
6.3.1.1 General Model Structure  
Summarising research by Sculpher et al. (2006), the conclusions from chapter two 
suggest decision analytic models (DAMs) are the most appropriate vehicle for health economic 
evaluation. One of the most common types of DAM is the decision tree which was the model 
type selected by NICE (2018). Decision trees map all potential decisions (i.e. treatment 
strategies) and subsequent patient outcomes on different branches within the tree. Decision 
endpoints and probabilities are assigned to each patient outcome and mean costs and benefits 
are calculated for each strategy by simulating a hypothetical population through the model, 
multiplying the proportion of the population achieving each patient outcome by the assigned 
decision endpoints and summing across all the relevant branches (Brennan et al., 2006).  
The decision tree in this analysis compared four formal case identification (screening) strategies 
for postnatal depression against the comparator of case identification through standard GP 
care. It was assumed that all screening strategies would be administered six weeks postnatally – 
this was selected as the optimal time for screening in analyses by NICE (2018) and Hewitt et al. 
(2009) as it is the period of peak incidence for postnatal depression where new mothers 
continue to have regular interaction with primary care services through GP appointments and 
home health visits.   
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Following screening, mothers could be grouped into four possible treatment pathways up to the 
model’s endpoint at 52 weeks. The model included the (hypothetical) population of all postnatal 
women in the UK who are eligible to use the NHS. As informed by NICE (2018), postnatal 
depression was categorised as women with sub threshold, minor and major depression 
symptoms, occurring at a prevalence of 8.7%.  
6.3.1.2 Screening Pathways  
The first screening strategy was the Edinburgh Postnatal Depression Scale (EPDS), a 
ten- item instrument developed specifically to detect cases of depression in women during the 
antenatal and postnatal period (Cox et al., 1987). The ten items in the EPDS relate to symptoms 
of depression (e.g. misery, anxiousness, irritability and panic) and each is scored based on the 
frequency of symptom occurrence from zero (never) to three (most of the time/a lot). A total 
score is generated by summing scores across all items and ranges from zero to thirty. Upon 
conception Cox et al. (1987) suggested that probable cases of depression could be identified 
using a threshold of 12/13 with possible cases using a threshold of 9/10.  
As identified in a meta-analysis by Paulden et al. (2009) and Hewitt et al. (2009), the sensitivity 
and specificity of the EPDS is dependent on the selected threshold. The NICE (2018) model 
did not assess cost-effectiveness across the full range of threshold values shown to influence the 
specificity and sensitivity of the EPDS/PHQ-9 screening instruments, instead investigating the 
EPDS as a single strategy using a combined threshold of 9 or 10. It was therefore limited in 
scope.  
Consequently, this analysis extended the NICE (2018) screening model by assessing a range of 
thresholds for the EPDS (from 7-16) as competing strategies. The sensitivity and specificity of 
each EPDS threshold was obtained directly from Paulden et al. (2009) and is summarised in 
Table 6.1. 
The second screening strategy investigated administration of the Patient Health Questionnaire 9 
(PHQ-9). The PHQ-9 contains nine items for each of the DSM-IV criteria for depression, 
which are scored from zero (“not at all”) to three (“nearly every day”), a total score ranging 
from 0-27 is obtained by summing scores for each item. Whilst the PHQ-9 is most commonly 
used as a tool to for identifying depression in the general population, it has reasonable 
sensitivity (0.75) and specificity (0.88) in postnatal women at threshold value of 9/10 (NICE, 
2018). The PHQ-9 strategy was limited to this single threshold as no studies have identified the 
sensitivity and specificity of the PHQ-9 in postnatal women at a range of threshold values 
(NICE, 2018). 
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Table 6.1: Sensitivity and Specificity of Case Identification Strategies 
Strategy Mean  SE Probabilistic  
Distribution  
Source  
Sensitivities  
  
EPDS (threshold=7) 0.9117  Log Normal, Cholesky* (Paulden et al., 2009)  
EPDS (threshold=8)  0.9120  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=9)  0.8528  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=10)  0.8170  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=11)  0.7221  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=12)  0.6805  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=13)  0.6619  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=14)  0.5331  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=15) 0.3910  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=16) 0.3127  Log Normal, Cholesky* (Paulden et al., 2009) 
Whooley Questions  0.9500 0.04 Beta (α=34, β=2) (Bosanquet et al., 2015) 
PHQ-9 (threshold=9/10) 0.7500 0.06 Beta (α=44, β=15) (NICE, 2018) 
Standard Care 0.5100 0.05 Beta (α=52, β=50) (NICE, 2018) 
     
Specificities  
  
EPDS (threshold=7) 0.6699  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=8)  0.7454  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=9)  0.8216  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=10)  0.8626  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=11)  0.9110  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=12)  0.9306  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=13)  0.9271  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=14)  0.9572  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=15) 0.9776  Log Normal, Cholesky* (Paulden et al., 2009) 
EPDS (threshold=16) 0.9893  Log Normal, Cholesky* (Paulden et al., 2009) 
Whooley Questions  0.6500 0.05 Beta (α=69, β=37) (Bosanquet et al., 2015) 
PHQ-9 (threshold=9/10) 0.8800 0.02 Beta (α=396, β=54) (NICE, 2018) 
Standard Care 0.8100 0.03 Beta (α=102, β=23) (NICE, 2018) 
Notes:  No SE is reported for EPDS by Paulden et al. (2009), variances on the Log Odds scale are available in the 
 original report.   
 *Cholesky matrix was obtained through decomposition of variance-covariance matrices which 
 were obtained through correspondence with authors. 
The third and fourth case identification strategy consisted of two stages: an initial screen using 
the Whooley questions, followed by a second screen with either the EPDS or PHQ-9 for the 
subgroup of mothers who were categorised as positive cases by the first screen. The Whooley 
questions consist of two items asking mothers if they have (i) often been bothered by feeling 
down, depressed or hopeless and (ii) had little interest or pleasure in doing things. Affirmative 
responses to either of the questions result in a positive test (Bosanquet et al., 2015). The 
Whooley questions have a very high sensitivity (0.95) but low specificity (0.65) for depression in 
the general population (Bosanquet et al., 2015) and given the short administration time the 
combination of Whooley questions followed by a more specific instrument was considered as a 
potentially cost-effective strategy by NICE (2018).  
The NICE (2018) model assumed the Whooley questions had a sensitivity of 1.00 based on the 
results from two studies using a population of postnatal women (Gjerdingen et al., 2009), 
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(Mann et al., 2012). This analysis updated these parameters using evidence by Bosanquet et al. 
(2015) who identified the specificity and sensitivity of the Whooley questions for detecting 
depression in a general population in a ten study meta-analysis including studies for postnatal 
populations by Gjerdingen et al. (2009) and Mann et al. (2012). It was decided that evidence 
from the eight additional studies in the general population would be relevant for the postnatal 
population and provide more precise estimation of sensitivity/specificity. As previously, this 
analysis investigated a variety of EPDS threshold values (ranging from 7-16) during the second 
screen for positive cases identified by the Whooley questions.  
 
 
Figure 6.1: Illustrates the diagnostic component of the decision tree.  
*=Ten different strategies were investigated for different thresholds for the EPDS ranging from 7-16.  
 
The final strategy was the comparator, standard care case identification which assumed that a 
proportion of postnatally depressed women would be identified as depressed by a GP through 
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contact with the health service during the postnatal period. Standard case care identification was 
assumed to occur with a sensitivity of 0.51 and specificity of 0.81 as identified by NICE (2018).  
Each case identification strategy established four distinct groups which followed diverging 
treatment components: “true positives” were depressed mothers who correctly identified; “false 
positives” were non-depressed mothers who had a positive screen; “true negatives” were non-
depressed women who had a negative screen; while “false negatives” were depressed mothers 
who were not identified through screening. The strategies assessed in this analysis and the 
associated groups identified through screening are depicted in Figure 6.1.  
6.3.1.3 True Positive & False Positive Treatment Component Assumptions 
Both the true positive and false positive mothers were assumed to receive treatment for 
depression and therefore followed the same treatment components. It was expected that 
allocated treatments would depend on the severity of depression. Using prevalence rates 
reported by (NICE, 2018), it was assumed that 72% of women suffered from mild-moderate 
symptoms whilst 28% of women suffered from moderate-severe symptoms.  
In cases of mild-moderate depression, women were assumed to be offered facilitated guided 
self-help. This is a treatment which teaches individuals to personally tackle symptoms of 
depression using cognitive behavioural strategies, delivered through self-help manuals with 
assistance being provided by therapists, computer software, and web applications (NICE, 2018). 
Women were expected to complete seven sessions over a period of ten and a half weeks, this 
being the mean reported in NICE (2018) guidelines. In addition, mild-moderately depressed 
women were also expected to attend three GP appointments during this period.  
Cases of moderate-severe depression were expected to be offered either intensive psychological 
therapy (72%), or pharmacological treatment (28%). It was assumed that psychological therapy 
would consist of 16 sessions of cognitive behavioural therapy conducted over a three-month 
period and be delivered by a trained therapist (NICE, 2018). Women receiving pharmacological 
treatments were assumed to receive sertraline (or similar antidepressants) for eight weeks of 
intensive treatment followed by six months of maintenance therapy. Fifteen percent (15%) of 
mothers receiving pharmacological therapy were assumed to have two specialist psychiatric 
appointments while the remainder (85%) were managed in primary care with an expected mean 
of four GP appointments (NICE, 2018).  
At 52 weeks, true positive mothers were categorised as depressed/not depressed depending on 
whether they responded or failed to respond to treatments. The absolute risk of non-response 
for facilitated self-help (0.4891), intensive psychological therapy (0.3120) and pharmacological 
therapy (0.3120) were not directly reported by NICE (2018) and were therefore derived by 
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multiplying the reported relative risks with the reported absolute risk of no improvement in 
standard care (mild-moderate depression=0.65, moderate-severe depression=0.67) (NICE, 
2018). As all false positive mothers were wrongly identified as depressed, they were assumed to 
follow the “response” pathway and were categorised as non-depressed at the model endpoint. 
The true positive/false positive treatment components are illustrated in Figure 6.2.  
 
 
Figure 6.2: Depicts the true positive and false positive treatment components of the decision tree.  
 
6.3.1.4 True Negative Treatment Component Assumptions 
 The true negative population consisted of mothers who were correctly identified as not 
depressed and, as such, were assumed to receive no treatment for depression throughout the 
duration of the decision model. This true negative treatment component is illustrated in Figure 
6.3.  
 
 
Figure 6.3: Illustrates the true negative treatment component of the decision tree 
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6.3.1.5 False Negative Treatment Component Assumptions 
 Depressed mothers who were wrongly identified as not depressed followed the false 
negative treatment component as is illustrated in Figure 6.4. It was assumed that 33% of these 
mothers would spontaneously recover from postnatal depression three months following child 
birth without receiving any formal treatment, and that they would remain in the non-depressed 
disease state throughout the remainder of the model (NICE, 2018). 
  
 
 
Figure 6.4: The false negative treatment component of the decision tree.  
 
The false negative population who did not spontaneously recover were either identified (8%) or 
not identified (92%) as depressed by a GP at six months postpartum. Those who were not 
identified by a GP received no treatment and were categorised as depressed at 52 weeks. 
Mothers who were identified as depressed by a GP were assumed to immediately begin 
treatment, following the same pathway as true positive/false positives (NICE, 2018). All 
probabilities used within the economic model are described in Table 6.2.  
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Table 6.2: Probability Parameters  
Parameter Mean  SE Probabilistic 
Distribution 
Source 
Postnatal depression prevalence 0.087  0.004 Normal  (NICE, 2018) 
     
Mild-moderate symptoms |depressed 0.725  0.030 Normal (NICE, 2018) 
     
Moderate-severe symptoms |depressed 0.275  0.030 Normal (NICE, 2018) 
     
Absolute risk of no response  
Standard care (mild-moderate symptoms)  
 
0.67  
 
0.020 
 
Normal  
 
(NICE, 2018) 
     
Absolute risk of no response in standard 
care (moderate-severe symptoms)  
 
0.65  
 
0.020 
 
Normal 
 
(NICE, 2018) 
     
Relative risk of no improvement facilitated 
self-help (vs. standard care) 
 
0.73  
 
0.100 
 
Log Normal  
 
(NICE, 2018) 
     
Relative risk of no improvement 
psychological therapy (vs. standard care) 
 
0.48  
 
0.050 
 
Log Normal  
 
(NICE, 2018) 
     
Relative risk of no improvement 
pharmacological therapy (vs. standard care) 
 
0.48  
 
0.050 
 
Log Normal  
 
(NICE, 2018) 
     
Absolute rate of spontaneous recovery at 13 
weeks  
 
0.33  
 
0.004 
 
Normal  
 
(NICE, 2018) 
     
Absolute rate of GP identification at 26 
weeks 
 
0.08  
 
0.040 
 
Beta (α=4, β=50)*  
 
(NICE, 2018) 
Notes:  *Probabilistic values obtained directly from Kessler et al. (2002), a study used to inform the NICE (2018) 
 model. 
 
6.3.2 Model Parameters  
6.3.2.1 Maternal Healthcare Cost Assumptions 
All maternal healthcare costs were obtained from the original NICE (2018) report and 
uprated to 2018 prices using the consumer price index (ONS, 2018b). Overall treatment costs 
(including additional care) equalled £386.87 for facilitated guided self-help, £231.08 for 
pharmacological therapy and £1710.14 for intensive psychological therapy. It was assumed that 
false positive cases would discontinue treatment before its conclusion, incurring 20% of the 
total treatment costs.  
An additional cost of £8.82 for health and social care was applied for each week mothers were 
in the depressed disease state. This additional cost excluded the first six weeks following child 
birth, as it was assumed that both depressed and non-depressed mothers would have similarly 
frequent contact with the health services meaning net costs over this period would equal zero.  
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Costs of screening were estimated based on the hourly (uprated) cost for a GP consultation 
(£250.19). The EPDS/PHQ-9 screen was expected to take 15 minutes to complete at a cost of 
£62.55, while the Whooley questions were assumed to take 1 minute to administer costing 
£4.17. The duration of standard care case identification was set equal to the mean GP 
appointment time (11.7 minutes) and therefore cost £48.79. A further cost of £52.67 for an 
hourly appointment with a health visitor was applied to all positive cases that were identified 
through screening. A full description of all costing categories is provided in NICE (2018). 
6.3.2.2 Maternal Quality Adjusted Life Years Assumptions 
All utility scores reported by NICE (2018) were obtained from a trial conducted by 
Sapin et al. (2004) and were identified using the EQ-5D questionnaires in a general UK 
population. Postnatally depressed mothers were assumed to incur the same utility decrement as 
depressed individuals in the general population and thus assigned utility scores of 0.74 for mild-
moderate symptoms and 0.44 for moderate-severe symptoms. Non-depressed mothers were 
assigned a health-related quality of life score of 0.86 which was associated with the remission 
health state in Sapin et al. (2004).  
The NICE (2018) analysis did not report the QALYs for each maternal health state directly, 
instead stating QALYs as being calculated using the “area under the curve” method. Therefore, 
this analysis derived QALYs by applying the trapezium rule9 to estimate the integral across the 
appropriate HRQoL utility scores. As the model was conducted over 52 weeks, QALYs were 
equivalent to HRQoL utilities for mothers who remained solely in one disease state (i.e. never 
depressed/depressed and no treatment response).  
Mothers who responded to treatment did not have the same HRQoL scores throughout the 
model as they transitioned from the depressed to non-depressed disease states. The NICE 
(2018) methodology showed this transition occurring as a linear improvement in HRQoL over 
the duration of treatment. An example of the linear improvement in HRQoL is depicted in 
Figure 6.5 for a mother with moderate-severe depression who responds to intensive 
psychological therapy. Several QALYs values were derived in this analysis (using the trapezium 
rule) for maternal responders who differed in terms of on initial depression severity, the date of 
treatment initiation, and the total duration of treatment.  
                                                     
9 For a full description of the trapezium rule see chapter five, section 5.3.3.6 
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Figure 6.5: Illustrates the HRQoL and associated QALYs for mothers who initially suffered from symptoms of 
moderate-severe depression and who responded to three months of intensive psychological therapy during the 
model. A=treatment initiation at 6 weeks, B=treatment conclusion at 19 weeks.  
 
The final maternal QALYs variable was assigned to false positive mothers who were assumed to 
be non-depressed but incur a 2% reduction in utility due to a wrong diagnosis. This assumption 
was obtained from the NICE (2018) model which was informed through NICE Guideline 
Development Group (GDG) expert opinion. Discounting was not applied to maternal 
healthcare costs or QALYs as the duration of the model was over a single year. A summary of 
all costs and utility parameters is provided in Table 6.3 
 
Table 6.3: Maternal Cost and Utility Parameters  
Parameter Mean SE Probability 
Distribution 
Source 
Maternal Costs 
     
Facilitated guided self-help £386.87 N/A Fixed (NICE, 2018) 
Intensive psychological therapy £1710.14 N/A Fixed (NICE, 2018) 
Pharmacological therapy £231.08 N/A Fixed (NICE, 2018) 
Weekly health & social care1 £8.82 N/A Fixed (NICE, 2018) 
Treatment costs for false positives2 20.0% N/A Fixed (NICE, 2018) 
EPDS/PHQ-9 screen  £62.55 N/A Fixed (NICE, 2018) 
Whooley screen  £4.17 N/A Fixed (NICE, 2018) 
Standard care case identification  £48.79 N/A Fixed (NICE, 2018) 
     
Maternal Utilities 
     
No depression symptoms  0.86 0.13 Beta (α=215, β=35) (NICE, 2018) 
Mild-moderate depression symptoms 0.74 0.19 Beta (α=133, β=47) (NICE, 2018) 
Moderate-severe depression symptoms 0.44 0.27 Beta (α=31, β=39) (NICE, 2018) 
Utility decrement for false positives3  2.00% N/A Beta (α=2, β=98) (NICE, 2018) 
Notes:  1: Weekly health and social care costs for depressed mothers only 
 2: Treatment costs are a percentage of the total treatment costs for true positives 
 3: Percentage utility decrement from utility for “no depression symptoms”  
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6.3.2.3 Children’s Lifetime Outcomes Assumptions 
This analysis departs from the NICE (2018) methodology by including children’s lifetime 
outcomes in the decision tree. The theoretical literature indicates children are affected by 
postnatal depression through the detrimental influence of symptoms on the maternal-child 
attachment relationship (Bowlby, 1978), (Cummings and Davies, 1994), (Sanger et al., 2015). In 
support of this assertion, a meta-analysis by Cuijpers et al. (2015) identifies significant benefits 
from psychological treatments for postnatal depression on maternal depression outcomes, 
maternal-child attachment outcomes and on early child development outcomes. This analysis 
assigned incremental lifetime outcomes by classifying children as being “exposed” or “not-
exposed” to postnatal depression symptoms.  
Children were assumed to be exposed to postnatal depression symptoms if their mothers were 
in the “depressed” disease state at 52 weeks. The primary analysis assumes that children were 
not exposed to symptoms of postnatal depression if their mothers were never depressed or 
initially depressed but responded to treatment (i.e. successful treatment assumed to prevent the 
effects of postnatal depression). This was assumed as chapter three identified postnatal 
depression at 9- months after child birth, resulting in a control group of “non-depressed” 
mothers which also contained a group of responders within it (mothers who had symptoms 
shortly after birth but did not have symptoms by the 9-month measurement point) This 
assumption is investigated in the deterministic sensitivity analysis. Figure 6.6 illustrates the 
assignment of exposure status groups for the true positive/false positive treatment component.  
 
 
Figure 6.6: True positive/false positive treatment components including effects to children.   
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Table 6.4: Children’s Lifetime Costs and Utilities  
Parameter Mean SE Probability 
Distribution 
Source 
Intermediate Development Effects1  
 PND on GCA -0.27  0.63 Normal, Cholesky  Chapter 3 
 PND on SDQ 2.07 
 
0.28 Normal, Cholesky Chapter 3 
Development to Lifetime Outcomes2    
 QALYs  
      RBS 
      GCA 
 
-0.004 
0.003 
 
0.003 
0.001 
 
Normal, Cholesky 
Normal, Cholesky 
 
Appendix 5.4 
Appendix 5.4 
 Healthcare costs  
      RBS  
      GCA 
 
£58.76 
-£15.81 
 
£22.53 
£6.71 
 
Normal, Cholesky 
Normal, Cholesky 
 
Appendix 5.4 
Appendix 5.4 
 Returns to Education 
      RBS 
      GCA 
 
-£625.13 
£4,524.81 
 
£2,063.10 
£701.63 
 
Normal, Cholesky 
Normal, Cholesky 
 
Appendix 5.4 
Appendix 5.4 
 
PND on Lifetime Outcomes3     
 QALYS -0.01   Derived  
 Healthcare Costs £125.61   Derived 
 Returns in Education -£2,512.52   Derived 
Notes: 1: Incremental effects of exposure to postnatal depression symptoms at 9-months vs. non-exposure on 
 child development outcomes obtained from Chapter 3, growth curve model 1.  
 2: Marginal effects per unit increase in child development measures on lifetime outcomes, obtained from 
 mathematical models in Chapter 5 (Appendix 5.4).  
 3: Incremental effect of exposure to postnatal depression symptoms at 9-months vs non-exposure on 
 lifetime outcomes derived by multiplying intermediate development effect sizes (Chapter 3) by marginal 
 effect coefficients (Appendix 5.4).  
 
Children exposed to symptoms of postnatal depression were assigned estimates of incremental 
lifetime QALYs, healthcare costs and returns to education as previously identified in chapter 
five. As the estimates were incremental, non-exposed children were assigned lifetime outcomes 
equal to zero. The primary analysis assigned incremental lifetime outcomes discounted at 3.5%, 
equalling -0.01 QALYs, £125.61 healthcare costs, and -£2,512.52 returns to education. Costs to 
the criminal justice sector were not included in the decision model as the added difficulty of 
incorporating costs across an additional sector was not considered worthwhile given the 
insubstantial effect sizes identified in chapter five. It was assumed that lifetime estimates 
obtained in this thesis at nine-months would be applicable to exposure occurring at 12-months 
in this model. All child model parameters are reported in Table 6.4.  
6.3.3 Analytical Perspectives    
Two different perspectives were adopted in this research. The first two objectives were 
investigated by adopting a health centric decision maker’s perspective which accounted for 
health benefits (QALYs), and healthcare costs incurred by the NHS and PSS. For the first 
objective, only maternal health outcomes were considered, whilst the second objective 
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expanded these outcomes to include both maternal and child health outcomes. The third 
objective was investigated by adopting the perspective of a cross-sectoral decision maker. This 
perspective accounted for child and maternal health outcomes but also included children’s 
lifetime monetary returns in education as a decision endpoint.  
6.3.4 Decision Rules  
Economic evaluation should primarily inform policy through a deterministic analysis which 
accounts for the mean costs and mean benefits associated with each strategy (Claxton, 1999), 
(Drummond et al., 2015). Deterministic analyses establish cost-effectiveness by applying 
decision rules to appropriately rank competing strategies in terms of their incremental mean 
costs and benefits. Decision rules in economic evaluation typically require the calculation of the 
incremental cost-effectiveness ratio (ICER), this being incremental costs divided by incremental 
benefits for two competing strategies (Drummond et al., 2015), Equation 6.1a.  
The first analysis, which adopted a health centric decision perspective, identified cost-
effectiveness using dominance decision rules. Initially strongly dominated strategies were 
identified and excluded from the cost-effectiveness decision if they had lower associated mean 
QALYs and higher mean healthcare costs than a competing strategy. Next, extended 
dominance was calculated by ranking each remaining strategy in terms of mean costs and 
calculating ICERs between strategies of increasing costs. Extendedly dominated strategies were 
identified (and excluded) if their ICER (with a higher costing strategy) decreased (Drummond et 
al., 2015). For instance, if assessing the cost-effectiveness of strategies A, B and C, strategy B is 
extendedly dominated if the ICER between A and B is larger than the ICER between B and C, 
and the associated healthcare costs are strategy C > strategy B > strategy A. 
The first analysis identified the cost-effective strategy by comparing the ICERs between all non-
dominated/extendedly dominated strategies with a cost-effectiveness threshold (k). The cost-
effectiveness threshold is the opportunity cost associated with health technologies (i.e. the 
resources which could have been spent elsewhere in the health sector) and the value of k 
equates to the monetary value placed by the health sector per each additional unit of health (i.e. 
QALY) (Woods et al., 2016). The cost-effective strategy was identified here as that with the 
highest mean benefit and an ICER (with the next non-dominated higher costing strategy) strictly 
less than the cost-effectiveness threshold. Deterministic cost-effectiveness results are reported 
in analysis for thresholds of k=£20,000 and k=£30,000. Whilst there is currently some debate 
in the literature as to the appropriate value for k (Claxton et al., 2013), UK economic 
evaluations usually follow NICE (2013) reference case guidelines and conduct cost-effectiveness 
analysis using these values for k (Woods et al., 2016). 
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Equation 6.1a: Decision Rules for a Health Decision Maker’s Perspective 
A strategy is considered cost-effective (when compared with standard care) if:  
 ICER:  [Δch/Δh] > k 
 NHB:  [Δh - Δch/k] > 0 
Equation 6.1b: Decision Rules for a Cross-Sectoral Decision Maker’s Perspective 
A strategy is considered cost-effective (when compared with standard care) if:  
 NHB:  [Δh - Δch/k] – Δcc/v > 0 
Or equivalently:  
 NCB: v.[Δh - Δch/k] – Δcc > 0 
Where: 
Δh = incremental QALYs 
Δch = incremental healthcare costs 
Δcc=  incremental education costs  
k=  cost-effectiveness threshold (the additional costs that would displace 1 unit of 
 health elsewhere in the healthcare system)  
v=  The consumption value of health (the amount of consumption regarded as 
 equivalent to 1 unit of health  
 
Notes:  Equations obtained from Claxton et al. (2010). Decision rules establish cost-effectiveness by comparing a 
 strategy to a relevant comparator e.g. standard/usual care. ICERs is the incremental cost-effectiveness 
 ratios; NHB is the net health benefit; NCB is the net consumption benefit.  
 
The second analytical perspective required children’s monetised returns to education to be 
considered within the decision rule. The literature review in chapter two identified a study by 
Claxton et al. (2010) suggesting a decision rule which can account for monetised outcomes 
outside of health when evaluating the cost-effectiveness of public health interventions. The 
recommended decision rule identifies incremental net health benefits for each treatment 
strategy versus standard care.  
When applied to analyses which only include health related decision endpoints, the formula for 
Net Health Benefit (NHB), or equivalently net consumption benefit (NCB), is a simple 
rearrangement of ICER inequality, Equation 6.1a. Claxton et al. (2010) modify the NHB 
equation to account for both extra consumption costs and a consumption value for health (v), 
Equation 6.1b. As described in chapter two, it may be that £1 consumption in the health sector 
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is not equivalent to £1 consumption in other government sectors. The consumption value for 
health provides a mechanism to weight costs and benefits falling on the wider economy 
differently to the costs and benefits falling within the health sector. For the second analytical 
perspective NHBs/NCBs were calculated for all strategies vs. standard care using Equation 
6.1b. The cost-effective strategy was identified as that with the largest overall net benefit.  
As no current research establishing an appropriate value for the consumption value of health (v) 
was identified, results are presented across a range of potentially feasible values. This began with 
the assumption that v/k=1 meaning that £1.00 spent in the health sector was assumed 
equivalent to £1.00 spent in the education sector. The ratio of v/k was then decreased in 
increments to a minimum value of 0.25 where £1 health = £0.25 education and increased in 
increments to a maximum of value of 4.00 where £1 health= £4 education. Results at each v/k 
ratio are identified for thresholds of k=£20,000 and k=£30,000.  
6.3.5 Evaluating Uncertainty 
All economic evaluations using decision analytic models contain some form of uncertainty 
through methodological choice or through imprecision in the estimation of the model 
(Drummond et al., 2015). Common sources of uncertainty include: structural uncertainty, 
usually resulting from the assumptions made when building the model; and parameter 
uncertainty resulting from imprecision in empirical estimates used to inform parameter values 
i.e. confidence intervals around sample means from clinical trials/observation studies (Andronis 
et al., 2009), (Drummond et al., 2015). Therefore, it is important, and a requirement for 
submissions to NICE (2013), that appropriate sensitivity analyses be conducted to characterise 
this uncertainty.  
6.3.5.1 Deterministic Sensitivity Analysis  
One method of characterising uncertainty is through deterministic sensitivity analysis 
which assigns a specific input value to model parameters in exchange for the original parameter 
value. This type of sensitivity analysis is particularly useful for identifying the impact of 
structural uncertainties as it allows cost-effectiveness to be assessed in different scenarios by 
relaxing or adjusting the assumptions made when building the model (Drummond et al., 2015).   
Deterministic sensitivity analysis was undertaken for several questionable assumptions in this 
analysis.  Firstly, the assumption that all false positive mothers receive a 2% utility decrement 
from being wrongly diagnosed was based on GDG expert opinion and not on empirical 
evidence (NICE, 2018). Therefore, the first scenario investigated the case where false positive 
mothers achieved the same utility as true negative mothers (i.e. no utility reduction).  
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The second scenario investigated assumptions regarding the transmission of treatment benefit 
from mother to child. The primary analysis assumed that children were not exposed to 
symptoms if their mother recovered from postnatal depression during the model. In contrast, 
the sensitivity analysis assumed children were affected by depression symptoms proportionate 
to the duration their mother was in the depressed disease state. For instance, if a mother was in 
the depressed disease state for three months and was non-depressed for nine months, their 
child incurred 25% of the total healthcare cost and QALYs of a child whose mother was 
depressed for the full 52 weeks.  
Thirdly, the lifetime effects of children exposed to symptoms of postnatal depression were 
indirectly estimated in this thesis by assuming exposure effects on development outcomes 
continued and remained consistent throughout the child’s lifespan. This assumption was 
informed by the results of Growth Curve Model 1 in chapter three, which identified equivalent 
incremental effects on GCA and SDQ outcomes for all observations for children aged 3-11. 
Whilst incremental effects appeared to remain consistent within the study period, it is possible 
that the effects of postnatal depression changed and had either an increasing or decreasing 
impact on children beyond the study time horizon observed in chapter three. To investigate the 
influence of this assumption the cost-effective screening strategy was identified for scenarios 
which apply an (arbitrary) 25% reduction/increase to all children’s lifetime outcomes.  
Deterministic sensitivity analysis allows cost-effectiveness to be established for a range of sub-
populations (Andronis et al., 2009). For postnatal depression there is evidence that prevalence 
rates vary according to demographic characteristics, for instance, first time mothers with low 
income are more likely to suffer from postnatal depression than the general population (Goyal 
et al., 2010). Representative values for low income populations were investigated in a fourth 
sensitivity analysis by increasing the prevalence rates of postnatal depression from 8.7% to 
20.0%, which is towards the upper bounds reported by Goyal et al. (2010).  
Finally, as described in chapter five, there is debate regarding the value of the discount rate 
applied to decision endpoints in economic evaluation. All maternal decision endpoints were 
unaffected by discounting as they occurred within the 52-week time horizon. In contrast, child 
outcomes were identified across the lifetime and the results of chapter five estimated 
substantially smaller lifetime effects for lower discount rates. This research reports all primary 
results with costs, QALYs and monetised returns to education discounted at 3.5%. In addition, 
a deterministic sensitivity analysis was conducted identifying the cost-effective strategy for a 
scenario where all costs and benefits are discounted at 1.5%, and for a scenario where unequal 
discount rates are applied with healthcare costs and monetised returns to education discounted 
at 3.5% and QALYs discounted at 1.5%.  
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6.3.5.2 Probabilistic Sensitivity Analysis  
To evaluate how parameter uncertainty affected the overall decision, probabilistic 
sensitivity analysis (PSA) was performed. This type of sensitivity analysis applies probability 
distributions to model parameters and draws n random sample from each of these distributions. 
The cost-effective strategy is identified by calculating the Net Health Benefit for each strategy in 
each random draw. PSA is used to determine the probability of a correct decision being made by 
identifying the probability of cost-effectiveness associated with each strategy. These are 
obtained by summing the total number of times a strategy is cost-effective across all draws and 
dividing this by the total number of draws (n) (Briggs et al., 2002), (Drummond et al., 2015), 
(Fenwick et al., 2001).   
To conduct PSA, appropriate distributions need to be assigned to each model parameter. As 
model parameters are averages (i.e. means), the distribution selected for PSA should represent 
the expected sampling distribution for the parameter of interest rather than the expected 
distribution of the population parameter (Briggs et al., 2002).10 Because PSA is concerned with 
sample distributions, there is a relatively small range of candidate distributions (Briggs et al., 
2002). 
Briggs et al. (2002) recommend the normal distribution as an option for most model parameters 
in PSA. According to central limit theorem, sample distributions are normally distributed if 
sample sizes are large enough even if the population distributions of the parameter are not. 
However, normal distributions may not be suitable for probabilities and utility values which are 
bounded by zero and one as random draws could identify model parameter values outside of 
this feasible range. For bounded model parameters, Briggs et al. (2002) suggests researchers 
consider the gamma distribution. As a continuous form of the binomial distribution, the gamma 
distribution can be fit to various probability/utility data by altering the distributional parameters 
α (number of outcomes) and β (number of trials), thus producing random draws within the 
possible bounds of the model parameter.  
Similarly, normal distributions might not be appropriate if assigned to relative risk parameters as 
these are probability ratios (i.e. probability of outcome in exposed group: probability of 
outcome in control group). As described by Briggs et al. (2002), and according to central limit 
theorem, sample distribution for relative risks are expected to be normally distributed following 
                                                     
10 A population distribution is simply the distribution (or occurrence) of the parameter of interest (e.g. mean) across 
the whole population. As it is not usually possible to measure outcomes across the entire population, empirical 
studies estimate population parameters by conducting analyses on sub-sections, or samples, of the population.  A 
sampling distribution is the distribution of all the different sample means obtained from many different samples of a 
population.   
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the application of a natural log transformation. Consequently, the log normal distribution might 
be the most appropriate selection of distribution for relative risk parameters in PSA.  
The distributions selected for this analysis were informed by Paulden et al. (2009) who 
conducted PSA in an economic evaluation assessing the cost-effectiveness of screening for 
postnatal depression. All distributional assumptions made by Paulden et al. (2009) were 
confirmed to be consistent with the above recommendations by Briggs et al. (2002). The 
distributions applied to each parameter are described alongside the associated parameters 
previously in Tables 6.1-6.4. Fixed distributions (i.e. non-random) were applied to treatment 
costs as there is little uncertainty regarding the value of these variables (Briggs et al., 2002). 
A final consideration during the assignment of distributions in PSA is the possibility of 
dependencies between model parameters (Claxton et al., 2005), (Naveršnik and Rojnik, 2012). 
For instance, the specificity of a screening strategy is likely to be dependent on the test’s 
sensitivity. Assumptions of independence between test sensitivity and specificity could lead to 
improbable outcomes for random draws within PSA, e.g. individual draws might assign a test 
with very high specificity and sensitivity. PSA can be conducted with correlated random 
variables to account for potential dependencies between model parameters (Claxton et al., 
2005), (Naveršnik and Rojnik, 2012). Correlated random variables are obtained for PSA by 
algebraically manipulating the covariance-variance matrix for dependent model parameters using 
a technique called Cholesky decomposition (Briggs et al., 2006), (Naveršnik and Rojnik, 2012). 
It is only usually possible to apply Cholesky decomposition in primary analyses as the variance-
covariance matrix is rarely reported in secondary literature.  
This analysis identified correlated random variables for: all EPDS screening parameters where 
the covariance-variance matrix was obtained from Paulden et al.(2009) through liaison with 
authors; and for all child parameters where the covariance-variance matrix between cognitive 
and socioemotional variables was obtained for the analyses conducted in chapters 3 and 5. It 
was not possible to identify this information for the Whooley screens, which were assigned as 
single random variables with a beta distribution.  
This analysis conducted PSA using 10,000 random draws. Probabilities of cost-effectiveness 
were established for cost-effective thresholds ranging from £0 - £100,000 per QALY. Separate 
PSA results were obtained for each decision perspective. PSA identifies probabilities of cost-
effectiveness for each strategy which are dependent on the cost-effectiveness threshold. This is 
because cost-effectiveness is calculated using the Net Health Benefit equation which includes 
the cost-effectiveness threshold within it (see equation 6.1a). The results of PSA are presented 
as cost-effectiveness acceptability curves (CEACs) and cost-effectiveness acceptability frontiers 
(CEAFs) (Barton et al., 2008), (Fenwick et al., 2001).  
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Figure 6.7: Illustrates an example cost-effectiveness acceptability curve (left) and cost-effectiveness acceptability 
frontier (right) for strategies A, B and C. CEACs display PSA results for all strategies across different cost-
effectiveness thresholds, CEAFs display PSA results for the mean cost-effective strategy across cost-effectiveness 
thresholds. In this hypothetical example the mean cost-effective strategy is assumed to be: strategy A when 
k<£25,000; strategy B when £25,000<=k<£40,000; and strategy C when k>=£40,000.  
 
Cost-effectiveness acceptability curves plot each strategy’s probability of cost-effectiveness 
across the range of cost-effectiveness thresholds under investigation. Similarly, CEAFs plot the 
probability of cost-effectiveness across threshold ranges, but only plot this for a single strategy 
identified as cost-effective through deterministic analysis of mean model parameters. Therefore, 
assuming policy makers adopt the mean cost-effective strategy, the CEAF illustrates the 
associated probability of a correct decision being made across the feasible range of cost-
effectiveness thresholds. An example illustration of CEACs and CEAFs is provided in Figure 
6.7. Fenwick et al. (2001) recommend CEAFs when displaying PSA results as the mean cost-
effective strategy is not always the strategy with the highest probability of being cost-effective.  
6.3.5.3 Value of Information Analysis: EVPI 
In addition to informing decisions about the cost-effectiveness of implementing a 
specific strategy, economic evaluation should also establish whether it is cost-effective to 
conduct further research (Drummond et al., 2015). This question can be addressed using the 
results of PSA to conduct a value of information analysis (Barton et al., 2008). The first figure 
estimated in a value of information analysis is typically the expected value of perfect information 
(EVPI). The EVPI calculates the cost of removing all the uncertainty from decision making 
and, therefore, represents the maximum value of information obtained through additional 
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research (Drummond et al., 2015). If the costs of future research are expected to exceed the 
EVPI then it should not to be commissioned as it will not be cost-effective.  
Following the methodological guidance in Ades et al. (2004), Brennan et al. (2007) and 
Drummond et al. (2015), the EVPI was calculated in this analysis by applying the following 
procedures to the outputs of the PSA: 
(1) The optimal decision given current information was identified as the strategy with the 
largest mean net benefit across all draws in the PSA. The largest mean net benefit given 
current information (NBci) entered the EVPI calculation. 
(2) The expected net benefit of a decision taken when given perfect information was 
calculated by: firstly, identifying the maximum net benefit (for any strategy) within 
individual probabilistic draws and secondly calculating the mean of the individual 
maximum net benefits across all probabilistic draws. This calculated mean value was 
termed the mean maximum net benefit given perfect information (NBpi).  
(3) The final EVPI was calculated as NBpi - NBci.  
For further clarity Table 6.5 provides an example of an EVPI being calculated for a hypothetical 
cost-effectiveness analysis of strategies A, B and C.  
The above procedure identifies the EVPI per individual. Healthcare policy decisions are 
primarily concerned with the appropriate allocation of healthcare at a population level. 
Therefore, it is most appropriate to present the EVPI results per population rather than per 
individual. The EVPI per population is obtained by multiplying the number of individuals 
expected to benefit from the strategy (patient population) by the value of the EVPI per 
individual (Ades et al., 2004), (Brennan et al., 2007).  
Following methods by Paulden et al. (2009), this evaluation identified the patient population 
assuming screening would be offered to all new mothers from England and Wales and would 
continue to be offered for the next twenty years. ONS (2018a) data indicated that 685,320 
mothers gave birth in England and Wales during 2018. The cumulative number of potential 
beneficiaries was summed over twenty years assuming a consistent birth rate during this period 
and applying a discount rate of 3.5%. The final discounted patient population who could 
potentially benefit from postnatal depression screening was estimated to equal 10,080,946.  
 
  
188 
 
Table 6.5: Illustration of EVPI Calculation 
Draw Number Net Benefit 
A 
Net Benefit 
B 
Net Benefit 
C 
Best 
Strategy 
Maximum 
Net Benefit* 
1 10 9 8 A 10  
2 11 11 9 A and B 11  
3 8 7 11 C 11  
4 9 13 8 B 13  
5 12 10 7 A 12  
6 10 14 6 B 14  
7 8 13 12 B 13  
8 9 12 8 B 12  
9 9 7 9 A and C 9  
10 10 13 8 B 13 
      
Mean Net Benefit 9.6 10.9** 8.6  11.8*** 
EVPI****   11.8-10.9=0.9 
Notes:  The table demonstrates how an EVPI is calculated for a hypothetical PSA conducted using 10 random draws 
 for strategies A, B and C.  
 * The maximum net benefit per draw is calculated as the net benefit associated with the best  strategy. 
 **The largest mean net benefit given current information is calculated by estimating the mean net benefit 
 for each strategy across all draws and identifying the largest of these values.  
 ***The mean maximum net benefit given perfect information is calculated by summing the maximum net 
 benefits across all draws and dividing by the number of draws (i.e. 118/10). 
 ****The EVPI (per individual) is calculated by subtracting B from C.  
 
6.3.5.4 Value of Information Analysis: EVPPI 
 As well as the overall EVPI, value of information analysis can identify the expected 
value of partial perfect information (EVPPI). Specifically, the EVPPI identifies the maximum 
monetary benefit that would be achieved by reducing the uncertainty associated with individual 
parameters or small groups of parameters. Therefore, the EVPPI places an upper limit on the 
cost of future research specific to these individual parameters or parameter groups (Ades et al., 
2004). Calculation of the EVPPI can inform future research objectives by indicating the type of 
additional evidence likely to be most useful for future decisions, and equally the type of 
evidence likely to be least useful (Drummond et al., 2015).  
The calculation of EVPPI followed guidance by Ades et al. (2004), Brennan et al. (2007) and 
Heath et al. (2016), requiring the PSA to be re-conducted in the following stages: 
(1) The parameter of interest Φ was identified and PSA was conducted over one draw to 
identify a random variable for Φ equal to φ. That is, the first stage in the EVPPI 
calculation identified Φ = φ. 
(2) PSA was conducted as previously described in Section 6.3.5.2 across n random draws. 
This excluded the parameter of interest Φ, whose value was held equal the value of the 
single random variable φ. That is, Φ = φ for all n draws whilst the value of other model 
parameters varied across individual probabilistic draws.  
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(3) The largest mean net benefit given current information (NBci) and the mean maximum 
net benefit given perfect information (NBpi) were calculated as described in Section 
6.3.5.3 and Table 6.5 
(4) Procedures (1) – (3) were repeated over N iterations with each iteration using a 
different fixed value of φ for Φ in the PSA (i.e. Φ= φ1 φ2, .., φN). Each iteration 
identified N distinct NBci and NBpi values. 
(5) The mean NBci and mean NBpi was obtained across all iterations by summing the 
distinct NBci and NBpi values for φ1, φ2, …, φN, and dividing these totals by N.  
(6) The final EVPPI was calculated as:  mean NBpi – mean NBci.  
The procedure was applied to identify multiple EVPPIs by changing the parameter of interest 
Φ. The EVPPI was calculated for the following parameter groups: EPDS probabilities; 
Whooley probabilities; prevalence and risk rates; maternal healthcare costs/utilities; children’s 
combined healthcare costs and QALYs and children’s returns to education. The EVPPIs were 
calculated for cost-effectiveness thresholds where k=£20,000 and k=£30,000 and for v/k=1 
when assuming a cross-sectoral decision maker’s perspective. Because of large computational 
requirements, this analysis reduced the PSA to n=1000 simulations, while N=100 iterations 
were used for Φ. 
6.4 Results  
6.4.1 Health Centric Perspective: Maternal Outcomes  
Strategy descriptions are abbreviated throughout the results. The number in parenthesis () 
following the strategy description indicates the cut-off point used for that strategy for instance 
EPDS (16) is the EPDS at a cut-off of 16. The first section of the results addresses research 
question one (6.2.3) assessing the cost-effectiveness of screening for postnatal depression without 
including effects to children, this being the approach adopted by NICE (2018). 
The cost-effective strategy for cost-effectiveness thresholds k=£20,000 and k=£30,000 was the 
administration of the Whooley + EPDS (16). This strategy dominated standard care case 
(standard GP care) identification, having lower mean costs and higher mean QALYs. The 
probability the strategy was cost-effective equalled 0.53 at k=£20,000. This probability 
decreased upon increasing the threshold value and was equal to 0.24 when k=£30,000. 
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Table 6.6: Mean Cost-Effectiveness Results for Health Centric Decision Perspective 
Strategy Mean 
QALYs 
Mean 
Healthcare 
Costs 
ICER1 Probability  
Cost-effective 
(k=£ 20,000) 
Probability 
Cost-effective 
(k=£30,000) 
Maternal Outcomes Only2 
Whooley + EPDS (12)  0.84897 £92.00 £37,621 0.102 0.167 
Whooley + EPDS (14)  0.84875 £83.78 £32,137 0.076 0.087 
Whooley + EPDS (16)  0.84838 £71.94   0.528 0.236 
      
Maternal & Child Outcomes3  
Whooley + EPDS (11)  0.8483 £100.51 £520,564 0.096 0.137 
Whooley + EPDS (12)  0.8483 £97.58 £30,914 0.107 0.141 
Whooley + EPDS (14)  0.8480 £89.67 £26,818 0.088 0.084 
Whooley + EPDS (16)  0.8476 £78.28   0.427 0.188 
Notes:  Strategies are ranked by mean healthcare costs (highest to lowest). Results are only reported for 
 non-dominated/extendedly dominated strategies.  
 1: ICERs were calculated vs the next non-dominated higher costing strategy. 
 2: Cost-effectiveness results for maternal health outcomes only.  
 3: Cost-effectiveness results for maternal and child health outcomes.  
 
 
  
Figure 6.8 Cost-effectiveness acceptability frontiers for maternal vs. maternal & child health outcomes  
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The cost-effective strategy was dependent on the lower bounds of the cost-effectiveness 
threshold. As indicated by the ICERs in Table 6.6: the Whooley + EPDS (14) was cost-effective 
at k=£32,137; while the Whooley +EPDS (12) was cost-effective with k>£37,621. The cost-
effective strategy and its associated probability of cost-effectiveness is displayed for thresholds 
from £0-£100,000 in the cost-effectiveness acceptability frontier in Figure 6.8. Decisions were 
most uncertain at higher cost-effectiveness thresholds where the probability of cost-
effectiveness for the Whooley + EPDS (12) plateaued at roughly p=0.12.   
All strategies involving the PHQ-9, case identification through standard care, and sole 
administration of the EPDS were dominated at all cost-effectiveness thresholds and had a 
probability of being cost-effective close or equal to zero. Table 6.6 reports results for all non-
dominated and extendedly dominated strategies. Full results across all strategies are available in 
Appendix 6.1. 
6.4.2 Health Centric Perspective: Maternal and Child Outcomes 
The second question expanded the analytical perspective beyond that addressed in the NICE 
(2018) analysis, establishing the cost-effective strategy when including the lifetime QALYs and 
healthcare costs for children exposed to postnatal depression symptoms. The inclusion of child 
health outcomes resulted in a change in the cost-effective strategy when k=£30,000, where a 
more sensitive and less specific strategy, the Whooley + EPDS (14), became the cost-effective 
option (p=0.08). However, the change in the cost-effective strategy was dependent on the value 
of the cost-effectiveness threshold as the Whooley + EPDS (16) remained cost-effective for 
k=£20,000 (p=0.43), Table 6.6. All strategies previously dominated or extendedly dominated 
for the maternal only perspective remained so. This excluded the Whooley + EPDS (11) 
strategy, which had an ICER of £520,564 far beyond the recommended cost-effectiveness 
threshold (NICE, 2013).  
The PSA produced similar results for both the maternal only and maternal & child health 
centric decision perspectives: As illustrated in Figure 6.8, the inclusion of child QALYs and 
healthcare costs appeared to shift the CEAF to the left. This resulted in increased decision 
uncertainty between cost-effectiveness thresholds of k=£20,000 and k=£30,000. Full cost-
effectiveness and PSA results for the maternal and child health centric decision perspective are 
described in Appendix 6.2.  
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6.4.3 Cross-Sectoral Perspective: Maternal and Child Outcomes  
The third research question established cost-effectiveness for a cross-sectoral decision 
perspective by including lifetime returns in the education sector as decision endpoint alongside 
maternal and child QALYs & healthcare costs. Firstly, a cross-sectoral analysis was conducted 
across all not dominated or extendedly dominated strategies from the previous section (6.4.2), 
indicating whether returns in the education sector were positive or negative when compared 
with standard care case identification. The EPDS strategies with high specificity (Whooley + 
EPDS (16) and Whooley + EPDS (14) had a negative incremental net benefit in the education 
sector, whereas strategies with more balanced sensitivity and specificity (Whooley + EPDS (12) 
and Whooley + EPDS (11)) had positive incremental returns in the education sector, Table 6.7. 
 
Table 6.7: Mean Cost-Effectiveness Results for Cross-Sectoral Decision Perspective  
Strategy Net Benefit 
in Education  
Incremental 
Returns in 
Education 
NCB1 
k=£10,000 
NCB1 
k=£20,000 
NCB1 
k=£30,000 
Whooley + EPDS (11)  Positive £7.68 24.65 54.18 83.70 
Whooley + EPDS (12)  Positive £5.96 25.80 55.27 84.74 
Whooley + EPDS (14)  Negative -£0.15 25.04 51.95 78.86 
Whooley + EPDS (16)  Negative -£9.29 23.04 45.70 68.37 
Notes:  1: NCB= Net Consumption Benefit  
 Results for all non-dominated/ extendedly dominated strategies. All net benefits are calculated 
 vs. standard care case identification. The cost-effective strategy is indicated in bold. 
 
Secondly, cost-effectiveness was more formally examined for the cross-sectoral perspective by 
estimating the incremental net consumption benefit of each strategy versus standard care, 
assuming consumption in the health and education sector is valued equivalently (v/k=1). The 
inclusion of children’s returns in education resulted in a change in the cost-effective strategy 
where a more sensitive and less specific strategy became cost-effective: the Whooley + EDPS 
(12) strategy was consistently cost-effective, having the highest incremental net health benefit at 
thresholds of k=£10,000, k=£20,000, and k=£30,000, Table 6.7.  
The cost-effective outcome was robust for most consumption ratios in health and education 
(v/k) where the Whooley + EPDS (12) remained cost-effective. The cost-effective strategy only 
changed once v/k was: reduced to 0.5 or lower where the Whooley + EPDS (10) strategy 
became cost-effective for both k=£20,000 and k=£30,000; or increased to 4 when where the 
Whooley + EPDS (16) strategy became cost-effective for k=£20,000. Figure 6.9A and 6.9B 
depict incremental net benefits of each strategy vs. standard care across a range of v/k ratios for 
k=£20,000 and k=£30,000. 
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Figure 6.9A: Cost-effectiveness results when including children’s QALYs, healthcare costs and education costs assuming a cost-effectiveness threshold of k=£20,000. Results are 
obtained across a range of feasible consumption values for health (v). Incremental net consumption benefits were calculated for all strategies vs. standard care case identification. All child 
outcomes are discounted at 3.5%.  
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Figure 6.9B: Cost-effectiveness results when including children’s QALYs, healthcare costs and education costs assuming a cost-effectiveness threshold of k=£30,000. Results are 
obtained across a range of feasible consumption values for health (v). Incremental net consumption benefits were calculated for all strategies vs. standard care case identification. All child 
outcomes are discounted at 3.5%.  
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The inclusion of costs incurred in the education sector appeared to decrease the overall decision 
uncertainty when compared with the analyses excluding these costs, as illustrated in Figure 6.10 
which presents the cost-effectiveness acceptability frontier for consumption ratios v/k=1. The 
probability of the cost-effective strategy being the correct decision did not exceed 0.5 and was less 
than 0.1 when cost-effectiveness thresholds ranged from £10,000-£30,000.  
 
 
Figure 6.10: Probabilistic sensitivity analysis results for the cross-sectoral perspective which includes children’s lifetime 
QALYs, healthcare costs and returns to education alongside maternal decision endpoints (all discounted at 3.5%) 
Above: A cost-effectiveness acceptability frontier where children’s returns to education costs are included in the decision 
problem using a ratio of v/k=1.  
Below: Cost effectiveness acceptability curves demonstrating the variability in probabilities of cost-effectiveness for non-
dominated/extendedly dominated strategies according to different v/k ratios.  
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Different levels of uncertainty were identified for different v/k ratios at the same cost-effectiveness 
thresholds. For instance, at k=£20,000 the Whooley + EPDS 16 strategy had a probability of being 
cost effective of p=0.3 when v/k=1.5, p=0.28 when v/k=1 and p=0.32 when v/k=0.67. As 
illustrated by the cost-effectiveness acceptability curves in Figure 6.10, each strategy’s probability of 
cost-effectiveness followed similar trajectories for each v/k ratio and differences were generally 
minimal when ratios which ranged from 0.67-1.50. Differences were most substantial for lower 
cost-effectiveness thresholds where k<£10,000.  
6.4.4 Deterministic Sensitivity Analyses  
The results of the deterministic sensitivity analysis are summarised in Table 6.8 and reported in full 
in Appendix 6.4. The scenario with the largest impact on the cost-effectiveness decision occurred 
when assuming false positive mothers incurred no reduction in utility rather than the 2% reduction 
assumed in the base case. Under this assumption several previously dominated became non-
dominated as a result of increases in their associated mean QALYs. This led to standard care case 
identification being identified as cost-effective at thresholds of k<£27,944, whilst the Whooley + 
EPDS (11) strategy was cost-effective when k=£30,000.  
The application of a 1.5% rather than a 3.5% discount rate to children’s lifetime QALYs and costs 
reduced the ICERs between all non-dominated or extendedly dominated strategies. The change in 
discount rate affected the cost-effective strategy. At a threshold of k=£30,000: the Whooley + 
EPDS (12) was cost-effective when accounting for children’s lifetime QALYs and healthcare costs 
(Table 6.8); meanwhile the Whooley + EPDS (10) became cost-effective for the cross-sectoral 
decision perspective (Appendix 6.4F). The scenario which discounted QALYs (1.5%) and costs 
(3.5%) at different rates influenced the cost-effectiveness result for the health-centric decision 
perspective where the Whooley + EPDS 12 strategy became cost-effective but had no effect for the 
cross-sectoral decision perspective (Appendix 6.4G).  
Similarly, changes to the prevalence rate of postnatal depression resulted in reduced ICERs between 
the non-dominated or extendedly dominated strategies. For the perspective which included 
maternal health outcomes, and when assuming a postnatal depression population prevalence of 
20% rather than 8.7%, the cost-effective strategy changed to the Whooley + EPDS (12) for 
k=£30,000. This finding was dependent on the value of the cost-effectiveness threshold as the 
Whooley + EPDS 16 remained cost-effective for a 20% prevalence rate when k=£20,000.  
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Table 6.8: Deterministic Sensitivity Analysis Mean Cost-Effectiveness Results  
Strategy Mean QALYs Mean Costs ICERs* 
Scenario 1B: Discount Rate= 1.5% 
Whooley + EPDS (10)  0.8474 £116.05 £251,856 
Whooley + EPDS (11)  0.8474 £109.47 £34,386 
Whooley + EPDS (12)  0.8473 £106.69 £24,109 
Whooley + EPDS (14)  0.8470 £99.27 £21,213 
Whooley + EPDS (16)  0.8465 £88.63  
 
Scenario 2A: Postnatal Depression Prevalence=20% 
Whooley + EPDS (9)  0.8356 £195.42 £998,450 
Whooley + EPDS (10)  0.8356 £189.62 £40,260 
Whooley + EPDS (11)  0.8353 £177.28 £37,522 
Whooley + EPDS (12)  0.8352 £171.96 £23,544 
Whooley + EPDS (14)  0.8345 £155.25 £22,403 
Whooley + EPDS (16)  0.8334 £130.64   
 
Scenario 3A: Utility reduction for false positive Mothers = 0%  
EPDS (8)  0.8500 £175.76 £527,538 
Whooley + EPDS (8)  0.8499 £113.15 £48,303 
Whooley + EPDS (9)  0.8498 £106.08 £45,033 
Whooley + EPDS (10)  0.8497 £102.10 £30,213 
Whooley + EPDS (11)  0.8495 £95.01 £29,322 
Whooley + EPDS (12)  0.8494 £92.00 £27,945 
Standard Care 0.8490 £82.07 £18,288 
Whooley + EPDS (16)  0.8484 £71.94   
 
Scenario 4B: Children’s Exposure Proportionate to Depression Duration 
Whooley + EPDS (11)  0.8482 £101.43 £6,297,315 
Whooley + EPDS (12)  0.8482 £98.46 £33,918 
Whooley + EPDS (14)  0.8479 £90.40 £29,712 
Whooley + EPDS (16)  0.8475 £78.79  
Notes:  Results reported for all non-dominated or extendedly dominated strategies. All 
 outcomes are discounted at 3.5% unless otherwise stated. 
 (A) Health centric decision perspective with maternal outcomes only.    
 (B) Health centric decision perspective with maternal and child outcomes. 
 *ICERs calculated vs the next non-dominated, higher costing strategy. 
 
Lifetime effects were estimated for the base case by assuming that the incremental effects of 
postnatal depression on children’s development remained constant beyond the age of eleven (the 
final age at which effects were observed in chapter three). This assumption was investigated for the 
health centric decision perspective in two scenario analyses by applying a 25% decrease and 25% 
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increase to the incremental effects to approximate diminishing and snowballing effect sizes over 
time. The scenario which applied a 25% diminishing effect sizes increased the value of the ICERs 
for all non-dominated or extendedly dominated strategies but did not influence the cost-
effectiveness result, where the Whooley + EPDS (16) strategy and Whooley + EPDS (14) strategy 
remained cost-effective when k=£20,000 and k=£30,000. In contrast, the scenario applying a 25% 
snowballing effect size decreased the value of the ICERs which changed the cost-effectiveness 
result, where the Whooley + EPDS (12) strategy became cost-effective for k=£30,000, Appendix 
6.4D.   
Finally, the assumption that children were not exposed to postnatal depression symptoms if their 
mothers responded to treatment was relaxed by assuming that these children incurred lifetime 
effects proportionate to the time their mothers were in the depressed disease state. This scenario 
had little impact on the decision and produced the same cost-effective strategies as the base case 
analysis at thresholds of k=£20,000 (Whooley + EPDS (16)) and k=£30,000 (Whooley + EPDS 
(14)).  
6.4.5 Value of Information Analysis  
6.4.5.1 Expected Value of Perfect Information  
The base case value of information analysis was conducted for the model including child 
healthcare costs and QALYs. At a cost-effectiveness threshold of k=£20,000, the base case EVPI 
was £3.50 per patient and £35,326,497 per population, which increased to £16.20 per patient and 
£163,264,542 per population when the threshold was raised to k=£30,000. There was a continued 
(linear) increase in the EVPI for thresholds above k=£30,000 which occurred as a result of a 
consistently high level of uncertainty associated with the Whooley + EPDS (12). In contrast, at 
lower cost-effectiveness thresholds (k<£20,000) the EVPI was close to zero due to the high 
probability of the Whooley + EPDS (16) being the cost-effective strategy, Figure 6.11.  
The inclusion of children’s educational outcomes resulted in substantially larger EVPIs which were 
equal to: £29.05 (person) and £292,901,679 (population) for k=£20,000 and v/k=1; and £32.83 
(person) £330,938,234 (population) for k=£30,000 and v/k=1. As illustrated in Figure 6.11, the 
EVPI increased (decreased) for all cost-effectiveness thresholds when v/k=0.67 (v/k=1.5) where it 
was assumed that consumption in the education sector is of a higher (lower) value than 
consumption in the health sector.  
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Figure 6.11: The population EVPI at different cost-effectiveness threshold for models with both maternal and child 
outcomes discounted at 3.5% and for an assumed patient population in England and Wales= 10,080,946: Above results 
are obtained for a health centric perspective (children’s QALYs and healthcare costs). Below results are obtained for a 
cross sectoral perspective (children’s QALYs, healthcare costs and returns to education) applying different v/k ratios.  
 
6.4.5.2 Expected Value of Partial Perfect Information 
 The population EVPPIs for all grouped parameters are illustrated in Figure 6.12 for cost-
effectiveness thresholds ranging from £0 to £50,000. Large population EVPPIs were associated 
with the group of EPDS model parameters (sensitivities and specificities) which were equal to 
£23,394,201 at a cost-effectiveness threshold of k=£20,000 and increased to £139,084,128 when 
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k=£30,000. This contrasted with the group of parameters estimating child healthcare costs and 
QALYs which had lower EVPPIs equal to zero for k=£20,000 and £44,570,493 when k=£30,000. 
Similarly, EVPPIs increased as cost-effectiveness thresholds increased for maternal QALYs 
(£26,187 (k=£20,000), £66,112,691 (k=£30,000)) and for the Whooley questions sensitivity & 
specificity parameters (£0.00 (k=20,000); £7,578,073 (k=£30,000)).  
 
 
Figure 6.12: Population EVPPI across cost-effectiveness thresholds £0-£50,000 for parameter groups (a) EPDS 
sensitivities and specificities; (b) maternal utility; (c) Whooley questions sensitivity and specificity; and (d) child lifetime 
QALYs and healthcare costs.  
 
6.5 Discussion  
6.5.1 Cost-Effectiveness Results   
6.5.1.1 General Cost-Effectiveness Results  
This analysis identified a dual screen using the Whooley questions followed by a formal 
screening strategy (EPDS/PHQ-9) for all positive initial screens as the general cost-effective case 
identification strategy for postnatal depression in the UK. The strategy consistently outperformed 
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all the other general strategies (standard care case identification, and single screening strategies with 
the EPDS/PHQ-9) from three different decision-making perspectives, across a range of cost-
effectiveness thresholds and for a variety of different scenario analyses. These results are consistent 
with current NICE (2018) recommendations which suggest that GPs should consider posing the 
Whooley question to mothers during their first contact with primary care after child birth and 
should follow-up with either an EPDS or PHQ-9 screen if women respond positively to the initial 
screen.  
6.5.1.2 Cost-Effectiveness: Maternal Outcomes Only  
When adopting a perspective limited to maternal QALYs/healthcare costs, this analysis 
identified the cost-effective screening strategy as the Whooley questions followed by the EPDS 
with a threshold equal to 16. Whilst the results are consistent with NICE (2018) recommendations, 
the specific cost-effectiveness results diverge from those obtained in the NICE (2018) economic 
evaluation. NICE (2018) identified the PHQ-9 as the cost-effective second screening instrument, 
whilst this research identified the EPDS as cost-effective. The difference in results is likely to have 
occurred as this analysis investigated the EPDS across a range of threshold values, in contrast to the 
single threshold investigated by NICE (2018). 
Whilst NICE (2018) identified a different instrument as cost-effective for the second screen, their 
results are consistent with this analysis in the sense that the cost-effective screen is that with the 
highest specificity. The cost-effective strategy in this analysis was the EPDS with a threshold of 16 
which had the highest associated specificity (0.99) and lowest sensitivity (0.28); meanwhile NICE 
(2018) identified the PHQ-9 with a threshold of 9 (specificity=0.88, sensitivity=0.75) as cost-
effective when compared to the EPDS with a cut-off of 9/10 (specificity=0.85, sensitivity=0.83). 
As this analysis utilised the same modelling structure and assumption as NICE (2018), it is likely the 
highly specific EPDS threshold would have been cost-effective in the NICE (2018) model had this 
strategy been investigated. These conclusions are supported by Paulden et al. (2009) who found the 
most specific threshold to be the cost-effective EPDS strategy when screening for postnatal 
depression, although all single screening strategies were dominated by standard care case 
identification. 
The impact of employing a highly sensitive screen (the Whooley questions) followed by a highly 
specific EPDS screen would result in treatments being targeted towards postnatal women with a 
very high probability of being depressed, thus minimising the costs and disutility occurring through 
incorrect treatment assigned to non-depressed women. However, the adoption of a high EPDS 
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threshold is also associated with a reduction in test sensitivity and therefore a reduction in the 
proportion of truly depressed women receiving treatment. This would be expected to equal 
approximately 33% for the EPDS 16 threshold, which is substantially less than the 54% of truly 
depressed women who would receive treatment under standard care case identification. Whilst not 
providing treatment to depressed women might seem counterintuitive and/or unethical, the 
negative effects are arguably outweighed by the benefits of not providing costly (and potentially 
harmful) treatments for women who do not need them – these resources might be better allocated 
elsewhere in the healthcare system.  
The results of the deterministic sensitivity analysis further illustrate how cost-effectiveness results 
were driven by the balance between providing beneficial treatment for true positive mothers and 
not providing costly/harmful treatment to false positive mothers. Where wrongly assigned 
treatment was assumed to only result in additional healthcare costs (and not a 2% disutility), the 
cost-effectiveness result moved towards less specific and more sensitive strategies (i.e. standard care 
case identification for k<£27,944 and the Whooley + EPDS (11) for k=£30,000). The change in 
cost-effectiveness occurred as more sensitive screening strategies are assumed to provide treatment 
for a higher proportion of depressed and non-depressed women than more specific strategies. The 
removal of the 2% disutility would mean that it is less important to avoid treating non-depressed 
women, thus allowing for screening strategies with relatively higher levels of overall treatment 
provision.  
6.5.1.3 Cost-Effectiveness: Maternal and Child Outcomes  
The inclusion of children’s lifetime decision endpoints had an influence on the cost-
effectiveness results. When children’s QALYs and healthcare costs were included in the decision-
making perspective at a willingness-to-pay of £30,000 per QALY, the cost-effective strategy 
changed to the less specific and more sensitive EPDS with a cut-off equal to 14. This 
recommendation might be more comfortable for policy makers as it would result in a similar 
proportion of truly depressed women being allocated treatment (53%) as in standard care case 
identification. The change in decision for this perspective is driven by the additional treatment 
benefits in children that were assigned to mothers who recovered from depression – these 
outweighing some of the costs/disutility associated with treating false positive cases.  
No change in the cost-effective strategy occurred for cost-effectiveness thresholds less than or 
equal to £20,000 per QALY: decreasing the value placed on each QALY resulted in less weighting 
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being applied to children’s lifetime health benefits which no longer outweighed the costs/disutility 
of treating false positive mothers.  
The influence of child outcomes on the cost-effective strategy was more pronounced when the 
decision perspective was expanded to also include children’s lifetime returns to education. The cost-
effective strategy changed at both cost-effectiveness thresholds (k=£20,000, k=£30,0000), where 
the Whooley questions followed by the EPDS with a threshold of 12 became the recommended 
screening strategy. This was a more sensitive (0.68) and less specific (0.93) cost-effective strategy 
than for the previous two perspectives and would be expected to result in the treatment of a greater 
proportion (73%) of truly depressed women than would be treated under standard care (54%). The 
change in policy recommendation occurs for the reason discussed above. The addition of 
educational outcomes attached further additional benefits to successful treatment of postnatal 
depression, making it more acceptable to incur costs through treatments wrongly assigned to non-
depressed women.  
Decision makers might have more confidence in the cross-sectoral results in this analysis given the 
cost-effective strategy remained robust across all v/k ratios. Whilst the consumption values for 
health and education are not known, it is unlikely that consumption (£s spent) in the health sector is 
valued four times higher or lower than consumption in the education sector. In addition, the results 
of this analysis can be interpreted to predict cost-effectiveness if it were assumed that the v/k ratios 
extended beyond the range investigated. Intuitively if less value is placed on consumption in 
education (v/k<1), the decision more closely resembles the health centric decision perspective thus 
tending towards a cost-effective with the EPDS cut-off equal to 14 at the lower v/k limit. In 
contrast, when greater value was placed on consumption in education (v/k>1), the cost-effective 
strategy tends towards strategies with higher sensitivities with an upper limit likely to be the EPDS 
strategy with the highest non-dominated ICER (threshold equal to 10).  
The results from both health centric and cross-sectoral decision perspectives also remained robust 
when applying different assumptions to child related model parameters. Informed by results from 
chapter three, the original model assumed the incremental lifetime effects of postnatal depression 
on child development continued as a consistent effect across the lifespan. Children’s lifetime 
outcomes still influenced cost-effective decision when assuming 25% of this effect was lost as 
children aged. Similarly, the influence of child lifetime parameters on the cost-effectiveness result 
were maintained when assuming mothers who were successfully treated for postnatal depression 
transmitted some effects to children during the time they were depressed. 
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In contrast, results were affected when changing the magnitude of the discount rate applied to 
children’s lifetime outcomes from 3.5% to 1.5%. The lower discount rate resulting in less specific 
and more sensitive EPDS strategies with lower thresholds becoming cost-effective. Changes to 
cost-effectiveness occurred as lower discount rates are associated with a larger magnitude of benefit 
for the lifetime outcomes, therefore applying more weighting to the benefits of treating true 
positive mothers. The effect of discounting was more pronounced for the perspective including 
children’s lifetime returns to education. These outcomes were larger in magnitude and had more 
influence on the overall cost-effectiveness when compared with children’s lifetime health decision 
endpoints.  
Whether decision makers should include costs and benefits related to children remains a 
controversial question. Drummond et al. (2015) suggests economic evaluation ought to identify all 
the important consequences associated with health technologies. Therefore, it is often sufficient to 
establish costs and benefits occurring only for the direct recipient of the health technology, 
assuming the effects on non-recipients are inconsequential. Ride (2018) indicates that non-patient 
effects have begun to be considered by key decision makers, like NICE, in the UK, stating several 
examples including economic evaluations of intervention for dementia which account for health 
effects in carers, and child vaccination programmes which have far reaching benefits in terms of 
reducing the spread of disease.  
There is, therefore, a strong argument for including children’s outcomes in policy decisions related 
to postnatal depression and its treatment. Empirical and theoretical evidence suggests a causal link 
between maternal depression and child development,11 and this analysis further demonstrates the 
influence and importance of child outcomes on these policy decisions.   
6.5.1.4 Cost-Effectiveness in Sub-Populations  
The deterministic sensitivity analysis suggested it might be appropriate to implement 
different EPDS strategies for different sub-populations. Lower EPDS thresholds are recommended 
for populations with a higher prevalence of postnatal depression. The rationale for increasing the 
EPDS test sensitivity is due to high prevalence populations having a greater proportion of truly 
depressed mothers, and therefore more profound overall treatment benefits for true positive cases. 
Separate policies might be advisable for populations with a higher risk of postnatal depression 
                                                     
11 See evidence reviewed in chapter three.  
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symptoms than the general population which include low income, poorly educated, and first-time 
mothers (Goyal et al., 2010).  
6.5.2 Probability of Cost-effectiveness  
The results of the probabilistic sensitivity analysis indicated a high level of decision uncertainty 
across all decision perspectives. For instance, when cost-effectiveness thresholds were between 
£20,000 and £30,000 the largest probability of cost-effectiveness were associated with the Whooley 
+ EPDS 16 strategy which reached a maximum of 0.48 when assessing maternal outcomes only, 
whilst the cost-effective strategies for the other decision perspectives (Whooley + EPDS 14/12) 
typically had a probability of cost-effectiveness close to 0.1 throughout this range. The relatively low 
probability of cost-effectiveness identified for the cost-effective strategies might alarm decision 
makers. A review by Adalsteinsson and Toumi (2013) suggest that health technologies with 
associated probabilities of cost-effectiveness less than 40% are rarely recommended by NICE.  
However, this economic evaluation assessed cost-effectiveness across a range of similar strategies 
which only differed in terms of the threshold applied to the EPDS. Consecutive EPDS strategies 
were only marginally different in terms of their associated specificity/sensitivity. For example, the 
EPDS with a threshold of 10 had specificity equal to 0.86 and a sensitivity of 0.82, whilst the EPDS 
with a threshold of 11 had specificity of 0.84 and sensitivity equal to 0.85. Because of the random 
nature of PSA, marginally different EPDS strategies would be expected to frequently outperform 
one another during the individual probabilistic draws, thus reducing the probability of cost-
effectiveness associated with individual EPDS strategies. 
If the strategies in this analysis are grouped in terms of a general strategy, then the probability of 
cost-effectiveness becomes much higher. The general strategy of applying the Whooley questions 
followed by any EPDS threshold in a dual screen was above 95% for all decision perspectives when 
k=£20,000 or £30,000. If decision makers choose not to adopt one of the dual screening strategies, 
they would necessarily be choosing to adopt another i.e. standard care case identification. Based on 
this research the adoption of standard care case identification would almost certainly be the wrong 
decision as it had an extremely low probability of being cost-effective, equalling close to 1% 
(k=£20,000) and 0.5% (k=£30,000) across all perspectives.  
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6.5.3 The Cost-Effectiveness of Conducting Future Research 
The relatively high decision uncertainty together with the size of the population potentially 
benefiting from screening explains the magnitude of the Expected Value of Perfect Information 
(EVPI). For decision perspectives including maternal and child health endpoints, this reached close 
to £200 million between cost-effectiveness thresholds of £20,000 and £30,000. The magnitude of 
the EVPI increased further still when adopting a cross-sectoral perspective. The value of the EVPI 
is an upper limit on the benefits that might be achieved through future research (Claxton et al., 
2002). As even the most expensive trial designs would be unlikely to exceed the identified EVPIs, 
the value of information analysis indicates future research has the potential to be cost-effective.  
According to the Expected Value of Partial Perfect Information (EVPPI) it might be most desirable 
to conduct future research to obtain a more precise estimation of the sensitivities and specificities 
associated with the EPDS. If this were achieved, then it may be possible to confidently recommend 
the EPDS at individual thresholds. Given the very large EVPPI, it might be cost-effective to obtain 
this information through a large randomised trial design despite their high associated costs.  
The potential cost-effectiveness of future research regarding the estimation of children’s lifetime 
effects appears to be dependent on the cost-effectiveness threshold. This analysis suggests future 
research estimating children’s lifetime QALYs/healthcare costs is potentially cost-effective for 
thresholds where k>=£30,000, where the EVPPI was close to £50 million. Again, it is very unlikely 
that any research costs would exceed these upper bounds, particularly given much of the evidence 
regarding lifetime effects utilises existing data from longitudinal birth cohorts. However, the 
decision to conduct future research should also consider the difficulty of obtaining accurate 
estimates over a long-term time horizon, and consequently the level of precision that might be 
achieved– i.e. it is likely that future research would only be able to address a small proportion of 
parameter uncertainty.  
The value of information analysis suggests that future research identifying children’s lifetime 
QALYs/healthcare costs does not have the potential to be cost-effective if k=£20,000 or less, 
where the associated EVPPI was equal to zero. The value of the EVPPI demonstrates the limited 
influence of children’s lifetime healthcare costs and QALYs at these threshold ranges, where the 
cost-effective strategy remained the same as that identified when assessing maternal health decision 
endpoints only. The limited influence of children’s health outcomes at these thresholds is likely to 
be due to the relatively small magnitude of effect size and associated confidence intervals for QALY 
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and healthcare costs endpoints. A full discussion regarding the magnitude of lifetime estimates is 
provided in chapter seven.  
6.5.4 Limitations and Areas of Investigation for Future Research  
The priority of this research was to address the overarching aim of the thesis by including estimates 
of children’s lifetime effects in an economic evaluation and discussing their influence on cost-
effectiveness results. The considerable time resources required to achieve this objective meant 
overlooking several limitations that were identified in the decision model.  
Firstly, the decision model is likely to have been limited by the time horizon, where maternal 
depression was only modelled over a 52- week period. There is empirical evidence suggesting that 
postnatal depression is a risk factor in the development of psychiatric disorders including major 
depressive disorder (Vliegen et al., 2014). In addition, the results from chapter three suggest 
substantial effects to child development are likely to occur through accumulated symptoms of 
maternal depression after the postnatal period.   
As discussed above, the cost-effective strategy was sensitive to scenarios where greater weighting 
was applied to treatment benefits for true positive cases, where more sensitive and less specific 
EPDS strategies became cost effective. If it is assumed that successful treatments for postnatal 
depression could reduce the likelihood of future psychiatric problems, then the 52 -week time 
horizon may underestimate the overall benefits of treatment for postnatal depression. If this were 
the case, then lower EPDS thresholds (than those recommended here) might become cost-
effective. An objective of future research could be the estimation of a decision model assessing the 
cost-effectiveness of screening for postnatal depression across a longer-term time horizon which 
could be achieved by applying a Markov model to extend the decision tree (Drummond et al., 
2015).  
Secondly, apart from the investigation of different EPDS thresholds, this analysis did not attempt to 
update any of the model parameters utilised in the NICE (2018) model. It was assumed that the 
parameters were up to date, given NICE (2018) recommendations for postnatal and antenatal care 
were updated during the same year as this analysis. However, it is possible that more recent data is 
available for some of the model parameters, for instance, maternal utility for postnatal depression 
was identified by NICE (2018) in a study by (Sapin et al., 2004), which is unlikely to be the most 
recent study available for this specific model parameter.  
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Similarly, this analysis did not attempt to change any NICE (2018) modelling assumptions. For 
example, the NICE (2018) model assumed a 2% reduction in health utility ought to be applied to 
false positive women, who received treatment but were not depressed. This assumption was shown 
to be highly influential on the cost-effectiveness results, where scenarios which applied a disutility 
equal to zero resulted in a much more sensitive and less specific EPDS strategies becoming cost-
effective across all decision perspectives. The influence of this assumption is unsurprising given the 
drivers of cost-effectiveness observed in this analysis – removing the disutility parameter removes 
part of the detriment attached to treating false positives.  
It would be beneficial for future research to update parameter estimates and address some of the 
more questionable modelling assumptions applied in the NICE (2018) model. The specific 
objectives of future research should be informed through the results of both the deterministic and 
probabilistic sensitivity analyses in this research. It would make most sense for new research 
priorities to focus on the assumptions shown to be influential on cost-effectiveness, and on model 
parameters with the largest EVPPIs.  
Thirdly, this research was not able to compare cost-effectiveness results for all potential strategies 
when screening for postnatal depression: There is only evidence regarding the specificity and 
sensitivity of the PHQ-9 instrument at one threshold value in postnatal women. This strategy 
instrument was consistently outperformed by at least one EPDS strategy, where 10 different 
threshold ranges were investigated. As the PHQ-9 is assumed to incur identical administration 
costs, the results for different EPDS strategies could be applied to the PHQ-9 instrument when 
additional data becomes available regarding sensitivities/specificities for different cut-off values. 
That is, policy makers could identify the cost-effectives of the PHQ-9 at a specific threshold by 
identifying results for the EPDS strategy which corresponded most closely to the estimated 
sensitivity/specificity).  
A fourth limitation may have occurred as a result of the economic evaluation being developed and 
error checked by a single researcher. Several validity checks were performed at extreme parameter 
values, confirming that the model results reflected these extreme scenarios. The validity of the 
model is also enhanced given the similar conclusions that were drawn with existing evidence from 
NICE (2018) and from Paulden et al. (2009).  
Finally, all the limitations regarding the estimation of lifetime child outcomes e.g. causality, 
imprecision, heteroscedasticity etc. that have been discussed in chapters three and five are 
applicable to this analysis. The overall validity of estimates obtained from indirect estimation is 
discussed in detail in chapter seven.  
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6.5.5 Conclusions  
The aims of this chapter are to demonstrate how indirect lifetime effects estimates can be used to 
inform an applied economic evaluation, and to determine their overall influence on a real -life 
healthcare allocation decision.  The chapter describes the results of an economic evaluation 
assessing the cost-effectiveness of screening for postnatal depression, for decision perspectives 
which both included and excluded children’s lifetime outcomes.  
When considering maternal outcomes only, the results of the analysis suggest it is cost-effective to 
use a dual case identification strategy of the Whooley questions, followed by the Edinburgh 
Postnatal Depression Scale (EPDS) at a threshold of 16 for all positive initial screens. In contrast, 
more sensitive and less specific EPDS cut-off thresholds of 14 or 12 are recommended if the 
decision maker’s perspective is to include child health, or child health and education outcomes. 
Policy recommendations were influenced as the inclusion of children’s lifetime outcomes applied 
additional benefits to successful treatment of postnatal depression.  The changes in strategy for each 
decision perspective may appear small but would have substantial clinical implications resulting in 
treatment provision for a larger proportion of postnatally depressed women.  
This evidence can be used to update current NICE (2018) recommendations which do not account 
for lifetime effects in children or establish cost-effectiveness across a full range of EPDS 
thresholds. Given the large treatment population and high level of decision uncertainty, there is a 
significant potential value in future research, particularly if the research further clarifies the 
sensitivity and specificity for different EPDS thresholds.  
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Chapter 7: Discussion  
7.1 Chapter Summary  
The overarching aim of the research described in this thesis was to address methods in the 
economic evaluation of childhood health technologies where analyses could be limited due to the 
unavailability of evidence across the lifetime. The specific aims were to develop and describe a 
methodology for indirectly estimating the lifetime effects of early childhood circumstances by 
linking results across two empirical analyses and to determine whether lifetime estimates influence 
the cost-effectiveness results in an applied, UK based, economic evaluation. The purpose of this 
chapter is to draw together the outcomes of the research, discuss in more detail aspects of the 
results and methodological approach, and highlight how the methodology could be applied in other 
research scenarios.  
7.2 Research Findings  
7.2.1 Key Findings 
The methodological approach applied in this research provides additional information to decision 
makers by indirectly estimating the lifetime effects of children exposed to postnatal depression and 
including these estimates in an applied economic evaluation assessing cost-effectiveness of 
screening strategies for postnatal depression, extending and updating a previous NICE (2018) 
analysis.  
The overall outcomes of the applied research demonstrated that indirectly estimated lifetime effects 
can influence cost-effectiveness results.  
The significance of use of estimated lifetime effects in decision making was shown by comparing 
results from analyses conducted with and without children’s lifetime outcomes. Postnatal 
depression exposure was predicted to reduce children’s lifetime Quality Adjusted Life Years, 
increase healthcare and crime costs, and generate fewer monetary returns in education and 
employment. Cost-effectiveness results changed when including children’s lifetime effects, leading 
to the recommendation of a less specific threshold for the Edinburgh Postnatal Depression Scale 
screening instrument.  This change in strategy would have potential clinical implications, providing 
treatment to a larger proportion of postnatally depressed women 
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In further detail, when excluding children’s lifetime effects, the cost-effective screening strategy for 
postnatal depression was the administration of Whooley questions followed by the Edinburgh 
Postnatal Depression Scale (EPDS), for all positive initial cases, at a highly specific threshold of 16. 
Similar strategies but with less specific EPDS thresholds were cost-effective when including 
children’s lifetime health (=14), and health & education (=10) outcomes.  
The development of methodologies for indirect estimation was the focus of the staged empirical 
research process described in chapters 3, 4, and 5. 
Chapter three demonstrated methodologies appropriate for the first stage of indirect estimation. A 
primary empirical analysis estimated the effects of early life circumstance (PND symptoms) on 
intermediate lifespan development endpoints identifying that postnatal depression was detrimentally 
associated with children’s cognitive and socioemotional development up to age 11.  
The second stage of indirect estimation was informed by a primary analysis undertaken in chapter 
five. A mathematical model was developed using data from the 1970 British Cohort Study to 
predict lifetime decision endpoints from measures of cognitive and socioemotional development. The 
full indirect estimation process was completed by entering the incremental effects from chapter 
three as input parameters in the mathematical model. The output of the model estimated the 
lifetime effects of children exposed to symptoms of postnatal depression, identifying a strong 
association between cognitive and socioemotional development at age 10 and later life outcomes 
relevant as decision endpoints for economic evaluation. This model delivers a potential method for 
indirectly predicting lifetime outcomes relevant for economic evaluation and UK policy making, 
thus fulfilling a key research aim in this thesis and filling a gap in the existing evidence base. 
7.2.2 Chapter Specific Findings 
Individual chapters in this thesis had findings specific to the focus of that chapter and may not be 
apparent from the report of overall findings. This section summarises these findings and identifies 
their additional contributions to scientific knowledge.  
The literature review in chapter two discussed appropriate methods for economic evaluation in the 
UK, focusing on the relevant perspectives, decision endpoints and decision rules when the costs 
and benefits of health technologies occur across sectors beyond health. Whilst the incorporation of 
cross-sectoral costs within the context of economic evaluation is not new (having been previously 
applied to the public health literature by Claxton et al. (2010)) no previous studies were identified 
that applied this theory to early intervention and child development. The review may be useful for 
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other researchers conducting economic evaluation of early interventions as it defines decision 
endpoints and type of analyses appropriate when informing UK health policy.  
Chapter three adds to existing knowledge by providing evidence on the effects of postnatal and 
subsequent maternal depression in a large longitudinal birth cohort (n=14,000). Previous research 
conducted by Bell (2014) estimated the effects of maternal depression and its treatment on the 
development of social & emotional skills and the vocabulary of children up to the age of seven. The 
research in chapter three extends findings from Bell (2014) by identifying effects (i) up to the age of 
eleven, (ii) on global measures of cognitive development (rather than just vocabulary); (iii) in models 
with different empirical specifications. No other literature was identified that estimated the effects 
of persistent maternal depression for samples sizes of equivalent scale and over a time horizon of 
similar duration.  
The aim of the scoping review reported in chapter four was to add to scientific knowledge by 
identifying a mathematical model predicting decision endpoints relevant for economic evaluation 
from earlier measures of child development. Whilst the review was not able to identify any studies 
which specifically estimated lifetime QALYs and healthcare costs, the null finding is useful as it 
highlighted a gap in the existing evidence and directed the objectives of the further research in the 
thesis. The additional synthesis performed for the expanded inclusion criteria identified several 
characteristics and assumptions aiding the design of the mathematical model in chapter five. These 
conclusions might be similarly used to inform the design of models elsewhere.  
The mathematical model described in chapter five predicted lifetime QALYs, healthcare costs, 
monetary returns to the education sector (including economic productivity), and monetary costs to 
the crime sector from measures of cognitive and socioemotional development at age ten. This 
model delivers a method for extrapolating intermediate measures of child development into lifetime 
outcomes relevant for economic evaluation and UK policy making, thus filling a gap in existing 
evidence identified in chapter four. Whilst the model is associated with several limitations, it 
advances scientific knowledge in the absence of other relevant model and could be applied by other 
researchers when estimating lifetime effects of other childhood health technologies.  
The results of the economic analysis in chapter six provides additional evidence that could be used 
to update existing policy recommendations regarding screening for postnatal depression. Current 
economic evaluations of screening strategies for postnatal depression do not consider the lifetime 
effects in children who are exposed to symptoms.  
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7.3 Discussion of Research Findings  
7.3.1 Introduction  
The following section elaborates on the key findings, beginning with a discussion of policy 
implications drawn from the results of the applied research. The section continues by describing the 
general importance of including children’s lifetime effects in economic evaluation, focussing on two 
methodological choices which affected their relative influence on cost-effectiveness results: the 
decision perspective adopted for economic evaluation, and the discount rate applied to costs and 
benefits. The section concludes by considering whether it would be cost-effective to conduct future 
research to reduce uncertainty in lifetime effects estimates.  
7.3.2 Policy Implications  
The major policy implications of the applied research derive from the results of the economic 
evaluation in chapter six. These suggest that (dual) population screening for postnatal depression 
would be cost-effective for the NHS if GPs were to administer the Whooley questions to all 
postnatal women during their first contact with primary care after childbirth and follow up all 
positive cases with a second screen using the EPDS.  
The results of the economic evaluation can be used as evidence by NICE when updating 
recommendations regarding population screening for postnatal depression. The current NICE 
guidelines are primarily informed through the results of a NICE (2018) decision model. By 
extending the structure of the NICE (2018) decision model, research in this thesis demonstrates the 
impact of children’s lifetime outcomes on cost-effectiveness results. Namely, this is to reduce the 
recommended diagnostic threshold for the EPDS from 16 to 14. The results suggest more sensitive 
postnatal depression screening strategies become cost-effective if decision makers extend their 
perspective to account for both maternal and child outcomes.  
When making policy recommendations, decision makers ought to interpret evidence from 
economic evaluations by considering both the validity of modelling assumptions and the 
applicability of results to local clinical practice (Heyland et al., 1999). One of the key implications of 
screening for postnatal depression at the recommended EPDS threshold (14) is to increase the 
uptake of treatment in primary care. The potential for screening to increase treatment uptake is 
contingent on two clinical assumptions made within the original NICE (2018) model, where GPs 
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are expected to: (i) use screening tools to obtain a postnatal depression diagnosis; and (ii) follow up 
on positive diagnoses with an appropriate treatment.  
Evidence from the broader literature on depression screening in the general population raises 
uncertainty regarding the above assumptions: In a systematic review, Gilbody et al. (2001) identified 
nine randomised studies which administered psychiatric screening tests to patients in primary care. 
Each study assigned patients into either an intervention group where test results were fed back to 
GPs, or a control group where results were not fed back. Feedback did not increase the recognition 
of depression or anxiety, lead to an increase in treatment uptake, or improve patient outcomes 
(Gilbody et al., 2001).  
There are a variety of reasons why GPs may fail to act upon the results of psychiatric screens. For 
example, Dorwick et al. (2009) conducted qualitative interviews in a sample of GPs, where the 
majority viewed their own clinical judgement, rather than screening, as the gold standard for 
obtaining a diagnosis. This could explain findings by Kendrick et al. (2009) who identified 
significant associations between anti-depressant prescription/psychological referral rates and scores 
on depression screening questionnaires, but also found other factors such as patient age, depression 
history and comorbidities to independently influence diagnoses. In addition, GPs may be restricted 
by the resources available to treat depression. GPs consistently identify long waiting times, poor 
access to treatment, lack of available consultation time, and a lack of training as reasons for not 
offering psychological therapy to depressed patients (Toner et al., 2010). 
The evidence from the wider depression literature leaves policy makers with a difficult decision 
regarding guidelines for postnatal depression screening. The results from this thesis suggests 
population screening can be cost-effective if GPs are willing/able to administer tests and act upon 
their results. However, if screening fails to change treatment practices then, as stated by Gilbody et 
al. (2001), its implementation is a “costly and bureaucratic exercise”. If recommending screening, 
policy makers should ensure appropriate treatments are available. This may require the expansion of 
local services and additional resources for psychological therapies, which are typically the preferred 
treatment option for postnatal women (Milgrom et al., 2015).  
7.3.3 Influence and Importance of Lifetime Estimates in Economic Evaluation of 
Childhood Health Technologies  
A key requirement for economic evaluation is to account for all the important costs and benefits of a 
technology (Drummond et al., 2015) and/or, to include all relevant evidence in an analysis (Sculpher 
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et al., 2006). Some economic evaluations of childhood health technologies do not account for 
lifetime effects despite evidence suggesting the potential significance of their inclusion. For 
example, early childhood visual impairments are associated with cognitive (Bruce et al., 2017) and 
fine motor (Webber et al, 2008) development but current polices assessing the cost-effectiveness of 
vision screening in pre-school children do not account for subsequent lifetime outcomes (Carlton et 
al., 2008). There is a well-established causal association between hearing and development (Moeller 
et al., 2000) but Bond et al. (2009) did not include lifetime effects in an economic evaluation of 
childhood cochlear implantation. Meanwhile, Wright et al. (2015) describes how parenting 
interventions benefit socio-emotional outcomes for children with conduct disorder but could not 
address these in an economic evaluation because of insufficient evidence regarding lifetime effects. 
And finally, the applied example in this thesis expanded on a NICE (2018) economic evaluation 
assessing the cost effectiveness of screening for post-natal depression which did not include 
lifespan development effects in children exposed to symptoms, describing these as “intangible”.  
Whether evidence is relevant or important arguably depends on its relative influence on cost-
effectiveness results. If results remain unchanged irrespective of the inclusion/exclusion of 
evidence, then it could be deemed irrelevant/unimportant. The results of the applied economic 
evaluation in this thesis demonstrated the influence and consequently the importance/relevance of 
including lifetime estimates as the cost-effective screening strategy for postnatal depression changed 
for analyses which included/excluded children’s lifetime effects. The results of this research 
therefore do not justify the exclusion of lifetime effects from economic evaluation.  
The consequence of excluding relevant evidence from economic evaluation, according to Sculpher 
et al. (2006), is to “risk providing a partial analysis with potentially misleading results”. The 
exclusion of lifetime effects in individual evaluations could risk misleading individual healthcare 
allocation decisions. The routine exclusion of lifetime effects from all economic evaluation could 
introduce a general bias into decision making. In general, evidence from this thesis suggested that 
interventions which improve child development outcomes are likely to translate into more lifetime 
benefits and less lifetime costs across all sectors. Childhood health technologies which benefit 
cognitive and socioemotional development are, therefore, predicted to have a net benefit on lifetime 
outcomes. If these net benefits are consistently excluded from economic evaluation, then potentially 
fewer childhood health technologies might be considered cost-effective than perhaps should be. 
Research advancing methods for estimating lifetime effects, such as the research conducted in this 
thesis, is important as it addresses a potential bias in child health allocation decisions.  
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7.3.4 Perspectives for Child Health Economic Evaluation  
The applied research in this thesis suggests the influence of lifetime effects on policy decisions may 
depend on the analytical perspective adopted. Chapter six identified different cost-effective 
strategies for postnatal depression when conducting economic evaluation from health centric and 
cross-sectoral perspectives. The identification of different cost-effective strategies might lead to 
questions regarding the most appropriate decision perspective. Whether this is a relevant question 
depends on the role assigned to economic evaluation.  
Economic evaluation is sometimes viewed as a tool to prescribe decisions by establishing whether a 
health technology/social policy provides an overall social benefit by improving social welfare 
(Drummond et al., 2015). If economic evaluation is prescriptive then it might make most sense to 
account for all the costs and benefits of a health technology, irrespective of where they fall rather 
than just accounting for health benefits. Therefore, some might consider the cross-sectoral 
perspective as most appropriate in the economic evaluation of early childhood interventions as the 
perspective can account for a range of widespread costs and consequences.  
However, economic evaluation has tended to adopt a more modest role in the health sector, being 
typically used as a tool to inform (rather than prescribe) decisions (Drummond et al., 2015), 
(Claxton et al., 2007). In this case, the question as to the appropriate perspective ought not to be a 
theoretical choice made by the analyst, but be a choice based on the pragmatic restrictions of the 
decision maker whom the evaluation is intended to inform. The applied example presents two 
different analyses according to different decision perspectives which represent pragmatic conditions 
in the UK. One assumes a decision maker has the objective of only maximising health with respect 
to the healthcare budget; and the other assumes the objective is to maximise benefits across 
multiple sectors subject to the costs incurred in those sectors.  
The benefit of adopting multiple perspectives is to demonstrate differences in cost-effectiveness 
results and any trade-offs that decision makers might face. In chapter six, the cross-sectoral 
perspective recommended the Whooley questions followed by the EPDS 12 strategy (rather than 
the EPDS 14 strategy for health centric perspective) as cost effective when screening for postnatal 
depression, if the decision maker is willing to trade off additional costs incurred in the health sector 
with monetary benefits occurring in the education sector. This trade-off decision must also account 
for the relative consumption in health relative to consumption in education, which was represented 
as the v/k ratios (v=consumption value of health, k=monetary value of each additional QALY). 
The results remained robust for the cross-sectoral perspective for all v/k ratios up to a limit where 
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consumption in health is assumed to be four times the value of consumption in education. Whilst 
this would seem to be a reasonable trade-off, the ultimate decision is at the discretion of policy 
makers – if the policy maker’s objective is exclusively health, subject to money spent in the health 
sector then presumably no trade-off would be acceptable.  
It might be more relevant to question whether the health sector should necessarily incur the costs 
of childhood “health” technologies, or whether this burden ought to fall on the sector accruing 
most benefit (i.e. education). For the application in this thesis, it would make most sense for the 
health sector to fund screening for maternal postnatal depression as the largest benefits are 
expected to be accrued in the health sector in terms of increased maternal QALYs and reduced 
maternal healthcare costs. For other interventions, which exclusively benefit children, it may be that 
the education sector accrues the largest net benefit: As described in chapter five, the relative 
magnitude of benefits from unit changes in measures of cognitive and socioemotional development 
was much larger for the education sector than for the health sector. This could result in 
technologies which are not justified through later QALYs and decreased healthcare costs but are 
through increased returns in education (i.e. increased human capital).  
However, in the example in this thesis, it is not certain whether the benefits of child development 
are actually larger in education when compared with the health sector. Larger magnitudes may have 
been observed in chapter five because more data was available regarding children’s lifetime returns 
to education. Several limitations in the analysis of health outcomes were noted, most importantly 
the ending of the observed study time horizon at age 42 when most health effects likely to occur 
after the study end point. It is possible the analysis underestimated the increased QALYs and 
reduced healthcare costs associated with improved child development outcomes. On the other 
hand, a lifetime horizon may have identified increased healthcare costs as a result of extensions to 
life expectancy. As described in chapter five it would be useful to estimate a model predicting 
lifetime QALYs/healthcare costs from measures of child development using appropriate 
questionnaires (i.e. items to identify health related utility e.g. EQ-5D/and resource use 
questionnaires, over an extended time horizon). 
7.3.5 Discount Rate Applied to Lifetime Decision Endpoints 
The results of chapter five (Section 5.5) demonstrated the substantial difference discounting can 
have on the magnitude of lifetime predictions per unit change in cognitive and socio-emotional 
development measures. Further, results from chapter six identified different cost-effectiveness 
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results for scenarios estimating lifetime effects at different discount rates (Section 6.4/6.5). As 
discounting can have fundamental effects on outcomes it is discussed in more detail in this section.     
As the lifetime effects of early life circumstances are expected to occur far into the future, different 
discount rates can lead to very different values assigned to costs and benefits. For example, a cost 
equal to £100,000 which occurs fifty years into the future would have a present-day value equal to 
£47,500 discounted at a rate of 1.5%, or equal to roughly £18,000 if discounted at 3.5%.  
The appropriate rate to discount costs and benefits is uncertain as it depends on factors which 
might change over time. Firstly, the calculation of discount rates depends on the relative discount 
rate of consumption, usually calculated by economists using the Ramsey rule which accounts for 
both society’s time preferences (i.e. prefer consumption now rather than later) and for changes in 
the value of consumption over time (i.e. decreases in value of money as a result of increases in 
economic productivity) (Arrow et al., 2014). Neither time preference nor the value of consumption 
is necessarily constant, for example, political/environmental instability might result in society 
placing more weight on current utility if prosperity in the future is uncertain. Meanwhile, a myriad 
of factors could influence economic productivity, e.g. stock market crashes, technological 
advancements, political conflicts, environmental disasters etc.  
In addition to uncertainty regarding the appropriate discount rate for consumption, changes to the 
consumption value for health, the budget for healthcare, and the cost-effectiveness threshold can 
influence specific discount rates applied to health outcomes (Drummond et al., 2015). There is also 
growing consensus in the literature that health should be discounted at a lower rate than healthcare 
costs (Attema et al., 2018). Claxton et al. (2011) advocates lower discount rates for health if it is 
assumed the budget for healthcare is not fixed and that consumption in health grows relative to 
consumption in other sectors. Claxton et al. (2011) suggests this a likely scenario as “the health of 
the population is expected to grow more slowly than its consumption of goods and services” 
meaning “welfare gain from better health will increase relative to welfare gain from increases in 
consumption”. The application of different discount rates on costs and QALYs can have 
implications on cost-effectiveness results, as was demonstrated for the health centric decision 
perspective in chapter six (Appendix 6.4G).   
In the face of uncertain discount rates likely to influence cost-effectiveness results, an analyst’s best 
response might be to present the results for several scenario analyses applying different assumptions 
regarding the discount rate. Currently, the Treasury (2018) Green Book suggests a 3.5% discount 
rate, which is reflected in NICE (2013) guidelines. The research in this analysis followed NICE 
(2013) guidelines for healthcare costs/monetary returns (3.5%) but also identified cost-effectiveness 
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for scenarios with QALYs, healthcare costs and consumption costs discounted at 1.5%, and 
different discounting costs (3.5%) and QALYs (1.5%). These scenarios could be extended by 
investigating a larger range of discount rates. They might also be extended by applying different 
discount rates according to when outcomes occur, for instance Arrow et al. (2014) recommend the 
application of declining discount rates over time.  
7.3.6 Cost-Effectiveness of Future Research 
The results from chapter six suggest the potential cost-effectiveness of future research depends 
both on the perspective adopted for evaluation, and the value of the cost-effectiveness threshold. 
The Expected Value of Perfect Information (EVPI) was much larger for the cross-sectoral than the 
health centric decision-making perspective. Meanwhile, the Expected Value of Partial Perfect 
Information (EVPPI) for the child parameters was equal to zero at a cost-effectiveness threshold of 
£20,000, but equal to almost £50 million at a cost-effectiveness threshold equal to £30,000.  
Future research could attempt to reduce the uncertainty associated with indirect lifetime estimates. 
The preferred method of reducing uncertainty is to include multiple sources of evidence from 
secondary literature sources and methods for evidence synthesis are discussed in more detail in 
section 7.4.3. Uncertainty could also be reduced by taking forward research priorities identified at 
the end of each empirical chapter. These included the estimation of a multivariate growth curve 
model to identify the effects of postnatal depression on joint outcomes for cognitive and 
socioemotional development (chapter three) and a path model to account for adulthood variables 
when predicting lifetime outcomes from intermediate measures of child development (chapter five).  
7.4 Discussion of Methods for Estimating Lifetime Effects  
7.4.1 Overview of Methodological Approach in this thesis 
The methodological approach applied in this thesis indirectly estimated the incremental mean lifetime 
QALYs, healthcare costs, monetary costs/returns in education and crime sectors for children 
exposed to symptoms of postnatal depression vs. children not exposed, as depicted in Figure 7.1. 
Initially, the incremental effects of exposure to postnatal depression (vs. non-exposure) were 
identified on intermediate outcomes for children’s cognitive (General Cognitive Ability (GCA)) and 
socioemotional development (Strength and Difficulties Questionnaire (SDQ)) in chapter three. 
Growth curve modelling was used to observe the association between maternal postnatal 
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depression and GCA/SDQ scores at four separate intervals in a time series database allowing mean 
exposure effects and changes in exposure effect to be identified between the ages of three and 
eleven. 
 
  
Figure 7.1: Depiction of the methodological approach for indirect estimation.  
 
Chapter five addressed the second stage of indirect estimation, which required effects of postnatal 
depression on intermediate outcomes to be translated to effects on final decision endpoints. 
Mathematical models were used to predict the effect of a unit change in measures of cognitive 
(GCA) and socioemotional development (Rutter Behaviour Scale (RBS)) on lifetime QALYs, 
healthcare costs, and monetary returns to education/crime sectors. Mean incremental lifetime 
effects in children exposed to postnatal depression were predicted by linking the results from the 
two studies. Coefficients attached to the GCA/RBS variables in the mathematical model (chapter 
five) were multiplied by the corresponding incremental effect size identified for GCA/SDQ 
outcomes in the growth curve models (chapter three).  
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7.4.2 Validity of Methodological Approach  
7.4.2.1 Validity of Indirect Estimation  
An implicit assumption of indirect estimation is that the effects of an early life 
circumstance on lifetime endpoints can be predicted without the need for direct observation. 
Instead, lifetime effects are identified by linking the results of two direct studies which (a) observe 
the relationship between early life circumstances and intermediate outcomes and, (b) observe the 
relationship between intermediate outcomes and lifetime endpoints. As indicated in chapter one 
(Section 1.2.5) questions addressing the validity of this assumption, and the general appropriateness 
of indirect estimation, can be informed by considering the surrogate endpoints literature.  
A common application of indirect estimation in health economic evaluation is the use of surrogate 
endpoints, which act as substitutes (or intermediates) for final clinical or decision endpoints (Hawkins 
et al., 2012). Surrogate endpoints are often referred to as biomarkers and might include measures of 
biological process, pathogenic process, or pharmacological response to a therapeutic intervention 
(Aronson, 2005). As a biomarker, surrogate endpoints are assumed to occur on the treatment 
pathway before the final endpoints, Figure 7.2. Examples of validated surrogate endpoints include 
HIV infection to predict final clinical endpoints related to AIDs (Fleming and Powers, 2012) and 
blood pressure as a biomarker for later cardiovascular events (Aronson, 2005).  
 
 
 Figure 7.2:  Illustrates the path from treatment to decision endpoint via effects on a surrogate endpoint.  
 
According to Fleming and DeMets (1996), a common misconception is to assume validity if there 
are associations observed between treatment assignment and the (proposed) surrogate endpoints, 
and between the surrogate and final endpoints. For a surrogate outcome to be a true substitute for a 
decision or clinical endpoint, it must predict the full effect of an intervention on the final endpoints 
and not merely be correlated (Fleming and DeMets, 1996). Four criteria proposed by Prentice 
(1989) have been widely adopted to assess the validity of surrogate endpoints. As demonstrated by 
the inserted parenthesis, the Prentice (1989) criteria can equally be applied to assess the validity of 
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cognitive and socioemotional development measures as intermediate outcomes during indirect 
estimation of lifetime endpoint: 
1. Treatment (an early life circumstance) has a significant impact on the surrogate 
(intermediate) endpoint(s).  
2. The surrogate (intermediate) endpoint(s) has a significant impact on the true endpoint.  
3. Treatment (an early life circumstance) has a significant impact on the true endpoint.  
4. The full effect of treatment (an early life circumstance) upon the true endpoint is captured 
by the surrogate (intermediate) endpoint(s). 
The research in this thesis immediately fulfils the first two requirements. Significant associations 
were identified between postnatal depression and cognitive and socioemotional outcomes (chapter 
three), and between cognitive and socioemotional outcomes and lifetime decision endpoints 
(chapter five). In contrast, it is not possible to formally validate the third and fourth criteria as both 
require direct evidence of the effects of postnatal depression on lifetime decision endpoints. The 
reason for using indirect estimation here was specifically due to the unavailability of direct evidence. 
Whilst formal validation is not possible, justification for the third criteria was previously 
summarised in the literature review in chapter two, which identified an effect pathway between early 
life circumstances and lifetime decision endpoints. The review suggested early life circumstances, 
such as postnatal depression, can influence the individual ←→ context relation (the mechanism 
driving lifespan development) which necessarily determine an individual’s function, behaviour and 
capabilities across the remainder of their lifespan.  
Whilst not specifically related to postnatal depression, there is some direct evidence from 
randomised controlled trials confirming the pathway of effect between early life 
technologies/interventions and adulthood decision endpoints. For example, Currie (2001) reviews 
the Head Start preschool programme, a group of educational interventions that began in 1965 and 
aimed to boost the development of underprivileged children in the USA. Three interventions were 
found to have positive effects on adulthood outcomes in long term randomised controlled trials 
when compared with control. The Perry school project reported beneficial effects on academic 
attainment and earnings, and negative effects on crime participant and welfare use (Currie, 2001), 
(Heckman et al., 2010); the Carolina Abecedarian Project treatment group achieved higher academic 
test scores, were more likely to be in further education at age 21 (Currie, 2001), and had more years 
of schooling than the control group at age 30 (Campbell et al., 2012) and the Early Training Project 
intervention group achieved (non-significant) increases in academic achievement and high school 
graduation (Currie, 2001).  
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Despite the evidence supporting the existence of a significant effect pathway (criteria three), it is not 
possible to validate the fourth criteria and establish whether the full effects of early life circumstances 
on children’s final endpoint are captured on intermediate measures of child development. Other 
effect pathways might exist between maternal depression and children’s lifetime outcomes. For 
example, postnatal depression could feasibly influence family socioeconomic status (SES); family 
SES might determine children’s SES in later adulthood separate from the effects of family SES on 
child development (i.e. poor children are likely to remain poor regardless of their development 
status); and adulthood SES might be associated with relevant adulthood outcomes e.g. heath, 
earnings, education, crime etc. Figure 7.3.  
Whilst multiple effect pathways may exist between early life circumstances and lifetime decision 
endpoints, it would seem likely that these occur predominantly in the same direction as the indirect 
estimates. That is, it is difficult to think of legitimate reasons why maternal depression would have a 
positive impact on children’s later life outcomes. So, while it is not possible to validate the fourth 
criteria, it might be reasonable to suggest the effects of maternal depression on children’s lifetime 
outcomes at least match those identified in this thesis. Even if the indirect methods underestimate 
the true magnitude of association between early life circumstances and adulthood decision 
endpoints, their inclusion in economic evaluation still represents an improvement on the initial 
decision-making conditions. It is better to include some of the overall effect rather than exclude it 
from the analysis completely.  
 
 
Figure 7.3: A hypothetical effect pathway between postnatal depression and children’s lifetime decision endpoints. Effects 
may occur through the indirect pathway which includes effects to child development. Different effect pathways may also 
exist, for example through the impact of postnatal depression on family, and later child socioeconomic status (SES).  
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7.4.2.2 Additional Structural Uncertainties within Indirect Estimation 
In addition to assuming the appropriateness of the general pathway for indirect estimation, 
two potentially questionable assumptions were made within the process. Firstly, the data available 
from the empirical studies used slightly different measures to assess children’s socioemotional 
development, where the Strengths and Difficulties Questionnaire was used in chapter three, and the 
Rutter Behavioural Scale used in chapter five. Secondly, it was assumed the incremental effects of 
postnatal depression on child development remained constant beyond the observed time horizon in 
chapter three (after age eleven). 
Uncertain assumptions in analytical methods and scientific judgements are termed structural 
uncertainties by Bojke et al. (2009). The most common method of addressing structural 
uncertainties in economic evaluation is to conduct a deterministic sensitivity analysis and present 
results across scenarios which differ in terms of the structural assumptions made (Bojke et al., 
2009). When assessing the cost-effectiveness of screening for postnatal depression, the research in 
chapter six conducted deterministic sensitivity analysis for the two structural uncertainties identified 
above. Cost-effectiveness was established for scenarios where (a) indirect estimation was conducted 
with an intermediate measure for socioemotional development which only included categories 
appearing on both SDQ and RBS scales (Appendix 6.5), and (b) increasing/decreasing development 
effect sizes were assumed when estimating lifetime outcomes by multiplying the estimated effects 
by a proportion of 0.75 or 1.25 (Appendix 6.4). Neither structural assumption altered the key 
findings in this research, this being the potential for lifetime effects to influence the cost-
effectiveness result.   
Whilst not affecting the key findings, different structural assumptions did influence the specific 
screening strategy recommended within the deterministic scenarios (Appendix 6.4). In this case, 
presenting results across several scenarios may not appropriately inform decision makers as they 
may not be able to determine the relative importance of each structural uncertainty. This analysis 
could have been extended by applying a technique called model averaging to identify a single cost-
effectiveness result whilst accounting for results across multiple scenarios (Bojke et al., 2009). 
Model averaging requires weights to be applied to each uncertain scenario relative to the likelihood 
of that scenario being the correct assumption (Bojke et al, 2009). Cost-effectiveness across all 
scenarios could be established by calculating incremental cost-effectiveness ratios (ICERs) across 
weighted QALYs and healthcare costs.  
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7.4.2.3 Causality in Observational Study Designs  
 The previous sections considered the validity of the indirect estimation procedure. There 
may also be concerns regarding the validity of the two pieces of empirical evidence used to inform 
the indirect estimation of lifetime effects in this thesis, as both chapters three and five utilised data 
form observational birth cohorts. As stated by Kaplan (2018), observational studies identify 
correlations, but do not prove causation.  
It could be that the association between maternal depression and child development, identified in 
chapter three, occurred due to factors unaccounted for in the growth curve analysis. For example, 
children might have been exposed to antenatal depression symptoms which also exhibit detrimental 
associations with child development (Kingston and Tough, 2014). However, this may be unlikely 
given that several studies have identified associations for both antenatal and postnatal depression 
within the same model (Kingston and Tough, 2014). Meanwhile, depression genes could be passed 
from mothers subsequently manifesting as behavioural/emotional problems during childhood, 
though this would not explain the relationship between maternal depression and cognitive 
development outcomes.  
There are several reasons why a causal relationship might be assumed for the associations identified 
in chapter three. Firstly, there is abundant theoretical literature assigning an effect pathway between 
maternal depression symptoms and child development through the maternal-child attachment 
relationship (Bowlby, 1978). Secondly, the theoretical literature is supported by evidence from 
experimental studies where depression interventions are found to decrease symptoms, improve the 
maternal-child attachment relationship and positively influence early child development (Cuijpers et 
al., 2015). Thirdly, associations between maternal depression and child development have been 
consistently identified in other observational study designs (Sanger et al., 2015). Finally, causality is 
supported by associations which exhibit biological gradients i.e. dose-dependencies (Fedak et al., 
2015), and the growth curve models identified a strong accumulative effect of maternal depression 
symptoms on both child development outcomes.   
A similar rationale can be used to infer causality for the associations between measures of child 
development and lifetime outcomes in chapter five. Again, dose dependent responses were 
identified where each unit increase in child development measures resulted in increases in the 
magnitude of association with lifetime outcomes. Meanwhile, chapter four identified evidence from 
several observational studies where consistent associations were identified between child 
development and different adulthood outcomes including earnings (Cunha and Heckman, 2008), 
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well-being (Layard et al., 2014), self-rated health (Hertzman et al., 2001), and high school graduation 
(Cunha et al., 2010). The causal assumption is also supported by the theoretical and empirical 
evidence used to previously support the validity of indirect estimation (in section 7.4.2.1).  
 The best way to address validity issues related to causality for both empirical studies might be to 
combine all the available evidence using methods for evidence synthesis. Appropriate techniques 
for evidence synthesis during indirect estimation are discussed in the following section. 
7.4.3 Evidence Synthesis and Indirect Estimation   
As described in section 7.2.3.1, economic evaluations should be informed by all the relevant 
evidence (Sculpher et al., 2006). The research in this thesis partially addresses this requirement, 
developing a method for indirect estimation which provides a mechanism to use additional evidence 
in economic evaluations by linking findings from two empirical studies. To comply fully with the 
requirements suggested by Sculpher et al. (2006), the methodology for indirect estimation ought to 
be expanded to include evidence from all relevant sources.  
There are likely to be relevant sources of evidence available in the current literature base to more 
fully inform the first stage of indirect estimation, which requires effects from early life 
circumstances to be identified on intermediate development outcomes. For example, there are 
several sources of evidence establishing the association between postnatal depression exposure and 
measures of cognitive and socioemotional development (for examples see Kingston and Tough 
(2014) & Sanger et al. (2015)).  
Typically, health research synthesises evidence on effect sizes in a meta-analysis, a statistical 
technique combining results from multiple empirical studies into a single pooled (mean) estimate 
(Sharpe, 1997). The effects of early life circumstances could potentially be estimated using all the 
available evidence in separate meta-analyses with pooled effects for cognitive and socioemotional 
development outcomes.  
A key assumption of meta-analyses is homogeneity between the included studies. This means 
pooled effect sizes should only be calculated across studies measuring the same outcomes, against 
the same comparator, and in the same population (Sharpe, 1997). The synthesis of evidence across 
studies evaluating effects on child development outcomes might be problematic due to prevalence 
of study heterogeneity. Study heterogeneity occurs due to the diverse outcome measures available to 
assess child development. For example, when estimating effects of exposure to postnatal depression 
symptoms, systematic reviews by Kingston and Tough (2014) and Sanger et al. (2015) identified ten 
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different cognitive development measures and eight socioemotional development outcome 
measures.  
The problem of outcome heterogeneity might be addressed in multiple operationalism, a method 
allowing different types of measures to be combined in a meta-analysis if the heterogeneous 
outcome measures identify a similar underlying construct. Behavioural and social sciences often rely 
of multiple operationalism meta-analyses as studies regularly use diverse measures that capture 
different facets of the same latent variable (Noble Jr, 2006). The technique has been applied by 
Beck (1998) to estimate a pooled effect for children exposed to symptoms of postnatal depression 
on cognitive and emotional developmental outcomes occurring throughout infancy and early 
childhood.  
A second source of study heterogeneity may occur if studies identify effects on development 
outcomes at different ages. Chapter three described how growth curve models were required to 
account for potentially changing effect sizes which may occur as children develop. Even pooled 
results in a multi-operationalism meta-analysis may not be appropriate if, for example, one study 
identifies outcomes at age two, and the other at age eleven.  
To avoid heterogeneity, analysts could restrict the meta-analysis by specifying an age range for the 
development outcome. The appropriate age range is likely to depend on the evidence available in 
specific research scenarios. Ideally, pooled effects would be obtained on outcomes occurring 
towards the later stages of child development. This would reduce the potential for changing effect 
sizes over time, as most developmental change will have occurred by this age. Increasing 
effectiveness evidence, which could facilitate the conduct of a meta-analysis, is likely to become 
available due to the additional emphasis being placed on the Early Years literature. For instance, the 
Born in Bradford Better Start study (BiBBs) was recently commissioned, an experimental birth 
cohort study aiming to identify effectiveness evidence for over twenty early interventions and 
follow up children until they are aged ten (Dickerson et al., 2016).  
However, in some cases, it may be that too few long terms studies are available to sufficiently 
inform a meta-analysis across child development outcomes occurring in mid childhood. Most 
evidence, particularly robust trial-based evidence, is likely to be available across studies with shorter 
time horizons. For instance; the meta-analysis by Beck (1998) identified eight studies with outcomes 
collected at ages ranging from one to four, but only two studies with outcomes occurring after the 
age of four. Analysts may need to trade off the length of the time horizon with the number of 
available studies. 
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If indirect estimation were to be informed through a meta-analysis conducted during early 
childhood, some method would be required to predict the size of the pooled effect at age 10 (the 
age corresponding with the developmental input parameters for the mathematical model in chapter 
five). As is described in chapter three, statistical methods such as growth curve models can utilise 
time series data to establish whether mean effect sizes on developmental outcomes were likely to 
change over time. Evidence from time series analyses could be used to predict any changes 
expected to occur in the pooled effect between early childhood and age 10 as indicated in the 
following hypothetical example: If a pooled effect size equal to X was identified on cognitive 
development outcomes at age three and a time series analysis identified an effect size on cognitive 
outcomes at age three equal to Y, which changed to an effect size equal to Y/A at age ten; then a 
pooled effect size for cognitive development outcomes at age ten might be estimated as X/A, 
assuming the pooled effect changed proportionately to the effect in the long term study. This 
approach to evidence synthesis is used by the Washington State Institute for Public Policy when 
establishing the cost-benefit of several early childhood health and social policies (WSIPP, 2017).  
The evidence synthesis framework could be further expanded by using different mathematical 
models to translate intermediate pooled effects to final decision endpoints in the second stage of 
indirect estimation. Whilst no other models estimating lifetime QALYs and healthcare costs were 
identified in chapter four, these may become available in the future. It would not be appropriate to 
pool estimates from different mathematical models in a meta-analysis because models are usually 
heterogeneous applying a diverse set of structural assumptions. Instead of conducting a meta-
analysis, separate lifetime estimates could be obtained for each individual model and used to inform 
different scenario analyses within an economic evaluation. This method might be extended further 
by obtaining a single estimated effect size through model averaging, as was described when 
discussing structural uncertainties in the previous section. The full evidence synthesis framework 
suggested for indirect estimation is illustrated in Figure 7.4. 
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Figure 7.4: Illustrates an evidence synthesis framework that could be applied to estimate the lifetime effects associated 
with children exposed to postnatal depression symptoms (or other childhood diseases/exposures/health technologies).  
Above (most desirable): Assumes evidence is available to conduct a meta-analysis across intermediate development 
outcomes in mid-childhood; pooled effects in mid-childhood are extrapolated to adulthood decision endpoints in 
different scenarios using separate mathematical models.  
Below: Assumes evidence is only available to conduct a meta-analysis across development outcomes in early childhood; 
pooled effects during early childhood are adjusted based on the results of a time series analysis to obtain pooled effects 
during mid-childhood; adjusted pooled effects in mid-childhood are extrapolated to adulthood decision endpoints in 
different scenarios using separate mathematical models.  
7.4.4 Alternative Approaches to Acquiring Lifetime Evidence   
7.4.4.1 Introduction  
The methodology applied in this research is one of several approaches that might be used 
to identify the lifetime effects associated with early life circumstances. This section considers the 
range of approaches that could be available to researchers and suggests a ranking of different 
methods for estimating lifetime effects through direct and indirect estimation. This section might 
provide a useful guide for other researchers. 
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7.4.4.2 Direct Estimation  
Whilst not available for the applied example in this thesis, usually, the best and most 
reliable sources of evidence are obtained by directly measuring effects on relevant decision endpoints 
within a trial-based design. Randomised controlled trials (RCTs) are often termed the “gold 
standard” for direct estimation, as they eliminate several sources of bias through random allocation 
of participants to different (treatment) groups (Akobeng, 2005). Section 7.4.2.1 identified the 
outcomes of early education programmes including the Perry preschool programme (Heckman et 
al., 2010) and the Carolina Abecedarian project (Muennig et al., 2011). Such research demonstrates 
the possibility of conducting randomised trials over a long-term time horizon and identifying 
relevant decision outcomes during adulthood. However, probably due to high associated costs, 
there are few other examples in the literature where direct lifetime evidence is available from long 
term RCTs. 
A more pragmatic approach to obtaining direct long-term evidence might be to conduct trials 
within cohorts, utilising the multiple randomised controlled trial (cmRCT) design advocated by 
Relton et al. (2010). The cmRCT recruits participants with a condition into a large observational 
cohort. Different interventions are randomly offered to the cohort members who are followed up 
similarly to typical longitudinal studies with repeated outcomes obtained across several data 
collection sweeps. Treatment effects are identified as in RCTs, by comparing the outcomes in 
intervention and control groups (Relton et al., 2010). When compared with RCTs, cmRCT designs 
are associated with reduced costs as multiple RCTs can be conducted within the same cohort. 
Likely due to their lower associated costs, Relton et al. (2010) state that cmRCTs can collect longer 
term evidence “as standard”, which might make them an appropriate study design when estimating 
lifetime effects.  
In some cases, RCTs and cmRCTs might not be ethical if research questions relate to the effects of 
diseases or exposures. For instance, in this research it would not have been appropriate to 
knowingly expose a group of children to harmful symptoms of postnatal depression. Where RCTs 
are unethical, direct evidence can be obtained from observational study designs which include 
cohort, case control, and cross-sectional studies. Ethical allocation of disease and exposure groups 
can be achieved within observational studies as this is assigned in nature and not controlled by 
researchers. Because randomisation is not possible, evidence from observational studies is often 
interpreted with caution as biases may be introduced particularly if the study groups are imbalanced 
for certain characteristics that may affect the final outcomes (Webb et al., 2016).  
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Birth cohort studies are likely to provide lifespan development researchers with the most useful 
sources of evidence from observational studies as they obtain repeated evidence on participants as 
they progress from early childhood into adulthood. The most relevant UK birth cohorts that have 
currently reached adulthood include the 1958 National Child Development Study and the 1970 
British Cohort Study. Additional direct evidence from observational studies will also become 
available in the future when recent birth cohorts, such as the Millennium Cohort (MCS) and the 
Born in Bradford (BiB) studies, reach adulthood. 
Researchers and decision makers might question the appropriateness of direct estimation given the 
time horizon required between early life circumstance and the final observed outcome. For 
example, if direct evidence were collected from the 1958 National Child Development Study the 
evidence would rely on the relevance of historical data collected 50 years ago. A key consideration 
in economic evaluation is the external validity of the evidence used to inform the analysis i.e. 
whether findings for study participants hold true for the target population of the intervention 
(Sculpher et al., 2006), (Murad et al., 2018). Decision makers may be reluctant to rely on direct 
evidence from the 1950s given the fundamental changes that have occurred in the UK to 
technology, science, demographics, politics, economics etc. Lifetime effects estimated through 
indirect methods might be considered more valid as the procedure links multiple sources of 
evidence with shorter time horizons. Rather than relying on the effectiveness of interventions 
assessed in the 1950, indirect estimation could utilise evidence from UK birth cohorts 
commissioned as recently as 2000 (the MCS) or even 2007 (BiB).  
7.4.4.3 Using Indirect Estimation  
Indirect estimation might, therefore, be conducted if there is either no direct evidence 
available or if it is considered the most (externally) valid approach to obtain lifetime effects 
estimates. The evidence synthesis framework described in the section 7.4.3 (Figure 7.4), which 
incorporates all the available literature, represents the most desirable method for indirect estimation. 
Where there is insufficient evidence available to conduct evidence synthesis, researchers could 
adopt a methodology like that applied in this thesis and estimate indirect effects by linking evidence 
from two (or more) empirical studies.  
Data linkage during indirect estimation need not be approached homogenously by all researchers. 
For example, researchers should consider the age of children when studies are linked, i.e. the age at 
which intermediate development measures are obtained. It is suggested that where possible, longer 
term intermediate outcomes ought to be prioritised. In the approach in this thesis the first stage of 
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indirect estimation directly observed the effects of an early life circumstance on measures of child 
development. In contrast, the second stage of indirect estimation used a mathematical model to 
predict the effects of development on relevant lifetime outcomes. To reduce uncertainty, it would 
make sense to maximise the time horizon of the more reliable first stage and minimise the time 
horizon over which effects are being predicted.  For this research, intermediate outcomes were 
measured for ages 10-11 simply because it was the oldest age for which data was available in the 
Millennium Cohort Study.  
Indirect estimation could also be conducted by using multiple sets of intermediate endpoints to link 
the results of more than two studies. A study by Hummel et al. (2011), for example, estimated the 
lifetime effects of early parenting interventions indirectly using three stages where: effects of early 
intervention were obtained on measures of cognitive and socioemotional development at age three; 
a mathematical model was used to extrapolate these effects to cognitive and socioemotional 
development measures at age five; and a second mathematical model was used to extrapolate 
children’s age five outcomes to lifetime decision endpoints at age thirty-four.  
Ideally extra modelling stages should not be introduced. Whilst the additional modelling stages 
might improve the external validity of the estimates by further reducing the time horizon of the 
required evidence, they simultaneously increase the associated structural uncertainty. Each 
additional extrapolation requires an added assumption about the continuation of an effect pathway 
which cannot be formally validated in the absence of direct evidence. However, such methods 
might be appropriate if evidence on the effects of early life circumstances on measures of child 
development is only available for early childhood.  
Figure 7.5 summarises the discussion in this section, ranking different methods for estimating 
lifetime effects through direct and indirect estimation which might provide a useful guide for other 
researchers.  
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Figure 7.5: Hierarchy of evidence when estimating the effect of early life exposures that affect child development on 
lifetime decision endpoints. *Can be interchanged with a different early life circumstance according to study design e.g. 
disease status, treatment status etc.  
7.4.4.4 Expert Opinion   
If there is insufficient direct and/or indirect empirical evidence, economic evaluation could 
be informed through expert opinion where specific parameter values are established through 
estimates provided by expert professionals or researchers. As expert opinion is subjective, it has 
often been viewed with caution (Leal et al., 2007). Recent research has attempted to establish 
structured methods to quantify experts’ beliefs to increase the reliability of the derived parameters 
(Soares et al., 2018). If expert elicitation is used to inform economic evaluation, methods are 
required to identify both a mean value and the likely distribution for the parameter of interests. 
Soares et al. (2018) describe two methods that can be used to quantify expert opinion, these being: 
the fixed interval method, where experts are provided with a range of values and assess the 
probability that the value of a parameter lies between the interval; and the variable interval method 
where experts are asked to attach values to specific predefined percentiles of the distribution.  
There are several reasons why expert opinion might not be appropriate when obtaining estimates 
for lifetime outcomes. Firstly, expert opinion requires evidence to be obtained from professionals 
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with enough expertise in the parameter of interest. For instance, whilst GPs might have sufficient 
patient experience to provide useful and informed beliefs regarding the likely effects of a particular 
treatment and be in a position to observe effects of certain diseases/exposures/treatments on a 
child’s early development, it is unlikely that they have necessary experience of health economics to 
understand how these effects might influence lifetime health, education and employment and crime 
outcomes. Similarly, economists and social researchers may be able to provide opinions on lifetime 
decision endpoints but might be unlikely to have relevant experience regarding the effects of the 
early life circumstance on their early health and development.  
Secondly, and as described by Soares et al. (2018), expert opinion can be problematic as individuals 
often find it difficult to quantify their beliefs, particularly if they are not trained in quantitative 
methods. It would seem particularly difficult in the case of lifetime estimates, as these require 
complex calculations. For example, experts estimating incremental effects on lifetime earnings 
might need to first calculate mean lifetime earnings by aggregating individual earnings over the 
duration of the employment; and then multiply this value by an appropriate proportion according to 
the expected size of the incremental effect. Analysts should carefully consider whether lifetime 
estimates informed through expert opinion are a reliable source of information for economic 
evaluation.   
7.4.4.5 Modelling Development within a Decision Analytic Model  
Direct/indirect estimation and expert elicitation might all be used to obtain evidence 
regarding the incremental lifetime effects associated with a specific early life circumstance versus a 
relevant comparator. Such evidence can be used to estimate parameter values attached to different 
states in decision analytic models (DAMs). For example, this research obtained and assigned 
lifetime QALYs, healthcare costs and returns to education for health states where children were 
categorised as either exposed or not exposed to symptoms of postnatal depression. A similar 
approach might also be utilised in trial based economic evaluations requiring identification of the 
lifetime outcomes associated with a specific intervention versus a relevant control (e.g. usual care).  
Alternatively, economic evaluations could account for lifetime consequences of early life health 
technologies by incorporating the process of child development within the structure of a DAM. 
Typically, DAMs identify the effects of health technologies by assuming that a cohort of 
hypothetical patients pass through a series of different health/disease states; for example, an 
intervention to treat cancer might be assessed in terms of its effect on patients’ progression through 
states for disease, remission, relapse and death.  
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Equally, “development” states might be used to capture the effects of early health technologies in 
terms of how they affect the progression of a hypothetical cohort of children through the 
development process. When identifying the cost-effective treatment for postnatal depression Ride 
(2018) theorised a Markov model that contained “development” states, classifying children as either 
having or not having a cognitive impairment following their exposure to symptoms. The model by 
Ride (2018) represents a small expansion to the DAM in chapter six as it moves beyond disease 
states in mothers (depressed/not depressed) and models states during early childhood (cognitive 
impairment/no cognitive impairment). The model might be expanded upon further by including 
additional states that extended later into the development process (e.g. cognitive impairment in 
adolescence/no cognitive impairment in adolescence).  
There are two criticisms that might be directed at methodologies attempting to incorporate the 
progression of development within the structure of a DAM. Firstly, the approach assumes that 
development can be appropriately specified into specific qualitative states and this might be 
controversial. For instance, Ride (2018) dichotomises children as having cognitive impairment or 
not and, therefore, requires a diagnosis for cognitive impairment – this is assigned based on 
whether children score below an arbitrary threshold on a psychometric test. This dichotomy might 
be inappropriate in the context of this thesis if it was assumed that exposure to postnatal depression 
could have detrimental effects across all children. For instance, children initially predisposed as high 
achievers would have to be severely affected for them to reach a diagnosis that moved them to a 
state of cognitive impairment. As defined in chapter two, development is change that occurs within 
individuals over time and is likely to occur (at least partially) as a continuous process. It may not 
make sense to model continuous individual changes within discrete states in a DAM.  
A second criticism relates to the pragmatic restrictions that could make it impossible to estimate a 
DAM that appropriately captures the process of lifespan development. It might be argued that the 
framework suggested by Ride (2018) should be expanded into a more complex structure including 
in this case additional effects of postnatal depression on socio-emotional development. The 
inclusion of socio-emotional effects would require exponential expansions to the total number of 
development states included in the model e.g. no impairment, cognitive impairment only, socio-
emotional impairment only, both cognitive and socioemotional impairment. A fully representative 
model of lifespan development that could be utilised more generally to assess the cost-effectiveness 
of wide range of early health technologies might require more additional development states e.g. in 
physical and environmental domains.  
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Further complexity might be incorporated in a development DAM given the potential for change 
within states over time. For example, cognitive impairment during infancy might not be defined 
equivalently to cognitive impairment during childhood, adolescence or adulthood. Each separate 
development stage could require separate development states. 
Economic evaluations using DAMs to model child development might not be possible given the 
information required to populate the mode. Parameters would be required regarding the probability 
of children transitioning from and into each of the individual development states across all life 
stages and health related utilities, healthcare costs, and cross-sectoral costs and benefits would need 
to be assigned to each development state. Because of these complexities it might be more 
appropriate to estimate lifetime effects of early life health technologies using direct or indirect 
sources of empirical evidence.   
7.5 Research Recommendations and Application of Methodology 
The following recommendations are intended to inform researchers when estimating lifetime effects 
of early life circumstances for economic evaluation. The recommendations indicate how 
methodologies adopted/advanced in this thesis might be applied in other research scenarios:  
1. A decision perspective should be specified together with the relevant decision endpoints 
for this perspective. The economic evaluation of UK child health 
technologies/interventions might follow methods in this thesis and adopt two perspectives 
conducting analyses from: (i) a health centric decision maker’s perspective using QALYs 
and healthcare costs as decision endpoints; and (ii) a cross-sectoral perspective including 
QALYs, healthcare costs and monetary returns to other sectors as decision endpoints. 
Ultimately which perspective is presented as primary or secondary should depend on the 
decision maker who the evaluation is intended to inform.   
2. The early life circumstances and relevant comparator should be specified prior to the 
conduct of primary research. This will be self-evident for trial based economic evaluations 
which require evidence regarding the incremental lifetime effects of each treatment vs. the 
relevant control. The relevant early life circumstance may be less obvious when conducting 
economic evaluation using a DAM. It might not be appropriate/possible to model the 
development process as states within the DAM. It might be more appropriate to attach 
empirical estimates regarding lifetime effects to health states already defined within the 
model. For example, the DAM in this research contained health states for children exposed 
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to postnatal depression, and children not exposed to postnatal depression, thus requiring 
evidence regarding the incremental lifetime effects for children exposed to postnatal 
depression symptoms (compared with children not exposed). Each different DAM will 
have specific disease states that determine the type of evidence and comparison required. 
3. Lifetime effects could be estimated by directly observing the relationship between early life 
circumstance and final decision endpoint. Direct evidence is unlikely to be available from 
RCTs, may be available from cmRCT designs (trials within cohorts), but is most likely to be 
available from birth cohorts who have reached adulthood. For the UK, relevant 
longitudinal cohorts include the 1970 British Cohort Study, the 1958 National Child 
Development study, and the 1946 National Survey of Health & Development.  
4. Lifetime effects could also be estimated through indirect estimation by linking data across 
multiple studies. The first stage of indirect estimation requires evidence about the effect of 
early life circumstances on intermediate measures of child development. If possible, 
primary research should identify effects on development measures in time series data. 
Primary data could be obtained by conducting relatively long-term experimental studies 
which utilise data from promising new sources such as the Born in Bradford’s Better Start 
experimental birth cohort. Equally, as was demonstrated in this thesis, observational 
evidence can be obtained from recent birth cohorts such as the Millennium Cohort and the 
(original) Born in Bradford studies. As described in chapter three, growth curve models 
provide an appropriate method when establishing longitudinal effects on child 
development measures. Secondary evidence sources may be available and should be 
searched to determine whether an evidence synthesis through meta-analysis is possible. 
Ideally, the effect sizes identified in primary research would be pooled with all the available 
secondary data in a meta-analysis.  
5. The second stage of indirect estimation requires the effects on intermediate outcomes to be 
translated to effects on lifetime outcomes. The mathematical model in chapter five might 
be useful for other analysts when translating effects. This would require the effects of early 
life circumstances to be measured on equivalent intermediate endpoints as used as model 
input parameters in chapter five, i.e. General Cognitive Ability at age ten, and the Rutter 
Behaviour Scale, or the Strength and Difficulties Questionnaire at age ten. New 
mathematical models are likely to be developed in the future so researchers should search 
the contemporary literature base. It would be most appropriate to obtain predictions for 
each of the available models.  
6. The final economic evaluation should establish the cost-effective strategy alongside the 
associated probability of cost-effectiveness. Decision makers are likely to benefit from 
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results with and without lifetime parameters to illustrate how their inclusion affects the 
cost-effectiveness decision. Similarly, results should be presented for all perspectives being 
investigated. In addition, appropriate figures should be included that illustrate cost-
effectiveness results across a range of values for the cost-effectiveness threshold (k) and the 
consumption value for health (v). If predictions have been obtained from different models, 
they might be presented as different scenario analyses, or could be combined into a single 
estimate using model averaging. Scenario analyses/model averaging could also be used to 
address any other structural assumption made during indirect estimation, for example the 
assumption of increasing, decreasing or consistent effect sizes over time.  
7.6 Conclusions  
This thesis addresses a limitation common to economic evaluations of childhood health 
technologies. A technology may affect child development and subsequently influence lifetime health 
and economic outcomes, but these lifetime effects may be excluded from an analysis in the absence 
of typical sources of direct evidence. The research in this thesis describes and advances methods for 
indirect estimation by linking data from two empirical studies and applies these methods to estimate 
lifetime effects in children exposed to symptoms of postnatal depression. The lifetime effects 
estimates were used to update an existing UK based economic evaluation assessing the cost-
effectiveness of screening for postnatal depression.  
The influence of lifetime effects on policy recommendations was demonstrated as their inclusion 
affected the cost-effective screening strategy.  
The findings from this thesis suggest that if economic evaluations exclude lifetime effects, they risk 
providing a partial analysis and may underestimate the benefits of childhood health technologies if 
the technology fosters lifespan development.  
The methods advanced in this research could be applied when assessing the cost-effectiveness of 
other child health technologies. Methods for indirect estimation could reduce the risk of bias in 
decision making which may occur if lifetime effects are routinely excluded from economic 
evaluation.  
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Appendices  
Chapter 3 Appendices 
Appendix 3.1 Maternal Depression Questionnaire Items  
Appendix 3.1A: The 9-Item Rutter Malaise Index  
Questionnaire Item   Responses (and scoring) 
Do your feel tired most of the time?  Yes (=1)/ No (=0) 
Do you often feel miserable or depressed?  Yes (=1)/ No (=0) 
Do you often get worried about things?  Yes (=1)/ No (=0) 
Do you often get into violent rage?  Yes (=1)/ No (=0) 
Do you often suddenly become scared for no good reason?  Yes (=1)/ No (=0) 
Are you easily upset or irritated?  Yes (=1)/ No (=0) 
Are you constantly keyed up and jittery?  Yes (=1)/ No (=0) 
Does every little thing get on your nerves and wear you out?  Yes (=1)/ No (=0) 
Does your heart often race like mad?  Yes (=1)/ No (=0) 
 
Notes: Administered during sweep one of the Millennium Cohort Study.  
 Total score are derive by summing responses for each item, scores >=4 indicate symptoms of 
 postnatal depression,  
 
Appendix 3.1B: The Kessler 6 Index 
Questionnaire Item   Responses (and scoring) 
During the last 30 days, how often did you 
feel so depressed that nothing could cheer 
you up? 
 
None of the time (=0); a little of the time (=1); some of 
the time (=2); most of the time (=3); all of the time (=4).  
During the last 30 days, about how often did 
you feel hopeless? 
 
None of the time (=0); a little of the time (=1); some of 
the time (=2); most of the time (=3); all of the time (=4). 
During the last 30 days, about how often did 
you feel restless or fidgety? 
 
None of the time (=0); a little of the time (=1); some of 
the time (=2); most of the time (=3); all of the time (=4). 
During the last 30 days, about how often did 
you feel that everything was an effort? 
 
None of the time (=0); a little of the time (=1); some of 
the time (=2); most of the time (=3); all of the time (=4). 
During the last 30 days, about how often did 
you feel worthless? 
 
None of the time (=0); a little of the time (=1); some of 
the time (=2); most of the time (=3); all of the time (=4). 
During the last 30 days, about how often did 
you feel nervous? 
None of the time (=0); a little of the time (=1); some of 
the time (=2); most of the time (=3); all of the time (=4). 
 
Notes:  Administered during sweeps 2-5 of the Millennium Cohort Study.  
 Total scores are derived by summing responses for each item, scores >=13 indicate symptoms of 
 maternal psychological distress.  
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Appendix 3.2: Scree Plots from Principal Component Analysis  
 
Notes:  Scree Plots of eignevalues for unrotated factors identified in PCA for sweep two (top left), sweep 
 three (top right), sweep four (bottom left) and sweep five (bottom right).  
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Appendix 3.3: Full Results Growth Curve Model 1. 
Appendix 3.3A: SQRT SDQ Total Difficulties Model  
 Coefficient Standard 
Error 
P-Value 
Maternal Depression Variables     
 Postnatal Depression Symptoms  0.386 0.033 0.000 
 Maternal Distress Symptoms  0.253 0.021 0.000 
    
Covariates     
 Male Child 0.242 0.021 0.000 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
0.021 
-0.236 
-0.051 
-0.039  
0.006 
 
0.071 
0.088 
0.075 
0.085  
0.148 
 
0.766 
0.007 
0.496 
0.644  
0.966 
 Siblings (ref. =0)  
  1 
  2 
  3+ 
 
-0.020 
-0.353  
-0.006 
 
0.016 
0.021 
0.030 
 
0.198 
 0.101 
0.837 
 Maternal Age at Child Birth  -0.019 0.002 0.000 
 Low Household Income  0.132 0.031 0.000 
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
0.026 
-0.075 
 -0.188 
 -0.249 
 0.187 
 0.180 
 
0.047 
0.032 
0.027 
0.037 
0.081 
0.049 
 
0.581 
0.019  
0.000 
0.000 
0.021 
 0.000 
 Single Mother  0.139 0.023 0.000 
 Mother in Employment    -0.041 0.010 0.000 
    
Time Metrics    
 Age at SDQ Assessment (months) 0.010 0.001 0.000 
 Age2 0.001 0.000 0.000 
    
Time Interaction Terms (with Age)     
 Postnatal Depression Symptoms  0.000 0.000 0.644 
 Maternal Distress Symptoms  -0.002 0.001 0.054 
 Male Child -0.001 0.001 0.138 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
-0.002 
-0.004 
-0.001 
-0.003  
-0.007 
 
0.002 
0.002 
0.002 
0.002  
0.004 
 
0.134 
0.089 
0.714 
0.191  
0.080 
 Maternal Age at Child Birth  0.000 0.000 0.076 
 Low Household Income  0.005 0.001 0.000 
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Appendix 3.3A: SQRT SDQ Total Difficulties Model continued 
 Coefficient Standard 
Error 
P-Value 
Time Interaction Terms (with Age) continued   
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
-0.003 
-0.000 
 -0.001 
 -0.005 
 -0.003 
 -0.001 
 
0.001 
0.001 
0.001 
0.001 
0.002 
0.001 
 
0.047 
0.800  
0.072 
0.000 
0.158 
 0.259 
  Single Mother  -0.001 0.001 0.317 
 
Time Interaction Terms (with Age2) 
   
 Postnatal Depression Symptoms  0.0003 0.0008 0.722 
 Maternal Distress Symptoms  -0.0005 0.0010 0.616 
 Male Child -0.0017 0.0006 0.003 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
-0.0002 
-0.0000 
0.0003 
-0.0002  
-0.0009 
 
0.0001 
0.0002 
0.0002 
0.0003  
0.0001 
 
0.196 
0.827 
0.120 
0.348  
0.096 
 Maternal Age at Child Birth  0.0009 0.0006 0.123 
 Low Household Income  0.0004 0.0000 0.000 
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
-0.0002 
-0.0004 
 -0.0001 
 -0.0006 
 -0.0005 
 -0.0000 
 
0.0001 
0.0009 
0.0000 
0.0001 
0.0002 
0.0001 
 
0.188 
0.655  
0.020 
0.000 
0.058 
 0.447 
  Single Mother -0.0002 0.0000 0.016 
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Appendix 3.3B: GCA Model  
 Coefficient Standard 
Error 
P-Value 
Maternal Depression Variables     
 Postnatal Depression Symptoms  -0.274 0.843 0.673 
 Maternal Distress Symptoms  -1.832 0.116 0.000 
Covariates     
 Male Child -0.588 0.2950 0.049 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
0.484 
2.333 
-3.278 
-4.076  
2.965 
 
1.082 
1.324 
1.141 
1.283  
2.224 
 
0.655 
0.078 
0.004 
0.001 
0.182 
 Siblings (ref. =0)  
  1 
  2 
  3+ 
 
-1.502 
-3.224  
-4.363 
 
0.366 
0.507 
0.737 
 
0.000 
 0.000 
0.000 
 Maternal Age at Child Birth  0.336 0.033 0.000 
 Low Household Income  -1.216 0.545 0.026 
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
-1.911 
1.012 
 3.847 
 5.151 
 -2.435 
 -4.369 
 
0.725 
0.496 
0.411 
0.575 
1.303 
0.781 
 
0.008 
0.041  
0.000 
0.000 
0.062 
 0.000 
 Single Mother  -0.718 0.211 0.001 
 Mother in Employment    0.670 0.465 0.328 
    
Time Metrics (Dummy Variables)    
 Sweep 2 105.948 0.339 0.000 
 Sweep 3  
 Sweep 4   
 Sweep 5 
104.056 
101.865 
101.136 
0.348 
0.374 
0.439 
0.000 
0.000 
0.000 
    
Time Interaction Terms (with Sweep 2)     
 Postnatal Depression Symptoms  -0.381 0.556 0.543 
 Maternal Distress Symptoms  -0.218 0.746 0.448 
 Male Child -3.200 0.359 0.000 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
-0.601 
-8.285 
-9.398 
-2.223  
-9.656 
 
1.216 
1.488 
1.275 
1.438 
2.526 
 
0.621 
0.000 
0.000 
0.122  
0.000 
 Siblings (ref. =0)  
  1 
  2 
  3+ 
 
-2.219 
-3.706  
-4.679 
 
0.418 
0.580 
0.840 
 
0.000 
 0.000 
0.000 
 Maternal Age at Child Birth  -0.027 0.037 0.468 
 Low Household Income  -0.853 0.615 0.165 
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Appendix 3.3B: GCA Model continued 
 Coefficient Standard 
Error 
P-Value 
Time Interaction Terms (with Sweep 2) continued   
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
-0.249 
0.525 
 -0.136 
 -0.187 
 -0.618 
 0.586 
 
0.813 
0.576 
0.481 
0.797 
1.502 
0.857 
 
0.759 
0.363  
0.777 
0.814 
0.681 
 0.494 
    
Time Interaction Terms (with Sweep 3)     
 Postnatal Depression Symptoms  -0.009 0.525 0.601 
 Maternal Distress Symptoms  -0.078 0.500 0.853 
 Male Child -1.405 0.336 0.000 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
-1.231 
-3.831 
-4.271 
-1.107  
-5.595 
 
1.115 
1.405 
1.206 
1.363 
2.373 
 
0.284 
0.006 
0.000 
0.417  
0.018 
 Siblings (ref. =0)  
  1 
  2 
  3+ 
 
-0.644 
-0.544  
-2.306 
 
0.392 
0.544 
0.791 
 
0.100 
 0.317 
0.004 
 Maternal Age at Child Birth  -0.056 0.035 0.112 
 Low Household Income  0.847 0.602 0.159 
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
-0.372 
-0.502 
-1.220 
 -1.564 
0.233  
 0.390 
 
0.777 
0.546 
0.454 
0.703 
1.437 
0.824 
 
0.632 
0.357  
0.007 
0.026 
0.871 
 0.636 
    
Time Interaction Terms (with Sweep 4)     
 Postnatal Depression Symptoms  -0.762 0.410 0.045 
 Maternal Distress Symptoms  0.242 0.101 0.002 
 Male Child -0.348 0.326 0.285 
 Child Ethnicity (ref. White British) 
  Mixed Race 
  Indian 
  Pakistani/Bangladeshi 
  Black  
  Other   
 
-0.537 
2.116 
3.700 
1.636  
1.285 
 
1.116 
1.363 
1.182 
1.333 
2.314 
 
0.631 
0.120 
0.002 
0.219  
0.579 
 Siblings (ref. =0)  
  1 
  2 
  3+ 
 
0.205 
-0.434  
-1.042 
 
0.380 
0.527 
0.769 
 
0.588 
 0.411 
0.176 
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Appendix 3.3B: GCA Model continued 
 Coefficient Standard 
Error 
P-Value 
Time Interaction Terms (with Sweep 4) continued   
 Maternal Age at Child Birth  -0.027 0.034 0.066 
 Low Household Income  -0.737 0.603 0.222 
 Maternal Education (ref. NVQ 2) 
  NVQ Level 1 
  NVQ Level 3 
  NVQ Level 4  
  NVQ Level 5 
  Overseas Qualification 
  No Qualifications 
 
-1.718 
0.250 
 -0.440 
 -0.516 
 0.381 
 0.175 
 
0.763 
0.531 
0.440 
0.657 
1.409 
0.0.814 
 
0.024 
0.638  
0.318 
0.432 
0.787 
 0.830 
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Appendix 3.4: Results of Growth Curve Model 2. 
Appendix 3.4A: Sweep 5 Mean Incremental Effects and 95% CI for Growth Curve Model 2 
Maternal Depression 
Trajectory 
SQRT SDQ Total 
Difficulties* 
SDQ Total 
Difficulties  
GCA 
 Mean  95% CI Mean 95% CI Mean  95% CI 
PND Symptoms  
+ No Later Symptoms  
 
1.90  (1.50, 2.31) 1.88  (1.48, 2.28) -0.16  (-1.62, 1.31) 
No PND Symptoms  
+ Later Episodic Symptoms  
 
3.51  (2.89, 4.14) 3.71  (3.16, 4.27) -4.94  (-6.93, -2.96) 
PND Symptoms  
+ Later Episodic Symptoms  
 
4.23  (3.41, 5.05) 4.26  (3.56, 4.96) -2.39  (-4.93, 0.14) 
No PND  
+ Later Persistent Symptoms 
 
6.72  (3.94, 9.51) 7.25  (5.08, 9.42) -4.22  (-11.40, 2.97) 
PND  
+ Later Persistent Symptoms  
6.47  (4.77, 8.16) 6.68   (5.37, 7.99) -5.90  (-10.59, -1.21) 
 
Notes:  Incremental effects in children exposed to symptoms by maternal depression trajectory.  
 PND=postnatal depression symptoms identified during sweep one.  
 Later episodic depression= 1 or 2 episodes of maternal depression symptoms during sweeps 2-5.  
 Later persistent depression= 3 or 4 episodes of maternal depression symptoms during sweeps 2-5.  
 All incremental effects vs. trajectory with: no PND symptoms + no later symptoms.  
 *Results back transformed to raw scale.   
 SDQ n= 7,9701; GCA n= 4,270  
 
 
Appendix 3.4B: Sweep 5 SDQ Total Difficulties Mean Incremental Effects and 95% CI  
 
Notes:  Figure plots incremental effect sizes and 95% confidence intervals for children aged 11 (sweep five) 
 whose mothers follow different trajectories for distress symptoms. All incremental effects are vs. no 
 symptoms of distress for any sweep. SDQ Total Difficulties outcomes are reported on the raw scale 
 for the non-transformed outcome (crosses) and on the back transformed scale for the square root 
 outcome (dots).  
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Appendix 3.4C: Sweep 5 GCA Mean Incremental Effects and 95% CI  
 
Notes:  Figure plots incremental effect sizes and 95% confidence intervals on GCA outcomes for children 
 aged 11 (sweep five) whose mothers follow different trajectories for distress symptoms. All 
 incremental effects are vs. no symptoms of distress for any sweep. 
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Appendix 3.5: Mean “Moderate” Threshold Results at Sweep 5  
 SQRT SDQ Total Difficulties  GCA 
 Moderate1  Severe2 Moderate1  Severe2 
Growth Curve Model 1 Results 
Cumulative Distress 0.21*** 0.25*** -0.80*** -1.83*** 
     
 
Growth Curve Model 2 Results  
PND Only  0.26** 0.37*** -1.03 -0.16 
PND & Episodic Symptoms  0.51*** 0.65*** -2.65 -4.94*** 
No PND & Persistent Symptoms 0.59*** 0.76*** -0.74*** -2.39 
PND & Persistent Symptoms  0.85*** 1.14*** -3.40*** -4.22 
No PND & Persistent Symptoms 0.99*** 1.10*** -3.46*** -5.90*** 
 
Notes:  All results are reported for outcomes at sweep five (age eleven) as β coefficients.   
  Compares results of Growth Curve Model 1 & Growth Curve Model 2 using different threshold 
 values for the Kessler 6 Instrument.  
1: Moderate symptoms are defined as scores >=5  
2: Severe symptoms are scores >=13.  
 ***p<0.001, **p<0.01, *p<0.05. 
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Chapter 4 Appendices 
Appendix 4.1: Search Strategies  
Appendix 4.1A:  EMBASE Databases Search Strategy   
N Search Term  
1 ((develop$ or grow$ or matur$ or inance$ or inanc$ or evolu$) adj2 (human$ or child$ or juvenile$ or 
youth$ or youngster$ or adolescen$ or kindergart$ or pre school$ or preschool$ or newborn$ or new 
born$ or neonat$ or toddler$ or teen$ or kid or kids or infant$ or paediatric$ or pediatric$ or 
fetus$ or foetus$ or fetal$ or foetal$)).ti,ab. 
 
2 exp child development/ or exp fetus development/ or exp human development/ or exp postnatal 
development/ or exp adolescent development/ or exp child growth/ 
 
3 (exp “growth, development and aging”/ or exp language development/ or exp “growth, development 
and aging disorders”/ or exp psychomotor development/ or exp physical development/ or exp 
nervous system development/ or exp cognitive development/ or exp speech development/ or exp 
motor development/ or exp mental development/ or exp brain maturation/) and (child$ or 
juvenile$ or youth$ or youngster$ or adolescen$ or kindergart$ or pre school$ or preschool$ or 
newborn$ or new born$ or neonat$ or toddler$ or teen$ or kid or kids or infant$ or paediatric$ or 
pediatric$ or fetus$ or foetus$ or fetal$ or foetal$).ti,ab. 
 
4 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or simulat$ or 
concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ or 
predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or crystalball or cost$ or 
economet$ or economic$ or monte carlo or montecarlo or informat$ or inance$ or disease$ or 
physical or inancey$ or process$ or experiment$ or informat$ or explan$ or explain$) adj5 
model$).ti,ab. 
 
5 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or simulat$ or 
concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ or 
predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or crystalball or cost$ or 
economet$ or economic$ or monte carlo or montecarlo or informat$ or disease$ or informat$ or 
explan$ or explain$ or life cycle or lifecycle) adj5 framework$).ti,ab. 
 
6 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or simulat$ or 
concept$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ or predict$ or 
forecast$ or monte carlo or montecarlo or explain$ or explan$ or lifecycle or life cycle) adj2 (outcome 
or outcomes or input or inputs or output or outputs or variab$ or function$)).ti,ab. 
 
7 exp individual based population model/ or exp information model/ or exp statistical model/ or exp 
physical model/ or exp stochastic model/ or exp experimental model/ or exp computer model/ or 
exp mathematical model/ or exp biological model/ or exp psychological model/ or exp nonbiological 
model/ or exp compartment model/ or exp educational model/ or exp disease model/ or exp process 
model/ or exp theoretical model/ or exp population model/ or exp genetic model/ or exp loglinear 
model/ or exp hidden Markov model/ or exp model/ 
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Appendix 4.1A: Continued   
N Search Term  
8 Socioeconomics 
9 Cost benefit analysis/ 
10 Cost effectiveness analysis/ 
11 Cost of illness/ 
12 Cost control/ 
13 Economic aspect/ 
14 Financial management/ 
15 Health care cost/ 
16 Health care financing/ 
17 Health economics/ 
18 Hospital cost/ 
19 (fiscal or financial or finance or funding).tw. 
20 Cost minimization analysis/ 
21 (cost adj estimate$).mp. 
22 (cost adj variable$).mp. 
23 (unit adj cost$).mp. 
24 exp economic aspect/ or costs.tw 
25 (Economic or economics).tw. 
26 1 or 2 or 3 
27 4 or 5 or 6 or 7 
28 Or/8-25 
29  26 and 27 and 28 
30  Limit 29 to (inance language and human and yr=”2000 –Current”) 
31  30 not (human epidermal growth or human growth hormone or HGH).ti,ab. 
 
Notes:  NHS EED filter (Glanville et al., 2008) was applied to identify economic studies in EMBASE 
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Appendix 4.1B: Medline Database Search Strategy 
N Search Term  
1 ((human$ or child$ or juvenile$ or youth$ or youngster$ or adolescen$ or kindergart$ or pre school$ 
or preschool$ or newborn$ or new born$ or neonat$ or toddler$ or teen$ or kid or kids or infant$ or 
paediatric$ or pediatric$ or fetus$ or foetus$ or fetal$ or foetal$) adj2 (develop$ or grow$ or matur$ 
or inance$ or inanc$ or evolu$)).ti,ab. 
 
2 exp Child Development/or exp Adolescent Development/ or exp Human Development/ or exp 
Embryonic Development/ or exp Fetal Development/ 
 
3 (exp Program Development/ or exp Developmental Disabilities/ or exp Language Development/ or 
exp Language Development Disorders/ or exp “Growth and Development”/ or exp Personality 
Development/) and (child$ or juvenile$ or youth$ or youngster$ or adolescen$ or kindergart$ or pre 
school$ or preschool$ or newborn$ or new born$ or neonat$ or toddler$ or teen$ or kid or kids or 
infant$ or paediatric$ or pediatric$ or fetus$ or foetus$ or fetal$ or foetal$).ti,ab. 
 
4 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or simulat$ or 
concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ 
or predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or crystalball or cost$ or 
economet$ or economic$ or monte carlo or montecarlo or informat$ or inance$ or disease$ or 
physical or inancey$ or process$ or experiment$ or informat$ or explan$ or explain$) adj5 
model$).ti,ab. 
 
5 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or simulat$ or 
concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ 
or predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or crystalball or cost$ or 
economet$ or economic$ or monte carlo or montecarlo or informat$ or disease$ or informat$ or 
explan$ or explain$ or life cycle or lifecycle) adj5 framework$).ti,ab. 
 
6 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or simulat$ or concept$ 
or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ or predict$ or forecast$ 
or monte carlo or montecarlo or explain$ or explan$ or lifecycle or life cycle) adj2 (outcome or 
outcomes or input or inputs or output or outputs or variab$ or function$)).ti,ab. 
 
7 exp Models, Theoretical/ or exp Models, Biological/ or exp Models, Statistical/ or exp Computer 
Simulation/ or exp Linear Models/ or exp Models, Genetic/ or exp Models, Psychological/ or exp 
Markov Chains/ or exp Models, Economic/ or exp Models, Econometric/ 
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Appendix 4.1B continued 
N Search Term  
8 Economics/ 
9 “costs and cost analysis”/ 
10 Cost allocation/ 
11 Cost-benefit analysis/ 
12 Cost control/ 
13 Cost savings/ 
14 Cost of illness/ 
15 Cost sharing/ 
16 “deductibles and coinsurance”/ 
17 Medical savings accounts/ 
18 Health care costs/ 
19 Direct service costs/ 
20 Drug costs/ 
21 Employer health costs/ 
22 Hospital costs/ 
23 Health expenditures/ 
24 Capital expenditures/ 
25 Value of life/ 
26 Exp economics, hospital/ 
27 Exp economics, medical/ 
28 Economics, nursing/ 
29 Economics, pharmaceutical/ 
30 Exp “fees and charges”/ 
31 Exp budgets/ 
32 (low adj cost).mp. 
32 (low adj cost).mp. 
33 (high adj cost).mp. 
34 (health?care adj cost$).mp. 
35 (fiscal or funding or financial or finance).tw. 
36 (cost adj estimate$).mp. 
37 (cost adj variable).mp. 
38 (unit adj cost$).mp. 
39 (economic$ or pharmacoeconomic$ or price$ or pricing).tw. 
40 or/8-39 
41  exp economics/ 
42 cost:.mp. 
43 1 or 2 or 3 
44 Or/4-7  
45 40 or 41 or 42  
46 43 and 44 and 45   
47 Limit 46 to (inance language and human and yr=”2000 –Current”) 
48  47 not (human epidermal growth or human growth hormone or HGH).ti,ab. 
Notes:  The SIGN filter for economic studies (in Medline) was used as part of the search strategy (Glanville 
 et al., 2008). 
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Appendix 4.1C: PSYCINFO Database Search Strategy 
N Search Term  
1 ((human$ or child$ or juvenile$ or youth$ or youngster$ or adolescen$ or kindergart$ or pre 
school$ or preschool$ or newborn$ or new born$ or neonat$ or toddler$ or teen$ or kid or kids 
or infant$ or paediatric$ or pediatric$ or fetus$ or foetus$ or fetal$ or foetal$) adj2 (develop$ or 
grow$ or matur$ or inance$ or inanc$ or evolu$)).ti,ab. 
 
2 exp Neonatal Development/ or exp Human Development / or exp Adolescent Development/ or 
exp Early Childhood Development/ or exp Childhood Development/ or exp Prenatal 
Development/ or exp Infant Development/  
 
3  (exp Physical Development/ or exp Intellectual Development Disorder/ or exp Perceptual Motor 
Development/ or exp Emotional Development/ or exp Language Development/ or exp 
Perceptual Development/ or exp Speech Development/ or exp Neural Development/ or exp 
Motor Development/ or exp Psychosexual Development/ or exp Psychosocial Development/ or 
exp Development/ or exp Reading Development/ or exp Ego Development/ or exp Intellectual 
Development/ or exp Cognitive Development/ or exp Psychomotor Development/ or exp Brain 
Development/ or exp Moral Development/ or exp Psychological Development/ or exp 
Personality Development/) and (child$ or juvenile$ or youth$ or youngster$ or adolescen$ or 
kindergart$ or pre school$ or preschool$ or newborn$ or new born$ or neonat$ or toddler$ or 
teen$ or kid or kids or infant$ or paediatric$ or pediatric$ or fetus$ or foetus$ or fetal$ or 
foetal$).ti,ab. 
 
4 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or 
simulat$ or concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or 
markov$ or inance$ or predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or 
crystalball or cost$ or economet$ or economic$ or monte carlo or montecarlo or informat$ or 
inance$ or disease$ or physical or inancey$ or process$ or experiment$ or informat$ or explan$ or 
explain$) adj5 model$).ti,ab. 
 
5 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or 
simulat$ or concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or 
markov$ or inance$ or predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or 
crystalball or cost$ or economet$ or economic$ or monte carlo or montecarlo or informat$ or 
disease$ or informat$ or explan$ or explain$ or life cycle or lifecycle) adj5 framework$).ti,ab. 
 
6 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear or 
loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or simulat$ or 
concept$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ or 
predict$ or forecast$ or monte carlo or montecarlo or explain$ or explan$ or lifecycle or life cycle) 
adj2 (outcome or outcomes or input or inputs or output or outputs or variab$ or function$)).ti,ab. 
 
7 exp Clinical Models/ or exp Models/ or exp Decision Making/ or exp Mathematical Modeling/ 
or exp Computer Software/ or exp Simulation/ or exp Statistical Analysis/ or exp Prediction/ or 
exp Theories/ or exp Theoretical Interpretation/ or exp Statistical Estimation/ or exp 
Multivariate Analysis/ or exp Psychological Theories/ 
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Appendix 4.1C: continued 
N Search Term  
8 “costs and cost analysis”/ 
9 “Cost Containment”/ 
10 (economic adj2 evaluation$).ti,ab. 
11 (economic adj2 analy$).ti,ab. 
12 (economic adj2 (study or studies)).ti,ab. 
13 (cost adj2 evaluation$).ti,ab. 
14 (cost adj2 analy$).ti,ab. 
15 (cost adj2 (study or studies)).ti,ab. 
16 (cost adj2 effective$).ti,ab. 
17 (cost adj2 benefit$).ti,ab. 
18 (cost adj2 utili$).ti,ab. 
19 (cost adj2 minimi$).ti,ab. 
20 (cost adj2 consequence$).ti,ab. 
21 (cost adj2 comparison$).ti,ab. 
22 (cost adj2 identificat$).ti,ab. 
23 (pharmacoeconomic$ or pharmaco-economic$).ti,ab. 
24 exp “Costs and Cost Analysis”/ or exp “Cost Containment”/ or exp “Response Cost”/ or exp 
Finance/ or exp Salaries/ or exp Human Capital/ or exp Health Education/ or exp Resource 
Allocation/ or exp “Income (Economic)”/ or exp Health Care Services/ or exp Health Care 
Costs/ or exp Economy/ or exp Health Care Utilization/ or exp Economics/ or exp Financial 
Strain/ or exp Health Care Delivery/ or exp Financial Services/ or exp Government/ or exp 
Academic Achievement/ or exp Government Policy Making/ or exp Budgets/ or exp Behavioral 
Economics/ or exp Health Care Economics/ or exp Evolutionary Economics/ 
 
25 (Economic$ or Cost$ or Econometric or (fiscal or financial or finance or funding) or 
Socioeconomic$).ti,ab. 
26 or/8-25 
27 (task adj2 cost$).ti,ab,id. 
28 (switch$ adj2 cost$).ti,ab,id. 
29 (metabolic adj cost).ti,ab,id. 
30 ((energy or oxygen) adj cost).ti,ab,id. 
31 ((energy or oxygen) adj expenditure).ti,ab,id. 
32 Or/27-31 
33 (animal or animals or rat or rats or mouse or mice or hamster or hamsters or dog or dogs or cat or 
cats or bovine or sheep or ovine or pig or pigs).ab,ti,id,de. 
34 editorial.dt. 
35 letter.dt. 
36 dissertation abstract.pt. 
37 or/33-36 
38 (0003-4819 or 0003-9926 or 0959-8146 or 0098-7484 or 0140-6736 or 0028-4793 or 1469-
493X).is. 
39 26 not (32 or 37 or 38)  
40 1 or 2 or 3  
41 4 or 5 or 6 or 7 
42 
43 
39 and 40 and 41  
limit 42 to (human and inance language and yr=”2000 –Current”) 
Notes:  The NHS CRD NHS EED search filter was used as the economics search filter. As this search filter is designed 
 only to obtain economic evaluations additional search terms were used as part of the “economics” search term. 
 Key search terms were also identified from SIGN filters (Glanville et al., 2008) and from McKinlay et al. (2006) 
 (both designed for EMBASE/MEDLINE and translated to the PSYCINFO database).  
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Appendix 4.1D: ECONLIT Database Search Strategy  
N Search Term  
1 ((human$ or child$ or juvenile$ or youth$ or youngster$ or adolescen$ or kindergart$ or pre 
school$ or preschool$ or newborn$ or new born$ or neonat$ or toddler$ or teen$ or kid or 
kids or infant$ or paediatric$ or pediatric$ or fetus$ or foetus$ or fetal$ or foetal$) adj2 
(develop$ or grow$ or matur$ or inance$ or inanc$ or evolu$)).ti,ab. 
 
2 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or 
simulat$ or concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or 
markov$ or inance$ or predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or 
crystalball or cost$ or economet$ or economic$ or monte carlo or montecarlo or informat$ or 
inance$ or disease$ or physical or inancey$ or process$ or experiment$ or informat$ or 
explan$ or explain$) adj5 model$).ti,ab.. 
 
3 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or theor$ or 
simulat$ or concept$ or decision$ or statistic$ or comput$ or analytic$ or data or inanc$ or 
markov$ or inance$ or predict$ or forecast$ or prognostic$ or prognosis$ or crystal ball or 
crystalball or cost$ or economet$ or economic$ or monte carlo or montecarlo or informat$ or 
disease$ or informat$ or explan$ or explain$ or life cycle or lifecycle) adj5 framework$).ti,ab. 
 
4 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili$ or stochastic or empiric$ or simulat$ or 
concept$ or statistic$ or comput$ or analytic$ or data or inanc$ or markov$ or inance$ or 
predict$ or forecast$ or monte carlo or montecarlo or explain$ or explan$ or lifecycle or life 
cycle) adj2 (outcome or outcomes or input or inputs or output or outputs or variab$ or 
function$)).ti,ab. 
 
5 2 or 3 or 4 
6 1 and 5  
7 limit 6 to (yr=”2000 –Current” and inance) 
8 limit 7 to dissertations 
9 7 not 8  
Notes:  As ECONLIT is a database for economic articles the economics filter was removed from the search strategy. 
 MeSH headings and exploded terms were not used as these were not supported in this database. 
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Appendix 4.1E: Maternity and Infant Care Database Search Strategy  
N Search Term  
1 (develop$ or grow$ or matur$ or inance$ or inanc$ or evolu$).ti,ab.  
 
2 (Development or Growth or Outcome – long term or Child development or 
Neurodevelopmental outcome or “Infant – growth and development”or Human 
Development or Fetal development or Infant development or Infant growth or Child 
growth or “Adolescent – growth and development” or Fetal growth).de.  
 
3 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or 
non linear or loglinear or log linear or deterministic or probabili$ or stochastic or 
empiric$ or theor$ or simulat$ or concept$ or decision$ or statistic$ or comput$ or 
analytic$ or data or inanc$ or markov$ or inance$ or predict$ or forecast$ or 
prognostic$ or prognosis$ or crystal ball or crystalball or cost$ or economet$ or 
economic$ or monte carlo or montecarlo or informat$ or inance$ or disease$ or 
physical or inancey$ or process$ or experiment$ or informat$ or explan$ or explain$) 
adj5 model$).ti,ab. 
 
4 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or 
non linear or loglinear or log linear or deterministic or probabili$ or stochastic or 
empiric$ or theor$ or simulat$ or concept$ or decision$ or statistic$ or comput$ or 
analytic$ or data or inanc$ or markov$ or inance$ or predict$ or forecast$ or 
prognostic$ or prognosis$ or crystal ball or crystalball or cost$ or economet$ or 
economic$ or monte carlo or montecarlo or informat$ or disease$ or informat$ or 
explan$ or explain$ or life cycle or lifecycle) adj5 framework$).ti,ab. 
 
5 ((mathematic$ or maths or math or numeric$ or number$ or linear or nonlinear or 
non linear or loglinear or log linear or deterministic or probabili$ or stochastic or 
empiric$ or simulat$ or concept$ or statistic$ or comput$ or analytic$ or data or 
inanc$ or markov$ or inance$ or predict$ or forecast$ or monte carlo or montecarlo 
or explain$ or explan$ or lifecycle or life cycle) adj2 (outcome or outcomes or input or 
inputs or output or outputs or variab$ or function$)).ti,ab. 
 
6 (Models or Long term outcome or Models – statistical).de. 
 
7 (Cost-benefit analysis or Economics or “Costs and cost analysis” or Insurance or 
Insurance – liability or Finance or Health care costs – statistics or “Cost savings” or 
Socioeconomic factors).de. 
 
8 (Economic$ or economet$ or economy or cost$ or deductible$ or coinsurance or 
insur$ or savings or expenditure$ or socioeconomic$ or inance$ or fiscal or funding or 
pricing or price$ or salary or salaries or capital or allocation or income or incomes or 
budget$ or money or monetary or profit$).ti,ab. 
 
9 1 or 2 
9 3 or 4 or 5 or 6  
10  7 or 8 
11 9 and 10 and 11 
12  limit 12 to yr=”2000 –Current” 
Notes:  As the maternity and infant care database is specifically for publications relating to children and mothers the 
 “child” component of the “child” “development” term was omitted.  
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Appendix 4.1F: Child Development & Adolescent Studies Database (Ebsco Host) Search 
Strategy  
N Search Term  
1 TI (develop* or grow* or matur* or inance* or inanc* or evolu*) or AB (develop* or grow* or 
matur* or inance* or inanc* or evolu*)  
 
2 TI (mathematic* or maths or math or numeric* or number* or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili* or stochastic or empiric* or theor* or 
simulat* or concept* or decision* or statistic* or comput* or analytic* or data or inanc* or 
markov* or inance* or predict* or forecast* or prognostic* or prognosis* or crystal ball or 
crystalball or cost* or economet* or economic* or monte carlo or montecarlo or informat* or 
inance* or disease* or physical or inancey* or process* or experiment* or informat* or explan* 
or explain* or lifecycle or life cycle) N5 TI (Model*) 
 
3 AB (mathematic* or maths or math or numeric* or number* or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili* or stochastic or empiric* or theor* or 
simulat* or concept* or decision* or statistic* or comput* or analytic* or data or inanc* or 
markov* or inance* or predict* or forecast* or prognostic* or prognosis* or crystal ball or 
crystalball or cost* or economet* or economic* or monte carlo or montecarlo or informat* or 
inance* or disease* or physical or inancey* or process* or experiment* or informat* or explan* 
or explain* or lifecycle or life cycle) N5 AB (Model*) 
 
4 TI (mathematic* or maths or math or numeric* or number* or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili* or stochastic or empiric* or theor* or 
simulat* or concept* or decision* or statistic* or comput* or analytic* or data or inanc* or 
markov* or inance* or predict* or forecast* or prognostic* or prognosis* or crystal ball or 
crystalball or cost* or economet* or economic* or monte carlo or montecarlo or informat* or 
disease* or  informat* or explan* or explain* or life cycle or lifecycle) N5 TI (framework*)   
 
5 AB (mathematic* or maths or math or numeric* or number* or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili* or stochastic or empiric* or theor* or 
simulat* or concept* or decision* or statistic* or comput* or analytic* or data or inanc* or 
markov* or inance* or predict* or forecast* or prognostic* or prognosis* or crystal ball or 
crystalball or cost* or economet* or economic* or monte carlo or montecarlo or informat* or 
disease* or  informat* or explan* or explain* or life cycle or lifecycle) N5 AB (framework*)  
 
6 TI (mathematic* or maths or math or numeric* or number* or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili* or stochastic or empiric* or simulat* or 
concept* or statistic* or comput* or analytic* or data or inanc* or markov* or inance* or 
predict* or forecast* or monte carlo or montecarlo or explain* or explan* or lifecycle or life 
cycle) N2 TI (outcome or outcomes or input or inputs or output or outputs or variab* or 
function*)  
 
7 AB (mathematic* or maths or math or numeric* or number* or linear or nonlinear or non linear 
or loglinear or log linear or deterministic or probabili* or stochastic or empiric* or simulat* or 
concept* or statistic* or comput* or analytic* or data or inanc* or markov* or inance* or 
predict* or forecast* or monte carlo or montecarlo or explain* or explan* or lifecycle or life 
cycle) N2 AB (outcome or outcomes or input or inputs or output or outputs or variab* or 
function*)  
 
8 TI (Economic* or economet* or economy or cost* or deductible* or coinsurance or insur* or 
savings or expenditure* or socioeconomic* or inance* or fiscal or funding or pricing or price* or 
salary or salaries or capital or allocation or income or incomes or budget* or money or monetary 
or profit*) 
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Appendix 4.1F: continued  
N Search Term  
9 AB (Economic* or economet* or economy or cost* or deductible* or coinsurance or insur* or 
savings or expenditure* or socioeconomic* or inance* or fiscal or funding or pricing or price* or 
salary or salaries or capital or allocation or income or incomes or budget* or money or monetary 
or profit*) 
10 2 or 3 or 4 or 5 or 6 or 7 
11 8 or 9 
12 1 and 10 and 11  
Notes:  As a child related database the “child” component was omitted from the “child” “development” term. Despite 
 the database being specifically for child development, the “development” term was required as results were not 
 specific enough with this term omitted. It was not possible to include additional limitations (e.g. English 
 language only) as these were not supported in the database.  
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Appendix 4.2: Screening Forms  
Appendix 4.2A: Screening Form 1: Title & Abstracts  
Has the search strategy identified the correct development term (e.g. economic development, development of the model)?  
Yes (include) 
No (exclude) 
Can’t tell (include)  
 
Does the study report an empirical model?  
Yes (include)  
No (exclude)  
Can’t tell (include)  
 
Is the study sample for a diseased population?  
Yes (exclude)  
No (include)   
Can’t tell (exclude)  
 
Are any model outcomes reported at age 16 or above?  
Yes (include)  
No (exclude)  
Can’t tell (include)  
 
Are there any model inputs at age 12 or below?   
Yes (include)  
No (exclude)  
Can’t tell (include)  
 
Is the outcome relevant to health economic evaluation?  
Yes (include)  
No (exclude)  
Can’t Tell (include)  
 
Is the model outcome specific to a single disease/health condition? 
Yes (exclude)  
No (include) 
Can’t tell (include) 
 
Is the study an animal study?  
Yes (exclude)  
No (include)  
Can’t tell (include)  
 
Is the study written in a language other than English?  
Yes (include)  
No (exclude)  
Can’t tell (include)  
 
Is the study published after the 1st January 2000?   
Yes (include)  
No (exclude) 
Can’t tell (include)  
 
Notes:  Studies were excluded if any of the below criteria resulted in an “exclude” answer.  
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Appendix 4.2B: Screening Form 2: Full Texts 
 
(For objective 1 only): 
Does the model include QALYs and Healthcare Costs as outcome variables?  
Yes (include) 
No (exclude)  
 
(For objectives 1 & 2):  
Is there any discussion of the child development literature?  
Yes (include) 
No (exclude)  
 
Does the study report an empirical model?  
Yes (include) 
No (exclude)  
 
Are any model outcomes reported at age 16 or above?  
Yes (include) 
No (exclude) 
 
Are there any model inputs at age 12 or below?  
Yes (include)  
No (exclude)  
 
Is the outcome relevant to health economic evaluation?  
Yes (include)  
No (exclude)  
 
Is the study sample a diseased population only?  
Yes (exclude)  
No (include)  
 
Is the model outcome specific to a single disease/health condition? 
Yes (exclude)  
No (include)  
 
Notes:  Studies were excluded if any of the below criteria resulted in an “exclude” answer.  
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Appendix 4.3: Data Charting Form  
Primary 
Author 
Year Location Discipline Individual 
Development Domains 
Environmental Parameters Model Type Outcome Sectors Time Horizon 
(years) 
Adair, L. 2013 Multiple  
 
Health Sciences  Physical Family economic GLM regression  Education & health  31 
Boyle, M.  2007 Canada Human 
Development  
Cognitive, socioemotional 
& physical 
Family economic, family 
psychosocial & neighbourhood  
 
Hierarchical linear 
model 
Education  30 
Chandola, T.  2006 UK  Epidemiology  Cognitive & physical Family economic Structural equation 
model 
 
Health  42 
 
Chartier, M.  2010 Canada  Health Sciences  None Family economic & family 
psychosocial 
 
GLM regression  Education & health  Not stated 
Creel, M.  2006 USA Economics Cognitive Family economic Quadratic parametric 
model 
 
Education  11 
Cunha, F.  2008 USA Economics Cognitive & 
socioemotional 
Family economic & family 
psychosocial  
Dynamic factor 
model  
Education & 
employment  
 
22 
Cunha, F.  2010 USA Economics Cognitive & 
socioemotional 
Family economic & family 
psychosocial 
 
Dynamic factor 
model  
Crime & education Not stated 
Daniels, M.  2004 Philippines Other Cognitive & physical Family economic & family 
psychosocial  
 
GLM regression  Education 17 
Dishion, T.  2010 USA  Psychology  Cognitive & 
socioemotional 
 
None Structural equation 
model 
Crime  8 
Dubow, E.  2009 USA Psychology  Cognitive & 
socioemotional 
Family economic & family 
psychosocial 
 
Structural equation 
model 
Education & 
employment  
11 
Engle, P.  2011 Multiple  Human 
Development  
Socioemotional School/peer & neighbourhood GLM regression  Employment  Not stated 
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Appendix 4.3 continued 
Primary 
Author 
Year Location Discipline Individual 
Development Domains 
Environmental Parameters Model Type Outcome Sectors Time Horizon 
(years) 
Fergusson, D. 2004 New 
Zealand  
Psychology  Socioemotional Family economic, family 
psychosocial & school/peer 
 
GLM regression  Crime  11 
Ferrer, E. 2004 USA Psychology  Cognitive None  Growth curve model 
 
Education  30 
Friedman, H. 2014 USA Psychology  Socioemotional None Structural equation 
model 
 
Education & health  44 
Frijters, P.  2010 UK  Economics Physical Family economic & neighbourhood Cox proportional 
hazard model  
 
Health Not stated 
Hagger-
Johnson, G.  
2012 UK  Psychology  Cognitive Family economic Structural equation 
model 
 
Health  60 
Hagger-
Johnson, G.  
2011 UK  Epidemiology  Cognitive Family economic, family 
psychosocial 
Structural equation 
model 
 
Employment & health  42 
Hampson, S. 2015 USA Psychology Socioemotional None  Structural equation 
Model 
 
Health 41 
Hatch, S. 2010 UK  Psychology  Cognitive, socioemotional 
& physical 
Family economic & family 
psychosocial  
 
GLM regression  Education & health  33 
Healey, A. 2004 UK  Economics Cognitive & 
socioemotional 
Family economic & family 
psychosocial  
 
Dynamic factor 
analysis  
Crime, education & 
employment  
24 
Herrenkohl, T.  2010 USA Sociology  Socioemotional Family economic & family 
psychosocial  
 
Structural equation 
model 
Crime & health  20 
Hertzman, C.  2001 UK  Epidemiology  Cognitive, socioemotional 
& physical 
Family economic & family 
psychosocial 
 
GLM regression  Health 31 
Huang, C. 2011 Mexico  Public Health  Physical Family economic & neighbourhood GLM regression  Education, employment 
& health 
 
40 
Jimerson, S.  2001 USA Psychology  Cognitive & 
socioemotional 
Family economic, family 
psychosocial & school/peer 
Hierarchical linear 
model 
Education 14 
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Appendix 4.3 continued 
Primary 
Author 
Year Location Discipline Individual 
Development Domains 
Environmental Parameters Model Type Outcome Sectors Time Horizon 
(years) 
Johnson, W. 2006 USA Human 
Development  
Cognitive, socioemotional 
& physical 
None Hierarchical linear 
model 
 
Education 6 
Kuh, D. 2004 UK  Epidemiology  Cognitive Family economic & family 
psychosocial 
Cox proportional 
hazard model  
 
Health 45 
Kuh, D. 2009 UK  Epidemiology  Cognitive, socioemotional, 
physical 
Family economic & family 
psychosocial 
Cox proportional 
hazard model  
 
Health 54 
Lacourse E. 2002 Canada  Human 
Development   
Socioemotional Family economic GLM regression  Crime 12 
Lacourse, E. 2006 Canada Health Sciences None None Hierarchical linear 
model 
 
Crime Not stated 
Lager, A. 2012 Sweden  Health Sciences  Cognitive Family economic Structural equation 
model 
 
Health 68 
Layard, R.  2014 UK  Economics Cognitive, socioemotional, 
physical 
Family economic & family 
psychosocial 
 
GLM regression  Education, 
employment & health  
29 
Lee, T.  2013 USA Human 
Development  
None Family economic & family 
psychosocial 
Structural equation 
model 
 
Health  Not stated 
Lindeboom, 
M. 
2006 UK  Economics Cognitive, socioemotional 
& physical 
 
Family economic GLM regression  Employment & health  42 
Martens, P.  2014 Canada Public Health  None Family economic, family 
psychosocial & neighbourhood 
 
GLM regression  Education Not stated 
Mason, P. 2010 USA Psychology  Socioemotional Family economic 
 
Growth curve model Crime 14 
Mason, W. 2007 USA Economics None Family economic 
 
GLM regression  Employment Not stated 
Moffit, T. 2011 New 
Zealand  
Psychology  Cognitive & 
socioemotional 
 
Family economic GLM regression  Crime, employment & 
health 
29 
Moody-Ayers, 
S.  
 
2007 USA Epidemiology  None Family economic GLM regression  Health Not stated 
Muennig, P. 2009 USA Economics Cognitive Family economic & family 
psychosocial 
Unsure Crime, employment & 
health 
Not stated 
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Appendix 4.3 continued  
Primary 
Author 
Year Location Discipline Individual development 
domains 
Environmental Parameters Model type Outcome Sectors Time Horizon 
(years) 
Nandi, A. 2014 USA  Epidemiology  Physical Family economic Structural equation 
model 
 
Health Not stated 
Nikulina, V. 2011 USA Psychology  None Family economic, family 
psychosocial & neighbourhood 
Hierarchical linear 
model 
 
Crime, education & 
health 
Not stated 
Petras, H.  2005 USA Public Health  Cognitive & 
socioemotional 
Family economic, school/peer & 
neighbourhood 
General growth 
mixture model 
 
Crime & health 15 
Reynolds, A.  2011 USA Human 
Development  
Cognitive & 
socioemotional 
Family economic & family 
psychosocial 
Structural equation 
model 
 
Crime, employment & 
health 
21 
Risi, S.  2003 USA Psychology  Cognitive & 
socioemotional 
 
School/peer GLM regression  Education 13 
Roeser, R.  2003 USA Psychology  Cognitive, socioemotional 
& physical 
 
Family economic Structural equation 
model 
Education 8 
Rosa Dias, P. 2009 UK  
 
Economics Physical Family economic Unsure Health 46 
Savage, J. 2002 Multiple  Psychology  None Family psychosocial & 
neighbourhood 
 
GLM regression  Crime Not stated 
Schoon, I. 2003 UK  Psychology  Socioemotional & physical Family economic & family 
psychosocial 
 
Structural equation 
model 
Health 28 
Sharieff, W. 2008 Pakistan  Economics Cognitive & physical None 
 
Unsure Employment 55 
Shen, K 2014 China Epidemiology  Physical Family economic & neighbourhood Structural equation 
model 
Education, employment 
& health 
65 
Slopen, N. 2014 USA Psychology  Cognitive, socioemotional 
& physical 
Family economic, family 
psychosocial & neighbourhood 
GLM regression  Health Not stated 
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Appendix 4.3 continued 
Primary 
Author 
Year Location Discipline Individual 
Development Domains 
Environmental Parameters Model Type Outcome Sectors Time Horizon 
(years) 
         
Te Velde, S. 2008 Netherlands Economics Socioemotional None 
 
Unsure Health Not stated 
Tran, B. 2015 Canada Public Health  Physical None Growth curve 
model 
Health 60 
Tubeuf, S. 2013 UK  Health 
Sciences  
Physical Family economic & family 
psychosocial 
 
GLM regression  Education & health 46 
Vartanian, T.  2005 USA Sociology  None Family economic & neighbourhood 
 
GLM regression  Employment Not stated 
Wodtke, G. 2016 USA Sociology  None Family economic, family  
psychosocial & neighbourhood 
 
Two stage 
regression  
Education Not stated 
World Bank  2003 Multiple  Economics Socioemotional Family economic, family 
psychosocial & school/peer 
GLM regression  Crime, education, 
employment & health 
Not stated 
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Chapter 5 Appendices 
Appendix 5.1: Items on the Rutter ‘A’ Behaviour Scale 
Questionnaire Item:  Responses (and scoring) 
Very restless. Often running about or jumping up and 
down. Hardly ever still. 
 
No (=0), somewhat (=1), certainly applies (=2) 
Is squirmy or fidgety No (=0), somewhat (=1), certainly applies (=2) 
  
Often destroys own or others’ belongings 
 
No (=0), somewhat (=1), certainly applies (=2) 
Frequently fights other children 
 
No (=0), somewhat (=1), certainly applies (=2) 
Not much liked by other children 
 
No (=0), somewhat (=1), certainly applies (=2) 
Often worried, worries about many things 
 
No (=0), somewhat (=1), certainly applies (=2) 
Tends to do things on his/her own – rather solitary 
 
No (=0), somewhat (=1), certainly applies (=2) 
Irritable. Is quick to fly off the handle 
 
No (=0), somewhat (=1), certainly applies (=2) 
Often appears miserable, unhappy, tearful or distressed 
 
No (=0), somewhat (=1), certainly applies (=2) 
Sometimes takes things belonging to others 
 
No (=0), somewhat (=1), certainly applies (=2) 
Has twitches, mannerisms or tics of the face or body 
 
No (=0), somewhat (=1), certainly applies (=2) 
Frequently sucks thumb or finger 
 
No (=0), somewhat (=1), certainly applies (=2) 
Frequently bites nails or fingers 
 
No (=0), somewhat (=1), certainly applies (=2) 
Is often disobedient 
 
No (=0), somewhat (=1), certainly applies (=2) 
Cannot settle to anything for more than a few 
moments 
 
No (=0), somewhat (=1), certainly applies (=2) 
Tends to be fearful or afraid of new things or new 
situations 
 
No (=0), somewhat (=1), certainly applies (=2) 
Is over fussy or over particular 
 
No (=0), somewhat (=1), certainly applies (=2) 
Often tells lies 
 
No (=0), somewhat (=1), certainly applies (=2) 
Bullies other children No (=0), somewhat (=1), certainly applies (=2) 
Notes:  The 19-Item Rutter ‘A’ Behaviour Scale. The questionnaire was administered to participants’ mothers for the 
 age 10 sweep. Each mother was presented with a statement (questionnaire item) and asked how often this 
 statement applied to their child (response). Total scores were obtained by summing all response items. 
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Appendix 5.2: Description of Statistical Tools used to Inform Model Selection   
The modified Park’s test assess the relationship between the variance and mean of a selected GLM 
distribution (Jones, 2010). As described by Jones (2010), the relationship between variance and 
mean in GLM regression “implies:  
 ln[ var( yi | xi ) ] = ln (α) + υ ln (μi)  
The [Park] test exploits this by regressing ln[(yi - ŷi )2] on ln (ŷi) and a constant, typically using a 
GLM to estimate the model, having tested for the appropriate form of the link function to use”. 
The modified Park test provides guidance on the appropriate distribution according to the slope 
coefficient for ln (ŷi) from the regression equation (Jones, 2010). Slopes equal to: 0 suggest a 
Gaussain, 1 a Poisson, 2 a gamma, and 3 an inverse Guassian distribution.  
Pregibon’s link test is often used to identify a range of possible link functions given the associated 
GLM distribution. The Pregibon test assesses the suitability of a link by (i) conducting a GLM with 
the hypothesized link function; (ii) generating the predicted value, ŷ, and the predicted value 
squared, ŷ2, of the outcome variables from the GLM; and (iii) estimating a second GLM regression 
that is identical to the first but including ŷ and ŷ2 as explanatory variables. The Pregibon test 
identifies a link function as incorrectly specified if the ŷ2 coefficient is statistically significant 
(p<0.05) (Jones, 2010), (Pregibon, 1980).  
The Akaike Information Criterion (AIC) is a statistic that estimates the amount of information that is 
lost from a given model based on the number of model parameters and the models maximum 
likelihood function. The AIC establishes model desirability according to goodness of fit and level of 
overfitting, where a lower AIC value is indicative of a more desirable model. As suggested by Jones 
and O’Donnell (2002), AIC values can be used to select the most appropriate model when 
comparing a range of different candidate models that are no necessarily nested. These including 
GLM, transformed OLS and two part regression models.  
The Vuong test compares the fit of two non-nested models estimated in same dataset using a 
maximum likelihood function by testing null hypotheses that the models fit the data equally well 
(Desmarais and Harden, 2013). The Vuong test is commonly applied in to test whether a single part 
Poission or two part zero inflation model better fits count data. Desmarais and Harden (2013) 
suggest the default Vuong test in STATA can produce biased results as it does not correct for the 
increased number of parameters in two part models. The authors provide a bias corrected STATA 
command which was used in this research.  
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Appendix 5.3: Marginal Effects and 95% CI for Transformed Rutter Behavioural Scale  
 Within Study 
(3.5%)  
Lifetime  
(3.5%)  
Lifetime 
(1.5%) 
Lifetime  
(0 %) 
QALYs 
 GCA 0.001 
(0.001, 0.002) 
0.003 
(0.001, 0.004) 
0.007 
(0.004, 0.010) 
0.019 
(0.010, 0.027) 
 RBS -0.002 
(-0.004, -0.000) 
-0.004 
(-0.008, -0.001) 
-0.011 
(-0.020, -0.002) 
-0.031 
(-0.057, -0.005) 
Healthcare Costs 
 GCA -£8.06 
(-£14.50, -£1.63) 
-£15.81  
(-£28.96, -£2.66) 
-£40.63 
(-£75.40, -£5.85) 
-£133.58 
(-£249.67, -£17.49) 
 RBS £28.78 
(£7.13, £50.43) 
£58.76 
(£14.61, £102.91) 
£154.71 
(£32.57, £276.85) 
£515.33 
(£127.30, £903.37) 
Returns to Education* 
 GCA £2,514.17 
(£1,611.30, £3,419.10) 
£4,524.81 
(£3,153.16, £5,899.61) 
£10,895.39 
(£7,839.96, £13,958.04) 
£21,781.50 
(£15,913.75, £24,690.36) 
 RBS  -£638.38 
(-£3,283.21, £2,024.72 
-£625.13 
(-£4,641.40, £3,418.54) 
-£873.82 
(-£9,817.45, £8,131.26) 
-£1,068.46 
(-£18,240.27, £16,222.67) 
Crime Costs 
 GCA -£0.92 
(-£1.55, -£0.30) 
-£1.00 
(-£1.68, -£0.32) 
-£1.29 
(-£2.16, -£0.42) 
-£2.02 
(-£3.38, -£0.65) 
 RBS £2.98 
(£0.99, £4.98 
£3.24 
(£1.07, £5.41) 
£4.16 
(£1.38, £6.95) 
£6.52 
(£2.16, £10.89) 
Notes:  Marginal effects of General Cognitive Ability and the Rutter Behavioural Scale with measurement scale 
 transformed to range from 0-40.  
 Each marginal effect is per unit increase in GCA and (transformed) RBS.  
 Outcomes obtained according to time horizon (study/lifetime) and discount rate.  
 *Results were back transformed to the raw scale using Duan’s smearing estimator. 
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Appendix 5.4: Predicted Mean Lifetime Effects by Childhood Exposure to Maternal 
Depression Trajectory 
Maternal Depression 
Trajectory  
Childhood Adulthood 
 GCA SDQ/ 
Rutter 
QALYs 
 
Healthcare  
Costs 
Returns to 
Education 
Crime 
Costs 
PND Symptoms  
+ No Later Symptoms  
 
-0.16  
 
1.90 
 
-0.008 £114.17 -£1,911.72 £6.32 
No PND Symptoms  
+ Later Episodic Symptoms  
 
-4.94 
 
3.51 
 
-0.029 £284.35 -£24,546.77 £16.31 
PND Symptoms  
+ Later Episodic Symptoms  
 
-2.39  
 
4.23 
 
-0.024 £286.34 -£13,458.60 £16.10 
No PND Symptoms  
+ Later Persistent Symptoms  
 
-4.22  
 
6.72 
 
-0.040 £461.59 -£23,295.57 £25.99 
PND Symptoms  
+ Later Persistent Symptoms  
-5.90 
 
6.47 
 
-0.044 £473.46 -£30,740.97 £26.86 
Notes:  Predicted mean lifetime outcomes (discounted at 3.5%) for children grouped according to maternal 
 depression trajectory.  
 All are incremental costs/benefits compared with a “no depression symptoms” control group.  
 GCA and SDQ scores were taken from chapter three, Growth Curve Model 2. 
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Chapter 6 Appendices 
Appendix 6.1: Deterministic Cost-effectiveness Results: Health Centric Decision 
Perspective & Maternal Outcomes  
Strategy QALYs Healthcare 
Costs 
ICERs vs. Lower 
Costing Strategy 
EPDS (cutoff 7)  0.84486 £188.17 Dominated 
EPDS (cutoff 8)  0.84604 £175.76 Dominated 
EPDS (cutoff 9)  0.84709 £160.40 Dominated 
EPDS (cutoff 10)  0.84764 £151.95 Dominated 
PHQ9 (cutoff 9/10) 0.84774 £145.90 Dominated 
EPDS (cutoff 11)  0.84815 £139.47 Dominated 
EPDS (cutoff 12)  0.84835 £134.26 Dominated 
EPDS (cutoff 13)  0.84825 £133.94 Dominated 
EPDS (cutoff 14)  0.84838 £122.85 Dominated 
Whooley + EPDS (cutoff 7)  0.84811 £117.49 Dominated 
Whooley + EPDS (cutoff 8)  0.84852 £113.15 Dominated 
EPDS (cutoff 15)  0.84833 £112.71 Dominated 
EPDS (cutoff 16)  0.84831 £107.05 Dominated 
Whooley + EPDS (cutoff 9)  0.84880 £106.08 Dominated 
Whooley + EPDS (cutoff 10)  0.84893 £102.10 Dominated 
Whooely + PHQ9 (cutoff 9/10) 0.84886 £98.06 Dominated 
Whooley + EPDS (cutoff 11)  0.84896 £95.01 Dominated 
Whooley + EPDS (cutoff 12)  0.84897 £92.00 £37,621 
Whooley + EPDS (cutoff 13)  0.84890 £91.35 Extendedly Dominated 
Whooley + EPDS (cutoff 14)  0.84875 £83.78 £32,137 
Standard Care 0.84606 £82.07 Dominated 
Whooley + EPDS (cutoff 15)  0.84851 £76.16 Extendedly Dominated 
Whooley + EPDS (cutoff 16)  0.84838 £71.94   
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Appendix 6.2: Deterministic Cost-effectiveness Results: Health Centric Decision 
Perspective & Maternal and Child Outcomes 
Strategy QALYs Healthcare 
Costs 
ICERs vs. Lower 
Costing Strategy 
EPDS (cutoff 7)  0.8442 £193.18 Dominated 
EPDS (cutoff 8)  0.8454 £180.76 Dominated 
EPDS (cutoff 9)  0.8465 £165.54 Dominated 
EPDS (cutoff 10)  0.8470 £157.17 Dominated 
PHQ-9 (cutoff 9/10) 0.8471 £151.26 Dominated 
EPDS (cutoff 11)  0.8475 £144.88 Dominated 
EPDS (cutoff 12)  0.8477 £139.77 Dominated 
EPDS (cutoff 13)  0.8476 £139.49 Dominated 
EPDS (cutoff 14)  0.8477 £128.68 Dominated 
Whooley + EPDS (cutoff 7)  0.8475 £122.60 Dominated 
EPDS (cutoff 15)  0.8476 £118.85 Dominated 
Whooley + EPDS (cutoff 8)  0.8479 £118.26 Dominated 
EPDS (cutoff 16)  0.8475 £113.36 Dominated 
Whooley + EPDS (cutoff 9)  0.8482 £111.31 Dominated 
Whooley + EPDS (cutoff 10)  0.8483 £107.40 Dominated 
Whooely + PHQ9 (cutoff 9/10) 0.8482 £103.50 Dominated 
Whooley + EPDS (cutoff 11)  0.8483 £100.51 £520,564.14 
Whooley + EPDS (cutoff 12)  0.8483 £97.58 £30,914.30 
Whooley + EPDS (cutoff 13)  0.8482 £96.97 Extendedly Dominated 
Whooley + EPDS (cutoff 14)  0.8480 £89.67 £26,817.93 
Standard Care 0.8453 £87.95 Dominated 
Whooley + EPDS (cutoff 15)  0.8478 £82.34 Extendedly Dominated 
Whooley + EPDS (cutoff 16)  0.8476 £78.28   
Notes:  QALYs and healthcare costs discounted at 3.5% 
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Appendix 6.3: Deterministic Cost-effectiveness Results: Cross-Sectoral Decision 
Perspective & Maternal and Child Outcomes 
Strategy QALYs Healthcare 
Costs 
Education 
Costs 
NCB  
k=£20,000 
v=£20,000 
NCB  
k=£30,000 
v=£30,000 
EPDS (cutoff 7)  0.8442 £193.18 £100.11 -109.59 -120.54 
EPDS (cutoff 8)  0.8454 £180.76 £100.10 -73.41 -72.48 
EPDS (cutoff 9)  0.8465 £165.54 £102.68 -40.24 -29.04 
EPDS (cutoff 10)  0.8470 £157.17 £104.24 -22.60 -6.00 
EPDS (cutoff 11)  0.8475 £144.88 £108.39 -4.72 16.76 
EPDS (cutoff 12)  0.8477 £139.77 £110.20 2.35 25.71 
EPDS (cutoff 13)  0.8476 £139.49 £111.02 -0.36 21.92 
EPDS (cutoff 14)  0.8477 £128.68 £116.63 6.89 30.19 
EPDS (cutoff 15)  0.8476 £118.85 £122.84 8.77 31.20 
EPDS (cutoff 16)  0.8475 £113.36 £126.25 10.01 32.03 
PHQ9 (cuttof 9/10) 0.8471 £151.26 £107.17 -17.58 0.05 
Whooley + EPDS (cutoff 7)  0.8475 £122.60 £102.10 23.78 45.22 
Whooley + EPDS (cutoff 8)  0.8479 £118.26 £102.09 36.45 62.06 
Whooley + EPDS (cutoff 9)  0.8482 £111.31 £104.54 46.09 74.27 
Whooley + EPDS (cutoff 10)  0.8483 £107.40 £106.03 51.07 80.53 
Whooley + EPDS (cutoff 11)  0.8483 £100.51 £109.96 54.18 83.70 
Whooley + EPDS (cutoff 12)  0.8483 £97.58 £111.68 55.27 84.74 
Whooley + EPDS (cutoff 13)  0.8482 £96.97 £112.46 53.70 82.46 
Whooley + EPDS (cutoff 14)  0.8480 £89.67 £117.80 51.95 78.86 
Whooley + EPDS (cutoff 15)  0.8478 £82.34 £123.69 47.88 72.03 
Whooley + EPDS (cutoff 16)  0.8476 £78.28 £126.93 45.70 68.37 
Whooely + PHQ9 (cutoff 9/10) 0.8482 £103.50 £108.80 50.45 79.04 
Standard Care 0.8453 £87.95 £117.64 0.00 0.00 
Notes:  NCB is net consumption benefit. The cost-effective strategy is marked in bold.  
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Appendix 6.4: Deterministic Sensitivity Analysis Cost-effectiveness Results  
Appendix 6.4A Utility Decrement for False Positive Mother’s (from 2% to 0%) 
Strategy QALYs Costs ICERs vs. lower 
costing strategy 
EPDS (cutoff 7)  0.850041 £188.17 Dominated 
EPDS (cutoff 8)  0.850042 £175.76 £527,537.76 
EPDS (cutoff 9)  0.849888 £160.40 Dominated 
EPDS (cutoff 10)  0.849795 £151.95 Dominated 
PHQ9 (cutoff 9/10) 0.849620 £145.90 Dominated 
EPDS (cutoff 11)  0.849548 £139.47 Dominated 
EPDS (cutoff 12)  0.849440 £134.26 Dominated 
EPDS (cutoff 13)  0.849391 £133.94 Dominated 
EPDS (cutoff 14)  0.849056 £122.85 Dominated 
Whooley + EPDS (cutoff 7)  0.849923 £117.49 Dominated 
Whooley + EPDS (cutoff 8)  0.849923 £113.15 £48,303.18 
EPDS (cutoff 15)  0.848686 £112.71 Dominated 
EPDS (cutoff 16)  0.848482 £107.05 Dominated 
Whooley + EPDS (cutoff 9)  0.849777 £106.08 £45,032.05 
Whooley + EPDS (cutoff 10)  0.849688 £102.10 £30,212.54 
Whooely + PHQ9 (cutoff 9/10) 0.849523 £98.06 Extendedly Dominated 
Whooley + EPDS (cutoff 11)  0.849454 £95.01 £29,322.47 
Whooley + EPDS (cutoff 12)  0.849351 £92.00 £27,944.62 
Whooley + EPDS (cutoff 13)  0.849305 £91.35 Extendedly Dominated 
Whooley + EPDS (cutoff 14)  0.848987 £83.78 Dominated 
Standard Care 0.848996 £82.07 £18,287.60 
Whooley + EPDS (cutoff 15)  0.848635 £76.16 Extendedly Dominated 
Whooley + EPDS (cutoff 16)  0.848442 £71.94   
Notes:  Results for health centric perspective with maternal outcomes only.  
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Appendix 6.4B Prevalence of Postnatal Depression =20%  
Strategy QALYs Costs ICERs vs. lower 
costing strategy 
EPDS (cutoff 7)  0.8326 £274.12 Dominated 
EPDS (cutoff 8)  0.8336 £263.26 Dominated 
EPDS (cutoff 9)  0.8343 £245.78 Dominated 
EPDS (cutoff 10)  0.8346 £235.95 Dominated 
PHQ9 (cutoff 9/10) 0.8344 £226.09 Dominated 
EPDS (cutoff 11)  0.8347 £218.56 Dominated 
EPDS (cutoff 12)  0.8348 £211.18 Dominated 
EPDS (cutoff 13)  0.8346 £209.63 Dominated 
Whooley + EPDS (cutoff 7)  0.8352 £209.22 Dominated 
Whooley + EPDS (cutoff 8)  0.8356 £205.43 Dominated 
Whooley + EPDS (cutoff 9)  0.8356 £195.42 £998,449.63 
EPDS (cutoff 14)  0.8343 £191.16 Dominated 
Whooley + EPDS (cutoff 10)  0.8356 £189.62 £40,259.60 
Whooely + PHQ9 (cutoff 9/10) 0.8353 £181.76 Extendedly Dominated 
Whooley + EPDS (cutoff 11)  0.8353 £177.28 £37,522.09 
EPDS (cutoff 15)  0.8337 £172.62 Dominated 
Whooley + EPDS (cutoff 12)  0.8352 £171.96 £23,543.98 
Whooley + EPDS (cutoff 13)  0.8351 £170.19 Extendedly Dominated 
EPDS (cutoff 16)  0.8334 £162.35 Dominated 
Whooley + EPDS (cutoff 14)  0.8345 £155.25 £22,403.24 
Standard Care 0.8321 £145.87 Dominated 
Whooley + EPDS (cutoff 15)  0.8338 £139.40 Extendedly Dominated 
Whooley + EPDS (cutoff 16)  0.8334 £130.64   
Notes:  Results for health centric perspective with maternal outcomes only.  
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Appendix 6.4C Lifetime Effects Proportionate to Duration of Exposure to Depression 
Symptoms   
Strategy QALYs Costs ICERs vs. lower 
costing strategy 
EPDS (cutoff 7)  0.8441 £194.34 Dominated 
EPDS (cutoff 8)  0.8453 £181.92 Dominated 
EPDS (cutoff 9)  0.8463 £166.64 Dominated 
EPDS (cutoff 10)  0.8469 £158.23 Dominated 
PHQ9 (cutoff 9/10) 0.8470 £152.25 Dominated 
EPDS (cutoff 11)  0.8474 £145.85 Dominated 
EPDS (cutoff 12)  0.8476 £140.69 Dominated 
EPDS (cutoff 13)  0.8475 £140.39 Dominated 
EPDS (cutoff 14)  0.8476 £129.44 Dominated 
Whooley + EPDS (cutoff 7)  0.8473 £123.71 Dominated 
EPDS (cutoff 15)  0.8475 £119.46 Dominated 
Whooley + EPDS (cutoff 8)  0.8478 £119.37 Dominated 
EPDS (cutoff 16) 0.8475 £113.88 Dominated 
Whooley + EPDS (cutoff 9)  0.8480 £112.36 Dominated 
Whooley + EPDS (cutoff 10)  0.84816 £108.42 Dominated 
Whooely + PHQ9 (cutoff 9/10) 0.84808 £104.45 Dominated 
Whooley + EPDS (cutoff 11)  0.84818 £101.43 £6,297,314.62 
Whooley + EPDS (cutoff 12)  0.84818 £98.46 £33,917.61 
Whooley + EPDS (cutoff 13)  0.84811 £97.84 Extendedly Dominated 
Whooley + EPDS (cutoff 14)  0.84794 £90.40 £29,242.09 
Standard Care 0.84525 £88.69 Dominated 
Whooley + EPDS (cutoff 15)  0.84768 £82.93 £29,711.51 
Whooley + EPDS (cutoff 16)  0.84754 £78.79  
Notes:  Results for health centric perspective with maternal and child outcomes discounted at 3.5%.  
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Appendix 6.4D Effects of Postnatal Depression on Child Development Reduce by 25%  
Strategy QALYs Costs ICERs vs. lower 
costing strategy 
EPDS (cutoff 7)  0.84440 £191.92 Dominated 
EPDS (cutoff 8)  0.84558 £179.51 Dominated 
EPDS (cutoff 9)  0.84661 £164.25 Dominated 
EPDS (cutoff 10)  0.84716 £155.86 Dominated 
PHQ9 (cutoff 9/10) 0.84724 £149.92 Dominated 
EPDS (cutoff 11)  0.84765 £143.53 Dominated 
EPDS (cutoff 12)  0.84784 £138.39 Dominated 
EPDS (cutoff 13)  0.84774 £138.11 Dominated 
EPDS (cutoff 14)  0.84785 £127.23 Dominated 
Whooley + EPDS (cutoff 7)  0.84764 £121.32 Dominated 
EPDS (cutoff 15)  0.84777 £117.32 Dominated 
Whooley + EPDS (cutoff 8)  0.84805 £116.98 Dominated 
EPDS (cutoff 16) 0.84773 £111.78 Dominated 
Whooley + EPDS (cutoff 9)  0.84832 £110.00 Dominated 
Whooley + EPDS (cutoff 10)  0.84845 £106.08 Dominated 
Whooely + PHQ9 (cutoff 9/10) 0.84836 £102.14 Dominated 
Whooley + EPDS (cutoff 11)  0.84846 £99.13 £989,596.05 
Whooley + EPDS (cutoff 12)  0.84846 £96.19 £32,399.74 
Whooley + EPDS (cutoff 13)  0.84839 £95.57 Extendedly Dominated 
Whooley + EPDS (cutoff 14)  0.84821 £88.20 £28,030.44 
Standard Care 0.84552 £86.48 Dominated 
Whooley + EPDS (cutoff 15)  0.84794 £80.80 Extendedly Dominated 
Whooley + EPDS (cutoff 16)  0.84780 £76.69 
 
Notes:  Results for health centric perspective with maternal and child outcomes discounted at 3.5%.  
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Appendix 6.4E Effects of Postnatal Depression on Child Development Increase by 25%  
Strategy QALYs Costs ICERs vs. lower 
costing strategy 
EPDS (cutoff 7)  0.84409 £194.43 Dominated 
EPDS (cutoff 8)  0.84528 £182.01 Dominated 
EPDS (cutoff 9)  0.84630 £166.82 Dominated 
EPDS (cutoff 10)  0.84684 £158.47 Dominated 
PHQ9 (cutoff 9/10) 0.84691 £152.60 Dominated 
EPDS (cutoff 11)  0.84732 £146.24 Dominated 
EPDS (cutoff 12)  0.84750 £141.15 Dominated 
EPDS (cutoff 13)  0.84739 £140.88 Dominated 
EPDS (cutoff 14)  0.84749 £130.14 Dominated 
Whooley + EPDS (cutoff 7)  0.84732 £123.87 Dominated 
EPDS (cutoff 15)  0.84739 £120.39 Dominated 
Whooley + EPDS (cutoff 8)  0.84774 £119.53 Dominated 
EPDS (cutoff 16) 0.84735 £114.94 Dominated 
Whooley + EPDS (cutoff 9)  0.84799 £112.62 Dominated 
Whooley + EPDS (cutoff 10)  0.84812 £108.73 Dominated 
Whooely + PHQ9 (cutoff 9/10) 0.84803 £104.86 Dominated 
Whooley + EPDS (cutoff 11)  0.84812 £101.88 £351,497.63 
Whooley + EPDS (cutoff 12)  0.84811 £98.98 £29,533.85 
Whooley + EPDS (cutoff 13)  0.84804 £98.38 Extendedly Dominated 
Whooley + EPDS (cutoff 14)  0.84785 £91.14 £25,717.32 
Standard Care 0.84516 £89.42 Dominated 
Whooley + EPDS (cutoff 15)  0.84756 £83.89 Extendedly Dominated 
Whooley + EPDS (cutoff 16)  0.84741 £79.87 
 
Notes:  Results for health centric perspective with maternal and child outcomes discounted at 3.5%.  
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Appendix 6.4F Discount Rate Equal to 1.5% for Costs & QALYs  
Strategy QALYs Healthcare 
Costs 
Education 
Costs 
Health 
Centric 
Perspective 
ICERs*  
Cross-Sectoral 
Results:  
NCB 
k=£30,000 
v=£30,000 
EPDS (cutoff 7)  0.8434 £201.34 £189.11 Dominated -99.09 
EPDS (cutoff 8)  0.8446 £188.92 £189.09 Dominated -51.02 
EPDS (cutoff 9)  0.8456 £173.91 £193.97 Dominated -10.74 
EPDS (cutoff 10)  0.8461 £165.66 £196.91 Dominated 10.39 
PHQ9 (cutoff 9/10) 0.8462 £159.99 £202.44 Dominated 12.22 
EPDS (cutoff 11)  0.8466 £153.72 £204.74 Dominated 28.09 
EPDS (cutoff 12)  0.8467 £148.76 £208.16 Dominated 34.82 
EPDS (cutoff 13)  0.8466 £148.54 £209.70 Dominated 30.03 
EPDS (cutoff 14)  0.8467 £138.19 £220.32 Dominated 31.42 
Whooley + EPDS (cutoff 7)  0.8466 £130.92 £192.87 Dominated 64.24 
EPDS (cutoff 15)  0.8465 £128.86 £232.03 Dominated 24.85 
Whooley + EPDS (cutoff 8)  0.8470 £126.58 £192.85 Dominated 81.09 
EPDS (cutoff 16) 0.8465 £123.81 £238.49 Dominated 21.49 
Whooley + EPDS (cutoff 9)  0.8473 £119.83 £197.48 Dominated 90.30 
Whooley + EPDS (cutoff 10)  0.8474 £116.05 £200.28 £251,855.94 94.74 
Whooely + PHQ9 (cutoff 9/10) 0.8473 £112.37 £205.53 Dominated 89.85 
Whooley + EPDS (cutoff 11)  0.8474 £109.47 £207.72 £138,200.67 93.10 
Whooley + EPDS (cutoff 12)  0.8473 £106.69 £210.97 £24,108.81 92.03 
Whooley + EPDS (cutoff 13)  0.8473 £106.14 £212.43 ED 88.81 
Whooley + EPDS (cutoff 14)  0.8470 £99.27 £222.52 £21,064.12 78.67 
Standard Care 0.8443 £97.54 £222.22 Dominated 0.00 
Whooley + EPDS (cutoff 15)  0.8467 £92.43 £233.64 £20,554.74 64.63 
Whooley + EPDS (cutoff 16)  0.8465 £88.69 £239.78  57.00 
Notes: *ICERs calculated vs. next lower costing non-dominated or extendedly dominated strategy.  
 NCB is net consumption benefit. The cost-effective strategy at k=£30,000 is marked in bold.  
 ED= Extendedly Dominated 
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Appendix 6.4G Discount Rate Equal to 3.5% for Costs and 1.5% for QALYs  
Strategy QALYs Healthcare 
Costs 
Education 
Costs 
Health 
Centric 
Perspective 
ICERs*  
Cross-Sectoral 
Results:  
NCB 
k=£30,000 
v=£30,000 
EPDS (cutoff 7)  0.8434 £193.18 £100.11 Dominated -116.10 
EPDS (cutoff 8)  0.8446 £180.76 £100.10 Dominated -68.04 
EPDS (cutoff 9)  0.8456 £165.54 £102.68 Dominated -25.26 
EPDS (cutoff 10)  0.8461 £157.17 £104.24 Dominated -2.61 
PHQ-9 (cutoff 9/10) 0.8462 £151.26 £107.17 Dominated 2.05 
EPDS (cutoff 11)  0.8466 £144.88 £108.39 Dominated 19.10 
EPDS (cutoff 12)  0.8467 £139.77 £110.20 Dominated 27.59 
EPDS (cutoff 13)  0.8466 £139.49 £111.02 Dominated 23.60 
EPDS (cutoff 14)  0.8467 £128.68 £116.63 Dominated 30.45 
Whooley + EPDS (cutoff 7)  0.8466 £122.60 £102.10 Dominated 49.16 
EPDS (cutoff 15)  0.8465 £118.85 £122.84 Dominated 29.89 
Whooley + EPDS (cutoff 8)  0.8470 £118.26 £102.09 Dominated 65.99 
EPDS (cutoff 16)  0.8465 £113.36 £126.25 Dominated 29.85 
Whooley + EPDS (cutoff 9)  0.8473 £111.31 £104.54 Dominated 77.59 
Whooley + EPDS (cutoff 10)  0.8474 £107.40 £106.03 £264,148.60 83.47 
Whooely + PHQ9 (cutoff 9/10) 0.8473 £103.50 £108.80 Dominated 81.27 
Whooley + EPDS (cutoff 11)  0.8474 £100.51 £109.96 £145,167.41 85.65 
Whooley + EPDS (cutoff 12)  0.8473 £97.58 £111.68 £25,729.17 86.24 
Whooley + EPDS (cutoff 13)  0.8473 £96.97 £112.46 ED 83.78 
Whooley + EPDS (cutoff 14)  0.8470 £89.67 £117.80 £22,541.81 78.82 
Standard Care 0.8443 £87.95 £117.64 Dominated 0.00 
Whooley + EPDS (cutoff 15)  0.8467 £82.34 £123.69 £22,313.88 70.50 
Whooley + EPDS (cutoff 16)  0.8465 £78.28 £126.93  66.02 
Notes: *ICERs calculated vs. next lower costing non-dominated or extendedly dominated strategy.  
 NCB is net consumption benefit. The cost-effective strategy at k=£30,000 is marked in bold.  
 ED= Extendedly Dominated 
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Appendix 6.5: Cost-effectiveness results using cross cohort measures for SDQ/RBS.  
Appendix 6.5A Items in Both the SDQ and RBS Questionnaires 
Item  SDQ Item  RBS Item  Responses 
1 Restless, overactive, cannot 
stay still long 
Very restless. Often running 
about or jumping up and 
down. Hardly ever still. 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
2 Often has temper tantrums Irritable. Is quick to fly off the 
handle 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
3 Tends to play alone Tends to do things on his/her 
own – rather solitary 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
5 Generally obedient* Is often disobedient 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
 
6 Often seems worried Often worried, worries about 
many things 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
7 Constantly fidgeting Is squirmy or fidgety 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
 
8 Fights with or bullies other 
children 
Bullies other children 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
 
9 Often unhappy Often appears miserable, 
unhappy, tearful or distressed 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
10 Generally liked by other 
children* 
Not much liked by other 
children 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
 
11 Easily distracted Cannot settle to anything for 
more than a few moments 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
12 Picked on or bullied by other 
children 
Frequently fights other 
children 
 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
 
13 Many fears, easily scared Tends to be fearful or afraid 
of new things or new 
situations 
Doesn’t (=0), somewhat (=1), 
or certainly applies (=2) 
Notes:  Items used to generate the cross cohort measure.  
 Cross cohort measure generated by summing responses to produce a continuous variable from 0-26.  
 *Item is opposite, inverse scoring system applied e.g. responses are doesn’t (=2), somewhat (=1), and certainly 
 (=0) applies.  
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Appendix 6.5B: Mean Incremental Effects of Postnatal Depression Exposure on Child 
Development Outcomes at age 11 
 Mean 95% Lower 95% Upper 
GCA -0.270  -.510 0.970) 
SDQ Total Difficulties 
Cross Cohort Index  
1.201 0.821  1.581 
Notes:  Incremental effect size and 95% confidence interval for children exposed to postnatal depression 
 symptoms vs. no symptoms for the SDQ cross cohort index.  
 Results obtained from chapter three, growth curve model 1.  
 SDQ: Individuals n=11,804; Observations n=40,401; Exposed to PND n=1706  
 GCA: Individuals n=5,457; Observations n=19,186; Exposed to PND n=775 
 
Appendix 6.5C: Mean Marginal Effects of Postnatal Depression Exposure on Lifetime 
Outcomes for RBS Cross Cohort Index  
 QALYs 
 
Healthcare 
Costs  
Returns to 
Education* 
Crime Costs 
GCA 0.001 
(0.001, 0.002) 
-£13.56 
(-£27.62, -£0.50) 
£4,614.01 
(£3,284, £5,947) 
-£1.69 
(-£2.79, -£0.60) 
RBS Cross Cohort 
Index 
-0.004 
(-0.006, -0.001) 
£87.70 
(£22.99 £152.42) 
-£212.40 
(-£6,373, £6,012) 
£6.81 
(£1.14, £12.47) 
Notes:  Marginal effects of General Cognitive Ability and the Rutter Behavioural Scale cross cohort index on lifetime 
 outcomes discounted at 3.5%. Each marginal effect is per unit increase in GCA and RBS. Results obtained 
 from GLMs in chapter five 
 *Results were back transformed to the raw scale using Duan’s smearing estimator. 
 
 
Appendix 6.5D: Mean Incremental Lifetime Effects in Children Exposed to Postnatal 
Depression for SDQ/RBS Cross Cohort Index 
 QALY s Healthcare  
Costs 
Returns to 
Education 
Crime Costs 
Postnatal depression 
symptoms (9 months) 
-0.01 £108.99 -£1,500.88 £8.64 
Notes:  Incremental lifetime outcomes for children exposed to symptoms of postnatal depression vs  children not 
 exposed to symptoms of depression. Lifetime outcomes estimated indirectly using intermediate measures of 
 GCA and the SDQ/ RBS cross cohort index. Lifetime outcomes are discounted at 3.5%. 
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Appendix 6.5E: Deterministic Cost-effectiveness Results for Cross Cohort SDQ /RBS 
Measure 
Strategy QALYs Healthcare 
Costs 
Education 
Costs 
Health 
Centric 
Perspective 
ICERs*  
Cross-Sectoral 
Results:  
NCB 
k=£30,000 
v=£30,000 
EPDS (cutoff 7)  0.844500 £192.51 £59.80 Dominated -127.87  
EPDS (cutoff 8)  0.845700 £180.10 £59.80 Dominated -79.46  
EPDS (cutoff 9)  0.846700 £164.86 £61.34 Dominated -35.76  
EPDS (cutoff 10)  0.847300 £156.48 £62.27 Dominated -10.31  
PHQ9 (cutoff 9/10) 0.847300 £150.55 £64.03 Dominated -6.14  
EPDS (cutoff 11)  0.847700 £144.17 £64.75 Dominated 11.52  
EPDS (cutoff 12)  0.847900 £139.04 £65.83 Dominated 21.57  
EPDS (cutoff 13)  0.847800 £138.76 £66.32 Dominated 18.36  
EPDS (cutoff 14)  0.848000 £127.91 £69.67 Dominated 31.86  
Whooley + EPDS (cutoff 7)  0.847700 £121.92 £60.99 Dominated 37.53  
EPDS (cutoff 15)  0.847900 £118.04 £73.38 Dominated 35.02  
Whooley + EPDS (cutoff 8)  0.848100 £117.58 £60.98 Dominated 53.88  
EPDS (cutoff 16)  0.847800 £112.53 £75.42 Dominated 35.49  
Whooley + EPDS (cutoff 9)  0.848400 £110.62 £62.45 Dominated 68.37  
Whooley + EPDS (cutoff 10)  0.848500 £106.70 £63.34 Dominated 74.40  
Whooely + PHQ9 (cutoff 9/10) 0.848500 £102.78 £65.00 Dominated 76.66  
Whooley + EPDS (cutoff 11)  0.848608 £99.78 £65.69 £367,500.00 82.21  
Whooley + EPDS (cutoff 12)  0.8486 £96.84 £66.72 £27,714.29 83.88  
Whooley + EPDS (cutoff 13)  0.8485 £96.23 £67.18 ED 81.03  
Whooley + EPDS (cutoff 14)  0.8483 £88.89 £70.37 Dominated 79.18  
Standard Care 0.8456 £87.17 £70.27 Dominated 0.00  
Whooley + EPDS (cutoff 15)  0.8481 £81.53 £73.89 Dominated 77.02  
Whooley + EPDS (cutoff 16)  0.8479 £77.44 £75.83  73.17  
Notes: *ICERs calculated vs. next lower costing non-dominated or extendedly dominated strategy.  
 NCB is net consumption benefit. The cost-effective strategy at k=£30,000 is marked in bold.  
 All costs and QALYs are discounted at 3.5%.  
 ED= Extendedly Dominated 
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